Document:

EX-10.10.1

 Exhibit 10.10.1 

CONFIDENTIAL TREATMENT REQUESTED 

PURSUANT TO RULE 406 

AMENDED AND RESTATED 

DISTRIBUTION AGREEMENT 

BY AND BETWEEN 

BIOVENTUS LLC 
 AND

 SEIKAGAKU CORPORATION 

DATED AS OF JUNE 30, 2016 

 AMENDED AND RESTATED 

DISTRIBUTION AGREEMENT 

This Amended and Restated Distribution Agreement (the “Agreement”), dated as of June 30, 2016 (the “Effective Date”), by
and between BIOVENTUS LLC, a Delaware limited liability company having its principal place of business at 4721 Emperor Boulevard, Durham, NC 27703 (“Distributor”) and SEIKAGAKU CORPORATION, a Japanese corporation having its principal place
of business at Marunouchi Center Building, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-0005, Japan (“Company”) amends and restates, in its entirety, the Amended and Restated Exclusive Distribution Agreement (the “A&R Exclusive
Distribution Agreement”), in effect as of May 4, 2012, by and between Distributor and Company. Distributor and Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” 

RECITALS 
 A. Company has
developed and has produced in Japan over 20 years a hyaluronic acid (“HA”) product and has obtained or is going to obtain the following marketing authorizations in some regions outside Japan for the Products which is more specifically
defined in Section 22 and now wishes to appoint a distributor to certain regions for such Products: [***]. 
 B. Company and SMITH &
NEPHEW, INC. entered into an Exclusive Distribution Agreement on January 1, 1999 (“EDA”) and amendments and supplements to the EDA thereafter (hereinafter, the EDA and any and all amendments and supplements thereto shall be collectively
referred to as “Existing Agreements”), under which Company appointed SMITH & NEPHEW, INC. as the exclusive distributor of SUPARTZ, Company’s HA product, in certain territories. 

C. SMITH & NEPHEW, INC. has assigned all of its rights and an obligation under the Existing Agreements to Distributor and Company has
consented to such assignment. 
 D. Company and Distributor are parties to the A&R Exclusive Distribution Agreement which superseded and
replaced the Existing Agreements and set forth the terms and conditions for Company to supply and sell the Product (as defined herein) to Distributor and Distributor to distribute and sell the Product (as defined herein) throughout the Territory (as
defined herein). 
 E. Company and Distributor desire to amend and restate the A&R Exclusive Distribution Agreement in its entirety as
herein set forth. 
 G. Unless defined elsewhere in this Agreement, capitalized terms used in this Agreement shall have the meanings set
forth in Section 22. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 1 

 NOW, THEREFORE, in consideration of the mutual covenants and agreements of the Parties contained
in this Agreement, the Parties agree as follows: 
  

	1.	APPOINTMENT AS DISTRIBUTOR 

 Subject to the terms of and conditions of this
Agreement, Company hereby appoints Distributor and Distributor hereby accepts such appointment (a) during the Initial Term, as Company’s sole and exclusive distributor and Company grants Distributor the exclusive right to market, distribute and
sell the Product in the Territory and (b) during the Renewal Period, as Company’s non-exclusive distributor and Company grants Distributor the non-exclusive right to market, distribute and sell the Product in the Territory. Distributor may
appoint as subdistributors wholly-owned subsidiaries of Distributor, upon prior written notice to Company. Distributor may appoint other third parties as subdistributors from time to time for the sale of the
Product; provided, however, that Distributor shall notify Company of the name, address and outline of the business of such third party subdistributors and whether Distributor has an equity interest in such subdistributors in writing and obtain the
approval of Company in writing prior to appointment, such approval not to be unreasonably withheld, delayed or conditioned on terms not directly related to the third party subdistribution arrangements. The terms and conditions of the agreement
between Distributor and each subdistributor shall confirm to the provisions of this Agreement, and Distributor shall require the subdistributors to observe the duties of Distributor as provided for in this Agreement, to the extent applicable. 

 

	2.	RIGHTS AND TERRITORY 

 (a) During the Initial Term, Distributor shall have the
sole and exclusive right to market, promote, distribute and sell the Product in the United States (the “Territory”). 
 (b) During
the Renewal Period, Distributor shall have the non-exclusive right to market, promote, distribute and sell the Product in the Territory. 

(c) Distributor may submit to Company a business plan to market, promote, distribute and sell the Product in [***] within [***] of the LOA
Effective Date. Company shall promptly notify Distributor if and when Company obtains regulatory approval necessary for sale of the Product in [***]. Distributor may submit to Company a business plan to market, promote, distribute and sell
the Product in [***] within [***] of the date it receives such notice. If Company approves of a business plan that Distributor submits under this Section 2(c), then the Parties shall amend this Agreement to include within the definition of
Territory in Section 2(a) the country ([***]) to which the approved business plan relates. Approval by Company of a business plan pursuant to this Section 2(c) shall not be unreasonably withheld, delayed or conditioned [***]. In the event
that the Agreement is amended to include [***], (i) Section 4(a) shall also be amended to provide for a Purchase Price equal to [***] percent ([***]) of the Average Sales Price per Unit for Units sold outside the United States, but not less than
(US) [***] per Unit in any situation ([***]), and (ii) Section 4(j) shall also be added to provide that, with respect to Products sold outside of the United States and denominated in a foreign currency, the Net Sales attributable thereto shall be
converted from such foreign currency into United States Dollars by utilizing the “Noon Fed Fixing Rate” announced by the Federal Reserve for the average of the first and last day of the reporting period. At Distributor’s request in
connection with its preparation of a business plan for [***], and [***], the Parties shall negotiate in good faith a reduction in the foregoing minimum price per Unit based upon market conditions applicable to such country. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 2 

 (d) During the Initial Term of this Agreement, [***] unless (i) [***], and (ii) [***]. 

(e) Notwithstanding any provision in the MOU between the Parties dated October 25, 2013, Distributor hereby agrees and acknowledges that (i)
[***] and (ii) Company may sell VISCO-3, at any time commencing on the date of this Agreement. 
  

	3.	GENERAL TERMS OF SUPPLY 

 (a) During the Term of this Agreement, Company shall
deliver and supply Units to Distributor, according to and in conformity with the shipping instructions of Distributor’s purchase order for same. 

(b) Orders for Units placed by Distributor shall be made by Distributor issuing to Company a purchase order which specifies (i) quantities and
destination(s) of Units to be shipped, (ii) delivery dates at least [***] ([***]) days after the date of such purchase order, (iii) particulars of warehouses in [***] area, where the delivery of Product in question shall be made, and (iv) transport
means (air or sea). If Company becomes aware of an event of Force Majeure, or any other event that it expects would prevent it from supplying Units ordered or forecasted to be ordered by Distributor on the specified delivery date(s), Company
shall promptly notify Distributor. Provided, however, nothing contained in this Section 3(b) shall relieve Company of liability for failure to supply Product as required by an actual purchase order, except as excused for Force
Majeure. Company will try, with its best efforts, to fill purchase orders placed by Distributor with delivery dates less than [***] days from the date of the purchase order, however, the actual delivery dates in this case shall be decided by
Company in its sole discretion. In any such event, Company will confirm in writing the purchase order issued by Distributor, regardless of whether it is with regular or shorter delivery dates and each such purchase order shall become binding on
both Parties upon and according to the confirmation in writing by Company. 
 (c) During the Term of this Agreement, Distributor shall
provide Company with a [***]-rolling order and delivery forecast [***] (the “Annual Forecast”) in Dollars and Units ([***]) each [***]. During the Initial Term, in accordance with the terms and conditions of this Agreement, Distributor
shall purchase at least 70% of the Units indicated on the Annual Forecast in the forecasted year as a minimum purchase quantity. Company shall use its [***] to supply Units [***] of the Annual Forecast, if so required by the purchase orders of
Distributor. Notwithstanding any other term of this Section 3(c), to the extent that a failure to meet the purchase requirements set forth in this Section 3(c) can be reasonably attributed to [***] (“Negative Developments”), including
[***], then the Parties shall negotiate in good faith an appropriate reduction in the minimum purchase quantity or other appropriate means to offset the impact of the Negative Developments. 

(d) After termination of this Agreement, Distributor shall cease promoting, distributing and selling the Product anywhere in the world, except
for its promotion, distribution and sale of any Products remaining in its inventory as of the date of such termination within [***] of the termination. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 3 

	4.	PRICE AND PAYMENT TERMS 

 (a) During the Term of this Agreement, the purchase
price payable by Distributor to Company for each Unit (“Purchase Price”) shall be equal to [***] percent ([***]) of the Average Selling Price per Unit, but not less than (US) $18.50 per Unit in any situation ([***]). The “Average
Selling Price per Unit” is defined as (i) Net Sales for each Period divided by (ii) “Net Units Sold” in the same Period. “Period” shall mean the period consisting of [***], which will be announced by Distributor for each
[***]. A [***] consists of [***] Periods. “Net Units Sold” shall mean the total number of Units sold by Distributor to third parties ([***]), less reasonable returns of Units. The purchase price hereunder shall be settled in U.S. currency.
Notwithstanding any other provision of this Section 4(a), to the extent that Negative Developments can be reasonably anticipated to adversely affect the market for the Product, then at any time thereafter Distributor may request that the Parties
negotiate in good faith an appropriate reduction of the minimum purchase price or other appropriate means to offset the impact of the Negative Developments. 

(b) For purposes of calculating the Average Selling Price per Unit, Distributor shall provide Company with a statement (the
“Statement”) (i) describing the calculation of the Net Sales from the gross sales, and (ii) Net Units Sold from the total number of Units sold; with a description of each numbers and amounts of the items reducible pursuant to Section 4(a),
which were accrued during each Period, for each of the United States and the countries outside the United States no later than [***] ([***]) days after the Period in question. 

(c) (i) Within [***] ([***]) days after the [***] (defined below) in question, Company shall provide a written summary on [***] for the [***]
and the [***] (“Adjustment”). 
 “[***]” shall mean [***]. 

(ii) Within [***] ([***]) days after Distributor’s receipt of Company’s summary above, Distributor shall express its agreement or
disagreement to any Adjustment by Company. Such agreement shall be expressed in writing with a signature of any authorized Distributor’s financial officer. If Distributor disagrees, both Parties shall enter into good faith discussion to settle
the Adjustment. 
 (iii) Upon the agreement on the Adjustment, either of Company or Distributor, who [***], shall provide the other Party
with [***], which shall [***], for [***], for [***]. 
 (iv) The notices to be made under this Section 4 between the Parties may be made by
e-mail with work files, which shall be followed by written notices satisfying the requirements of Section 17. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 4 

 (d) Company shall have the right to appoint an independent public accountant, reasonably
acceptable to Distributor to verify Distributor’s calculation of Net Sales, Net Units Sold and Average Selling Price per Unit (the “Audit”). In the absence of any intentional misstatement of material fact by Distributor, Company shall
bear the cost of such Audit unless Distributor’s calculation of the Net Sales, Net Units Sold or Average Selling Price per Unit is more than [***] percent ([***]%) lower than the amounts determined by the Audit, in which case [***]. 

(e) Company shall supply Distributor with Samples of the Product (“Samples”) [***]. The total number of Sample Units shall be [***]
and shall not exceed [***] of the Units ordered by Distributor on the current purchase order. Distributor shall [***]. 
 (f) The Purchase
Price for the Product shall be based on sales terms of FCA (warehouse in Greater Tokyo Area designated by Distributor) (Incoterms 2010), subject to the following provisions of this Section 4(f). Title, ownership, and risk of loss of the Product
shall pass to Distributor upon [***]. The Parties shall cooperate in processing all claims for loss or damage to the Product. For purposes of the foregoing, the Parties intend and agree that “FCA (warehouse in Greater Tokyo Area designated by
Distributor)” shall mean that (A) Company shall bear the cost, risk and responsibility to: (i) [***], (ii) [***], and (iii) [***], and (B) prior to each delivery by Company, Distributor shall bear the cost, risk and responsibility to notify
Company: (i) [***], (ii) [***], and (iii) [***]. Thereafter, Distributor shall be responsible for all costs it incurs to ship the Product from the designated warehouse to the United States or other locations, including, but not limited to, freight,
insurance, terminal handling charges and U.S. import customs’ fees. If and insofar as the Parties’ intended meaning of “FCA (warehouse in Greater Tokyo Area designated by Distributor)” is inconsistent with or contrary to the
definition of such term in Incoterms 2010, the Parties’ intended meaning, as detailed above, shall apply. 
 (g) Company shall invoice
Distributor for each shipment separately and shall reference the applicable Distributor purchase order number, mode of transportation, date of shipment payment terms. 

(h) Payment terms for purchases of Product by Distributor shall be net [***] ([***]) days from the date of Company’s invoice by
wire-transfer to Company’s bank account designated on the invoice. Distributor shall pay Company a late charge of one percent ([***]%) per month for all payments made after the payment deadline as provided in the immediately preceding sentence.

 (i) Distributor shall have absolute discretion to determine its own sale prices for the Product. 

 

	5.	PRODUCT SPECIFICATIONS; QUALITY CONTROL; REGULATORY MATTERS AND COMPLIANCE WITH LAW 

(a) Company shall (i) manufacture the Product in strict accordance with the quality specifications described in the Registration Dossier(s),
which is exactly disclosed in ANNEX A 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 5 

 
attached herewith, or in effect from time to time in the applicable Territory, and other additional specifications agreed to by the Parties from time to time, when additional specifications are
written as amendments to ANNEX A as provided in Section 5(b) below and (ii) package and label the Product in accordance with the packaging and labeling requirements decided by the Parties as provided in the Section 12(c) and added later to this
Agreement as ANNEX B (collectively, the “Specifications”). Either Party shall have the right to request a change to the Specifications at any time during the Term of this Agreement. In such event, the Party wishing to request a change (the
“Requesting Party”) shall notify the other Party (the “Receiving Party”) of its request in writing. If the Receiving Party agrees to such request, the Parties shall cooperate with each other, in good faith, to have such change to
the Specifications approved in each applicable country in the Territory, and Company shall maintain sufficient inventory of the original Product to supply Distributor until the change in Specifications is so approved and the new Product can be
marketed and sold. In the event of a dispute between Company and Distributor concerning the change of Specifications relating to the formulation or the manufacturing of the Product, then Company shall make the final decision. In the event of a
dispute between Company and Distributor concerning change of packaging or labeling, then Distributor shall make the final decision unless such change is not cost effective or feasible, in Company’s opinion. If any regulatory agency having
jurisdiction in any country in the Territory requires a change to the Specifications, Company shall use its [***] to make such changes, with respect to the Products sold in the affected jurisdiction, unless such change is not cost effective or
feasible as determined mutually by the Parties. If Company cannot make such change the Product shall not be sold by either Party in that jurisdiction. All expenses incurred with respect to a change in the Specifications required by a regulatory
agency with respect to the sale or use of the Product in the Territory will be [***]. All expenses incurred with respect to a change in the Specifications required by a regulatory agency outside the Territory will be [***]. All expenses incurred in
connection with any and all changes to Specifications except those changes to Specifications required by the FDA, or similar regulatory agency of any country in the Territory, shall be [***]. If [***] is the Requesting Party and such change in
Specifications would [***], then Distributor shall [***]. 
 (b) All changes to Specifications allowed by the provisions in Section 5(a)
made subsequent to the Effective Date of this Agreement, must be made in the form of a written amendment to ANNEX A or ANNEX B. 
 (c)
Company shall conduct quality control testing of the Product prior to shipment in accordance with the Specifications and regulatory requirements with respect to the Product as are in effect from time to time in the Territory, and such other
validated quality control testing procedures agreed to by the Parties from time to time (the “Testing Methods”). Company shall retain records pertaining to such testing for a minimum of [***] ([***]) years following the expiration date of
life of the Product. 
 (d) Company shall provide Distributor with a certificate of analysis of each shipment of Product made to
Distributor. Nothing contained herein shall waive Distributor’s rights with respect to latent defects or with respect to Distributor’s rights under the representation and warranty provisions of this Agreement. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 6 

 (e) Distributor shall notify Company and all applicable regulatory authorities in writing of
reportable events involving the Product for which Distributor receives appropriate notification, as required by applicable Laws, including, without limitation, Medical Device Reports under the Post Market Surveillance program of the FDA, and
maintain the files of these reports and investigations as required by applicable Laws. Company shall likewise notify Distributor in writing of any of such reportable events, including, if and to the extent required in connection with applicable
Laws in the Territory, Device Vigilance Reports required by the countries of the European Union. The reporting Party shall notify the other within a reasonable time in a manner consistent with the requirements of the Law in the applicable
jurisdictions. 
 (f) Each Party shall communicate to the other regarding any complaints received from users of the Product or Product-Drug,
within a reasonable time following receipt of each complaint. Each notification of a complaint shall contain, but shall not be limited to, the lot number, expiration date, indication for actual use and description of circumstances involved in
the alleged failure of the Product, to the extent such information is available. Each Party will provide additional information to the other Party as it becomes available. If Distributor receives the Product associated with a complaint
relating to the performance of a Product, Distributor will mail the Product to Company via express courier for evaluation of the Product and investigation of the complaint by Company. Company shall investigate the complaint and report to
Distributor the results of the investigation and decision made concerning corrective actions and detailed information concerning the corrective actions taken, if any. 

(g) Each Party agrees to notify the other Party as soon as practical of any information of which it becomes aware which relates to the safety
or efficacy of the Product or Product-Drug. Upon receipt of any such information, the Parties shall consult with each other in an effort to arrive at a mutually agreeable course of action that is consistent with the obligations of the Parties
under this Agreement. 
 (h) (1) If a Party is notified by a governmental agency that a Product or Product-Drug recall or other general
corrective action with respect to the Product or Product-Drug is necessary it shall immediately advise the other Party in writing of such notification by such governmental agency, and proceed with the recall or corrective action as instructed by
such governmental agency. 
 (2) In the event either Company or Distributor believes in good faith (without notification by a governmental
agency) that a Product or Product-Drug recall or other general corrective action with respect to the Product or Product-Drug is necessary or appropriate (“Proposed Recall”), the Party advocating the Proposed Recall shall notify the other
Party in writing regarding its belief in this regard, and provide the other Party with a complete written explanation of the reason(s) for its belief regarding such Proposed Recall. As soon as reasonably possible following delivery of the written
explanation, the Parties will mutually determine what actions are appropriate regarding such Proposed Recall. If the Parties cannot agree upon such actions, then this matter will be decided by arbitration pursuant to Section 16. Distributor will
keep detailed distribution records for each lot number detailing the quantity shipped and the location where the lot was shipped as required by Law so that in the event of recall, Distributor will be able to contact the consignees. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 7 

 (3) In the event any recall or general corrective action is taken with respect to the Product or
Product-Drug, whether ordered by a governmental agency or otherwise, Distributor and Company will jointly determine in good faith the cause(s) of the non-conformance(s) prompting the recall or general corrective action within the time required by
the applicable Law, but no later than [***] ([***]) days after the date of such recall or general corrective action, in order to establish preventive measures for the future and to assess responsibility for costs and expenses arising from the
recall. At the end of this [***] ([***]) day period following the recall or general corrective action, the matter of costs and expenses will be submitted to the Presidents of Distributor and Company for their joint resolution. If the
matter cannot be resolved by the Presidents of Distributor and Company within [***] ([***]) days after it has been submitted to them, either Party may initiate arbitration pursuant to Section 16. 

(i) Each Party covenants that all of its activities (and the activities of its suppliers in the case of Company, and in the case of
Distributor, the activities of Distributor’s subdistributors under or pursuant to this Agreement) shall comply with all applicable laws, ordinances, statutes, rules and regulations (collectively “Laws”), including, without limitation,
Laws arising under the federal Food, Drug and Cosmetic Act, the Safe Medical Device Act and their respective amendments. 
 (j) Distributor
and Company shall have the right to visit each other’s facilities where the Product is manufactured, stored or delivered [***] during the Term of this Agreement and for the purposes of performing an audit of the operations, facilities and
records concerning the manufacturing procedures, and storage and distribution (including shipping and handling) of the Products of the other Party; provided, however, that such visits shall not give access to the other Party’s proprietary
technology and shall be restricted to only those persons who are directly involved in determining compliance with the terms of this Agreement and who, as provided below, received a prior written approval of other Party and that each Party shall be
required to furnish to the other Party only that information necessary to make a determination of the other Party’s compliance with the terms of this Agreement. Such visits shall be conducted upon written notice received at least [***] prior to
the visit and during normal business hours; provided that the person who will perform the audit received the prior written approval of the other Party prior to such visit, such approval not to be unreasonably withheld or delayed. The Party who
requests the audit shall select and retain at its discretion and its own cost the auditor or auditing consultant who shall conduct or otherwise assist such Party in performing the audit. 

(k) In principle, Company shall obtain, by using the data it holds as of the Effective Date, the regulatory approval for the marketing, sale,
distribution and use of the Product in the Territory at [***] and Distributor shall assist such efforts of Company. 
 (l) Each Party will
be granted rights to access, make reference to, and use the clinical data and regulatory filings owned by the other Party relating to the Products or Product-Drug other than Confidential and proprietary clinical data or regulatory filings of Company
related to the manufacture of Products which Company shall not be obligated to provide to Distributor, but shall be obligated to provide to legal or regulatory agencies or bodies. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 8 

 (m) Each Party will inform the other within a reasonable period of time as it becomes aware of
any new version or amendment to any Laws which may materially affect the procedures, process, practice or activities with respect to the import, marketing, sale or use of the Product in the Territory or the manufacture of the Product. 

(n) If despite reasonable efforts of a Party under Section 6(d) or Section 8(d) below, Product or Product-Drug is offered for sale or sold
into the Territory by an uncontrollable third party in derogation of the rights of Distributor or outside the Territory in derogation of the rights of Company and its other distributors, Distributor and Company agree that such event shall not be
deemed to constitute a breach of Section 6(d) or Section 8(d) below, respectively. 
  

	6.	COMPANY’S GENERAL OBLIGATIONS 

 (a) During the Term of this Agreement,
Company agrees to provide Distributor with the following at Company’s cost in order to assist Distributor’s promotional activities for Product in the Territory. Company shall have the right to hold a meeting with Distributor at the time
and place to be agreed upon by the Parties to discuss alternative activities. 
 (i) Reasonable quantities of promotional materials and
literature in English as requested by Distributor. 
 (ii) Medical and commercial advice and information to assist Distributor in responding
to inquiries and questions made concerning the Product by other Persons, including, customers and governmental authorities. 
 (iii)
Technical and marketing training on the Product at a designated facility of Company for reasonable, but limited number of, Distributor’s competent technical and sales representatives at times and for durations to be agreed upon by the Parties;
provided, however, [***] out-of-pocket costs for such training of Distributor’s representatives and employees such as travelling, lodging and insurance are to be [***]. 

(b) Company shall maintain ISO 13485 and Medical Device Directive certification to support the right to continue to use the CE mark in
commerce on the Product, but only if maintaining ISO 13485 and Medical Device Directive certification is required to sell the product in the Territory. 

(c) Company will maintain the CE marked status for the Product for the countries covered by the CE mark and maintain all certificates and
approvals required in the European Union, but only if maintaining CE marked status for the Product is required to sell the Product in the Territory. 

(d) During the Initial Term, Company shall [***]. During the Term, Company shall [***]. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 9 

 (e) Company shall not, at any time during the Initial Term, directly or indirectly import,
supply, promote, market, distribute, sell or otherwise commercialize in the Territory [***]. For purposes of clarity, the foregoing is not intended to and shall not limit Company’s rights to commercialize Gel-One or the Gel-One repeat treatment
label expansion or to commercialize any Product through Distributor. Finally, for the avoidance of doubt, the prohibitions set forth in this Section 6(e) shall not apply during the Renewal Period. 

(f) In accordance with Distributor’s request and pursuant to Section 6(a) above, Company shall prepare and file all regulatory filings as
may be required in the Territory to replace SMITH & NEPHEW, Inc.’s name, logo and other identifying details of the Product label with those of the Distributor. 
  

	7.	COMPANY’S REPRESENTATIONS AND WARRANTIES 

 Company hereby represents and
warrants to Distributor as follows: 
 (a) Company is a corporation duly organized, validly existing and in good standing under the laws of
Japan and has all requisite corporate power and lawful authority to own, lease and operate its assets and to carry on its business as heretofore conducted. Company has the full legal right, corporate power and authority to execute and deliver
this Agreement and the other agreements contemplated hereby and to consummate the transactions contemplated hereby and thereby. This Agreement has been duly executed and delivered by Company and constitutes the valid and binding obligation of
Company, enforceable against Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally or by general equitable principles.

 (b) Company owns all rights, title and interest in the Product necessary to grant the rights contained in this Agreement to
Distributor. To [***], the Product does not and will not, in the Territory, infringe upon any patent, trademark, trade secret or other proprietary right of any person. Nothing contained in this Agreement is in conflict with any other
agreement to which Company is a party or is otherwise bound. 
 (c) Company has not granted and will not grant during the Initial Term the
right to market, sell or distribute the Product or Product-Drug in the Territory to any other Person. 
 (d) At the time of delivery to
Distributor, all Products (i) shall have been manufactured (A) in conformance with Good Manufacturing Practices (as such term is generally understood in the medical device and pharmaceutical industry), and (B) in accordance with all Laws; and (ii)
shall be free of all valid liens, encumbrances and security interests. 
 (e) Company shall promptly replace any Product which fails to meet
Specifications, or is misbranded (except to the extent such misbranding occurs as a result of the acts or omissions of Distributor) or which is otherwise defective, whether the Product is owned at the time of such event by Distributor or a third
party not under the control of Company. This warranty shall not apply to any Product which has been misused, improperly stored, adulterated or modified by Distributor or any of its subdistributors. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 10 

 (f) If CE Marking Certificate is required for sale of the Product in the Territory, then Company
represents and warrants that the CE Marking Certificate for distribution of the Products in Europe has been obtained and is in full force and effect. 

(g) At the time of delivery to Distributor, all Products shall be “merchantable” as defined in Section 2-314 of the Uniform
Commercial Code, but only to the extent such warranty would be implied. All other implied warranties at law between the Parties are hereby disclaimed. 
  

	8.	DISTRIBUTOR’S GENERAL OBLIGATION 

 During the Term of this Agreement, 

(a) Distributor shall, and Distributor shall have its permitted subdistributors, transport, store, distribute, market and sell the Product in
accordance with directions for storage and use as indicated on ANNEX A including any amendments thereto (as provided in Section 5(a) herein) which are in effect at the time of such transport, storage, distribution, marketing or sales. 

(b) During the Initial Term, Distributor shall exert its [***] to sell, distribute and promote the sales of the Product in the Territory.
During the Term, Distributor agrees to provide Company with the following information in English (subject to occasional missing or incomplete information or delayed or undelivered communications, as may occur): 

(i) Safety information relating to the Product including data, report or other information relating to its side effect in the Territory, if
any. 
 (ii) [***] sales and inventory records and marketing reports of Products in the Territory with substantially comparable detail as
are currently being provided to Company as of the LOA Effective Date, within [***] ([***]) days from the last day of each Period (as such term is defined in Section 4(a) above), including claims, complaints, questions and comments from customers
relating to quality, performance and effect of Product, if any. 
 (iii) 

(c) Distributor will provide Company with reasonable access to records for purposes of conducting quality control audits and to effect a
product recall, if necessary, as provided hereunder. 
 (d) Distributor shall not, either directly or indirectly or through a third party,
sell, deliver or market Product for sale outside the Territory without the prior written consent of Company, and shall promptly refer to Company any and all inquiries and/or orders received for sales outside the Territory. Distributor shall
[***]. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 11 

 (e) In consideration of the right granted hereunder Distributor shall not, during the Term of
this Agreement, promote, sell or distribute the Product in the Territory, except for Products purchased from Company. 
 (f) Distributor
shall prepare in good faith and provide Company with the first draft of a business plan for the Product for the following business year no later than [***] of each calendar year. The Parties shall enter into sufficient good faith discussion based on
such first draft. After considering such discussion with Company in good faith, no later than December 31 of each calendar year, Distributor shall complete, and provide Company with, the business plan for the Product for the following business
year. Distributor shall discuss with Company whether it is appropriate to amend such business plan on a [***] after providing Company with relevant information pursuant to Section 8(b). For avoidance of doubt, this paragraph requires communication
and discussion as provided, but does not restrict Distributor’s discretion with regard to all decisions and matters concerning the development, amendment or implementation of Distributor’s business plan. 

(g) In connection with the re-labeling of Products, in order to prevent any occurrence of problems such as shortage of stock, Distributor
shall [***] sell off any and all existing SUPARTZ products in the inventory that are in proper condition for sale and convert the packages for SUPARTZ products to Distributor’s packages at [***] cost, and use [***]. 

 

	9.	DISTRIBUTOR’S REPRESENTATIONS AND WARRANTIES 

 Distributor hereby represents
and warrants to Company as follows: 
 (a) Distributor is a limited liability company duly organized, validly existing and in good standing
under the laws of the State of Delaware and has all requisite corporate power and lawful authority to own, lease and operate its assets and to carry on its business as heretofore conducted. Distributor has the full legal right, corporate power and
authority to execute and deliver this Agreement and the other agreements contemplated hereby and to consummate the transactions contemplated hereby and thereby. This Agreement has been duly executed and delivered by Distributor and constitutes the
valid and binding obligation of Distributor, enforceable against Distributor in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights
generally or by general equitable principles. 
 (b) Nothing contained in this Agreement is in conflict with any other agreement to which
Distributor or its Affiliates is or may become a party or is otherwise bound. 
 (c) Distributor shall distribute, market, and sell the
Product in accordance with the Laws of the Territory. Company agrees to provide Distributor with all information and assistance required in order for Distributor to comply with the foregoing obligation to the extent reasonably possible. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 12 

	10.	TRANSFER OF DATA; CONFIDENTIALITY 

 (a) The Parties acknowledge that Company has
or is in the process of conducting studies on the Product or Product-Drugs necessary to register the Product for marketing and sales in the Territory. 

(b) During the Term of this Agreement: (i) Company shall provide to Distributor any subsequently acquired data which Company and Distributor
reasonably determine is relevant to the safety, efficacy, regulatory status, sale, marketing or distribution of the Product or Product-Drug; and (ii) each of the Parties shall deliver to the other Party all
relevant data and Registration Dossier(s) relating to use of the Product or Product-Drug, and results from any studies being conducted by or on behalf of either Party in connection therewith promptly after such data and/or Registration Dossier(s)
become available. 
 (c) The Parties acknowledge that discussions between Company and Distributor in written form and orally will
necessarily require the exchange of information that is considered confidential and proprietary by the disclosing Party. The Parties agree that any information on which the disclosing Party designates the mark “confidential” in the written
form or in a written confirmation made within thirty (30) days from the oral disclosure shall be considered “Confidential Information” and shall include, without limitation, (i) the Know-How; (ii) earnings, costs, and other financial
information; (iii) drawings, formulations, samples, technical data, photographs, specifications, manufacturing methods, testing procedures, clinical studies date; and (iv) marketing, sales and customer information relating to the disclosing
Party’s business. 
 (d) The Parties agree that both during the Term of this Agreement and for a period of [***] ([***]) years
thereafter each Party shall keep, and shall cause the directors, officers, employees and agents of such Party or its Affiliates or third party subdistributors to keep, confidential any and all Confidential Information acquired from the other Party
to the same extent as such Party protects its own confidential information, and shall not use for any other purpose than to discharge such Party’s obligations and exercise its rights hereunder. 

(e) Confidential Information shall not include information which (i) is or hereafter becomes available to the general public other than by
reason of any default with respect to a Party’s confidentiality obligation hereunder, (ii) is demonstrated by documentary evidence to have been known at the time of receipt thereof by the receiving Party, (iii) can be shown to have been
developed or acquired independently without breach of any obligations contained herein, or (iv) is required to be disclosed as a result of a judicial order or decree or applicable Law or regulation; provided however, that the Party whose
Confidential Information is the subject of such judicial order or decree is given the opportunity to contest the judicial order or decree prior to any disclosure. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 13 

	11.	PATENTS AND PROTECTION OF DISTRIBUTOR’S RIGHT TO DISTRIBUTE PRODUCT AND PRODUCT DRUG 

(a) Patent Prosecution. 
 (i)
Company will file, prosecute and maintain patents within the Territory relating to the Product packaging, use or sale (but not manufacture) of the Product (“Patents”) as Company may elect. If Company elects not to file, prosecute or
maintain a Patent in any country in the Territory, then Company shall notify Distributor. During the Initial Term, Distributor shall have the right, within [***] ([***]) days following receipt of Company’s notice, to assume responsibility for
filing, prosecuting or maintaining such Patent, which Patent shall be considered a “Distributor Sponsored Patent.” Distributor Sponsored Patents are considered Patents under this Agreement, except where expressly provided herein to the
contrary. 
 (ii) During the Initial Term, Company hereby grants to Distributor an exclusive royalty-free
non-transferable license to use the Patents (subject to the Confidentiality provisions of Section 10 herein) in the Territory in connection with the marketing, distribution and sale of the Product. Distributor
shall acknowledge the Patents (pending or granted) in Distributor’s labeling and promotional materials relating to the Product. For the avoidance of doubt, the royalty-free non-transferable license to use
the Patents set forth above shall become non-exclusive during the Renewal Period. 
 (iii) All costs and expenses incurred with respect to
the filing, prosecution and/or maintenance of Patents (other than Distributor Sponsored Patents) shall be paid by Company, including all reasonable costs for the prosecution, issuance and maintenance of Patent applications and Patents issuing
thereon, and any divisional, continuations, continuation-in-part, reissue applications or Patents, Patents of addition, Patents of revalidation or the registrations or any Patent or the like. 

(iv) Company shall cooperate and assist Distributor in the filing, prosecution and maintenance of Distributor Sponsored
Patents. Distributor shall own all Distributor Sponsored Patents. 
 (b) Patent Enforcement and Enforcement of Distributor’s Right
to Distribute Product. 
 (i) If any of the Patents in the Territory are infringed by a third party during the Initial Term, the Party which
discovers the infringement shall promptly notify the other Party in writing. The Parties shall [***] with enforcement of rights against the infringer and the division of any awards or settlement payments. [***]. The Parties shall keep
each other informed as to the prosecution of any action for such infringement. The Parties shall cooperate with each other with respect to any such action. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 14 

	12.	TRADEMARKS 

 (a) (i) Company hereby grants to Distributor for the Term of this
Agreement the exclusive, royalty-free right to use the trademark “SUPARTZ FX” (or such other trademarks as may be mutually agreed by the Parties) (the “Trademark”) in connection with the marketing, distribution and sale of the
Product in the Territory. 
 (ii) Nothing in this Section 12 shall limit Company’s and its third party distributors’ use of the
Trademark in the Territory in marketing and promotional materials for the Product for the purposes of referencing SUPARTZ FX in accurate and non-deceptive comparative advertising that is not for the purpose of selling a product in the Territory as
or under the name “SUPARTZ FX” or any other name likely to cause confusion. 
 (iii) In the event the name “SUPARTZ FX”
is not available for Company to register in a country in the Territory or is reasonably judged by the Parties to be inadequate based on special reason or situation of a country in the Territory, the Parties will select a new name from candidates
proposed by Company and verified by Company to be available in the country, which mark shall also be considered a Trademark for purposes of this Agreement. 

(iv) Company shall register, and maintain the Trademark in the Territory as Company may elect [***]. Distributor shall assist and
cooperate with Company in connection with the maintenance of Trademark in the Territory. If Company elects not to maintain the Trademark in a country within the Territory, Company shall notify Distributor and Distributor shall have the right to
require Company to register and maintain the Trademark in that country (“Distributor Sponsored Trademark”). In that event, all costs and expenses thereafter incurred by Company with respect to the preparation of Trademark registration
application for, and with respect to the filing and/or maintenance of the Trademark registration in that country shall be [***]. Distributor shall not use any trademark confusingly similar to the Trademark within or outside the Territory without the
prior written consent of Company. Company shall not use any trademark confusingly similar to the Trademark within the Territory without the prior written consent of Distributor. 

(b) Distributor may not sublicense the Trademark to any third party, however, the use of the Trademark by Distributor’s Affiliates and
subdistributors for marketing, distributing and selling Product is permitted and approved herewith by Company. 
 (c) Distributor and
Company shall work together to develop a mutually acceptable package and label for the Product, which package and label shall include the Trademark and other design elements as are mutually acceptable to both Parties. The use and presentation
of the names, Trademarks and logos on the packaging and labeling of the Product are to be attached hereto as ANNEX B. 
 (d) If the
Trademark is infringed by a third party in the Territory, the Party which discovers the infringement shall promptly notify the other Party in writing. The Parties shall [***] with enforcement of rights against the infringer and the division of
any awards or 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 15 

 
settlement payments. [***]. The Parties shall keep each other informed as to the prosecution of any action for such infringement. The Parties shall cooperate with each other with
respect to any such action. 
 (e) In the event of the institution of any suit by a third party against Company or Distributor for trademark
infringement involving the Trademark (other than Distributor Sponsored Trademarks), Company shall defend each such action [***] with attorneys selected by Company and reasonably acceptable to Distributor, Distributor shall assist and cooperate with
Company to the extent reasonably necessary in the defense. Company shall [***] with such third party. 
 (f) Except as provided in
Section 13, upon termination of this Agreement for any reason (other than breach by Company), the license granted in this Section 12 shall immediately terminate with respect to Trademarks (other than Distributor Sponsored Trademarks), and
Distributor shall immediately cease all use of the Trademark (other than Distributor Sponsored Trademarks), except with respect to Products acquired by Distributor prior to the termination of this Agreement. 

 

	13.	TERM AND TERMINATION 

 (a) This Agreement shall continue for a period of five (5)
years from the LOA Effective Date (Initial Term) and an additional two (2) years (Renewal Period) (both the Initial Term and the Renewal Period combined to be defined as the “Term”), unless terminated earlier as specifically provided in
this Section 13. 
 (b) If Distributor fails to order a minimum of [***] ([***]) Units from Company during any full calendar year of the
Initial Term, then (subject to the remainder of this Section), such failure shall not constitute a breach of this Agreement, but, in such event, Company shall have the right to change this Agreement from exclusive to non-exclusive upon at least
sixty (60) days’ prior notice to Distributor and this Agreement shall be amended accordingly. Notwithstanding any other provision of this Section 13(b), to the extent that a failure to meet the order requirements set forth in this Section can
be reasonably attributed to Negative Developments, then the Parties shall negotiate in good faith an appropriate reduction of the minimum order quantity or other appropriate means to offset the impact of a Negative Development. In addition, during
the Initial Term, Distributor shall have the right to reinstate this Agreement as exclusive by making a non-refundable payment to Company in an amount equal to the lesser of (i) the purchase price for the number of Units by which Distributor’s
orders fell short of the required minimum for the year and (ii) one million dollars ($1,000,000). Such payments shall be made no later than the expiration of the 60 day notice period or 30 days after completion of any negotiation of reduction in the
minimum order of quantity. Insofar as any payment in this Agreement is referred to as “non-refundable,” such reference shall be without prejudice to recovery by Distributor from Company of all or any portion of such payments in connection
with any rights or remedies that Distributor may seek as a result of a breach of this Agreement by Company including, but not limited to, recovery of the same as an element of damages. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 16 

 (c) Notwithstanding the foregoing, this Agreement may be terminated by giving written notice to
the other Party: (i) if the other Party commits a material breach of any term or condition of this Agreement which is susceptible to cure, and the breaching Party shall have failed to cure such breach within sixty (60) days from the receipt by it of
written notice thereof from the other Party; (ii) if the other Party commits a material breach which is not susceptible to cure; (iii) if the other Party shall commence any case, proceeding or other action (A) under any applicable Law relating to
bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it as bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, wind-up,
liquidation, dissolution, composition or other relief with respect to it or its debts, or (B) seeking appointment of a receiver trustee, custodian or other similar official for it or for all or any substantial part of its assets; (iv) if there shall
be commenced against the other Party any such case, proceeding or other action referred to in clause (iii) of this Section 13(c) which results in the entry of an order for relief; (v) if the other Party shall take any action authorizing, or in
furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth above in clauses (iii) or (iv) of this Section 13(c); or (vi) if the other Party shall admit in writing its inability to pay its debts as they
become due. Notwithstanding the termination of this Agreement pursuant to this subsection, the non-defaulting Party shall retain all rights and remedies available at law or in equity against the defaulting Party. 

(d) Company shall have the right to immediately terminate this Agreement if Distributor fails to pay any undisputed amount due under Section 4
within [***] ([***]) business days after Distributor receives written notice of nonpayment. 
 (e) The termination of this Agreement
for any reason (other than a breach by Company) shall be without prejudice to Company’s right to receive all payments accrued and unpaid at the effective date of termination or to the remedy, in accordance with the terms herein, of either Party
hereto in respect of any previous breach of any covenant contained herein. 
 (f) Upon termination of this Agreement, each Party shall
promptly (i) on request return to the requesting Party all of the requesting Party’s records, materials and Confidential Information in the possession or control of the other Party, or its Affiliates, suppliers or third party subdistributors,
except promotional materials reasonably required by Distributor to promote, distribute or sell Products remaining in its inventory as permitted by this Section 13(f), and (ii) discontinue all distribution of the Product, except as otherwise
permitted pursuant to Section 3(d) above and 13(g) below. 
 (g) Termination of this Agreement shall not terminate Distributor’s
obligation to pay the purchase price for Product which has been received by Distributor under this Agreement, and upon any termination of this Agreement, Distributor shall continue to sell all of the remaining Products in its inventory. 

(h) Upon the Effective Date the A&R Exclusive Distribution Agreement shall, except as expressly provided therein or herein, terminate. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 17 

	14.	INDEMNIFICATION 

 (a) Company shall indemnify, defend and hold harmless
Distributor, including its officers and directors, from and against any and all damages, liabilities, costs and expenses, including, without limitation, reasonable attorney’s fees, arising out of: (i) breach of Company’s representations
and warranties; (ii) any claim relating to the manufacture of the Product or delivery of the Product to Distributor, including without limitation death, personal injury or damage to property resulting from defects, contamination or other condition
of the Product; (iii) infringement of patents or trademarks of a third party; or (iv) the act or omission of Company, its agents and representatives. In the event the Product becomes, or if Company reasonably believes the Product is likely to
become, infringing upon the proprietary rights of a third party, Company shall, in addition to its other obligations hereunder, under consultation with Distributor, use its best efforts to take such actions so as to allow Distributor to continue to
sell, distribute and promote the Product in the Territory without infringement on the patents or trademarks of third parties. 
 In the event Distributor is
enjoined, prohibited, restricted for a period of at least six (6) months from selling, distributing or marketing the Product in any part of the Territory due to patent infringement, then Distributor shall have the right to terminate this Agreement
with respect to the affected portion of the Territory by providing Company with fifteen (15) days’ prior written notice. 
 (b)
Distributor shall indemnify, defend and hold harmless Company, including its officers and directors, from and against any and all damages, liabilities, costs and expenses, including without limitation reasonable attorney’s fees, arising out of
(i) any breach of Distributor’s representations and warranties or (ii) any claim relating to the sale, marketing, distribution or other disposition of the Product by Distributor, Distributor’s Affiliates or subdistributors, including
without limitation, death, personal injury or damage to property resulting from the sale, marketing, or handling of the Product by Distributor, Distributor’s Affiliates or Distributor’s sub-distributors, unless such damage liability, cost
or expense is caused by Company or breach of this Agreement by Company, in which case Company shall indemnify and hold Distributor harmless as set forth in Section 14(a) of this Agreement. 

(c) If Distributor or Company intends to claim indemnification under this Section, such Party (the “Claiming Party”) shall (i)
promptly notify the other Party in writing of any claim or loss for which it intends to claim such indemnification, (ii) cooperate fully with the other Party and its legal representatives in the investigation of any claim or loss covered by this
Section, and (iii) allow the other Party to control the defense and/or disposition of such suit or claim. Neither Party shall have any indemnification obligations hereunder to the extent that such Party’s ability to defend such suit or redress
such loss is prejudiced by the Claiming Party’s failure to perform the obligations set forth in the preceding sentence. 
 (d) Each
Party shall obtain and maintain a policy or policies of product liability insurance coverage that shall: (i) have a per occurrence and annual aggregate limit of not less than [***]); (ii) include Distributor as an insured with regard to
Company’s policy or policies, 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 18 

 
and include Company as an additional insured with regard to Distributor’s policy or policies, in both cases for occurrences arising out of issues related to the responsibility of each Party,
(iii) provides for at least [***] ([***]) days’ advance written notice to the other Party of cancellation or material reduction in coverage and (iv) have a policy scope of [***] which will provide coverage claims. Each Party shall provide the
other Party with a certificate evidencing such coverage upon reasonable request. 
  

	15.	ASSIGNMENT AND SUB-DISTRIBUTION RIGHTS AND RIGHT OF FIRST REFUSAL 

 (a) Except as
expressly provided herein to the contrary, neither Party shall assign or transfer (whether by operation of law or otherwise) its rights and obligations under this Agreement to any Person without the prior written consent of the other Party, such
consent not to be unreasonably withheld, delayed, or conditioned on terms not directly related to the assignment. This Agreement shall be binding upon and inure to the benefit of the successors and permitted assigns of the Parties hereto. 

(b) Notwithstanding anything herein to the contrary, this Agreement shall continue in full force and effect in the event of a Change in
Control (as defined below) involving either Party, unless as a result of or in connection with such Change in Control, (i) a Distributor Competitor (as defined below) becomes the beneficial owner of more than 50% of the voting capital stock
of Company or (ii) a Company Competitor (as defined below) becomes the beneficial owner of more than 50% of the voting capital stock of Distributor. In the case of such circumstances as described in the immediately preceding sentence, the
non-transferring Party shall have the right, in its sole discretion, to immediately terminate this Agreement. For purposes of this Agreement, (i) a “Change in Control” means a transaction or a series of transactions as a result of which a
Person or group (as defined in Section 13(D) of the Securities Act of 1933, as amended) acquires control (as defined in the definition of Affiliate) of a Party, (ii) “Distributor Competitor” means any Person which derives more than 50% of
its revenues from the sales of orthopedic medical devices and has in excess of [***], and (iii) “Company Competitor” means any Person which [***]. 
  

	16.	GOVERNING LAW AND DISPUTE RESOLUTION 

 (a) This Agreement shall be governed by and
construed in all respects in accordance with the laws of the State of New York, without reference to the conflict of laws rules thereof or the United Nations Convention on Contracts for the International Sale of Goods. 

(b) The Parties shall attempt in good faith to resolve any dispute or claim between them arising out of or relating to this Agreement promptly
by negotiations between executives or other representatives of the Parties with authority to resolve the dispute. If a dispute should arise, such representatives shall confer in person or by telephone at least once and attempt to resolve the
matter. Such conference shall take place within [***] ([***]) days of a written request therefor at a mutually agreed time and location. Such conference is a condition precedent to initiating arbitration as provided below, unless the
responding Party fails to confer 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 19 

 
within [***] ([***]) days of the request to do so, but is not a condition precedent to initiating an action for interim injunctive or provisional relief necessary to avoid irreparable harm or to
maintain the status quo. 
 If the dispute is not settled within [***] ([***]) days of the conference or time to confer described above, either Party may
submit the dispute for arbitration. The dispute shall be finally settled under the Rules of Arbitration (the “Rules”) of the International Chamber of Commerce (the “ICC”). The place of the arbitration shall be [***]. The language
of the arbitration shall be English with simultaneous translation into Japanese at the request of either Party. There shall be three (3) arbitrators, one (1) of whom shall be appointed by each of the Parties in accordance with the Rules, and the
third of whom shall be appointed by the ICC. The arbitrator appointed by the ICC shall act as the chairperson of the arbitrating body. The arbitrators shall decide the matters in the dispute in accordance with the laws of the State of New York,
without reference to the conflict of laws rules thereof or the United Nations Convention on Contracts for the International Sale of Goods. 
 The
arbitration shall also be governed by the United States Arbitration Act, 9 U.S.C. §§ 1-16, 201-208, including the United Nations Convention on the Recognition and Enforcement of Foreign Arbitral Awards of June 10, 1958. The arbitration
shall be commenced and shall proceed according to the Rules, except as otherwise provided herein. Any Confidential Information disclosed in the arbitration shall be subject to the confidentiality provisions of this Agreement. Any time period
specified in the Rules shall be extended or accelerated upon the Parties’ written agreement. At the request of either Party, all time periods specified in the Rules may, at the discretion of the arbitrators, be accelerated or extended to the
extent necessary to comply with the timetables specified in the Rules or for the reasonable management of the arbitration. 
 The procedures specified in
this Section 16(b) shall be the sole and exclusive procedures for the resolution of disputes; provided, however, that a Party may, in addition or as an alternative to seeking interim relief from the ICC, seek injunctive or other provisional judicial
relief in any court of competent jurisdiction if in its reasonable judgment such action is necessary to avoid irreparable harm or to preserve the status quo. The Parties agree to submit to the jurisdiction of [***], solely for the purposes of
any such action. Despite such action the Parties will continue to participate in good faith in the procedures specified in this Section 16(b). 
 The
decision of the arbitrators shall be final and binding on all Parties to the arbitration. Judgment upon any award rendered by the arbitrators may be entered by any court having jurisdiction over the Party against whom enforcement is
sought. Each of the Parties hereby consents, for the benefit of the other Party, to the service of process by certified mail or registered mail or by an express delivery service providing a return receipt at its address set forth for notices
herein. 
 While the procedures set forth above are being followed, the Parties shall continue to perform their respective obligations under this Agreement.
Each Party shall bear its own costs and fees, including attorneys’ fees and expenses, in connection with the arbitration, except that the arbitrators shall be empowered to assess costs and fees against any Party who the arbitrators find to have
acted in bad faith or to have maintained a frivolous position in the arbitration. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 20 

	17.	NOTICES 

 All notices given under this Agreement shall be in writing and shall be
delivered by first class mail or overnight courier or by facsimile transmission (receipt verified) and addressed to the Parties at their respective addresses set forth below: 

SEIKAGAKU CORPORATION 

Marunouchi Center Building 
 6-1,
Marunouchi 1-chome, Chiyoda-ku 
 Tokyo 100-0005, Japan 

Attention: [***] 
 Fax:
+81-3-5220-8975 
 BIOVENTUS LLC 

4721 Emperor Blvd. Suite 100 

Durham, NC 27703 
 Attention:
[***] 
 Fax: [***] 
 With a
copy to: 
 BIOVENTUS LLC 
 4721
Emperor Blvd. Suite 100 
 Durham, NC 27703 

Attention: [***] 
 Fax: [***] 

Either Party may change its address or its telecopy number for purposes of this Agreement by giving the other Party written notice of its new address or
telecopy number. Any such notice, if given by first class mail or overnight courier, shall be deemed to have been received on the date actually received and if given by telecopy transmission shall be deemed to have been received at the time of
dispatch or the next regular business day if received after 5:00 p.m. local time of the recipient. 
  

	18.	WAIVER AND DELAY 

 No waiver by either Party of any breach or series of breaches
by the other Party, and no failure, refusal or neglect of either Party to exercise any rights granted to it hereunder or to insist upon strict compliance with or performance of either Party’s obligations under this Agreement shall constitute a
waiver of the provisions of this Agreement with respect to any subsequent breach thereof or a waiver by either Party of its rights hereunder or otherwise at any time thereafter. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 21 

	19.	FORCE MAJEURE 

 A Party shall be excused from failure to perform its obligations
under this Agreement, including without limitation Distributor’s obligations to purchase a minimum purchase quantity pursuant to Section 3(c) above and for sanctions for failure to meet minimum order requirements pursuant to Section 13(b), if
any such failure is caused by a Force Majeure and without the fault or negligence of such Party. For the purposes of this Agreement, “Force Majeure” is defined as causes beyond the reasonable control of the Party, including, without
limitation, acts of God, storm, war, riot, earthquake, tsunami, fire, flood, terrorism, pandemic, nuclear accident, cyber incident, biochemical incident, explosion, governmental orders or restrictions, shortage of materials, power cut, power
shortage, or strikes or other labor troubles. Upon occurrence of a Force Majeure, the Party claiming Force Majeure shall immediately notify the other Party of such Force Majeure and its effect on such Party’s ability to perform its obligations
hereunder and the period during which such inability is expected to continue. The duties and obligations of the Parties shall be suspended for the duration of the event; provided, however, that if such suspension shall continue in excess of [***]
([***]) days, the Parties shall attempt to arrive at a mutually acceptable compromise within the spirit and intent of this Agreement. 
  

	20.	ENTIRE AGREEMENT 

 This Agreement (with Exhibits) contains all of the terms and
conditions agreed upon by the Parties hereto with respect to the subject matter hereof. No other agreement, oral or otherwise, shall be deemed to exist or to bind either of the Parties hereto, and all prior agreements and understandings with
respect to the subject matter hereof are superseded hereby. This Agreement cannot be modified or changed except by written instrument signed by both of the Parties hereto. 

 

	21.	SEVERABILITY 

 If any provision of this Agreement is declared invalid or
unenforceable by the arbitration or a court having competent jurisdiction, it is mutually agreed that the other provisions of this Agreement shall survive. The Parties shall consult and use all commercially reasonable efforts to agree upon a
valid and enforceable provision which shall be a reasonable substitute for such invalid or unenforceable provision in light of the intent of this Agreement. 
  

	22.	DEFINITIONS 

 As used in this Agreement, the following terms shall have the
meanings set forth in this Section unless the context dictates otherwise. 
 “A&R Exclusive Distribution Agreement”
shall have the meaning set forth in the first paragraph of this Agreement. 
 “Affiliate”, with respect to any Party, shall mean
any Person controlling, controlled by, or under common control with, such Party. For these purposes, “control” shall refer to (i) the 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 22 

 
possession, directly or indirectly, of the power to direct the management or policies of a Person or to veto any material decision relating to the management or policies of a Person, in each
case, whether through the ownership of voting securities, by contract or otherwise, or (ii) the ownership, directly or indirectly, of at least 50% of the voting securities of a Person. 

“Annual Forecast” shall have the meaning set forth in Section 3(c) of this Agreement. 

“Audit” shall have the meaning set forth in Section 4(d) of this Agreement. 

“Average Selling Price per Unit” shall have the meaning set forth in Section 4(a) of this Agreement. 

“Change in Control” shall have the meaning set forth in Section 15(b) of this Agreement. 

“Claiming Party” shall have the meaning set forth in Section 14(c) of this Agreement. 

“Company” shall have the meaning set forth in the first paragraph of this Agreement. 

“Company Competitor” shall have the meaning set forth in Section 15(b) of this Agreement. 

“Confidential Information” shall have the meaning set forth in Section 10(c) of this Agreement. 

“Distributor” shall have the meaning set forth in the first paragraph of this Agreement of this Agreement. 

“Distributor Competitor” shall have the meaning set forth in Section 15(b) of this Agreement. 

“Distributor Sponsored Patent” shall have the meaning set forth in Section 11(a)(i) of this Agreement. 

“Distributor Sponsored Trademark” shall have the meaning set forth in Section 12(a)(iii) of this Agreement. 

“Dollars” or “$” refers to United States dollars. 

“EDA” shall have the meaning set forth in Paragraph B of the recitals of this Agreement. 

“Effective Date” shall have the meaning set forth in the first paragraph of this Agreement. 

“Existing Agreements” shall have the meaning set forth in Paragraph B of the recitals of this Agreement. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 23 

 “FDA” shall mean the United States Food and Drug Administration. 

“Force Majeure” shall have the meaning set forth in Section 19 of this Agreement. 

“[***]” shall mean a [***]. 

“HA” shall have the meaning set forth in Paragraph A of the recitals in this Agreement. 

“Initial Term” shall mean a period of five (5) years from the LOA Effective Date. 

“Know-How” shall mean any and all technical data, information, materials and other know-how, developed or acquired by
Company, either as of the Effective Date or at any time during the Term of this Agreement, which relates to the manufacture and use of Products or Product-Drug. 

“Laws” shall have the meaning set forth in Section 5(i) of this Agreement. 

“LOA Effective Date” shall mean the date of the closing of the transaction transferring SMITH & NEPHEW Inc.’s
clinical therapies business, including the Product business, to Distributor the principal owners of which are SMITH & NEPHEW, INC. and/or its Affiliates and Essex Woodland Health Ventures and/or its Affiliates. For purposes of the foregoing,
“Affiliates” of SMITH & NEPHEW, INC. shall mean Affiliates as such term is defined in this Section 22, excluding, however, its clause (i) with regard to “control.” 

“Negative Developments” shall have the meaning as set forth in Section 3(c). 

“Net Sales” shall mean the gross amount invoiced by Distributor or its Affiliates for the sale of the Product to third
parties in the Territory, less (i) returns of Products; (ii) sales, use, value-added, excise, or other similar taxes, which taxes are included in the gross amount invoiced by Distributor or its Affiliates for the sale of the Product to third parties
in the Territory; (iii) trade discounts; and (iv) freight and insurance costs. A “sale” shall not include [***], or any transfer or disposition of the Product for pre-clinical, regulatory or governmental purposes prior to receiving
marketing approval. For purposes of calculating “Net Sales,” Product shall be considered “sold” upon the invoicing of such Product by Distributor or Distributor’s Affiliate to a third party. 

“Net Units Sold” shall have the meaning set forth in Section 4(a) of this Agreement. 

“Party” and “Parties” shall have the meaning set forth in the first paragraph of this Agreement. 

“Patents” shall have the meaning set forth in Section 11(a)(i) of this Agreement. 

“Person” shall mean any natural person, corporation, firm, limited liability corporation, limited liability partnership,
business trust, joint venture, association, organization, company, partnership or other business entity, or any government or any agency or political subdivision thereof. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 24 

 “Pharmacovigilance Agreement” shall mean the Agreement on Exchange of
Information on Post-Marketing Surveillance and Pharmacovigilance, entered into as of June 1, 2013, by and between Company and Distributor. 

“Product” shall mean an intra-articular, injectable solution of 1 wt% of highly purified HA in a syringe for treatment of
osteoarthritis of the knee and indicated for five (5) injections under the FDA approval PMA P980044 (including [***]), including SUPARTZ; provided, however, that the term “Product” shall not include VISCO-3. 

“Product-Drug” shall mean the Product. 

“Proposed Recall” shall have the meaning set forth in Section 5(h)(2) of this Agreement. 

“Purchase Price” shall have the meaning set forth in Section 4(a) of this Agreement. 

“Receiving Party” shall have the meaning set forth in Section 5(a) of this Agreement. 

“Registration Dossier” shall mean a written regulatory submission or document describing Product Specifications and
manufacturing methods as submitted by Company and approved by the applicable regulatory agency and Distributor. 
 “Renewal
Period” shall mean a period of two (2) years from the end of the Initial Term. 
 “Requesting Party” shall have
the meaning set forth in Section 5(a) of this Agreement. 
 “Sample” shall mean samples and [***]. 

“Specifications” shall have the meaning set forth in Section 5(a) of this Agreement. 

“Statement” shall have the meaning set forth in Section 4(b) of this Agreement. 

“SUPARTZ” shall mean the products sold by Distributor under the trademark SUPARTZ FX as of the Effective Date. 

“Term” shall have the meaning set forth in Section 13(a) of this Agreement. 

“Territory” shall have the meaning set forth in Section 2(a) of this Agreement. 

“Testing Methods” shall have the meaning set forth in Section 5(c) of this Agreement. 

“Trademark” shall have the meaning set forth in Section 12(a)(i) of this Agreement. 

“Unit” shall mean a syringe containing 2.5 ml solution of l.0wt% HA and blister packaged. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 25 

 “VISCO-3” shall mean an intra-articular, injectable solution of 1 wt% of highly
purified HA in a syringe for treatment of osteoarthritis of the knee and indicated for three (3) injections under the FDA approval PMA P980044/S027 (including [***]. 
  

	23.	PUBLIC ANNOUNCEMENTS 

 Except as required by applicable Law or any securities
exchange or the NASD, neither Party shall issue any press release or make any other public announcement concerning this Agreement or the subject matter hereof without the prior written consent of the other Party, which consent shall not be
unreasonably withheld. In the event of a required press release or other public announcement, the Party making such announcement shall provide the other Party with a copy of the proposed text prior to such announcement. The Parties agree
that if either Party is required to file this Agreement with any governmental agency, such Party shall delete the unrelated parts, provisions or words of this Agreement to the extent possible in order to keep the terms of this Agreement
confidential. 
  

	24.	MISCELLANEOUS 

 (a) The Parties agree that each Party is an independent
contractor. Employees and agents of one Party are not employees or agents of the other, shall not hold themselves out as such, and shall not have any authority or power to bind the other Party to any contract or other obligation. Nothing
in this Agreement is intended or shall be deemed to constitute a partnership, agency, employer-employee or joint venture relationship between the Parties. 

(b) Except as otherwise expressly provided in this Agreement, each Party shall bear all of its costs and expenses associated with the
performance of such Party’s obligation under this Agreement. 
 (c) Captions used in this Agreement are for convenience only and shall
not be deemed to affect the meaning or construction of this Agreement. 
 (d) This Agreement may be executed in one or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 (e) This Agreement is
neither expressly nor impliedly made for the benefit of any party other than the Parties. 
 (f) Company and Distributor hereby agree and acknowledge that
the Pharmacovigilance Agreement shall continue to be valid and in effect for the Term (as defined herein). 
  

	25.	SET-OFF 

 Each Party shall have a right of off-set against payment due from it to
recover any amounts due from the other Party under the terms of this Agreement. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 26 

 [Remainder of Page Intentionally Left Blank.] 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 27 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly
authorized representatives. 
  

			
	SEIKAGAKU CORPORATION
		
	By:	 	 /s/ Ken Mizutani

		 	Ken Mizutani, President
	
	BIOVENTUS LLC
		
	By:	 	 /s/ Anthony P. Bihl III

		 	Anthony P. Bihl III, CEO

 [Signature Page to Amended and Restated Distribution Agreement.] 

 ANNEX A 

(Quality Specification) 
 Product is a sterile
aqueous viscoelastic solution designed for intra-articular injection in order to treat osteoarthritis of the knee and indicated for 5 injections. 
 The
product is [***]. 
 Product Specification: 
  

			
	[***]	  	
		
	Shelf Life:	  	
		
	[***]	  	
		
	Storage	  	
		
	[***]	  	[***]
		
	Direction for Use:	  	
		
	[***]	  	

 As used above, [***]. 
 Company
shall be responsible, as the Requesting Party for the changes included in this attached ANNEX A as compared with any prior ANNEX A, to prepare and file all regulatory filings as may be required in the Territory as a result of such changes, and,
insofar as such filings are required, this ANNEX A shall not be effective prior to the date such filings are made become effective and, insofar as future regulatory filings in the Territory become necessary as a result of changes to the [***] where
referenced in the attached ANNEX A, Company, as the Requesting Party, shall prepare and file the same. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  

 ANNEX B 

The Parties acknowledge that the Existing Agreements do not include an ANNEX B as of the LOA Effective Date. 

  
 [***] Certain
information in this document has been omitted and filed separately with the Securities and Exchange Commission. 
 Confidential treatment has
been requested with respect to the omitted portions. 
  

  
 2EX-10.12

 Exhibit 10.12 

Execution Version 

AMENDMENT AND RESTATEMENT AGREEMENT 

AMENDMENT AND RESTATEMENT AGREEMENT, dated as of June 29, 2016 (this “Amendment”), to the First Lien Credit Agreement,
dated as of October 10, 2014 (as amended by that certain Amendment No. 1 to the First Lien Credit Agreement dated as of November 20, 2016, the “Existing Credit Agreement”), among BIOVENTUS LLC (the
“Borrower”), the several lenders from time to time parties thereto (the “Lenders”), JPMORGAN CHASE BANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”) and the other
agents parties thereto. 
 W I T N E S S E T H: 

WHEREAS, pursuant to the Existing Credit Agreement, the Lenders have agreed to make, and have made, certain loans and other extensions of
credit to the Borrower; 
 WHEREAS, the Borrower has requested that certain amendments be made to the Existing Credit Agreement as set forth
in Section 2 of this Amendment and that certain amendments be made to the Guarantee and Collateral Agreement as set forth in Section 3 of this Amendment; 

WHEREAS, the Borrower, the Administrative Agent, the Lenders, the Swingline Lender and the Issuing Lender are willing to agree to this
Amendment and the Restated Credit Agreement (as defined below) on the terms set forth herein. 
 NOW THEREFORE, in consideration of the
premises and mutual covenants hereinafter set forth, the parties hereto agree as follows: 
 SECTION 1. Definitions. Unless otherwise
defined herein, terms defined in the Restated Credit Agreement and used herein shall have the meanings given to them in the Restated Credit Agreement (irrespective of whether the Restatement Effective Date has occurred). The terms
“Collateral” and “Guarantor Obligations” shall have the meanings given to them in the Guarantee and Collateral Agreement. 

SECTION 2. Amendment and Restatement of Existing Credit Agreement. Effective as of the Restatement Effective Date, and subject to the
terms and conditions set forth herein: 
 (a) the Existing Credit Agreement is amended and restated in accordance with Annex I hereto
by deleting the stricken text in red (indicated textually in the same manner as the following example: stricken text) and by inserting the double-underlined text in blue (indicated textually in the same manner as the following
example: underlined text), and the Existing Credit Agreement shall read in its entirety as set forth in Annex I hereto (the Existing Credit Agreement, as so amended and restated, the
“Restated Credit Agreement”); 
 (b) new Exhibits K, L and M are added to the Restated Credit Agreement in the forms
attached hereto as Exhibits A, B and C, respectively, hereto; 
 (c) Schedules 1.1B, 4.15, 7.2(e), 7.3(f), 7.8(n) and
7.10 to the Existing Credit Agreement are amended in the form of Schedules 1.1B, 7.2(e), 7.3(f), 7.8(n) and 7.10, respectively, hereto; provided that the Borrower may deliver to the Administrative Agent an
updated version of any such Schedule on or prior to the date that is three Business Days prior to the Restatement Effective Date and such supplemental Schedule will be deemed to be effective as of the Restatement Effective Date and to have replaced
the corresponding Schedule attached hereto, unless the Administrative Agent or any Lender objects in writing to such replacement at least one Business Day prior to the Restatement Effective Date; and 

 (d) the Lenders authorize the Administrative Agent and the Borrower to make such additional
amendments to the Exhibits to the Existing Credit Agreement as the Administrative Agent deems reasonably necessary to reflect the terms of the Restated Credit Agreement. 

SECTION 3. Amendment of Guarantee and Collateral Agreement. Effective as of the Restatement Effective Date, and subject to the terms
and conditions set forth herein, Section 3 of the Guarantee and Collateral Agreement is hereby amended by: 
 (a) deleting the word
“and” from the end of clause (7) of the proviso appearing therein; 
 (b) deleting the period from the end of clause
(8) of the proviso appearing therein and inserting in lieu thereof “; and”; and 
 (c) inserting a new clause (9) at the
end of the proviso appearing therein as follows: “(9) any assets owned directly or indirectly by a Foreign Subsidiary.” 
 SECTION
4. Amendment Effective Date. This Amendment shall become effective as of the date (the “Amendment Effective Date”) on which the following conditions have been satisfied (or waived pursuant to Section 10.1 of the Restated
Credit Agreement): 
 (a) the Administrative Agent shall have received counterparts to this Amendment, duly executed by the Borrower, the
Administrative Agent, the Required Lenders, the Majority Facility Lenders in respect of the Term Facility, the Swingline Lender, and the Issuing Lender; and 

(b) the Administrative Agent shall have received (i) a certificate of each Loan Party, dated the Amendment Effective Date, substantially
in the form of Exhibit C-2 to the Existing Credit Agreement, with appropriate insertions and attachments, including the certificate of incorporation of each Loan Party that is a corporation certified by the relevant authority of the jurisdiction of
organization of such Loan Party, and (ii) a good standing certificate for each Loan Party from its jurisdiction of organization. 

SECTION 5. Restatement Effective Date. The Restated Credit Agreement shall become effective as of the date (the “Restatement
Effective Date”) on which the following conditions have been satisfied (or waived pursuant to Section 10.1 of the Existing Credit Agreement): 

(a) the Amendment Effective Date shall have occurred; 

(b) the Administrative Agent shall have received a certificate from the chief financial officer of the Borrower, dated as of the Restatement
Effective Date and in form and substance reasonably acceptable to the Administrative Agent, certifying that the Borrower and its subsidiaries, on a consolidated basis after giving effect to the Bioventus IPO Transactions and the other transactions
contemplated thereby, are solvent; 
 (c) (i) the Administrative Agent shall have received evidence reasonably satisfactory to it that
the Second Lien Loans shall have been repaid (or shall be repaid substantially contemporaneously), together with accrued interest, and all commitments, security interests and guarantees in connection therewith shall have been terminated, and
(ii) after giving effect to the consummation of the Bioventus IPO Transactions, none of the Borrower nor any of its Subsidiaries shall have any material third-party 

  
 2 

 
Indebtedness for borrowed money other than the Indebtedness incurred under the Restated Credit Agreement (it being understood that capital lease obligations and contingent consideration shall not
constitute “Indebtedness for borrowed money” for purposes of this clause (c)); 
 (d) on the Restatement Effective Date, the
Bioventus IPO shall have been consummated and yielded Net Cash Proceeds of at least $100,000,000 and such Net Cash Proceeds shall have been contributed to the Borrower as a capital contribution or as consideration for the issuance of additional
membership interests; 
 (e) as of the Pricing Date (as defined below), (i) the Borrower shall be in compliance, on a pro forma basis
after giving effect to the Bioventus IPO Transactions, with the financial covenants contained in the Restated Credit Agreement, (ii) all of the representations and warranties made by any Loan Party in the Loan Documents (including, for the
avoidance of doubt, the Restated Credit Agreement) shall be true and correct in all material respects and (iii) no Default or Event of Default shall have occurred and be continuing; for purposes of this clause (e), “Pricing
Date” shall mean the date on which the Bioventus IPO shall price; 
 (f) the Administrative Agent shall have received a duly
executed officer’s certificate from the Borrower certifying as to the satisfaction of the matters set forth in clauses (d) and (e) above; 

(g) the Administrative Agent shall have received, for distribution to the Lenders, (i) an unaudited consolidated balance sheet and related
statements of income, stockholders’ equity and cash flows of the Borrower and its consolidated subsidiaries, for each fiscal quarter ended after April 2, 2016 and at least 45 days before the Restatement Effective Date, and (ii) a pro
forma consolidated balance sheet and related pro forma consolidated statement of income of Bioventus Inc. and its consolidated subsidiaries as of the fiscal quarter and for the year-to-date period ending on the last day of the most recently
completed fiscal quarter ended at least 45 days prior to the Restatement Effective Date and a pro forma consolidated statement of income of Bioventus Inc. and its consolidated subsidiaries for the fiscal year ended December 31, 2015, prepared
after giving effect to the Bioventus IPO Transactions as if the Bioventus IPO Transactions had occurred as of such date (in the case of such balance sheet) or at the beginning of such period (in the case of such statement of income); 

(h) either (i) the Administrative Agent shall have received evidence reasonably satisfactory to it that Biostructures, LLC has merged with
and into the Borrower with the Borrower continuing as the surviving Person or (ii) BioStructures, LLC shall have become a party to the Guarantee and Collateral Agreement and shall have taken all such actions and shall have executed and
delivered to the Administrative Agent all such instruments or other documents as may be required of it as a Domestic Subsidiary acquired after the Closing Date by any Group Member pursuant to Section 6.10(c) of the Restated Credit Agreement;
and 
 (i) all expenses due to the Administrative Agent and the Lenders pursuant to Section 10.5 of the Restated Credit Agreement, to
the extent invoiced at least four (4) Business Days prior to the Restatement Effective Date, shall have been paid. 
 Notwithstanding
anything to the contrary herein, if the Restatement Effective Date shall not have occurred prior to October 1, 2016, this Amendment (and, for the avoidance of doubt, the Restated Credit Agreement) shall terminate and be of no further force or
effect. 
 SECTION 6. Representations and Warranties. The Borrower and each Guarantor represents and warrants to each of the Lenders
and the Administrative Agent that as of the Amendment Effective Date this Amendment has been duly authorized, executed and delivered by it and this 

  
 3 

 
Amendment constitutes its valid and binding obligation, enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws
affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. 

SECTION 7. Effect of Amendment; Reaffirmation. 

7.1. Except as expressly set forth herein, this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of or
otherwise affect the rights and remedies of the Lenders or the Administrative Agent under the Existing Credit Agreement or any other Loan Document, and shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations,
covenants or agreements contained in the Existing Credit Agreement or any other provision of the Existing Credit Agreement or of any other Loan Document. Nothing herein shall be deemed to entitle the Borrower or any Guarantor to a consent to, or a
waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document in similar or different circumstances. Nothing in this Amendment
shall be deemed to be a novation of any Obligations under the Credit Agreement or any other Loan Document. 
 7.2. Each Guarantor reaffirms
its guarantee of the Borrower’s Obligations under the Restated Credit Agreement on the terms and conditions of Section 2 of the Guarantee and Collateral Agreement (the “Guaranty”) and agrees that such Guaranty remains in
full force and effect and is hereby ratified, reaffirmed and confirmed. Each Guarantor hereby confirms that it consents to the terms of this Amendment. Each Guarantor hereby (i) confirms that each Loan Document to which it is a party or is
otherwise bound will continue to guarantee to the fullest extent possible in accordance with the Loan Documents, the payment and performance of the Guarantor Obligations, including without limitation the payment and performance of all such
applicable Guarantor Obligations that are joint and several obligations of each Guarantor now or hereafter existing; (ii) acknowledges and agrees that its Guaranty, the Guarantor Obligations and each of the Loan Documents to which it is a party
or otherwise bound shall continue in full force and effect and that all of its obligations thereunder shall be valid and enforceable and shall not be impaired, interrupted, discharged or limited by the execution or effectiveness of this Amendment;
and (iii) acknowledges, agrees and warrants for the benefit of the Administrative Agent, each other Agent and each Secured Party that there are no rights of set-off or counterclaim, nor any defenses of any kind, whether legal, equitable or
otherwise, that would enable such Guarantor to avoid or delay timely performance of its obligations under the Loan Documents (except to the extent such obligations constitute Excluded Swap Obligations with respect to such Guarantor). 

7.3. Each of the Borrower and the Guarantors (collectively, the “Grantors”) hereby acknowledges that it has reviewed and
consents to the terms and conditions of this Amendment and the transactions contemplated hereby. In addition, each Grantor reaffirms the security interests granted by such Grantor under the terms and conditions of the Guarantee and Collateral
Agreement to secure the Obligations and the Guarantor Obligations and agrees that such security interests remain in full force and effect and are hereby ratified, reaffirmed and confirmed. Each Grantor hereby (i) confirms that each Loan
Document to which it is a party or is otherwise bound and all Collateral encumbered thereby will continue to guarantee or secure, as the case may be, to the fullest extent possible in accordance with the Loan Documents, the payment and performance
of the Obligations and the Guarantor Obligations, as the case may be, including without limitation the payment and performance of all such applicable Obligations or Guarantor Obligations that are joint and several obligations of each Guarantor or
Grantor now or hereafter existing, (ii) confirms its respective grant to the Collateral Agent for the benefit of the Secured Parties of the security interest in and continuing Lien on all of such Grantor’s right, title and interest in, to
and under all Collateral, in each case whether now owned or existing or hereafter acquired or arising and wherever located, as collateral security for the prompt and complete payment and performance in full when due,

  
 4 

 
whether at stated maturity, by required prepayment, declaration, acceleration, demand or otherwise, of all applicable Obligations and Guarantor Obligations (including all such Obligations or
Guarantor Obligations as amended, reaffirmed and/or increased pursuant to this Amendment), subject to the terms contained in the applicable Loan Documents, and (iii) confirms its respective guarantees, pledges, grants of security interests and
other obligations, as applicable, under and subject to the terms of each of the Loan Documents to which it is a party. 
 7.4. Each Grantor
acknowledges and agrees that each of the Loan Documents to which it is a party or otherwise bound shall continue in full force and effect and that all of its obligations thereunder shall be valid and enforceable and shall not be impaired,
interrupted, discharged or limited by the execution or effectiveness of this Amendment, except to the extent expressly provided herein. 

7.5. Notwithstanding Sections 7.1 through 7.4 of this Amendment, the parties hereto acknowledge and agree that this Amendment and the Restated
Credit Agreement shall not constitute the incurrence of any Indebtedness by any Loan Party or the creation of any security interest with respect to any property or asset of any Loan Party hereunder or under the Restated Credit Agreement unless and
until the Restatement Effective Date has occurred. 
 7.6. On and after the Restatement Effective Date, each reference in the Existing Credit
Agreement to “this Agreement”, “hereunder”, “hereof”, “herein”, or words of like import, and each reference to the Credit Agreement in any other Loan Document, shall be deemed a reference to the Restated
Credit Agreement. This Amendment shall constitute a “Loan Document” for all purposes of the Restated Credit Agreement and the other Loan Documents (as defined in the Restated Credit Agreement). 

7.7. For purposes of determining withholding Taxes imposed under FATCA, from and after the Amendment Effective Date, the Lenders and the
Borrower agree that the Administrative Agent shall treat the Restated Credit Agreement as not qualifying as a “grandfathered obligation” within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i). 

SECTION 8. General. 
 8.1.
GOVERNING LAW. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 

8.2. Costs and Expenses. The Borrower agrees to reimburse the Administrative Agent for its reasonable and documented out-of-pocket
expenses in connection with this Amendment, including the reasonable fees, charges and disbursements of counsel for the Administrative Agent. 

8.3. Counterparts. This Amendment may be executed by one or more of the parties to this Amendment on any number of separate
counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Amendment by email or facsimile transmission shall be effective as delivery of a
manually executed counterpart hereof. 
 8.4. Headings. The headings of this Amendment are used for convenience of reference only, are
not part of this Amendment and shall not affect the construction of, or be taken into consideration in interpreting, this Amendment. 

[remainder of page intentionally left blank] 

  
 5 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and
delivered by their respective duly authorized officers as of the day and year first above written. 
  

			
	 Borrower:

	
	 BIOVENTUS LLC

		
	 By:
	 	 /s/ David Price

		 	 Name: David Price

		 	 Title: Chief Financial Officer

	
	 Guarantor:

	
	 EXOGEN, INC.

		
	 By:
	 	 /s/ David Price

		 	 Name: David Price

		 	 Title: Chief Financial Officer

  
 [Signature Page to
Amendment and Restatement Agreement] 

 
			
	JPMORGAN CHASE BANK, N.A., as Administrative Agent, Swingline Lender, Issuing Lender and a Lender
		
	By:	 	 /s/ Jason Lloyd

		 	 Name: Jason Lloyd

		 	 Title: Executive Director

  
 [Signature Page to
Amendment and Restatement Agreement] 

 
			
	 HSBC Bank USA N.A, as a Lender

		
	 By:
	 	 /s/ William L Otott

		 	 Name: William L Otott

		 	 Title: SVP

  
 [Signature Page to
Amendment and Restatement Agreement] 

			
	 Compass Bank, as a Lender

		
	 By:
	 	 /s/ Jeffrey E. Hauser

		 	 Jeffrey E. Hauser

		 	 Senior Vice President

  
 [Signature Page to
Amendment and Restatement Agreement] 

 
			
	 Citizens Bank, N.A., as a Lender

		
	 By:
	 	 /s/ Cheryl Carangelo

		 	 Name: Cheryl Carangelo

		 	 Title: Managing Director

  
 [Signature Page to
Amendment and Restatement Agreement] 

 
			
	 SYNOVUS BANK, as a Lender

		
	 By:
	 	 /s/ Terryl Herron

		 	 Name: Terryl Herron

		 	 Title: Senior Director, Corporate Banking

  
 [Signature Page to
Amendment and Restatement Agreement] 

 ANNEX I 

AMENDED CREDIT AGREEMENT 
 [See
attached] 

 ANNEX I TO 

AMENDMENT AND RESTATEMENT AGREEMENT 
  

 
  

AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT 

among 
 BIOVENTUS LLC, 

as Borrower, 
 The Several Lenders
from Time to Time Parties Hereto, 
 HSBC BANK USA, NATIONAL ASSOCIATION, 

CITIZENS BANK, N.A. and 
 BBVA
COMPASS, 
 as Co-Syndication Agents 

and 
 JPMORGAN CHASE BANK, N.A.,

 as Administrative Agent 

Dated as of October 10, 2014 

And Amended and Restated as of the Restatement Effective Date 
  

 
  

JPMORGAN CHASE BANK, N.A., 

CITIZENS BANK, N.A., 
 HSBC
SECURITIES (USA) INC. 
 and 

BBVA COMPASS, 
 as Joint Lead
Arrangers and Joint Bookrunners 

 TABLE OF CONTENTS 

 

					
	 	  	 	  	Page
	SECTION 1.	  	DEFINITIONS	  	1
	 1.1.
	  	Defined Terms	  	1
	 1.2.
	  	Other Definitional Provisions	  	34
	 1.3.
	  	Currency Conversion and Fluctuations	  	35
			
	SECTION 2.	  	AMOUNT AND TERMS OF COMMITMENTS	  	36
	 2.1.
	  	Term Commitments	  	36
	 2.2.
	  	Procedure for Term Loan Borrowing	  	36
	 2.3.
	  	Repayment of Term Loans	  	36
	 2.4.
	  	Revolving Commitments	  	37
	 2.5.
	  	Procedure for Revolving Loan Borrowing	  	37
	 2.6.
	  	Swingline Commitment	  	37
	 2.7.
	  	Procedure for Swingline Borrowing; Refunding of Swingline Loans	  	38
	 2.8.
	  	Commitment Fees, etc.	  	40
	 2.9.
	  	Termination or Reduction of Revolving Commitments	  	40
	 2.10.
	  	Optional Prepayments	  	40
	 2.11.
	  	Mandatory Prepayments	  	40
	 2.12.
	  	Conversion and Continuation Options	  	42
	 2.13.
	  	Limitations on Eurodollar Tranches	  	42
	 2.14.
	  	Interest Rates and Payment Dates	  	43
	 2.15.
	  	Computation of Interest and Fees	  	43
	 2.16.
	  	Inability to Determine Interest Rate	  	43
	 2.17.
	  	Pro Rata Treatment and Payments	  	44
	 2.18.
	  	Requirements of Law	  	45
	 2.19.
	  	Taxes	  	47
	 2.20.
	  	Indemnity	  	50
	 2.21.
	  	Change of Lending Office	  	51
	 2.22.
	  	Replacement of Lenders	  	51
	 2.23.
	  	Defaulting Lenders	  	51
	 2.24.
	  	Incremental Facilities	  	53
	 2.25.
	  	Extensions of Term Loans and Revolving Commitments	  	54
			
	SECTION 3.	  	LETTERS OF CREDIT	  	57
	 3.1.
	  	L/C Commitment	  	57
	 3.2.
	  	Procedure for Issuance of Letter of Credit	  	58
	 3.3.
	  	Fees and Other Charges	  	58
	 3.4.
	  	L/C Participations	  	58
	 3.5.
	  	Reimbursement Obligation of the Borrower	  	59
	 3.6.
	  	Obligations Absolute	  	60
	 3.7.
	  	Letter of Credit Payments	  	60
	 3.8.
	  	Applications	  	60
			
	SECTION 4.	  	REPRESENTATIONS AND WARRANTIES	  	60
	 4.1.
	  	Financial Condition	  	60
	 4.2.
	  	No Change	  	61
	 4.3.
	  	Existence; Compliance with Law	  	61
	 4.4.
	  	Power; Authorization; Enforceable Obligations	  	61

					
	 4.5.
	  	No Legal Bar	  	61
	 4.6.
	  	Litigation	  	62
	 4.7.
	  	No Default	  	62
	 4.8.
	  	Ownership of Property; Liens	  	62
	 4.9.
	  	Intellectual Property	  	62
	 4.10.
	  	Taxes	  	62
	 4.11.
	  	Federal Regulations	  	62
	 4.12.
	  	Labor Matters	  	63
	 4.13.
	  	ERISA	  	63
	 4.14.
	  	Investment Company Act; Other Regulations	  	63
	 4.15.
	  	Subsidiaries	  	63
	 4.16.
	  	Use of Proceeds	  	63
	 4.17.
	  	Environmental Matters	  	64
	 4.18.
	  	Accuracy of Information, etc.	  	64
	 4.19.
	  	Security Documents	  	65
	 4.20.
	  	Solvency	  	65
	 4.21.
	  	Anti-Corruption Laws and Sanctions	  	65
	 4.22.
	  	EEA Financial Institutions	  	65
			
	SECTION 5.	  	CONDITIONS PRECEDENT	  	66
	 5.1.
	  	Conditions to Initial Extension of Credit	  	66
	 5.2.
	  	Conditions to Each Extension of Credit	  	68
			
	SECTION 6.	  	AFFIRMATIVE COVENANTS	  	68
	 6.1.
	  	Financial Statements	  	68
	 6.2.
	  	Certificates; Other Information	  	69
	 6.3.
	  	Payment of Obligations	  	71
	 6.4.
	  	Maintenance of Existence; Compliance	  	71
	 6.5.
	  	Maintenance of Property; Insurance	  	71
	 6.6.
	  	Inspection of Property; Books and Records; Discussions	  	71
	 6.7.
	  	Notices	  	71
	 6.8.
	  	Environmental Laws	  	72
	 6.9.
	  	Interest Rate Protection	  	72
	 6.10.
	  	Additional Collateral, etc.	  	72
	 6.11.
	  	Designation of Subsidiaries	  	74
	 6.12.
	  	Post-Closing Obligations	  	74
			
	SECTION 7.	  	NEGATIVE COVENANTS	  	76
	 7.1.
	  	Financial Condition Covenants	  	76
	 7.2.
	  	Indebtedness	  	76
	 7.3.
	  	Liens	  	78
	 7.4.
	  	Fundamental Changes	  	79
	 7.5.
	  	Disposition of Property	  	80
	 7.6.
	  	Restricted Payments	  	81
	 7.7.
	  	Capital Expenditures	  	84
	 7.8.
	  	Investments	  	85
	 7.9.
	  	Optional Payments and Modifications of Certain Debt Instruments; Organizational Documents	  	87
	 7.10.
	  	Transactions with Affiliates	  	88
	 7.11.
	  	Sales and Leasebacks	  	89
	 7.12.
	  	Swap Agreements	  	89

  
 ii 

					
	 7.13.
	  	Changes in Fiscal Periods	  	89
	 7.14.
	  	Negative Pledge Clauses	  	89
	 7.15.
	  	Clauses Restricting Subsidiary Distributions	  	90
	 7.16.
	  	Lines of Business	  	90
	 7.17.
	  	Use of Proceeds	  	90
			
	SECTION 8.	  	EVENTS OF DEFAULT	  	90
	 8.1.
	  	Events of Default	  	90
	 8.2.
	  	Application of Proceeds	  	93
			
	SECTION 9.	  	THE AGENTS	  	94
	 9.1.
	  	Appointment	  	94
	 9.2.
	  	Delegation of Duties	  	94
	 9.3.
	  	Exculpatory Provisions	  	94
	 9.4.
	  	Reliance by Administrative Agent	  	95
	 9.5.
	  	Notice of Default	  	95
	 9.6.
	  	Non-Reliance on Agents and Other Lenders	  	95
	 9.7.
	  	Indemnification	  	96
	 9.8.
	  	Agent in Its Individual Capacity	  	96
	 9.9.
	  	Successor Administrative Agent	  	96
	 9.10.
	  	Arrangers and Syndication Agent	  	96
			
	SECTION 10.	  	MISCELLANEOUS	  	97
	 10.1.
	  	Amendments and Waivers	  	97
	 10.2.
	  	Notices	  	98
	 10.3.
	  	No Waiver; Cumulative Remedies	  	99
	 10.4.
	  	Survival of Representations and Warranties	  	99
	 10.5.
	  	Payment of Expenses and Taxes	  	99
	 10.6.
	  	Successors and Assigns; Participations and Assignments	  	101
	 10.7.
	  	Adjustments; Set-off	  	104
	 10.8.
	  	Counterparts	  	104
	 10.9.
	  	Severability	  	105
	 10.10.
	  	Integration	  	105
	 10.11.
	  	GOVERNING LAW	  	105
	 10.12.
	  	Submission To Jurisdiction; Waivers	  	105
	 10.13.
	  	Acknowledgements	  	105
	 10.14.
	  	Releases of Guarantees and Liens	  	106
	 10.15.
	  	Confidentiality	  	106
	 10.16.
	  	WAIVERS OF JURY TRIAL	  	107
	 10.17.
	  	USA Patriot Act	  	107
	 10.18.
	  	Intercreditor Agreement	  	107
	 10.19.
	  	Judgment Currency	  	108
	 10.20.
	  	Acknowledgement and Consent to Bail-In of EEA Financial Institutions	  	108

  
 iii 

 SCHEDULES: 
  

			
	1.1A	  	Commitments
	1.1B	  	Mortgaged Property
	4.4	  	Consents, Authorizations, Filings and Notices
	4.15	  	Subsidiaries
	4.19(a)	  	UCC Filing Jurisdictions
	4.19(b)	  	Mortgage Filing Jurisdictions
	7.2(e)	  	Existing Indebtedness
	7.3(f)	  	Existing Liens
	7.8(n)	  	Existing Investments
	7.10	  	Existing Transactions with Affiliates
	
	EXHIBITS:
		
	A	  	Form of Guarantee and Collateral Agreement
	B	  	Form of Compliance Certificate
	C	  	Form of Closing Certificate
	D	  	Form of Borrowing Notice
	E	  	Form of Assignment and Assumption
	F-1	  	Form of Legal Opinion of Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P.
	F-2	  	Form of Legal Opinion of Wollmuth Maher & Deutsche LLP
	G	  	Forms of U.S. Tax Compliance Certificate
	H-1	  	Form of Increased Facility Activation Notice––Incremental Term Loans
	H-2	  	Form of Increased Facility Activation Notice––Incremental Revolving Commitments
	H-3	  	Form of New Lender Supplement
	I	  	Form of Intercreditor Agreement
	J	  	Form of Loan Conversion and Continuation Notice
	K	  	Form of Bioventus IPO Common Unit Purchase Agreement
	L	  	Form of Borrower LLC Agreement (post Bioventus IPO)
	M	  	Form of Tax Receivable Agreement

  
 iv 

 AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT (this “Agreement”), dated as of
October 10, 2014, as amended by that Amendment No. 1 to the First Lien Credit Agreement dated as of November 20, 2015 (“Amendment No. 1”) and as amended and restated on as of the Restatement Effective Date (as
hereinafter defined) among BIOVENTUS LLC, a Delaware limited liability company (the “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (the
“Lenders”) and JPMORGAN CHASE BANK, N.A., as administrative agent. 
 The parties hereto hereby agree as follows: 

SECTION 1. DEFINITIONS 
 1.1.
Defined Terms. As used in this Agreement, the terms listed in this Section 1.1 shall have the respective meanings set forth in this Section 1.1. 

“ABR”: for any day, a rate per annum (rounded upwards, if necessary, to the next 1/16 of 1%) equal to the greatest of
(a) the Prime Rate in effect on such day, (b) the NYFRB Rate in effect on such day plus  1⁄2 of 1% and (c) the Eurodollar Rate on such
day (or, if such day is not a Business Day, the next preceding Business Day) for a deposit in Dollars with a maturity of one month plus 1.0%, provided that for the purpose of this definition, the Eurodollar Rate for any day shall be
based on the Screen Rate (or if the Screen Rate is not available for such one month Interest Period, the Interpolated Rate) at approximately 11:00 a.m. London time on such day. Any change in the ABR due to a change in the Prime Rate, the NYFRB Rate
or such Eurodollar Rate shall be effective from and including the effective date of such change in the Prime Rate, the NYFRB Rate or such Eurodollar Rate, respectively. 

“ABR Loans”: Loans the rate of interest applicable to which is based upon the ABR. 

“Adjustment Date”: as defined in the Applicable Pricing Grid. 

“Administrative Agent”: JPMorgan Chase Bank, N.A., as the administrative agent for the Lenders under this Agreement and the
other Loan Documents, together with any of its successors. 
 “Affiliate”: as to any Person, any other Person that,
directly or indirectly, is in control of, is controlled by, or is under common control with, such Person. For purposes of this definition, “control” of a Person means the power, directly or indirectly, either to (a) vote 10% or more
of the securities having ordinary voting power for the election of directors (or persons performing similar functions) of such Person or (b) direct or cause the direction of the management and policies of such Person, whether by contract or
otherwise. 
 “Agent Indemnitee”: as defined in Section 9.7. 

“Agents”: the collective reference to the Administrative Agent and any other agent identified on the cover page of this
Agreement. 
 “Aggregate Exposure”: with respect to any Lender at any time, an amount equal to (a) until the Closing
Date, the aggregate amount of such Lender’s Commitments at such time and (b) thereafter, the sum of (i) the aggregate then unpaid principal amount of such Lender’s Term Loans and (ii) the amount of such Lender’s
Revolving Commitment then in effect or, if the Revolving Commitments have been terminated, the amount of such Lender’s Revolving Extensions of Credit then outstanding. 

 “Aggregate Exposure Percentage”: with respect to any Lender at any time, the
ratio (expressed as a percentage) of such Lender’s Aggregate Exposure at such time to the Aggregate Exposure of all Lenders at such time. 

“Agreement”: as defined in the preamble hereto. 

“Agreed Currency”: (i) Dollars, (ii) the Euro, (iii) Pounds Sterling and (iv) any other Eligible Currency
which the Borrower requests the Issuing Lender (and the Issuing Lender agrees) to include as an Agreed Currency hereunder. 

“Amendment and Restatement Agreement”: that certain Amendment and Restatement Agreement, dated as of June 29, 2016, by
and among the Borrower, the Swingline Lender, the Issuing Lender, the Administrative Agent, the Lenders party thereto constituting the Required Lenders and the Majority Facility Lenders in respect of the Term Facility. 

“Amendment No. 1”: as defined in the preamble hereto. 

“Amendment No. 1 to the Second Lien Credit Agreement”: Amendment No. 1, dated as of November 20, 2015, to the
Second Lien Credit Agreement. 
 “Anti-Corruption Laws”: all laws, rules and regulations of any jurisdiction applicable to
the Borrower or its Affiliates from time to time concerning or relating to bribery or corruption. 
 “Applicable Margin”:
(a) for each Type of Loan other than Incremental Term Loans, the rate per annum set forth under the relevant column heading below: 
  

									
	 	  	ABR Loans	 	 	Eurodollar Loans	 
	 Revolving Loans and Swingline Loans
	  	 	2.00	% 	 	 	3.00	% 
	 Term Loans
	  	 	2.00	% 	 	 	3.00	% 

 ; provided, that on and after the first Adjustment Date occurring after the completion of the first full fiscal quarter
of the Borrower after the Closing Date, the Applicable Margin with respect to Revolving Loans, Swingline Loans and Term Loans will be determined pursuant to the Applicable Pricing Grid; and 

(b) for Incremental Term Loans, such per annum rates as shall be agreed to by the Borrower and the applicable Incremental Term Lenders as shown
in the applicable Increased Facility Activation Notice. 
 “Applicable Pricing Grid”: the table set forth below: 

 

													
	 Consolidated Leverage Ratio
	  	Applicable Margin for
Eurodollar Loans	 	 	Applicable Margin for
ABR Loans	 	 	Commitment
Fee Rate	 
	 3 4.00:1.00
	  	 	3.00	% 	 	 	2.00	% 	 	 	0.50	% 
	 3 3.00:1.00 but < 4.00:1.00
	  	 	2.75	% 	 	 	1.75	% 	 	 	0.45	% 
	 3 2.00:1.00 but < 3.00:1.00
	  	 	2.50	% 	 	 	1.50	% 	 	 	0.40	% 
	 < 2.00:1.00
	  	 	2.25	% 	 	 	1.25	% 	 	 	0.35	% 

  
 2 

 For the purposes of the Applicable Pricing Grid, changes in the Applicable Margin resulting from
changes in the Consolidated Leverage Ratio shall become effective on the date (the “Adjustment Date”) that is three Business Days after the date on which financial statements are delivered to the Lenders pursuant to Section 6.1
and shall remain in effect until the next change to be effected pursuant to this paragraph. If any financial statements referred to above are not delivered within the time periods specified in Section 6.1, then, until the date that is three
Business Days after the date on which such financial statements are delivered, the highest rate set forth in each column of the Applicable Pricing Grid shall apply. In addition, at all times while an Event of Default shall have occurred and be
continuing, the highest rate set forth in each column of the Applicable Pricing Grid shall apply. Each determination of the Consolidated Leverage Ratio pursuant to the Applicable Pricing Grid shall be made in a manner consistent with the
determination thereof pursuant to Section 7.1(a). 
 “Application”: an application, in such form as the Issuing Lender
may specify from time to time, requesting the Issuing Lender to open a Letter of Credit. 
 “Approved Fund”: as defined in
Section 10.6(b). 
 “Arrangers”: the Joint Lead Arrangers and Joint Bookrunners identified on the cover page of this
Agreement. 
 “Asset Sale”: any Disposition of property or series of related Dispositions of property of any Group Member
(excluding any such Disposition permitted by clause (a)-(k) of Section 7.5) that yields Net Cash Proceeds in excess of $1,000,000; provided, that the non-exclusive license or sublicense of Intellectual Property shall not constitute
an Asset Sale. 
 “Assignee”: as defined in Section 10.6(b). 

“Assignment and Assumption”: an Assignment and Assumption, substantially in the form of Exhibit E. 

“Available Foreign Currencies”: the Agreed Currencies other than Dollars. 

“Available Revolving Commitment”: as to any Revolving Lender at any time, an amount equal to the excess, if any, of
(a) such Lender’s Revolving Commitment then in effect over (b) such Lender’s Revolving Extensions of Credit then outstanding; provided, that in calculating any Lender’s Revolving Extensions of Credit for the purpose
of determining such Lender’s Available Revolving Commitment pursuant to Section 2.8(a), the aggregate principal amount of Swingline Loans then outstanding shall be deemed to be zero. 

“Bail-In Action”: the exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect
of any liability of an EEA Financial Institution. 
 “Bail-In Legislation”: with respect to any EEA Member Country
implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule. 

“Bankruptcy Event”: with respect to any Person, such Person becomes the subject of a bankruptcy or insolvency proceeding, or
has had a receiver, conservator, trustee, administrator, custodian, assignee for the benefit of creditors or similar Person charged with the reorganization or liquidation of its business appointed for it, or, in the good faith determination of the
Administrative Agent, has taken any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any such proceeding or appointment, provided that a Bankruptcy Event shall not result solely by virtue of any
ownership 

  
 3 

 
interest, or the acquisition of any ownership interest, in such Person by a Governmental Authority or instrumentality thereof, provided, further, that such ownership interest does
not result in or provide such Person with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Person (or such Governmental Authority or
instrumentality) to reject, repudiate, disavow or disaffirm any contracts or agreements made by such Person. 
 “Benefitted
Lender”: as defined in Section 10.7(a). 
 “Biostructures”: Biostructures LLC, a California limited liability
company. 
 “Biostructures Acquisition”: the acquisition of Biostructures by the Borrower pursuant to the Biostructures
Purchase Agreement. 
 “Biostructures Purchase Agreement”: the Membership Interest Purchase Agreement dated as of
November 24, 2015, by and among Biostructures, the Borrower and the sellers and sellers’ representatives named therein. 

“Bioventus Incentive Plan”: any of (a) the Bioventus Inc. 2016 Incentive Award Plan, the Bioventus Inc. 2016 Senior
Executive Incentive Bonus Plan, the Bioventus Inc. 2016 Employee Stock Purchase Plan, or any successor plan or similar plan approved by the compensation committee of the board of directors of Bioventus Inc. for the purpose of providing incentive
compensation to the directors, officers, employees, consultants or other agents of Bioventus Inc., the Borrower and the Subsidiaries and (b) any incentive compensation plan of the Borrower in effect prior to the Bioventus IPO Date (including
the phantom profits interest plan as may be amended (the “Phantom Profits Interest Plan”) or any successor plan thereto), the rights and obligations under which are assigned and delegated to Bioventus Inc. in connection with the Bioventus
IPO. 
 “Bioventus Inc.”: Bioventus Inc., a Delaware corporation formed at the direction of certain members of the
Borrower, for the purposes of effecting a Qualified IPO, together with its successors and assigns. 
 “Bioventus IPO”: a
Qualified IPO of Bioventus Inc. in connection with which (a) the Borrower amends and restates its limited liability company agreement substantially in the form of Exhibit L hereto, (b) Bioventus Inc. and the other parties thereto
consummate the Bioventus Merger Agreement, (c) Bioventus Inc. applies all or a portion of the net proceeds from such Qualified IPO to purchase additional common units of the Borrower and (d) Bioventus Inc. becomes the sole managing member
of the Borrower. 
 “Bioventus IPO Common Unit Purchase Agreement”: the IPO Common Unit Purchase Agreement substantially in
the form attached as Exhibit K hereto, as amended from time to time in any manner that the Borrower reasonably determines is not adverse to the interests of the Administrative Agent or the Lenders. 

“Bioventus IPO Date”: the closing date on which the Bioventus IPO is consummated (it being understood that any over-allotment
option may be consummated on a later date). 
 “Bioventus IPO Transactions”: (a) the entry into the Amendment and
Restatement Agreement, (b) the Bioventus IPO and the payment of all fees and expenses in connection therewith (including underwriter discounts and commissions, filing fees, listing fees, printer fees and roadshow expenses), (c) the
prepayment in full in cash of all obligations outstanding under the Second Lien Credit 

  
 4 

 
Agreement, including the principal amount of all Second Lien Loans, all accrued and unpaid interest thereunder to the date of prepayment, all premium, if any, with respect thereto, all breakage
and other amounts payable with respect thereto pursuant to the Second Lien Loan Documents (including fees and expenses of the Second Lien Administrative Agent and its counsel), and the termination of the Second Lien Loan Documents (except to the
extent the provisions thereof survive termination), (d) the entry into the Bioventus LLC Agreement, the Tax Receivable Agreement, the Bioventus IPO Common Unit Purchase Agreement, the Bioventus Merger Agreement, and the Bioventus Incentive
Plans and the performance thereof and (e) the other transactions described under the heading “Prospectus Summary—Summary of the transactions” in the prospectus included in the registration statement filed with the SEC for the
Bioventus IPO. 
 “Bioventus Merger Agreement”: the contribution and merger agreements entered among
Bioventus Inc., each of, inter alios, (i) Beluga I, Inc., (ii) Beluga II, Inc., (iii) Beluga III, Inc., (iv) Beluga IV, Inc., (v) Beluga V, Inc., (vi) Beluga VI, Inc., (vii) Beluga VII, Inc.,
(viii) Beluga VII-A, Inc., (ix) Beluga VIII, Inc. and (x) Smith & Nephew OUS, Inc. (collectively, the “Blocker Corporations”), and each shareholder of the Blocker Corporations on or prior to the Restatement
Effective Date pursuant to which Bioventus Inc. will directly or indirectly acquire the Capital Stock in the Borrower owned by the Blocker Corporations; provided that Bioventus Inc. will not incur any obligations or liabilities under the
Bioventus Merger Agreement that are materially adverse to the interests of the Lenders in the reasonable judgment of the Borrower (it being understood that (x) liabilities related to the acquisition of the Blocker Corporations, including the
obligation of Bioventus Inc. to issue shares of its Class A common Stock in exchange therefor, (y) the assumption by Bioventus Inc. of all liabilities of the Blocker Corporations (if any) at the time of effectiveness of such merger or
contribution and (z) obligations of Bioventus Inc. to pay fees and expenses related to such mergers or contributions and the consummation thereof, in each case shall be deemed not to be materially adverse to the interests of the Lenders). 

“Board”: the Board of Governors of the Federal Reserve System of the United States (or any successor). 

“Board of Directors”: with respect to any Person, (i) in the case of any corporation, the board of directors of such
Person, (ii) in the case of the Borrower, its Board of Managers or, following the Bioventus IPO, its sole managing member, (iii) in the case of any other limited liability company, the members, manager or the board of managers of such
Person, (iv) in the case of any partnership, the members, board of directors or board of managers of the general partner of such person and (v) in any other case, the functional equivalent of the foregoing. 

“Borrower”: as defined in the preamble hereto. 

“Borrower LLC Agreement”: (a) from the Restatement Effective Date to the Bioventus IPO Date (to the extent the
Restatement Effective Date occurs prior thereto), the First Amended and Restated Limited Liability Company Agreement of the Borrower as in effect on the Restatement Effective Date and (b) from and after the Bioventus IPO Date, the Second
Amended and Restated Limited Liability Company Agreement of the Borrower substantially in the form attached as Exhibit L hereto, as further amended from time to time in any manner that either (i) is required by the terms of such Second Amended
and Restated Limited Liability Company Agreement or (ii) the Borrower reasonably determines is not adverse to the interests of the Administrative Agent or the Lenders. 

“Borrowing Date”: any Business Day specified by the Borrower as a date on which the Borrower requests the relevant Lenders to
make Loans hereunder. 
 “Business”: as defined in Section 4.17(b). 

  
 5 

 “Business Day”: a day other than a Saturday, Sunday or other day on which
commercial banks in New York City are authorized or required by law to close, provided, that with respect to notices and determinations in connection with, and payments of principal and interest on, Loans having an interest rate determined by
reference to the Eurodollar Rate, such day is also a day for trading by and between banks in Dollar deposits in the interbank eurodollar market. 

“Calculation Date”: (a) the last Business Day of each month, (b) the date of issuance, amendment, renewal or
extension of a Letter of Credit, and (c) any other date selected by the Administrative Agent in its reasonable discretion. 

“Capital Expenditures”: for any period, with respect to any Person, the aggregate of all expenditures by such Person and its
Restricted Subsidiaries for the acquisition or leasing (pursuant to a capital lease) of fixed or capital assets or additions to equipment (including replacements, capitalized repairs and improvements during such period) that should be capitalized
under GAAP on a consolidated balance sheet of such Person and its Restricted Subsidiaries. 
 “Capital Lease Obligations”:
as to any Person, the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified
and accounted for as capital leases on a balance sheet of such Person under GAAP and, for the purposes of this Agreement, the amount of such obligations at any time shall be the capitalized amount thereof at such time determined in accordance with
GAAP. 
 “Capital Stock”: any and all shares, interests, rights, participations or other equivalents (however designated)
of capital stock of a corporation, any and all equivalent ownership or profit interests or units in, including any limited or general partnership interest and any limited liability company membership interest) in a Person (other than a corporation)
and any and all warrants, rights or options for the purchase, acquisition or exchange from such Person of any of the foregoing, but excluding (i) any debt securities convertible into any of the foregoing and (ii) in the case of the
Borrower at any time prior to the Bioventus IPO, its profits interest units awarded and outstanding under the Borrower’s profits interest plan (the “Management Incentive Plan”), phantom profits interest units awarded and outstanding
under the Borrower’s Phantom Profits Interest Plan and EPR Units. 
 “Cash Equivalents”: (a) marketable direct
obligations issued by, or unconditionally guaranteed by, the United States Government or issued by any agency thereof and backed by the full faith and credit of the United States, in each case maturing within one year from the date of acquisition;
(b) certificates of deposit, time deposits, eurodollar time deposits or overnight bank deposits having maturities of six months or less from the date of acquisition issued by any Lender or by any commercial bank organized under the laws of the
United States or any state thereof having combined capital and surplus of not less than $500,000,000; (c) commercial paper of an issuer rated at least A-1 by Standard & Poor’s Financial Services LLC (“S&P”) or
P-1 by Moody’s Investors Service, Inc. (“Moody’s”), or carrying an equivalent rating by a nationally recognized rating agency, if both of the two named rating agencies cease publishing ratings of commercial paper issuers
generally, and maturing within six months from the date of acquisition; (d) repurchase obligations of any Lender or of any commercial bank satisfying the requirements of clause (b) of this definition, having a term of not more than 30
days, with respect to securities issued or fully guaranteed or insured by the United States government; (e) securities with maturities of one year or less from the date of acquisition issued or fully guaranteed by any state, commonwealth or
territory of the United States, by any political subdivision or taxing authority of any such state, commonwealth or territory or by any foreign government, the securities of which state, commonwealth, territory, political subdivision, taxing
authority or foreign government (as the case may be) are rated at least A by S&P or A by Moody’s; (f) securities with maturities of six months or less from 

  
 6 

 
the date of acquisition backed by standby letters of credit issued by any Lender or any commercial bank satisfying the requirements of clause (b) of this definition; (g) money market
mutual or similar funds substantially all of whose investments are in assets satisfying the requirements of clauses (a) through (f) of this definition; or (h) money market funds that (i) comply with the criteria set forth in SEC
Rule 2a-7 under the Investment Company Act of 1940, as amended, (ii) are rated AAA by S&P and Aaa by Moody’s and (iii) have portfolio assets of at least $5,000,000,000. 

“Change in Control”: (a) prior to an IPO, the Permitted Investors shall cease to own, directly or indirectly,
beneficially or of record, at least a majority of the outstanding Capital Stock of the Borrower on a fully diluted basis or shall fail to have the right to elect or designate for election at least a majority of the Board of Directors of the
Borrower, and (b) after an IPO, the acquisition or ownership, directly or indirectly, beneficially or of record by any Person or group (with the meaning of the Exchange Act) other than the Permitted Investors of Capital Stock representing more
than 35% of the aggregate ordinary voting power represented by the issued and outstanding Capital Stock of the Qualified IPO Issuer and the percentage of the aggregate ordinary voting power so held is greater than the percentage of the aggregate
ordinary voting power represented by the issued and outstanding Capital Stock of the Qualified IPO Issuer beneficially owned, directly or indirectly, in the aggregate by the Permitted Investors. 

“Closing Date”: the date on which the conditions precedent set forth in Sections 5.1 and 5.2 shall have been satisfied,
which date is October 10, 2014. 
 “Code”: the Internal Revenue Code of 1986, as amended. 

“Collateral”: all property of the Loan Parties, now owned or hereafter acquired, upon which a Lien is purported to be created
by any Security Document. 
 “Commitment”: as to any Lender, the sum of the Term Commitment and the Revolving Commitment of
such Lender. 
 “Commitment Fee Rate”: 0.50% per annum; provided, that on and after the first Adjustment Date
occurring after the completion of four full fiscal quarters of the Borrower after the Closing Date, the Commitment Fee Rate will be determined pursuant to the Applicable Pricing Grid. 

“Commodity Exchange Act”: the Commodity Exchange Act (7 U.S.C. § 1 et seq.), as amended from time to time, and any
successor statute. 
 “Compliance Certificate”: a certificate duly executed by a Responsible Officer substantially in the
form of Exhibit B. 
 “Confidential Information Memorandum”: the Confidential Information Memorandum dated August
2014 and furnished to certain Lenders. 
 “Connection Income Taxes”: Other Connection Taxes that are imposed on or measured
by net income (however denominated) or that are franchise Taxes or branch profits Taxes. 
 “Consolidated Adjusted EBITDA”:
for any period, Consolidated EBITDA for such period minus any Restricted Payments paid in cash pursuant to Section 7.06(d) (other than subclause (iv) thereof) that are deducted in the calculation of the Consolidated Fixed Charge
Coverage Ratio pursuant to subclause (a)(ii) of the definition thereof. 

  
 7 

 “Consolidated Current Assets”: at any date, all amounts (other than cash and
Cash Equivalents) that would, in conformity with GAAP, be set forth opposite the caption “total current assets” (or any like caption) on a consolidated balance sheet of the Borrower and its Restricted Subsidiaries at such date. 

“Consolidated Current Liabilities”: at any date, all amounts that would, in conformity with GAAP, be set forth opposite the
caption “total current liabilities” (or any like caption) on a consolidated balance sheet of the Borrower and its Restricted Subsidiaries at such date, but excluding (a) the current portion of any Funded Debt of the Borrower and its
Restricted Subsidiaries and (b) without duplication of clause (a) above, all Indebtedness consisting of Revolving Loans or Swingline Loans to the extent otherwise included therein. 

“Consolidated EBITDA”: for any period, Consolidated Net Income for such period plus, without duplication and to the
extent reflected as a charge in the statement of such Consolidated Net Income for such period, the sum of (a) income tax expense, (b) interest expense and, to the extent not reflected in such interest expense, any non-cash losses with
respect to obligations under any Swap Agreements or other derivative instruments (including any applicable termination payment) entered into for the purpose of hedging interest rate risk, amortization or writeoff of debt discount and debt issuance
costs and commissions, discounts and other fees and charges associated with Indebtedness (including the Loans), (c) depreciation and amortization expense, (d) amortization of intangibles (including, but not limited to, goodwill) and
organization costs, (e) any non-recurring cash expenses or losses, which, for any fiscal period of the Borrower, shall not exceed 15% of Consolidated EBITDA for such fiscal period, (f) provision for taxes based on income or profits or
capital, including, without limitation, federal, state, provincial, franchise, excise, withholding and similar taxes, including any penalties and interest relating to any tax examinations, (g) the amount of any expense or deduction associated
with income of any Restricted Subsidiaries attributable to (x) controlling interests or majority interests of a non-wholly owned Restricted Subsidiary to the extent such amount is attributable to the unowned portion of such Restricted
Subsidiary or (y) non-controlling interests or minority interests owned by Restricted Subsidiaries to the extent such amount is actually paid in cash to such Restricted Subsidiary, (h) any extraordinary or non-cash expenses or losses
(including, whether or not otherwise includable as a separate item in the statement of such Consolidated Net Income for such period, non-cash losses on sales of assets outside of the ordinary course of business), (i) with respect to any period
ending on or prior to the fourth fiscal quarter ending after the Bioventus IPO Date, any non-recurring fees, costs, expenses or charges related to, or arising in connection with (regardless of whether or not consummated), the Bioventus IPO
Transactions (including, without limitation, (A) payment of consent fees to lenders, (B) payment of prepayment premium and breakage costs to lenders, (C) any incentive bonuses and other compensation, if any, paid or payable to
employees and/or members of the Board of Directors of any of the Credit Parties in connection with the Bioventus IPO or the Borrower’s Management Incentive Plan or Phantom Profits Interest Plan, (D) filing fees and exchange listing fees,
(E) “roadshow” expenses, printer costs and other offering expenses and (F) underwriter discounts and commissions), and (j) fees, expenses and other amounts payable by the Borrower or any of its Restricted Subsidiaries in
connection with the performance, or payable or reimbursable to Bioventus Inc. in connection with its performance, of its obligations under the Tax Receivable Agreement and the Bioventus IPO Common Unit Purchase Agreement, and minus,
(a) to the extent included in the statement of such Consolidated Net Income for such period, the sum of (i) interest income, (ii) any extraordinary, unusual or non-recurring income or gains (including, whether or not otherwise
includable as a separate item in the statement of such Consolidated Net Income for such period, gains on the sales of assets outside of the ordinary course of business), (iii) income tax credits (to the extent not netted from income tax
expense) and (iv) any other non-cash income and (b) any cash payments made during such period in respect of items described in clause (h) above subsequent to the fiscal quarter in which the relevant non-cash expenses or losses were
reflected as a charge in the statement of Consolidated Net Income, all as determined on a consolidated basis. For the purposes of 

  
 8 

 
calculating Consolidated EBITDA for any period of four consecutive fiscal quarters (each, a “Reference Period”) pursuant to any determination of the Consolidated Leverage Ratio
and Consolidated Fixed Charge Coverage Ratio, (i) if at any time during such Reference Period the Borrower or any Restricted Subsidiary shall have made any Material Disposition, the Consolidated EBITDA for such Reference Period shall be reduced
by an amount equal to the Consolidated EBITDA (if positive) attributable to the property that is the subject of such Material Disposition for such Reference Period or increased by an amount equal to the Consolidated EBITDA (if negative) attributable
thereto for such Reference Period and (ii) if during such Reference Period the Borrower or any Restricted Subsidiary shall have made a Material Acquisition (including, without limitation, the Biostructures Acquisition), Consolidated EBITDA for
such Reference Period shall be calculated after giving pro forma effect thereto as if such Material Acquisition occurred on the first day of such Reference Period. As used in this definition, “Material
Acquisition” means any acquisition of property or series of related acquisitions of property that (a) constitutes assets comprising all or substantially all of an operating unit of a business or constitutes all or substantially all of
the common stock of a Person and (b) involves the payment of consideration by the Borrower and its Restricted Subsidiaries in excess of $5,000,000; and “Material Disposition” means any Disposition of property or series of
related Dispositions of property that yields gross proceeds to the Borrower or any of its Restricted Subsidiaries in excess of $5,000,000. 

“Consolidated Fixed Charge Coverage Ratio”: for any period, the ratio of (a) the sum of (A) Consolidated EBITDA for
such period and (B) the Incremental BMP Expense (in an amount not to exceed $10,000,000) less the aggregate amount actually paid by the Borrower and its Restricted Subsidiaries during such period on account of (i) Unfinanced Capital
Expenditures (excluding Capital Expenditures made pursuant to Section 7.7(b)), (ii) Restricted Payments paid in cash (other than cash proceeds from the substantially simultaneous issuances of Capital Stock of the Borrower or capital
contributions to the Borrower (and, for the avoidance of doubt, excluding cash proceeds from the issuances of Capital Stock by or to a Subsidiary and capital contributions by or to a Subsidiary), in each case made after the Closing Date) pursuant to
Sections 7.6(b), 7.6(c), 7.6(d), 7.6(e) (other than (i) Restricted Payments under subclause (iv) of Section 7.6(d) and (ii) in the case of Sections 7.6(b), 7.6(c), 7.6(d) (other than subclause (iv) thereof) and 7.6(e),
any such Restricted Payment under such Sections but only to the extent that such Restricted Payment is related to an expense of such Parent that is an expense item which, if made by the Borrower or any Subsidiary and deducted in Consolidated Net
Income, would be added back in the calculation of Consolidated EBITDA), 7.6(f) and 7.6(g), (iii) Taxes paid in cash and (iv) cash payments (excluding cash payments financed solely with the proceeds of issuances of equity by the Borrower)
made in connection with any earn-out obligation (other than (x) earn-out obligations in connection with the Galderma Acquisition and (y) the Initial Biostructures Deferred Consideration Payment) relating to any acquisition, divestiture,
merger or similar transaction that are not accounted for or reflected in the consolidated statements of income of the Borrower and its consolidated Subsidiaries provided pursuant to Section 6.1(a) and 6.1(b) to (b) Consolidated Fixed
Charges for such period. 
 “Consolidated Fixed Charges”: for any period, the sum (without duplication) of
(a) Consolidated Interest Expense for such period and (b) scheduled payments made during such period on account of principal of Indebtedness (other than the Initial Biostructures Deferred Consideration Payment and other than any such
payment made on the Restatement Effective Date) of the Borrower or any of its Restricted Subsidiaries (including scheduled principal payments in respect of the Term Loans and payments of Revolving Loans accompanying scheduled reductions of the
Revolving Commitments). 
 “Consolidated Interest Expense”: for any period, total cash interest expense (including that
attributable to Capital Lease Obligations) of the Borrower and its Restricted Subsidiaries for such period with respect to all outstanding Indebtedness of the Borrower and its Restricted Subsidiaries (including all commissions, discounts and other
fees and charges owed with respect to letters of credit and bankers’ acceptance financing and net costs under Swap Agreements in respect of interest rates to the extent such net costs are allocable to such period in accordance with GAAP). 

  
 9 

 “Consolidated Leverage Ratio”: as at the last day of any period, the ratio of
(a) Consolidated Total Debt on such day to (b) Consolidated Adjusted EBITDA for such period. 
 “Consolidated Net
Income”: for any period, the consolidated net income (or loss) of the Borrower and its Restricted Subsidiaries, determined on a consolidated basis in accordance with GAAP; provided that there shall be excluded (a) the income (or
deficit) of any Person accrued prior to the date it becomes a Restricted Subsidiary of the Borrower or is merged into or consolidated with the Borrower or any of its Restricted Subsidiaries, (b) the income (or deficit) of any Person (other than
a Restricted Subsidiary of the Borrower) in which the Borrower or any of its Restricted Subsidiaries has an ownership interest, except to the extent that any such income is actually received by the Borrower or such Restricted Subsidiary in the form
of dividends or similar distributions, (c) the undistributed earnings of any Restricted Subsidiary of the Borrower to the extent that the declaration or payment of dividends or similar distributions by such Restricted Subsidiary is not at the
time permitted by the terms of any Contractual Obligation (other than under any Loan Document) or Requirement of Law applicable to such Restricted Subsidiary, (d) any non-cash net gain (or loss) resulting from currency translation gains or
losses related to currency remeasurements of Indebtedness (including any net gain (or loss) resulting from hedge agreements for currency exchange risk) and any foreign currency translation gain (or loss) and (e) any non-cash unrealized net gain
(or loss) resulting from obligations under Swap Agreements or other derivative instruments entered into for the purpose of hedging interest rate risk and the application of Financial Accounting Standards Board Accounting Standards Codification Topic
815, “Derivatives and Hedging,” as such Topic may be amended, updated, or supplemented from time to time. Notwithstanding the foregoing, for the purpose of calculating the Cumulative Credit only, there shall be excluded from Consolidated
Net Income, without duplication, any income consisting of dividends, repayments of loans or advances or other transfers of assets from Unrestricted Subsidiaries to the Borrower or a Restricted Subsidiary, and any income consisting of return of
capital, repayment or other proceeds from dispositions or repayments of Investments, in each case to the extent such income would be included in Consolidated Net Income and such related dividends, repayments, transfers, return of capital or other
proceeds are applied by the Group Members to increase the Cumulative Credit. 
 “Consolidated Total Assets”: the total
assets of the Borrower and its Subsidiaries on a consolidated basis as shown on the most recent balance sheet of the Borrower required to be delivered pursuant to Section 5.1(c) or Section 6.1(a) or (b) (it being understood that if
such required balance sheet is not delivered Consolidated Total Assets shall be deemed to be zero until such balance sheet is delivered). 

“Consolidated Total Debt”: at any date, the aggregate principal amount of all Indebtedness of the Borrower and its Restricted
Subsidiaries at such date, determined on a consolidated basis in accordance with GAAP. 
 “Consolidated Working Capital”:
at any date, the excess of Consolidated Current Assets on such date over Consolidated Current Liabilities on such date. 

“Contractual Obligation”: as to any Person, any provision of any security issued by such Person or of any agreement,
instrument or other undertaking to which such Person is a party or by which it or any of its property is bound. 

  
 10 

 “Controlled Investment Affiliate”: as to any Person, any other Person which
directly or indirectly is in control of, is controlled by, or is under common control with such Person and is organized by such Person (or any Person controlling such Person) primarily for making direct or indirect equity or debt investments in the
Borrower and/or other companies. 
 “Credit Party”: the Administrative Agent, the Issuing Lender, the Swingline Lenders or
any other Lender and, for the purposes of Section 10.13 only, any other Agent and the Arrangers. 
 “Cumulative
Credit”: at any date, an amount, not less than zero in the aggregate, determined on a cumulative basis equal to the sum of (without duplication): 

(a) an amount equal to (x) the cumulative amount of Excess Cash Flow (which amount shall not be less than zero in any
fiscal year) of the Borrower and its Restricted Subsidiaries for the period commencing on January 1, 2015 and ending on the last day of the most recent fiscal year for which financial statements required to be delivered pursuant to
Section 6.1(a), and the related Compliance Certificate required to be delivered pursuant to Section 6.2(b), have been received by the Administrative Agent minus (y) the portion of such Excess Cash Flow that has been (or is then
required to be) applied to the prepayment of Loans in accordance with Section 2.11(c), plus 
 (b) the Net Cash
Proceeds of any Permitted Equity Issuance after the Closing Date at such time Not Otherwise Applied, provided that for the avoidance of doubt, the amount of Net Cash Proceeds used to repay the Second Lien Loans on the Restatement Effective
Date shall not be included in the calculation of the Cumulative Credit, plus 
 (c) to the extent not included in
clause (a) above, the aggregate amount received by the Borrower or any Restricted Subsidiary from cash dividends and distributions received from any Unrestricted Subsidiaries and proceeds received in connection with the Disposition of its
equity interests in any Unrestricted Subsidiary, in each case, during the period from and including the Business Day immediately following the Closing Date through and including the date of calculation, in each case to the extent that the Investment
corresponding to the designation of such Subsidiary as an Unrestricted Subsidiary or any subsequent Investment in such Unrestricted Subsidiary, was made in reliance on the Cumulative Credit pursuant to Section 7.8(o); provided, that the
amount added to the Cumulative Credit pursuant to this clause (c) shall not exceed the amount of the Investment made in such Unrestricted Subsidiary pursuant to Section 7.8(o), plus 

(d) to the extent not included in clause (a) above, the aggregate amount of cash returns to the Borrower or any Restricted
Subsidiary in respect of Investments made pursuant to Section 7.8(o); provided, that the amount added to the Cumulative Credit pursuant to this clause (d) shall not exceed the amount of the Investment made pursuant to
Section 7.8(o), 
 as such amount shall be reduced dollar for dollar from time to time to the extent that all or a portion of the
Cumulative Credit is applied prior to such date to make Investments, Restricted Payments or Capital Expenditures to the extent permitted hereunder. 

“Declined Prepayment Amount”: as defined in Section 2.11(f). 

“Default”: any of the events specified in Section 8, whether or not any requirement for the giving of notice, the lapse
of time, or both, has been satisfied. 

  
 11 

 “Defaulting Lender”: any Lender that (a) has failed, within two Business
Days of the date required to be funded or paid, to (i) fund any portion of its Loans, (ii) fund any portion of its participations in Letters of Credit or Swingline Loans or (iii) pay over to any Credit Party any other amount required
to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender’s good faith determination that a condition precedent to funding
(specifically identified and including the particular default, if any) has not been satisfied, (b) has notified the Borrower or any Credit Party in writing, or has made a public statement to the effect, that it does not intend or expect to
comply with any of its funding obligations under this Agreement (unless such writing or public statement indicates that such position is based on such Lender’s good faith determination that a condition precedent (specifically identified and
including the particular default, if any) to funding a loan under this Agreement cannot be satisfied) or generally under other agreements in which it commits to extend credit, (c) has failed, within three Business Days after request by a Credit
Party, acting in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations (and is financially able to meet such obligations) to fund prospective Loans and participations in
then outstanding Letters of Credit and Swingline Loans under this Agreement, provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon such Credit Party’s receipt of such certification in form
and substance satisfactory to it and the Administrative Agent, or (d) has become the subject of (A) a Bankruptcy Event or (B) to the extent the Amendment and Restatement Agreement is executed by each affected Lender, a Bail-In Action.

 “Disposition”: with respect to any property, any sale, lease, sale and leaseback, assignment, conveyance, transfer or
other disposition thereof. The terms “Dispose” and “Disposed of” shall have correlative meanings. 

“Disqualified Stock”: with respect to any Person, any Capital Stock of such Person which, by its terms, or by the terms of
any security into which it is convertible or for which it is putable or exchangeable, or upon the happening of any event, matures or is mandatorily redeemable (other than for Capital Stock that is not Disqualified Stock or solely as a result of a
change of control or asset sale) pursuant to a sinking fund obligation or otherwise, or is redeemable at the option of the holder thereof (other than for Capital Stock that is not Disqualified Stock or solely as a result of a change of control or
asset sale), in whole or in part, in each case prior to the date that is 91 days after the earlier of the Maturity Date and the date the Term Loans have been permanently repaid and this Agreement is terminated (as in effect on the date of the
incurrence of such Disqualified Stock); provided that if such Capital Stock is issued to any plan for the benefit of employees of the Borrower or its Subsidiaries or by any such plan to such employees, such Capital Stock shall not constitute
Disqualified Stock solely because it may be required to be repurchased by the Borrower or its Subsidiaries in order to satisfy applicable statutory or regulatory obligations. 

“Dollars” and “$”: dollars in lawful currency of the United States. 

“Dollar Equivalent”: at any time as to any amount denominated in any Agreed Currency other than Dollars, the equivalent
amount in Dollars as determined by the Administrative Agent at such time on the basis of the Exchange Rate for the purchase of Dollars with such Agreed Currency, on the most recent Calculation Date for such currency. 

“Domestic Subsidiary”: any Subsidiary of the Borrower organized under the laws of the United States, any state thereof or the
District of Columbia, other than a Foreign Subsidiary Holdco. 
 “ECF Percentage”: 50%; provided, that the ECF
Percentage shall be reduced to (a) 25% if the Consolidated Leverage Ratio as of the last day of such fiscal year is less than 3.00 to 1.00 but greater than or equal to 2.00 to 1.00 and (b) 0% if the Consolidated Leverage Ratio as of
the last day of such fiscal year is less than 2.00 to 1.00. 

  
 12 

 “EEA Financial Institution”: (a) any institution established in any EEA
Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any
institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent. 

“EEA Member Country”: any of the member states of the European Union, Iceland, Liechtenstein, and Norway. 

“EEA Resolution Authority”: any public administrative authority or any Person entrusted with public administrative authority
of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution. 

“Eligible Currency”: any currency other than Dollars (i) that is readily available, (ii) that is freely traded,
(iii) in which deposits are customarily offered to banks in the London interbank market, (iv) that is convertible into Dollars in the international interbank market and (v) as to which a Dollar Equivalent may be readily calculated.
If, after the designation by the Issuing Lender of any currency as an Agreed Currency, (x) currency control or other exchange regulations are imposed in the country in which such currency is issued with the result that different types of such
currency are introduced, (y) such currency is, in the reasonable determination of the Issuing Lender, no longer readily available or freely traded or (z) in the reasonable determination of the Issuing Lender, a Dollar Equivalent Amount of
such currency is not readily calculable, the Issuing Lender shall promptly notify the L/C Participants and the Borrower, and such currency shall no longer be an Agreed Currency until such time as the Issuing Lender agrees to reinstate such currency
as an Agreed Currency. 
 “EMU”: the European Economic and Monetary Union in accordance with the Treaty of Rome 1957, as
amended by the Single European Act 1986, the Maastricht Treaty of 1992 and the Amsterdam Treaty of 1998. 
 “EMU
Legislation”: the legislative measures of the European Union for the introduction of, changeover to or operation of the Euro in one or more member states of the European Union. 

“Environmental Laws”: any and all foreign, Federal, state, local or municipal laws, rules, orders, regulations, statutes,
ordinances, codes, decrees, requirements of any Governmental Authority or other Requirements of Law (including common law) regulating, relating to or imposing liability or standards of conduct concerning protection of human health or the
environment, as now or may at any time hereafter be in effect. 
 “ERISA”: the Employee Retirement Income Security Act of
1974, as amended from time to time. 
 “ERISA Affiliate”: any trade or business (whether or not incorporated) that,
together with any Group Member, is treated as a single employer under Section 414 of the Code. 
 “ERISA Event”:
(a) the failure of any Plan to comply with any material provisions of ERISA and/or the Code (and applicable regulations under either) or with the material terms of such Plan; (b) the existence with respect to any Plan of a non-exempt
Prohibited Transaction; (c) the failure of any insured medical Plan to satisfy the non-discrimination requirements of Section 105 of the Code; (d) any Reportable Event; (e) the failure of any Group Member or ERISA Affiliate to
make by its due date a required installment under Section 430(j) of the Code with respect to any Pension Plan or any failure by any Pension Plan to satisfy the minimum funding standards (within the meaning of Section 412 of the

  
 13 

 
Code or Section 302 of ERISA) applicable to such Pension Plan, whether or not waived; (f) a determination that any Pension Plan is, or is expected to be, in “at risk” status
(within the meaning of Section 430 of the Code or Section 303 of ERISA); (g) the filing pursuant to Section 412 of the Code or Section 302 of ERISA of an application for a waiver of the minimum funding standard with respect
to any Pension Plan; (h) the occurrence of any event or condition which might constitute grounds under ERISA for the termination of, or the appointment of a trustee to administer, any Pension Plan or the incurrence by any Group Member or any
ERISA Affiliate of any liability under Title IV of ERISA with respect to the termination of any Pension Plan, including but not limited to the imposition of any Lien in favor of the PBGC or any Pension Plan; (i) the receipt by any Group Member
or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Pension Plan or to appoint a trustee to administer any Pension Plan under Section 4042 of ERISA; (j) the failure by any
Group Member or any of its ERISA Affiliates to make any required contribution to a Multiemployer Plan pursuant to Sections 431 or 432 of the Code; (k) the incurrence by any Group Member or any ERISA Affiliate of any liability with respect to
the withdrawal or partial withdrawal from any Pension Plan or Multiemployer Plan; (l) the receipt by any Group Member or any ERISA Affiliate of any notice, or the receipt by any Multiemployer Plan from a Group Member or any ERISA Affiliate of
any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, Insolvent, in Reorganization, in “endangered” or “critical” status (within the meaning of
Section 432 of the Code or Section 305 of ERISA), or terminated (within the meaning of Section 4041A of ERISA); or (m) the failure by any Group Member or any of its ERISA Affiliates to pay when due (after expiration of any
applicable grace period) any installment payment with respect to Withdrawal Liability under Section 4201 of ERISA. 
 “EU
Bail-In Legislation Schedule”: the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor Person), as in effect from time to time. 

“Euro”: the single currency unit of the member states of the European Union that have the euro as its lawful currency in
accordance with the EMU Legislation. 
 “Eurocurrency Reserve Requirements”: for any day as applied to a Eurodollar Loan,
the aggregate (without duplication) of the maximum rates (expressed as a decimal fraction) of reserve requirements in effect on such day (including basic, supplemental, marginal and emergency reserves) under any regulations of the Board or other
Governmental Authority having jurisdiction with respect thereto dealing with reserve requirements prescribed for eurocurrency funding (currently referred to as “Eurocurrency Liabilities” in Regulation D of the Board) maintained by a member
bank of the Federal Reserve System. 
 “Eurodollar Base Rate”: with respect to any Eurodollar Loan for any Interest Period,
the Screen Rate at approximately 11:00 A.M., London time, two Business Days prior to the commencement of such Interest Period; provided, that if the Screen Rate shall not be available at such time for such Interest Period (an
“Impacted Interest Period”) with respect to Dollars, then the Eurodollar Base Rate shall be the Interpolated Rate at such time. 

“Eurodollar Loans”: Loans the rate of interest applicable to which is based upon the Eurodollar Rate. 

“Eurodollar Rate”: with respect to each day during each Interest Period pertaining to a Eurodollar Loan, a rate per annum
determined for such day in accordance with the following formula: 
  

	
	                                Eurodollar Base
Rate                                
	1.00 - Eurocurrency Reserve Requirements

  
 14 

 “Eurodollar Tranche”: the collective reference to Eurodollar Loans under a
particular Facility the then current Interest Periods with respect to all of which begin on the same date and end on the same later date (whether or not such Loans shall originally have been made on the same day). 

“Event of Default”: any of the events specified in Section 8, provided, that any requirement for the giving of
notice, the lapse of time, or both, has been satisfied. 
 “Excess Cash Flow”: for any fiscal year of the Borrower, the
excess, if any, of (a) the sum, without duplication, of (i) Consolidated Net Income for such fiscal year, (ii) the amount of all non-cash charges (including depreciation and amortization) deducted in arriving at such Consolidated Net
Income, (iii) decreases in Consolidated Working Capital for such fiscal year, and (iv) the aggregate net amount of non-cash loss on the Disposition of property by the Borrower and its Restricted Subsidiaries during such fiscal year (other
than sales of inventory in the ordinary course of business), to the extent deducted in arriving at such Consolidated Net Income over (b) the sum, without duplication, of (i) the amount of all non-cash credits included in arriving at
such Consolidated Net Income, (ii) the aggregate amount actually paid by the Borrower and its Restricted Subsidiaries in cash during such fiscal year on account of Capital Expenditures (excluding the principal amount of Indebtedness (other than
Revolving Loans and Swingline Loans) incurred in connection with such expenditures and any such expenditures financed with the proceeds of any Reinvestment Deferred Amount), (iii) the aggregate amount of all prepayments of Revolving Loans and
Swingline Loans during such fiscal year to the extent accompanying permanent optional reductions of the Revolving Commitments and all optional prepayments of the Term Loans during such fiscal year, (iv) the aggregate amount of all regularly
scheduled principal payments of Funded Debt (including the Term Loans) of the Borrower and its Restricted Subsidiaries made during such fiscal year (other than in respect of any revolving credit facility to the extent there is not an equivalent
permanent reduction in commitments thereunder), (v) increases in Consolidated Working Capital for such fiscal year, (vi) the aggregate net amount of non-cash gain on the Disposition of property by the Borrower and its Restricted
Subsidiaries during such fiscal year (other than sales of inventory in the ordinary course of business), to the extent (x) included in arriving at such Consolidated Net Income and (y) such payments are not made with the Cumulative Credit
and (vii) the amount of Restricted Payments paid in cash during such period pursuant to Section 7.6(b), 7.6(c), 7.6(d), 7.6(e) (other than (i) Restricted Payments under subclause (iv) of Section 7.6(d) and (ii) in the
case of Sections 7.6(b), 7.6(c), 7.6(d) (other than subclause (iv) thereof) and 7.6(e), any such Restricted Payment under such Sections but only to the extent that such Restricted Payment is related to an expense of such Parent that is an
expense item which, if made by the Borrower or any Subsidiary and deducted in Consolidated Net Income, would be added back in the calculation of Consolidated EBITDA), 7.6(f) and 7.6(g), to the extent that such Restricted Payments were financed with
Internally Generated Cash Flow. 
 “Excess Cash Flow Application Date”: as defined in Section 2.11(c). 

“Exchange Act”: the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated
thereunder from time to time. 
 “Exchange Rate”: on any day, for purposes of determining the Dollar Equivalent of any
Eligible Currency, the rate at which such other currency may be exchanged into Dollars at the time of determination on such day on the Bloomberg WCR Page for such currency. If such rate does not appear on any Bloomberg WCR Page, the Exchange Rate
shall be determined by reference to such other publicly available service for displaying exchange rates as may be selected by the Administrative Agent, or, in the event no such service is selected, such Exchange Rate shall instead be the arithmetic
average of the spot rates of exchange of the Administrative Agent in the market where its foreign currency exchange operations in respect of such currency are then being conducted, at or about such time as the

  
 15 

 
Administrative Agent shall elect after determining that such rates shall be the basis for determining the Exchange Rate, on such date for the purchase of Dollars for delivery two Business Days
later; provided that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent, after consultation with the Company, may use any reasonable method it deems in good faith appropriate to
determine such rate, and such determination shall be presumed correct absent manifest error. 
 “Excluded Swap Obligation”:
with respect to any Guarantor, (a) any Swap Obligation if, and to the extent that, and only for so long as, all or a portion of the guarantee of such Guarantor of, or the grant by such Guarantor of a security interest to secure, as applicable,
such Swap Obligation (or any guarantee thereof) is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by
virtue of such Guarantor’s failure to constitute an “eligible contract participant,” as defined in the Commodity Exchange Act and the regulations thereunder, at the time the guarantee of (or grant of such security interest by, as
applicable) such Guarantor becomes or would become effective with respect to such Swap Obligation or (b) any other Swap Obligation designated as an “Excluded Swap Obligation” of such Guarantor as specified in any agreement between the
relevant Loan Parties and counterparty applicable to such Swap Obligations, and agreed by the Administrative Agent. If a Swap Obligation arises under a master agreement governing more than one Swap, such exclusion shall apply only to the portion of
such Swap Obligation that is attributable to Swaps for which such guarantee or security interest is or becomes illegal. 
 “Excluded
Taxes”: any of the following Taxes imposed on or with respect to a Credit Party or required to be withheld or deducted from a payment to a Credit Party, (a) Taxes imposed on or measured by net income (however denominated), franchise
Taxes, and branch profits Taxes, in each case, (i) imposed as a result of such Credit Party being organized under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the
jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) in the case of a Lender, U.S. Federal withholding Taxes imposed on amounts payable to or for the account of such Lender with
respect to an applicable interest in a Loan or Commitment pursuant to a law in effect on the date on which (i) such Lender acquires such interest in the Loan or Commitment (other than pursuant to an assignment request by the Borrower under
Section 2.22) or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to Section 2.19, amounts with respect to such Taxes were payable either to such Lender’s assignor immediately before
such Lender acquired the applicable interest in a Loan or Commitment or to such Lender immediately before it changed its lending office, (c) Taxes attributable to such Credit Party’s failure to comply with Section 2.19(f) and
(d) any U.S. Federal withholding Taxes imposed under FATCA. 
 “Existing Debt”: collectively, (a) the
Indebtedness under the Loan and Security Agreement, dated as of June 11, 2013, among the Borrower, Exogen, Inc., Bioventus Cooperatief U.A., and HSBC Bank USA, National Association and (b) the Senior Secured Note issued by the Borrower in
favor of Smith & Nephew, Inc. 
 “Extended Revolving Commitment”: as defined in Section 2.25(a). 

“Extended Revolving Loans”: as defined in Section 2.25(a). 

“Extended Term Loans”: as defined in Section 2.25(a). 

“Extension”: as defined in Section 2.25(a). 

  
 16 

 “Extension Offer”: as defined in Section 2.25(a). 

“Facility”: each of (a) the Term Commitments and the Term Loans made thereunder (the “Term Facility”)
and (b) the Revolving Commitments and the extensions of credit made thereunder (the “Revolving Facility”). 

“Fair Market Value”: the value that would be paid by a willing buyer to an unaffiliated willing seller in a transaction not
involving distress or necessity of either party, determined in good faith by the Board of Directors, chief executive officer or chief financial officer of the Borrower. 

“FATCA”: Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that
is substantively comparable and not materially more onerous to comply with), any current or future regulations issued thereunder or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any
intergovernmental agreement entered into in connection with any of the foregoing. 
 “Federal Funds Effective Rate”: for
any day, the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers, as published on the next succeeding Business Day by the NYFRB, or, if such rate is not
so published for any day that is a Business Day, the average of the quotations for the day of such transactions received by JPMorgan Chase Bank, N.A. from three federal funds brokers of recognized standing selected by it in good faith. If the
Federal Funds Effective Rate shall be less than zero it shall be deemed zero for purposes of this Agreement. 
 “Fee
Letter”: the Fee Letter, dated as of July 22, 2014, among the Borrower, J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. 

“Fee Payment Date”: (a) the third Business Day following the last day of each March, June, September and December and
(b) the last day of the Revolving Commitment Period. 
 “Foreign Benefit Arrangement”: any employee benefit
arrangement mandated by non-US law that is maintained or contributed to by any Group Member or any ERISA Affiliate. 
 “Foreign
Currency Letter of Credit”: a Letter of Credit denominated in any Available Currency. 
 “Foreign Plan”: each
employee benefit plan (within the meaning of Section 3(3) of ERISA, whether or not subject to ERISA) that is not subject to U.S. law and is maintained or contributed to by any Group Member or any ERISA Affiliate. 

“Foreign Plan Event”: with respect to any Foreign Benefit Arrangement or Foreign Plan, (a) the failure to make or, if
applicable, accrue in accordance with normal accounting practices, any employer or employee contributions required by applicable law or by the terms of such Foreign Benefit Arrangement or Foreign Plan; (b) the failure to register or loss of
good standing with applicable regulatory authorities of any such Foreign Benefit Arrangement or Foreign Plan required to be registered; or (c) the failure of any Foreign Benefit Arrangement or Foreign Plan to comply with any material provisions
of applicable law and regulations or with the material terms of such Foreign Benefit Arrangement or Foreign Plan. 
 “Foreign
Subsidiary”: any Subsidiary of the Borrower that is not a Domestic Subsidiary. 

  
 17 

 “Foreign Subsidiary Holdco”: means any Domestic Subsidiary that has no material
assets other than equity interests and/or indebtedness of one or more Foreign Subsidiaries. 
 “Funded Debt”: as to any
Person, all Indebtedness of such Person that matures more than one year from the date of its creation or matures within one year from such date but is renewable or extendible, at the option of such Person, to a date more than one year from such date
or arises under a revolving credit or similar agreement that obligates the lender or lenders to extend credit during a period of more than one year from such date, including all current maturities and current sinking fund payments in respect of such
Indebtedness whether or not required to be paid within one year from the date of its creation and, in the case of the Borrower and its Restricted Subsidiaries, Indebtedness in respect of the Loans and the Second Lien Loans (or, in the case of the
Second Lien Loans, any Permitted Refinancing Indebtedness in respect thereof) . 
 “Funding Office”: the office of the
Administrative Agent specified in Section 10.2 or such other office as may be specified from time to time by the Administrative Agent as its funding office by written notice to the Borrower and the Lenders. 

“GAAP”: generally accepted accounting principles in the United States as in effect from time to time. 

“Galderma Acquisition”: the Borrower’s acquisition on December 31, 2013 of commercialization and related rights to
the Durolane product outside the United States pursuant to the Amendment to License Agreement and Supply Agreement dated as of December 31, 2013, among Galderma S.A., Q-Med AB, Bioventus Cooperatief UA and the Borrower, and the Amended and
Restated License Agreement – Worldwide Excluding the US (ROW) dated as of December 31, 2013, among Galderma S.A., Q-Med AB, and the Borrower. 

“Global Intercompany Note”: a promissory note, in form and substance reasonably satisfactory to the Administrative Agent,
evidencing Indebtedness owed among the Loan Parties and their Subsidiaries. 
 “Governmental Authority”: any nation or
government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of
or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank), any securities exchange and any self-regulatory organization (including the National Association of Insurance Commissioners).

 “Group Members”: the collective reference to the Borrower and its Restricted Subsidiaries. 

“Guarantee and Collateral Agreement”: the First Lien Guarantee and Collateral Agreement executed and delivered by the
Borrower and each Subsidiary Guarantor on the Closing Date, substantially in the form of Exhibit A. 
 “Guarantee
Obligation”: as to any Person (the “guaranteeing person”), any obligation, including a reimbursement, counterindemnity or similar obligation, of the guaranteeing Person that guarantees or in effect guarantees, or which is
given to induce the creation of a separate obligation by another Person (including any bank under any letter of credit) that guarantees or in effect guarantees, any Indebtedness, leases, dividends or other obligations (the “primary
obligations”) of any other third Person (the “primary obligor”) in any manner, whether directly or indirectly, including any obligation of the 

  
 18 

 
guaranteeing person, whether or not contingent, (i) to purchase any such primary obligation or any property constituting direct or indirect security therefor, (ii) to advance or supply
funds (1) for the purchase or payment of any such primary obligation or (2) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (iii) to
purchase property, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation or (iv) otherwise to assure or hold
harmless the owner of any such primary obligation against loss in respect thereof; provided, however, that the term Guarantee Obligation shall not include endorsements of instruments for deposit or collection in the ordinary course of
business. The amount of any Guarantee Obligation of any guaranteeing person shall be deemed to be the lower of (a) an amount equal to the stated or determinable amount of the primary obligation in respect of which such Guarantee Obligation is
made and (b) the maximum amount for which such guaranteeing person may be liable pursuant to the terms of the instrument embodying such Guarantee Obligation, unless such primary obligation and the maximum amount for which such guaranteeing
person may be liable are not stated or determinable, in which case the amount of such Guarantee Obligation shall be such guaranteeing person’s maximum reasonably anticipated liability in respect thereof as determined by the Borrower in good
faith. 
 “Guarantors”: the collective reference to the Subsidiary Guarantors. 

“Increased Facility Activation Date”: any Business Day on which any Lender shall execute and deliver to the Administrative
Agent an Increased Facility Activation Notice pursuant to Section 2.24(a). 
 “Increased Facility Activation Notice”:
a notice substantially in the form of Exhibit H-1 or H-2, as applicable. 
 “Increased Facility Closing
Date”: any Business Day designated as such in an Increased Facility Activation Notice. 
 “Increased Revolving
Commitments”: as defined in Section 2.24(a). 
 “Incremental BMP Expense”: the excess of (a) research
and development expenses related to bone morphogenetic protein of the Borrower and its Restricted Subsidiaries recorded during the fiscal year ended December 31, 2016 over (b) the amount of such expenses recorded during the fiscal year
ended December 31, 2015. 
 “Incremental Facilities”: as defined in Section 2.24(a). 

“Incremental Term Facility”: as defined in Section 2.24(a). 

“Incremental Term Lenders”: (a) on any Increased Facility Activation Date relating to Incremental Term Loans, the
Lenders signatory to the relevant Increased Facility Activation Notice and (b) thereafter, each Lender that is a holder of an Incremental Term Loan. 

“Incremental Term Loans”: any term loans made pursuant to Section 2.24(a). 

“Incremental Term Maturity Date”: with respect to the Incremental Term Loans to be made pursuant to any Increased Facility
Activation Notice, the maturity date specified in such Increased Facility Activation Notice, which date shall not be earlier than the final maturity of the Term Loans. 

  
 19 

 “Indebtedness”: of any Person at any date, without duplication, (a) all
indebtedness of such Person for borrowed money, (b) all obligations of such Person for the deferred purchase price of property or services (other than trade payables incurred in the ordinary course of such Person’s business and not more
than 90 days past due); provided, that any obligations of such Person for the deferred purchase price of property or services incurred pursuant to (x) the Galderma Acquisition or (y) the Project Sandal Acquisition shall not be
Indebtedness; (c) all obligations of such Person evidenced by notes, bonds, debentures or other similar instruments, (d) all indebtedness created or arising under any conditional sale or other title retention agreement with respect to
property acquired by such Person (even though the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property), (e) all Capital Lease Obligations of such Person,
(f) all obligations of such Person, contingent or otherwise, as an account party or applicant under or in respect of acceptances, letters of credit, surety bonds or similar arrangements, (g) all Guarantee Obligations of such Person in
respect of obligations of the kind referred to in clauses (a) through (f) above, (h) all obligations of the kind referred to in clauses (a) through (g) above secured by (or for which the holder of such obligation has an
existing right, contingent or otherwise, to be secured by) any Lien on property (including accounts and contract rights) owned by such Person, whether or not such Person has assumed or become liable for the payment of such obligation;
provided, that if such Person has not assumed or become liable therefor then the amount of such obligations shall be deemed to be the lesser of (x) the Fair Market Value (determined as of the time such Lien was granted) of such property
and (y) the amount of such secured obligations, and (i) for the purposes of Section 8.1(e) only, all obligations of such Person in respect of Swap Agreements. The Indebtedness of any Person shall include the Indebtedness of any other
entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person’s ownership interest in or other relationship with such entity, except to the extent the terms
of such Indebtedness expressly provide that such Person is not liable therefor. 
 “Indemnified Liabilities”: as defined in
Section 10.5. 
 “Indemnified Taxes”: (a) Taxes, other than Excluded Taxes, imposed on or with respect to any
payment made by or on account of any obligation of any Loan Party under any Loan Document and (b) to the extent not otherwise described in clause (a) above, Other Taxes. 

“Indemnitee”: as defined in Section 10.5. 

“Initial Biostructures Deferred Consideration Payment”: the initial payment in the amount of $25,000,000 payable pursuant to
Section 2.3(a)(i) of the Biostructures Purchase Agreement. 
 “Insolvent”: with respect to any Multiemployer Plan, the
condition that such plan is insolvent within the meaning of Section 4245 of ERISA. 
 “Intellectual Property”: the
collective reference to all rights, priorities and privileges relating to intellectual property, whether arising under United States, multinational or foreign laws or otherwise, including copyrights, copyright licenses, patents, patent licenses,
trademarks, trademark licenses, domain names, social media identifiers, trade secrets, technology, know-how and processes, and all rights to sue at law or in equity for any infringement or other impairment thereof, including the right to receive all
proceeds and damages therefrom. 
 “Intercreditor Agreement”: the Intercreditor Agreement, dated as of the Closing Date,
among the Loan Parties, the Administrative Agent and the Second Lien Administrative Agent, substantially in the form of Exhibit I. 

  
 20 

 “Interest Payment Date”: (a) as to any ABR Loan (other than any Swingline
Loan), the last day of each March, June, September and December (or, if an Event of Default is in existence, the last day of each calendar month) to occur while such Loan is outstanding and the final maturity date of such Loan, (b) as to any
Eurodollar Loan having an Interest Period of three months or less, the last day of such Interest Period, (c) as to any Eurodollar Loan having an Interest Period longer than three months, each day that is three months, or a whole multiple
thereof, after the first day of such Interest Period and the last day of such Interest Period, (d) as to any Loan (other than any Revolving Loan that is an ABR Loan and any Swingline Loan), the date of any repayment or prepayment made in
respect thereof (but only with respect to the principal being repaid or prepaid on such date) and (e) as to any Swingline Loan, the day that such Loan is required to be repaid. 

“Interest Period”: as to any Eurodollar Loan, (a) initially, the period commencing on the borrowing or conversion date,
as the case may be, with respect to such Eurodollar Loan and ending one, two, three or six months thereafter, as selected by the Borrower in its notice of borrowing or notice of conversion, as the case may be, given with respect thereto; and
(b) thereafter, each period commencing on the last day of the next preceding Interest Period applicable to such Eurodollar Loan and ending one, two, three or six months thereafter, as selected by the Borrower by irrevocable notice to the
Administrative Agent not later than 11:00 A.M., New York City time, on the date that is three Business Days prior to the last day of the then current Interest Period with respect thereto; provided that, all of the foregoing provisions
relating to Interest Periods are subject to the following: 
 (i) if any Interest Period would otherwise end on a day that is not a Business
Day, such Interest Period shall be extended to the next succeeding Business Day unless the result of such extension would be to carry such Interest Period into another calendar month in which event such Interest Period shall end on the immediately
preceding Business Day; 
 (ii) the Borrower may not select an Interest Period under a particular Facility that would extend beyond the
Revolving Termination Date (or, with respect to any Extended Revolving Loans, the maturity date with respect thereto) or beyond the date final payment is due on the relevant Term Loans, as the case may be (or, with respect to any Extended Term Loans
or any Loans under any Incremental Term Facility, the maturity date with respect thereto); 
 (iii) any Interest Period that begins on the
last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of a calendar month; and 

(iv) the Borrower shall select Interest Periods so as not to knowingly require a payment or prepayment of any Eurodollar Loan during an
Interest Period for such Loan. 
 “Internally Generated Cash Flow”: funds not constituting (i) proceeds of debt
issuances (excluding borrowings under the Revolving Facility and any other revolving lines of credit), (ii) proceeds of equity issuances or (iii) a reinvestment by Borrower or any Restricted Subsidiary of the Net Cash Proceeds of any
Disposition due to any casualty event or condemnation proceeding pursuant to Section 7.5(g). 
 “Interpolated Rate”:
at any time, for any Interest Period, the rate per annum(rounded to the same number of decimal places as the Screen Rate) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal
to the rate that results from interpolating on a linear basis between: (a) the Screen Rate for the longest period (for which that Screen Rate is available in Dollars) that is shorter than the Impacted Interest Period and (b) the Screen
Rate for the shortest period (for which that Screen Rate is available for Dollars) that exceeds the Impacted Interest Period, in each case, at such time. 

  
 21 

 “Investments”: as defined in Section 7.8. 

“IPO”: the first public offering by a Qualified IPO Issuer of its Capital Stock after the Closing Date pursuant to a
registration statement that has been declared effective by the United States Securities and Exchange Commission. 
 “IRS”:
the United States Internal Revenue Service. 
 “Issuing Lender”: each of JPMorgan Chase Bank, N.A. and any other Revolving
Lender approved by the Administrative Agent and the Borrower that has agreed in its sole discretion to act as an “Issuing Lender” hereunder, or any of their respective affiliates, in each case in its capacity as issuer of any Letter of
Credit. Each reference herein to “the Issuing Lender” shall be deemed to be a reference to the relevant Issuing Lender. 

“Judgment Currency”: as defined in Section 10.19(c) 

“L/C Commitment”: $5,000,000. 

“L/C Exposure”: at any time, the total L/C Obligations. The L/C Exposure of any Revolving Lender at any time shall be its
Revolving Percentage of the total L/C Exposure at such time. 
 “L/C Obligations”: at any time, an amount equal to the sum
of (a) the aggregate then undrawn and unexpired amount of the then outstanding Letters of Credit and (b) the aggregate amount of drawings under Letters of Credit that have not then been reimbursed pursuant to Section 3.5;
provided, that such calculation shall, with respect to Foreign Currency Letters of Credit, be made using the Dollar Equivalent of any Foreign Currency Letters of Credit with respect to amounts denominated in Available Foreign Currencies. 

“L/C Participants”: the collective reference to all the Revolving Lenders other than the Issuing Lender. 

“Lender Parent”: with respect to any Lender, any Person as to which such Lender is, directly or indirectly, a Subsidiary.

 “Lenders”: as defined in the preamble hereto. 

“Letters of Credit”: as defined in Section 3.1(a). 

“Lien”: any mortgage, pledge, hypothecation, assignment, deposit arrangement, encumbrance, lien (statutory or other), charge
or other security interest or any preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any capital lease having
substantially the same economic effect as any of the foregoing). 
 “Loan”: any loan made by any Lender pursuant to this
Agreement. 

  
 22 

 “Loan Documents”: this Agreement, Amendment No. 1, the Amendment and
Restatement Agreement, the Security Documents, the Notes, any intercreditor agreement entered into pursuant to Section 10.18 and any amendment, waiver, supplement or other modification to any of the foregoing. 

“Loan Parties”: each Group Member that is a party to a Loan Document. 

“Majority Facility Lenders”: with respect to any Facility, the holders of more than 50% of the aggregate unpaid principal
amount of the Term Loans or the Total Revolving Extensions of Credit, as the case may be, outstanding under such Facility (or, in the case of the Revolving Facility, prior to any termination of the Revolving Commitments, the holders of more than 50%
of the Total Revolving Commitments). 
 “Material Adverse Effect”: a material adverse effect on (a) the business,
property, operations or financial condition of the Borrower and its Restricted Subsidiaries taken as a whole or (b) the validity or enforceability of this Agreement or any of the other Loan Documents or the rights or remedies of the
Administrative Agent or the Lenders hereunder or thereunder. 
 “Materials of Environmental Concern”: any gasoline or
petroleum (including crude oil or any fraction thereof) or petroleum products or any hazardous or toxic substances, materials or wastes, defined or regulated as such in or under any Environmental Law, including asbestos, polychlorinated biphenyls
and urea-formaldehyde insulation. 
 “Maturity Date”: October 10, 2019. 

“Minimum Extension Condition”: as defined in Section 2.25(b). 

“Minimum Tranche Amount”: as defined in Section 2.25(b). 

“Mortgaged Properties”: the owned real properties listed on Schedule 1.1B, as to which the Administrative Agent for
the benefit of the Lenders shall be granted a Lien pursuant to the Mortgages, and such other real property required to be made subject to a Mortgage pursuant to this Agreement. 

“Mortgages”: each of the mortgages and deeds of trust made by any Loan Party in favor of, or for the benefit of, the
Administrative Agent for the benefit of the Lenders, in form and substance reasonably satisfactory to the Administrative Agent and the Borrower and containing such provisions as shall be advisable under the law of the jurisdiction in which such
mortgage or deed of trust is to be recorded. 
 “Multiemployer Plan”: a multiemployer plan as defined in
Section 4001(a)(3) of ERISA. 
 “Net Cash Proceeds”: (a) in connection with any Asset Sale or any Recovery Event,
the proceeds thereof in the form of cash and Cash Equivalents (including any such proceeds received by way of deferred payment of principal pursuant to a note or installment receivable or purchase price adjustment receivable or otherwise, but only
as and when received), net of attorneys’ fees, accountants’ fees, investment banking fees, amounts required to be applied to the repayment of Indebtedness secured by a Lien expressly permitted hereunder on any asset that is the subject of
such Asset Sale or Recovery Event (other than any Lien pursuant to a Security Document) and other customary fees and expenses actually incurred in connection therewith and net of taxes paid or reasonably estimated to be payable as a result thereof
(after taking into account any available tax credits or deductions and any tax sharing arrangements); provided, that “Net Cash Proceeds” in respect of an Asset Sale shall not include any portion of such proceeds that the Borrower
determines in good faith (and notifies the Administrative Agent) should be reserved for post-closing adjustments until such time (not later than six months 

  
 23 

 
following the closing of such Asset Sale) as all such post-closing adjustments have been determined, at which time the excess (if any) of such reserves over such adjustments shall be deemed
“Net Cash Proceeds,” and (b) in connection with any issuance or sale of Capital Stock or any incurrence of Indebtedness, the cash proceeds received from such issuance or incurrence, net of attorneys’ fees, investment banking
fees, accountants’ fees, underwriting discounts and commissions and other customary fees and expenses actually incurred in connection therewith. 

“New Lender Supplement”: as defined in Section 2.24(b). 

“Non-U.S. Lender”: (a) if the Borrower is a U.S. Person, a Lender, with respect to the Borrower, that is not a U.S.
Person, and (b) if the Borrower is not a U.S. Person, a Lender, with respect to the Borrower, that is resident or organized under the laws of a jurisdiction other than that in which the Borrower is resident for tax purposes. 

“Not Otherwise Applied”: with reference to any proceeds of any transaction or event or of Excess Cash Flow or the Cumulative
Credit that is proposed to be applied to a particular use or transaction, that such amount (a) was not required to prepay Loans pursuant to Section 2.11(c) and (b) has not previously been (and is not simultaneously being) applied to
anything other than such particular use or transaction. 
 “Notes”: the collective reference to any promissory note
evidencing Loans. 
 “NYFRB”: the Federal Reserve Bank of New York. 

“NYFRB Rate”: for any day, the greater of (a) the Federal Funds Effective Rate in effect on such day and (b) the
Overnight Bank Funding Rate in effect on such day (or for any day that is not a Business Day, for the immediately preceding Business Day); provided that if none of such rates are published for any day that is a Business Day, the term “NYFRB
Rate” means the rate for a federal funds transaction quoted at 11:00 A.M., New York City time, on such day received to the Administrative Agent from a Federal funds broker of recognized standing selected by it; provided, further,
that if any of the aforesaid rates shall be less than zero, such rate shall be deemed to be zero for purposes of this Agreement. 

“Obligations”: the unpaid principal of and interest on (including interest accruing after the maturity of the Loans and
Reimbursement Obligations and interest accruing after the filing of any petition in bankruptcy, or the commencement of any insolvency, reorganization or like proceeding, relating to the Borrower, whether or not a claim for post-filing or
post-petition interest is allowed or allowable in such proceeding) the Loans and all other obligations and liabilities of the Borrower to the Administrative Agent or to any Lender (or, in the case of obligations and liabilities under
(a) Specified Swap Agreements, to a Person party thereto that is a Lender or an Affiliate of a Lender at the time such Specified Swap Agreement is entered into (or, in respect of any Swap Agreement entered into prior to the Closing Date, to any
Person party thereto that is a Lender or an Affiliate of a Lender on the Closing Date), notwithstanding whether such Person subsequently ceases at any time to be a Lender or an Affiliate thereof under this Agreement for any reason, and
(b) Specified Cash Management Agreements, to any affiliate of any Lender), whether direct or indirect, absolute or contingent, due or to become due, or now existing or hereafter incurred, in each case arising under, out of, or in connection
with, this Agreement, any other Loan Document, the Letters of Credit, any Specified Swap Agreement, any Specified Cash Management Agreement or any other document made, delivered or given in connection herewith or therewith, whether on account of
principal, interest, reimbursement obligations, fees, indemnities, costs, expenses (including all fees, charges and disbursements of counsel to the Administrative Agent or to any Lender that are required to be paid by the Borrower pursuant hereto)
or otherwise. 

  
 24 

 “Organizational Documents”: with respect to any Person, (i) in the case of
any corporation, the certificate of incorporation or deed of incorporation and by-laws (or similar documents) of such Person, (ii) in the case of any limited liability company, the certificate or articles of formation or organization and
operating agreement or memorandum and articles of association (or similar constitutive documents) of such Person, (iii) in the case of any limited partnership, the certificate of formation and limited partnership agreement (or similar
constitutive documents) of such Person (and, where applicable, the equityholders or shareholders registry of such Person), (iv) in the case of any general partnership, the partnership agreement (or similar constitutive document) of such Person,
(v) in any other case, the functional equivalent of the foregoing, and (vi) any shareholder, voting trust or similar agreement between or among any holders of Capital Stock of such Person. 

“Other Connection Taxes”: with respect to any Credit Party, Taxes imposed as a result of a present or former connection
between such Credit Party and the jurisdiction imposing such Tax (other than connections arising from such Credit Party having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a
security interest under, engaged in any other transaction pursuant to, or enforced, any Loan Document, or sold or assigned an interest in any Loan or Loan Document). 

“Other Taxes”: all present or future stamp, court, or documentary, intangible, recording, filing or similar Taxes that arise
from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are
Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to Section 2.22). 

“Overnight Bank Funding Rate”: for any day, the rate comprised of both overnight federal funds and overnight Eurodollar
borrowings by U.S.-managed banking offices of depository institutions (as such composite rate shall be determined by the NYFRB as set forth on its public website from time to time) and published on the next succeeding Business Day by the NYFRB as an
overnight bank funding rate (from and after such date as the NYFRB shall commence to publish such composite rate). 

“Parent”: any direct or indirect parent entity of the Borrower which does not own of record any Capital Stock in any other
Person (except for any other Parent); provided that from and after the Bioventus IPO, Bioventus Inc. shall be the Parent. 

“Participant”: as defined in Section 10.6(c). 

“Participant Register”: as defined in Section 10.6(c). 

“Patriot Act”: as defined in Section 10.17. 

“PBGC”: the Pension Benefit Guaranty Corporation established pursuant to ERISA and any successor entity performing similar
functions. 
 “Pension Plan”: any Plan subject to the provisions of Title IV of ERISA or Section 412 of the Code or
Section 302 of ERISA. 
 “Permitted Acquisition”: as defined in Section 7.8(p). 

  
 25 

 “Permitted Equity Issuance”: any sale or issuance of any Capital Stock (other
than Disqualified Stock) of the Borrower or (to the extent issued to a non-Group Member) any Restricted Subsidiary or the contribution to the capital of the Borrower or (to the extent made by a non-Group Member) any Restricted Subsidiary, in each
case the proceeds of which are received by, or contributed to the preferred equity (in a form satisfactory to the Administrative Agent in its reasonable discretion) or common equity of, the Borrower or such Restricted Subsidiary, as applicable. 

“Permitted Investors”: the collective reference to Smith & Nephew, Inc., Smith & Nephew OUS, Inc., Beluga
I, Inc., Beluga II, Inc., Beluga III, Inc., Beluga IV, Inc., Beluga V, Inc., Beluga VI, Inc., Beluga VII, Inc., Beluga VII-A, Inc., and Beluga VIII, Inc., each a Delaware corporation, and their respective Controlled Investment Affiliates;
provided that to the extent any such Person transfers its beneficial ownership in the Capital Stock of the Borrower to Bioventus Inc. or any of its Controlled Investment Affiliates (including by way of merger or liquidation into Bioventus
Inc. or any of its Controlled Investment Affiliates) in exchange (directly or indirectly) for Capital Stock of Bioventus Inc. in connection with the consummation of the Bioventus IPO, Bioventus Inc. and such of its Controlled Investment Affiliates
shall also constitute Permitted Investors. 
 “Permitted Refinancing Indebtedness”: any Indebtedness of any Person issued
in exchange for or the net proceeds of which are used to extend, refinance, renew, replace, defease or refund other Indebtedness of such Person (other than Indebtedness on account of intercompany advances); provided that: 

(a) the principal amount (or accreted value, if applicable) of such Permitted Refinancing Indebtedness does not exceed the principal amount (or
accreted value, if applicable) of the Indebtedness extended, refinanced, renewed, replaced, defeased or refunded, determined as of the Closing Date or, if later, the date initially incurred (plus all accrued interest on such Indebtedness and the
amount of all expenses and premiums incurred in connection with such extension, refinancing, renewal, replacement, defeasance or refunding); 

(b) such Indebtedness has a final maturity date later than the final maturity date of, and has a Weighted Average Life to Maturity equal to or
greater than the Weighted Average Life to Maturity of, the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded; 

(c) if the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded is subordinated in right of payment to the
Obligations, the Permitted Refinancing Indebtedness with respect thereto is subordinated in right of payment to the Obligations on terms at least as favorable to the Lenders as those contained in the documentation governing the Indebtedness being
extended, refinanced, renewed, replaced, defeased or refunded; 
 (d) such Indebtedness is recourse solely to the Persons which are obligated
on the Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded; and 
 (e) if the Indebtedness being extended,
refinanced, renewed, replaced, defeased or refunded is secured by the Collateral and/or subject to intercreditor arrangements for the benefit of the Lenders, Permitted Refinancing Indebtedness must be (1) unsecured or (2) secured subject
to intercreditor arrangements on terms at least as favorable to the Lenders as those contained in the documentation governing the Indebtedness being modified, refinanced, refunded, renewed, replaced or extended, and such modification, refinancing,
refunding, renewal, replacement or extension is incurred by one or more Persons who is an obligor of the Indebtedness being modified, refinanced, refunded, renewed, replaced or extended. 

  
 26 

 “Permitted Tax Receivable Payment”: the aggregate amount of any accelerated lump
sum amounts payable pursuant to the Tax Receivable Agreement by reason of any early termination of the Tax Receivable Agreement pursuant to the terms thereof. 

“Person”: an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust,
unincorporated association, joint venture, Governmental Authority or other entity of whatever nature. 
 “Plan”: any
employee benefit plan as defined in Section 3(3) of ERISA, including any employee welfare benefit plan (as defined in Section 3(1) of ERISA), any employee pension benefit plan (as defined in Section 3(2) of ERISA but excluding any
Multiemployer Plan), and any plan which is both an employee welfare benefit plan and an employee pension benefit plan, and in respect of which any Group Member or any ERISA Affiliate is (or, if such Plan were terminated, would under
Section 4069 of ERISA be deemed to be) an “employer” as defined in section 3(5) of ERISA. 
 “Pounds
Sterling”: the lawful currency of the United Kingdom of Great Britain and Northern Ireland. 
 “Prime Rate”: the
rate of interest per annum publicly announced from time to time by JPMorgan Chase Bank, N.A. as its prime rate in effect at its principal office in New York City (the Prime Rate not being intended to be the lowest rate of interest charged by
JPMorgan Chase Bank, N.A. in connection with extensions of credit to debtors). 
 “Pro Forma Balance Sheet”: the unaudited
pro forma consolidated balance sheet of the Borrower and its consolidated subsidiaries as at June 30, 2014 (including the notes thereto). 

“Pro Forma Statement of Operations Balance Sheet”: the pro forma statement of operations of the Borrower and its consolidated
subsidiaries relating to the Pro Forma Balance Sheet. 
 “Prohibited Transaction”: as defined in Section 406 of ERISA
and Section 4975(c) of the Code. 
 “Project Sandal Acquisition”: the Borrower’s acquisition from Advanced
Biologics LLC in the fourth quarter of 2014 of certain assets and related rights to OsteoAMP products worldwide, pursuant to the Asset Purchase Agreement, among the Borrower, Advanced Biologics LLC and Amit Goval. 

“Projections”: as defined in Section 6.2(c). 

“Properties”: as defined in Section 4.17(a). 

“Public Company Costs”: costs relating to compliance with the Sarbanes-Oxley Act of 2002, as amended, and other expenses
arising out of or incidental to the Borrower’s or any Parent’s status as a public reporting company, including costs, fees and expenses (including legal, accounting and other professional fees) relating to compliance with provisions of the
Securities Act and the Exchange Act (including without limitation annual, quarterly and other periodic reports and proxy statements); and compliance with FINRA rules and the rules of securities exchanges for companies with listed equity securities;
investor relations expenses; directors’ compensation, fees and expense reimbursement; transfer agent and proxy agent fees and expenses; franchise taxes based on authorized Capital Stock; shareholder meetings and reports to shareholders;
directors’ and officers’ insurance and other executive costs, legal and other professional fees; and listing and registration fees. 

  
 27 

 “Qualified Acquisition”: any acquisition of assets or property or series of
related acquisitions of assets or property that (a) constitutes all or substantially all of the assets and property of an operating unit of a business or constitutes all or substantially all of the common stock of a Person and (b) involves
the payment of consideration by the Borrower and its Restricted Subsidiaries in excess of $25,000,000. 
 “Qualified IPO”:
any IPO of the Qualified IPO Issuer that generates Net Cash Proceeds of at least $100,000,000 (including proceeds received in connection with the exercise of any over-allotment option, if applicable). 

“Qualified IPO Issuer”: Bioventus Inc. 

“Recovery Event”: any settlement of or payment in respect of any property or casualty insurance claim or any condemnation
proceeding relating to any asset of any Group Member that yields Net Cash Proceeds in excess of $1,000,000. 

“Refinancing”: the repayment in full of the Existing Debt. 

“Refunded Swingline Loans”: as defined in Section 2.7(c). 

“Register”: as defined in Section 10.6(b). 

“Regulation U”: Regulation U of the Board as in effect from time to time. 

“Reimbursement Obligation”: the obligation of the Borrower to reimburse the Issuing Lender pursuant to Section 3.5 for
amounts drawn under Letters of Credit. 
 “Reinvestment Deferred Amount”: with respect to any Reinvestment Event, the
aggregate Net Cash Proceeds received by any Group Member in connection therewith that are not applied to prepay the Term Loans or reduce the Revolving Commitments pursuant to Section 2.11(b) as a result of the delivery of a Reinvestment Notice.

 “Reinvestment Event”: any Asset Sale or Recovery Event in respect of which the Borrower has delivered a Reinvestment
Notice. 
 “Reinvestment Notice”: a written notice executed by a Responsible Officer stating that no Event of Default has
occurred and is continuing and that the Borrower (directly or indirectly through a Restricted Subsidiary) intends and expects to use all or a specified portion of the Net Cash Proceeds of an Asset Sale or Recovery Event to acquire or repair assets
(other than current assets) useful in its business. 
 “Reinvestment Prepayment Amount”: with respect to any Reinvestment
Event, the Reinvestment Deferred Amount relating thereto less any amount expended prior to the relevant Reinvestment Prepayment Date to acquire or repair assets (other than current assets) useful in the Borrower’s business. 

“Reinvestment Prepayment Date”: with respect to any Reinvestment Event, the earlier of (a) the date occurring 12 months
after such Reinvestment Event and (b) the date on which the Borrower shall have determined not to, or shall have otherwise ceased to, acquire or repair assets (other than current assets) useful in the Borrower’s business with all or any
portion of the relevant Reinvestment Deferred Amount. 

  
 28 

 “Reorganization”: with respect to any Multiemployer Plan, the condition that
such plan is in reorganization within the meaning of Section 4241 of ERISA. 
 “Replaced Term Loans”: as defined in
Section 10.1. 
 “Replacement Term Loans”: as defined in Section 10.1. 

“Reportable Event”: any of the events set forth in Section 4043(c) of ERISA or the regulations issued thereunder, with
respect to a Pension Plan, other than those events as to which notice is waived pursuant to DOL Reg. Section 4043 as in effect on the date hereof (no matter how such notice requirement may be changed in the future). 

“Required Lenders”: at any time, the holders of more than 50% of (a) until the Closing Date, the Commitments then in
effect and (b) thereafter, the sum of (i) the aggregate unpaid principal amount of the Term Loans then outstanding and (ii) the Total Revolving Commitments then in effect or, if the Revolving Commitments have been terminated, the
Total Revolving Extensions of Credit then outstanding; provided that at any time there is more than one Lender hereunder, the “Required Lenders” shall comprise at least two unaffiliated Lenders. 

“Requirement of Law”: (i) as to any Loan Party, Subsidiary or any Person in which a Loan Party or Subsidiary owns
Capital Stock, the Certificate of Incorporation and By-Laws or other organizational or governing documents of such Person, and (ii) as to any Person, any law, treaty, rule or regulation or determination of an arbitrator or a court or other
Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject. 

“Reset Date”: as defined in Section 1.3(c). 

“Responsible Officer”: the chief executive officer, president or chief financial officer of the Borrower. 

“Restatement Effective Date”: as defined in the Amendment and Restatement Agreement. 

“Restricted Payments”: as defined in Section 7.6. 

“Restricted Subsidiary”: any Subsidiary of the Borrower other than an Unrestricted Subsidiary. 

“Revolving Commitment”: as to any Lender, the obligation of such Lender, if any, to make Revolving Loans and participate in
Swingline Loans and Letters of Credit in an aggregate principal and/or face amount not to exceed the amount set forth under the heading “Revolving Commitment” opposite such Lender’s name on Schedule 1.1A or in the Assignment
and Assumption pursuant to which such Lender became a party hereto, as the same may be changed from time to time pursuant to the terms hereof. The original amount of the Total Revolving Commitments is $40,000,000. 

“Revolving Commitment Period”: the period from and including the Restatement Effective Date to the Revolving Termination
Date. 

  
 29 

 “Revolving Extensions of Credit”: as to any Revolving Lender at any time, an
amount equal to the sum of (a) the aggregate principal amount of all Revolving Loans held by such Lender then outstanding, (b) such Lender’s Revolving Percentage of the L/C Obligations then outstanding (including the Dollar Equivalent
of L/C Obligations of Letters of Credit issued in Available Foreign Currencies) and (c) such Lender’s Revolving Percentage of the aggregate principal amount of Swingline Loans then outstanding. 

“Revolving Facility”: as defined in the definition of “Facility.” 

“Revolving Lender”: each Lender that has a Revolving Commitment or that holds Revolving Loans. 

“Revolving Loans”: as defined in Section 2.4(a). 

“Revolving Percentage”: as to any Revolving Lender at any time, the percentage which such Lender’s Revolving Commitment
then constitutes of the Total Revolving Commitments or, at any time after the Revolving Commitments shall have expired or terminated, the percentage which the aggregate principal amount of such Lender’s Revolving Loans then outstanding
constitutes of the aggregate principal amount of the Revolving Loans then outstanding; provided, that, in the event that the Revolving Loans are paid in full prior to the reduction to zero of the L/C Obligations and the Swingline Exposure,
the Revolving Percentages shall be determined in a manner designed to ensure that the other outstanding Revolving Extensions of Credit shall be held by the Revolving Lenders on a comparable basis. Notwithstanding the foregoing, in the case of
Section 2.23 when a Defaulting Lender shall exist, Revolving Percentages shall be determined without regard to any Defaulting Lender’s Revolving Commitment. 

“Revolving Termination Date”: October 10, 2019 or such earlier date as the Revolving Commitments may be terminated
hereunder. 
 “Sanctioned Country”: at any time, a country or territory that is the subject or target of any Sanctions.

 “Sanctioned Person”: at any time, (a) any Person listed in any Sanctions-related list of designated Persons
maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State or by the United Nations Security Council, the European Union or any EU member state, (b) any Person operating, organized
or resident in a Sanctioned Country or (c) any Person controlled by any such Person. 
 “Sanctions”: economic or
financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S.
Department of State or (b) the United Nations Security Council, the European Union or Her Majesty’s Treasury of the United Kingdom. 

“Screen Rate”: for any day and time, with respect to any Eurodollar Loan for any Interest Period, the London interbank
offered rate as administered by ICE Benchmark Administration (or any other Person that takes over the administration of such rate) for Dollars for a period equal in length to such Interest Period as displayed on such day and time on pages LIBOR01 or
LIBOR02 of the Reuters screen that displays such rate (or, in the event such rate does not appear on a Reuters page or screen, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other
information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion); provided that if the LIBO Screen Rate shall be less than zero, such rate shall be deemed to be zero for the
purposes of this Agreement. 

  
 30 

 “SEC”: the Securities and Exchange Commission, any successor thereto and any
analogous Governmental Authority. 
 “Second Lien Administrative Agent”: the “Administrative Agent” as defined in
the Second Lien Credit Agreement. 
 “Second Lien Credit Agreement”: the Second Lien Credit Agreement, dated as of the date
hereof, among the Borrower, the lenders party thereto, the Second Lien Administrative Agent and the other agents party thereto, as amended by Amendment No. 1 to the Second Lien Credit Agreement. 

“Second Lien Loan Documents”: the “Loan Documents” as defined in the Second Lien Credit Agreement. 

“Second Lien Loans”: the loans outstanding under the Second Lien Credit Agreement. 

“Securities Act”: the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated by the SEC
thereunder from time to time. 
 “Security Documents”: the collective reference to the Guarantee and Collateral Agreement,
the Mortgages and all other security documents hereafter delivered to the Administrative Agent granting a Lien on any property of any Person to secure the obligations and liabilities of any Loan Party under any Loan Document. 

“Solvent”: when used with respect to any Person, means that, as of any date of determination, (a) the amount of the
“present fair saleable value” of the assets of such Person, as of such date, exceeds the amount of all “liabilities of such Person, contingent or otherwise”, as of such date, as such quoted terms are determined in accordance with
applicable federal and state laws governing determinations of the insolvency of debtors, (b) the present fair saleable value of the assets of such Person will, as of such date, be greater than the amount that will be required to pay the
liability of such Person on its debts as such debts become absolute and matured, (c) such Person will not have, as of such date, an unreasonably small amount of capital with which to conduct its business, and (d) such Person will be able
to pay its debts as they mature. For purposes of this definition, (i) “debt” means liability on a “claim”, (ii) “claim” means any (x) right to payment, whether or not such a right is reduced to judgment,
liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured or unsecured or (y) right to an equitable remedy for breach of performance if such breach gives rise to a right to payment, whether
or not such right to an equitable remedy is reduced to judgment, fixed, contingent, matured or unmatured, disputed, undisputed, secured or unsecured and (iii) with respect to clause (d), the amount of any contingent liability shall be computed
as the amount that, in light of relevant facts and circumstances, represents the amount that can reasonably be expected to become an actual or matured liability. 

“Specified Cash Management Agreement”: any agreement providing for treasury, depositary, purchasing card or cash management
services, including in connection with any automated clearing house transfers of funds or any similar transactions between the Borrower or any Guarantor and any Lender or affiliate thereof, which (other than for those agreements between the Borrower
or any Guarantor and the Administrative Agent or affiliate thereof, each of which shall automatically be deemed to be a “Specified Cash Management Agreement”) has been designated by such Lender and the Borrower, by notice to the
Administrative Agent not later than 90 days after the execution and delivery by the Borrower or such Guarantor, as a “Specified Cash Management Agreement”. 

  
 31 

 “Specified Swap Agreement”: any Swap Agreement in respect of interest rates,
currency exchange rates or commodity prices entered into by the Borrower or any Guarantor and any Person that is a Lender or an affiliate of a Lender at the time such Swap Agreement is entered into (or, in respect of any Swap Agreement entered into
prior to the Closing Date, any Person that is a Lender or an Affiliate of a Lender on the Closing Date), notwithstanding whether such Person subsequently ceases at any time to be a Lender or an Affiliate thereof under this Agreement for any reason.

 “Subsidiary”: as to any Person, a corporation, partnership, limited liability company or other entity of which shares of
stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers
of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person. Unless otherwise qualified, all
references to a “Subsidiary” or to “Subsidiaries” in this Agreement shall refer to a Subsidiary or Subsidiaries of the Borrower. 

“Subsidiary Guarantor”: each Restricted Subsidiary of the Borrower that is a Domestic Subsidiary. 

“Swap”: any agreement, contract, or transaction that constitutes a “swap” within the meaning of section 1a(47) of
the Commodity Exchange Act. 
 “Swap Agreement”: any agreement with respect to any swap, forward, future or derivative
transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or
pricing risk or value or any similar transaction or any combination of these transactions; provided, that no phantom stock, phantom profits interests, profits interests or similar plan providing for payments only on account of services
provided by current or former directors, managers, officers, employees or consultants of the Borrower or any of its Subsidiaries shall be a “Swap Agreement”. 

“Swap Obligation”: with respect to any Person, any obligation to pay or perform under any Swap. 

“Swingline Commitment”: the obligation of the Swingline Lenders to make Swingline Loans pursuant to Section 2.6 in an
aggregate principal amount at any one time outstanding not to exceed the lesser of (i) $5,000,000 and (ii) the Total Revolving Commitments. 

“Swingline Exposure”: at any time, the sum of the aggregate amount of all outstanding Swingline Loans at such time. The
Swingline Exposure of any Revolving Lender at any time shall be the sum of (a) its Revolving Percentage of the total Swingline Exposure at such time related to Swingline Loans other than any Swingline Loans made by such Lender in its capacity
as a Swingline Lender and (b) if such lender shall be a Swingline Lender, the principal amount of all Swingline Loans made by such Lender outstanding at such time (to the extent that the other Lenders shall not have funded their participations
in such Swingline Loans). 
 “Swingline Lenders”: JPMorgan Chase Bank, N.A. in its capacity as a lender of Swingline Loans.

  
 32 

 “Swingline Loans”: as defined in Section 2.6(a). 

“Swingline Participation Amount”: as defined in Section 2.7(d). 

“Syndication Agent”: the Co-Syndication Agents identified on the cover page of this Agreement. 

“Tax Receivable Agreement”: the Tax Receivable Agreement as in effect on the Bioventus IPO Date substantially in the form
attached as Exhibit M hereto, as amended from time to time in any manner that either (i) is required by the terms of such Tax Receivable Agreement or (ii) the Borrower reasonably determines is not adverse to the interests of the
Administrative Agent or the Lenders. 
 “Taxes”: all present or future taxes, levies, imposts, duties, deductions,
withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto. 

“Term Commitment”: as to any Lender, the obligation of such Lender, if any, to make a Term Loan to the Borrower in a
principal amount equal to the amount set forth under the heading “Term Commitment” opposite such Lender’s name on Schedule 1.1A. The original aggregate amount of the Term Commitments is $115,000,000. 

“Term Facility”: as defined in the definition of “Facility.” 

“Term Lenders”: each Lender that has a Term Commitment or that holds a Term Loan. 

“Term Loans”: as defined in Section 2.1. 

“Term Percentage”: as to any Term Lender at any time, the percentage which such Lender’s Term Commitment then
constitutes of the aggregate Term Commitments (or, at any time after the Closing Date, the percentage which the aggregate principal amount of such Lender’s Term Loans then outstanding constitutes of the aggregate principal amount of the Term
Loans then outstanding). 
 “Total Revolving Commitments”: at any time, the aggregate amount of the Revolving Commitments
then in effect. 
 “Total Revolving Extensions of Credit”: at any time, the aggregate amount of the Revolving Extensions of
Credit of the Revolving Lenders outstanding at such time; provided, that solely for the purpose of determining Total Revolving Extensions of Credit, clause (a) of the definition of Swingline Exposure shall be applicable to the extent
participation in such Swingline Loans have been funded. 
 “Transactions”: the Refinancing, the entering into of the Loan
Documents and the initial borrowings hereunder, the entering into of the Second Lien Loan Documents and the borrowings thereunder and the payments of fees, commissions and expenses in connection with each of the foregoing. 

“Transferee”: any Assignee or Participant. 

“Type”: as to any Loan, its nature as an ABR Loan or a Eurodollar Loan. 

  
 33 

 “U.S. Person”: a “United States person” within the meaning of
Section 7701(a)(30) of the Code. 
 “U.S. Tax Compliance Certificate”: as defined in Section 2.19(f)(ii)(B). 

“Unfinanced Capital Expenditures”: with respect to any Person and for any period, Capital Expenditures made by such Person
during such period and not financed from the proceeds of Indebtedness (other than any Loans), any issuance or sale of Capital Stock, Recovery Events or Asset Sales. 

“United States”: the United States of America. 

“Unrestricted Subsidiary”: (a) each of the Subsidiaries listed as an Unrestricted Subsidiary on Schedule 4.15
hereto and (b) any Subsidiary of the Borrower designated by the Board of Directors of the Borrower as an Unrestricted Subsidiary pursuant to Section 6.11 subsequent to the date hereof. 

“Weighted Average Life to Maturity”: when applied to any Indebtedness at any date, the number of years obtained by dividing:
(i) the sum of the products obtained by multiplying (a) the amount of each then remaining installment, sinking fund, serial maturity or other required payments of principal, including payment at final maturity, in respect thereof, by
(b) the number of years (calculated to the nearest one-twelfth) that will elapse between such date and the making of such payment by (ii) the then outstanding principal amount of such Indebtedness. 

“Withdrawal Liability”: any liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such
Multiemployer Plan, as such terms are defined in Title IV of ERISA. 
 “Write-Down and Conversion Powers”: with respect to
any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU
Bail-In Legislation Schedule. 
 1.2. Other Definitional Provisions. (a) Unless otherwise specified therein, all terms defined
in this Agreement shall have the defined meanings when used in the other Loan Documents or any certificate or other document made or delivered pursuant hereto or thereto. 

(b) As used herein and in the other Loan Documents, and any certificate or other document made or delivered pursuant hereto or thereto,
(i) accounting terms relating to any Group Member not defined in Section 1.1 and accounting terms partly defined in Section 1.1, to the extent not defined, shall have the respective meanings given to them under GAAP (provided,
that all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to (i) any election under Accounting Standards Codification
825-10-25 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of the Borrower or any Subsidiary at “fair value”, as defined
therein and (ii) any treatment of Indebtedness in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or
effect) to value any such Indebtedness in a reduced or bifurcated manner as described therein, and such Indebtedness shall at all times be valued at the full outstanding principal amount thereof), (ii) the words “include”,
“includes” and “including” shall be deemed to be followed by the phrase “without limitation”, (iii) the word “incur” shall be construed to mean incur, create, issue, assume, become liable in respect of or
suffer to exist (and 

  
 34 

 
the words “incurred” and “incurrence” shall have correlative meanings), (iv) the words “asset” and “property” shall be construed to have the same
meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, Capital Stock, securities, revenues, accounts, leasehold interests and contract rights, and (v) references to agreements or other
Contractual Obligations shall, unless otherwise specified, be deemed to refer to such agreements or Contractual Obligations as amended, supplemented, restated or otherwise modified from time to time. In the event that any Accounting Change (as
defined below) shall occur and such change results in a change in the method of determination or calculation under this Agreement and either the Borrower, the Administrative Agent or the Required Lenders shall so request, then the Borrower and the
Administrative Agent agree to enter into good faith negotiations in order to amend such provisions of this Agreement so as to equitably reflect such Accounting Change with the desired result that the criteria for evaluating the Borrower’s and
its Subsidiaries’ consolidated financial condition shall be the same after such Accounting Change as if such Accounting Change had not been made. Until such time as such an amendment shall have been executed and delivered by the Borrower, the
Administrative Agent and the Required Lenders, all accounting determinations and computations made hereunder (including under Section 7.1 and the definitions used in such calculation) shall continue to be calculated or construed as if such
Accounting Change had not occurred. “Accounting Change” refers to any change in accounting principles required by the promulgation of any rule, regulation, pronouncement or opinion by the Financial Accounting Standards Board of the
American Institute of Certified Public Accountants or, if applicable, the SEC. Unless otherwise expressly provided, Section 7.1 and all defined financial terms shall be computed on a consolidated basis for the Borrower and its Subsidiaries, in
each case without duplication. Notwithstanding anything in this Agreement or any other Loan Document to the contrary, for the purposes of calculating compliance with any covenant in this Agreement or any other Loan Document, no effect shall be given
to any change in GAAP arising out of a change described in the Proposed Accounting Standards Update to Leases (Topic 840) dated August 17, 2010 or a substantially similar pronouncement. 

(c) The words “hereof”, “herein” and “hereunder” and words of similar import, when used in this Agreement, shall
refer to this Agreement as a whole and not to any particular provision of this Agreement, and Section, Schedule and Exhibit references are to this Agreement unless otherwise specified. 

(d) The meanings given to terms defined herein shall be equally applicable to both the singular and plural forms of such terms. 

1.3. Currency Conversion and Fluctuations. 

(a) If more than one currency or currency unit are at the same time recognized by the central bank of any country as the lawful currency of
that country, then (i) any reference in the Loan Documents to, and any obligations arising under the Loan Documents in, the currency of that country shall be translated into or paid in the currency or currency unit of that country designated by
the Administrative Agent and (ii) any translation from one currency or currency unit to another shall be at the official rate of exchange recognized by the central bank for conversion of that currency or currency unit into the other, rounded up
or down (to the next 1/16 of 1%) by the Administrative Agent as it deems appropriate. 
 (b) If a change in any currency of a country occurs,
this Agreement shall be amended (and each party hereto agrees to enter into any supplemental agreement necessary to effect any such amendment) to the extent that the Administrative Agent determines such amendment to be necessary to reflect the
change in currency and to put the Lenders in the same position, so far as possible, that they would have been in if no change in currency had occurred. 

  
 35 

 (c) No later than 11:00 a.m. London time on each Calculation Date, the Administrative Agent shall
determine the Exchange Rate as of such Calculation Date with respect to each applicable currency, provided that, upon receipt of an Application for a Foreign Currency Letter of Credit pursuant to Section 3.2, the Administrative Agent
shall determine the Exchange Rate with respect to the relevant currency on the related Calculation Date (it being acknowledged and agreed that the Administrative Agent shall use such Exchange Rate for the purposes of determining compliance with
Section 3.1 with respect to such Application). The Exchange Rates so determined shall become effective on the relevant Calculation Date (a “Reset Date”), shall remain effective until the next succeeding Reset Date and shall for
all purposes of this Agreement (other than Section 10.19 and any other provision expressly requiring the use of a current Exchange Rate) be the Exchange Rates employed in converting any amounts between Dollars and any other currency. 

(d) No later than 11:00 a.m. London time on each Reset Date, the Administrative Agent shall determine the aggregate amount of the Dollar
Equivalents of the L/C Obligations then outstanding in a currency other than Dollars. 
 (e) The Administrative Agent shall promptly notify
the Borrower of each determination of an Exchange Rate hereunder. 
 SECTION 2. AMOUNT AND TERMS OF COMMITMENTS 

2.1. Term Commitments. Subject to the terms and conditions hereof, each Term Lender severally agrees to make a term loan (a
“Term Loan”) to the Borrower on the Closing Date in an amount equal to the amount of the Term Commitment of such Lender. The Term Loans may from time to time be Eurodollar Loans or ABR Loans, as determined by the Borrower and
notified to the Administrative Agent in accordance with Sections 2.2 and 2.12. 
 2.2. Procedure for Term Loan Borrowing. The Borrower
shall give the Administrative Agent irrevocable notice in the form of Exhibit D (which notice must be received by the Administrative Agent prior to 3:00 P.M., New York City time, one Business Day prior to the anticipated Closing Date)
requesting that the Term Lenders make the Term Loans on the Closing Date and specifying the amount to be borrowed. Upon receipt of such notice the Administrative Agent shall promptly notify each Term Lender thereof. The Administrative Agent shall
credit the account of the Borrower on the books of such office of the Administrative Agent with the aggregate of the amounts made available to the Administrative Agent by the Term Lenders in immediately available funds. 

2.3. Repayment of Term Loans. The Term Loan of each Lender shall mature in consecutive quarterly installments on the last day of each
fiscal quarter (or, in the case of the last installment, on the Maturity Date), commencing on December 31, 2014, each of which installments shall be in an aggregate principal amount equal to the original aggregate principal amount of the Term
Loans multiplied by (i) such Lender’s Term Percentage and (ii) the percentage set forth below with respect to such day: 
  

					
	 Period
	  	Quarterly
Percentage	 
	 December 31, 2014 to September 30, 2015
	  	 	1.25	% 
	 December 31, 2015 to September 30, 2016
	  	 	2.50	% 
	 December 31, 2016 to September 30, 2017
	  	 	3.75	% 
	 December 31, 2017 to September 30, 2018
	  	 	3.75	% 
	 December 31, 2018 to the Maturity Date
	  	 	5.00	% 

  
 36 

 ; provided, that with respect to the installment payable on the Maturity Date, such installment shall be
in an amount equal to the then outstanding principal amount of the Term Loans. 
 2.4. Revolving Commitments. (a) Subject to the
terms and conditions hereof, each Revolving Lender severally agrees to make revolving credit loans (“Revolving Loans”) to the Borrower from time to time during the Revolving Commitment Period in an aggregate principal amount at any
one time outstanding which, when added (after giving effect to any application of proceeds of such Revolving Loans pursuant to Section 2.6 or to reimburse the Issuing Lender pursuant to Section 3.5) to the sum of (i) such
Lender’s Revolving Percentage of the L/C Obligations then outstanding and (ii) such Lender’s Swingline Exposure then outstanding, does not exceed the amount of such Lender’s Revolving Commitment. During the Revolving Commitment
Period the Borrower may use the Revolving Commitments by borrowing, prepaying the Revolving Loans in whole or in part, and reborrowing, all in accordance with the terms and conditions hereof. The Revolving Loans may from time to time be Eurodollar
Loans or ABR Loans, as determined by the Borrower and notified to the Administrative Agent in accordance with Sections 2.5 and 2.12. 
 (b)
The Borrower shall repay all outstanding Revolving Loans on the Revolving Termination Date. 
 2.5. Procedure for Revolving Loan
Borrowing. The Borrower may borrow under the Revolving Commitments during the Revolving Commitment Period on any Business Day, provided, that the Borrower shall give the Administrative Agent irrevocable notice in the form of Exhibit D
(which notice must be received by the Administrative Agent prior to 11:00 A.M., New York City time, (a) three Business Days prior to the requested Borrowing Date, in the case of Eurodollar Loans, or (b) one Business Day prior to the
requested Borrowing Date, in the case of ABR Loans) (provided, that any such notice of a borrowing of ABR Loans under the Revolving Facility to finance payments required by Section 3.5 may be given not later than 10:00 A.M., New York
City time, on the requested Borrowing Date), specifying (i) the amount and Type of Revolving Loans to be borrowed, (ii) the requested Borrowing Date and (iii) in the case of Eurodollar Loans, the respective amounts of each such Type
of Loan and the respective lengths of the initial Interest Period therefor. Any Revolving Loans made on the Closing Date shall initially be ABR Loans. Each borrowing under the Revolving Commitments shall be in an amount equal to (x) in the case
of ABR Loans, $1,000,000 or a whole multiple thereof (or, if the then aggregate Available Revolving Commitments are less than $1,000,000, such lesser amount) and (y) in the case of Eurodollar Loans, $2,500,000 or a whole multiple of $500,000 in
excess thereof; provided, that any Swingline Lender may request, on behalf of the Borrower, borrowings under the Revolving Commitments that are ABR Loans in other amounts pursuant to Section 2.7. Upon receipt of any such notice from the
Borrower, the Administrative Agent shall promptly notify each Revolving Lender thereof. Each Revolving Lender will make the amount of its pro rata share of each borrowing available to the Administrative Agent for the account of the Borrower at the
Funding Office prior to 12:00 Noon, New York City time, on the Borrowing Date requested by the Borrower in funds immediately available to the Administrative Agent. Such borrowing will then be made available to the Borrower by the Administrative
Agent crediting the account of the Borrower on the books of such office with the aggregate of the amounts made available to the Administrative Agent by the Revolving Lenders and in like funds as received by the Administrative Agent. 

2.6. Swingline Commitment. (a) Subject to the terms and conditions hereof, from time to time during the Revolving Commitment
Period, each Swingline Lender severally agrees to make a portion of the credit otherwise available to the Borrower under the Revolving Commitments by making swing line loans (“Swingline Loans”) to the Borrower; provided, that
(i) the sum of (x) the Swingline Exposure of such Swingline Lender, (y) the aggregate principal amount of outstanding Revolving Loans made by such Swingline Lender (in its capacity as a Revolving Lender) and (z) the L/C Exposure
of such 

  
 37 

 
Swingline Lender (in its capacity as a Revolving Lender) shall not exceed its Revolving Commitment then in effect, (ii) the sum of the outstanding Swingline Loans shall not exceed the
Swingline Commitment and (iii) the Borrower shall not request, and no Swingline Lender shall make, any Swingline Loan if, after giving effect to the making of such Swingline Loan, the aggregate amount of the Available Revolving Commitments
would be less than zero. During the Revolving Commitment Period, the Borrower may use the Swingline Commitment by borrowing, repaying and reborrowing, all in accordance with the terms and conditions hereof. Swingline Loans shall be ABR Loans only.

 (b) The Borrower shall repay to the Swingline Lenders the then unpaid principal amount of each Swingline Loan on the earlier of the
Revolving Termination Date and five Business Days after such Swingline Loan is made; provided, that on each date that a Revolving Loan is borrowed, the Borrower shall repay all Swingline Loans then outstanding and the proceeds of any such
Revolving Loans shall be applied by the Administrative Agent first to repay any Swingline Loans outstanding. 
 (c) If the maturity date
shall have occurred in respect of any tranche of Revolving Commitments at a time when another tranche or tranches of Revolving Commitments is or are in effect with a longer maturity date, then on the earliest occurring maturity date all then
outstanding Swingline Loans shall be repaid in full on such date (and there shall be no adjustment to the participations in such Swingline Loans as a result of the occurrence of such maturity date); provided, that if on the occurrence of such
earliest maturity date (after giving effect to any repayments of Revolving Loans and any reallocation of Letter of Credit participations as contemplated in Section 3.1(c)), there shall exist sufficient unutilized Extended Revolving Commitments
so that the respective outstanding Swingline Loans could be incurred pursuant to the Extended Revolving Commitments which will remain in effect after the occurrence of such maturity date, then there shall be an automatic adjustment on such date of
the participations in such Swingline Loans and the same shall be deemed to have been incurred solely pursuant to the relevant Extended Revolving Commitments, and such Swingline Loans shall not be so required to be repaid in full on such earliest
maturity date. 
 2.7. Procedure for Swingline Borrowing; Refunding of Swingline Loans. (a) Whenever the Borrower desires that
the Swingline Lenders make Swingline Loans it shall give the Swingline Lenders irrevocable telephonic notice confirmed promptly in writing (which telephonic notice must be received by the Swingline Lenders not later than 1:00 P.M., New York City
time, on the proposed Borrowing Date), specifying (i) the amount to be borrowed and (ii) the requested Borrowing Date (which shall be a Business Day during the Revolving Commitment Period). Each borrowing under the Swingline Commitment
shall be in an amount equal to $500,000 or a whole multiple of $100,000 in excess thereof. Not later than 3:00 P.M., New York City time, on the Borrowing Date specified in a notice in respect of Swingline Loans, each Swingline Lender shall make
available to the Administrative Agent at the Funding Office an amount in immediately available funds equal to the amount of its ratable portion of the Swingline Loan to be made by such Swingline Lender (such ratable portion to be calculated based
upon such Swingline Lender’s Revolving Commitment (in its capacity as a Revolving Lender) to the total Revolving Commitments of all of the Swingline Lenders (in their respective capacities as Revolving Lenders)). The Administrative Agent shall
make the proceeds of such Swingline Loans available to the Borrower on such Borrowing Date by depositing such proceeds in the account of the Borrower with the Administrative Agent on such Borrowing Date in immediately available funds. 

(b) Independent Swingline Lender Obligations. The failure of any Swingline Lender to make its ratable portion of a Swingline Loan shall
not relieve any other Swingline Lender of its obligation hereunder to make its ratable portion of such Swingline Loan on the date of such Swingline Loan, but no Swingline Lender shall be responsible for the failure of any other Swingline Lender to
make the ratable portion of a Swingline Loan to be made by such other Swingline Lender on the date of any Swingline Loan. 

  
 38 

 (c) Any Swingline Lender, at any time and from time to time in its sole and absolute discretion
may, on behalf of the Borrower (which hereby irrevocably directs the Swingline Lenders to act on its behalf), on one Business Day’s notice given by such Swingline Lender no later than 12:00 Noon, New York City time, to the Administrative Agent,
who shall then request each Revolving Lender to make, and each Revolving Lender hereby agrees to make, a Revolving Loan, in an amount equal to such Revolving Lender’s Revolving Percentage of the aggregate amount of the Swingline Loans (the
“Refunded Swingline Loans”) outstanding on the date of such notice, to repay the Swingline Lenders. Subject to clause (d) below, each Revolving Lender shall make the amount of such Revolving Loan available to the Administrative
Agent at the Funding Office in immediately available funds, not later than 10:00 A.M., New York City time, one Business Day after the date of such notice. The proceeds of such Revolving Loans shall be immediately made available by the Administrative
Agent to the Swingline Lenders for application by the Swingline Lenders to the repayment of the Refunded Swingline Loans. The Borrower irrevocably authorizes the Swingline Lenders, following notice by the Swingline Lenders to the Administrative
Agent, to charge the Borrower’s accounts with the Administrative Agent (up to the amount available in each such account) in order to immediately pay the amount of such Refunded Swingline Loans to the extent amounts received from the Revolving
Lenders are not sufficient to repay in full such Refunded Swingline Loans. 
 (d) If prior to the time a Revolving Loan would have otherwise
been made pursuant to Section 2.7(c), one of the events described in Section 8.1(f) shall have occurred and be continuing with respect to the Borrower or if for any other reason, as determined by any Swingline Lender in its sole
discretion, Revolving Loans may not be made as contemplated by Section 2.7(c), each Revolving Lender shall, on the date such Revolving Loan was to have been made pursuant to the notice referred to in Section 2.7(c), purchase for cash an
undivided participating interest in the then outstanding Swingline Loans by paying to each Swingline Lender (through the Administrative Agent) an amount (the “Swingline Participation Amount”) equal to (i) such Revolving
Lender’s Revolving Percentage times (ii) the sum of the aggregate principal amount of Swingline Loans of such Swingline Lender then outstanding that were to have been repaid with such Revolving Loans. 

(e) Whenever, at any time after any Swingline Lender has received from any Revolving Lender (through the Administrative Agent) such
Lender’s Swingline Participation Amount, such Swingline Lender receives any payment on account of the Swingline Loans, such Swingline Lender will distribute (through the Administrative Agent) to such Lender its ratable portion of such payment
(appropriately adjusted, in the case of interest payments, to reflect the period of time during which such Lender’s participating interest was outstanding and funded and, in the case of principal and interest payments, to reflect such
Lender’s pro rata portion of such payment if such payment is not sufficient to pay the principal of and interest on all Swingline Loans then due); provided, however, that in the event that such payment received by such Swingline
Lender is required to be returned, such Revolving Lender will return (through the Administrative Agent) to such Swingline Lender any portion thereof previously distributed to it by such Swingline Lender. 

(f) Each Revolving Lender’s obligation to make the Refunded Swingline Loans referred to in Section 2.7(c) and to purchase
participating interests pursuant to Section 2.7(d) shall be absolute and unconditional and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such Revolving Lender or
the Borrower may have against any Swingline Lender, the Borrower or any other Person for any reason whatsoever, (ii) the occurrence or continuance of a Default or an Event of Default or the failure to satisfy any of the other conditions
specified in Section 5, (iii) any adverse change in the condition (financial or otherwise) of the Borrower, (iv) any breach of this Agreement or any other Loan Document by the Borrower, any other Loan Party or any other Revolving
Lender or (v) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing. 

  
 39 

 2.8. Commitment Fees, etc. (a) The Borrower agrees to pay to the Administrative Agent
for the account of each Revolving Lender a commitment fee for the period from and including the Closing Date to the last day of the Revolving Commitment Period, computed at the Commitment Fee Rate on the average daily amount of the Available
Revolving Commitment of such Lender during the period for which payment is made, payable quarterly in arrears on each Fee Payment Date, commencing on the first such date to occur after the date hereof. 

(b) The Borrower agrees to pay to the Administrative Agent the fees in the amounts and on the dates as set forth in any fee agreements with the
Administrative Agent and to perform any other obligations contained therein. 
 2.9. Termination or Reduction of Revolving
Commitments. The Borrower shall have the right, upon not less than three Business Days’ notice to the Administrative Agent, to terminate the Revolving Commitments or, from time to time, to reduce the amount of the Revolving Commitments;
provided, that no such termination or reduction of Revolving Commitments shall be permitted if, after giving effect thereto and to any prepayments of the Revolving Loans and Swingline Loans made on the effective date thereof, the Total
Revolving Extensions of Credit would exceed the Total Revolving Commitments. Each notice delivered by the Borrower pursuant to this Section 2.9 shall be irrevocable; provided, that such notice may state that it is conditioned upon the
effectiveness of other credit facilities, settlement of an offering of securities or a Change in Control, in each case, which such notice may be revoked by the Borrower (by notice to the Administrative Agent no later than 10:00 A.M., New York City
time, on the specified effective date) if such condition is not satisfied. Any such reduction shall be in an amount equal to $1,000,000, or a whole multiple thereof, and shall reduce permanently the Revolving Commitments then in effect. 

2.10. Optional Prepayments. The Borrower may at any time and from time to time prepay the Loans, in whole or in part, without premium or
penalty, upon irrevocable notice delivered to the Administrative Agent no later than 11:00 A.M., New York City time, three Business Days prior thereto, in the case of Eurodollar Loans, and no later than 11:00 A.M., New York City time, one Business
Day prior thereto, in the case of ABR Loans, which notice shall specify the date and amount of prepayment and whether the prepayment is of Eurodollar Loans or ABR Loans; provided, that if a Eurodollar Loan is prepaid on any day other than the last
day of the Interest Period applicable thereto, the Borrower shall also pay any amounts owing pursuant to Section 2.20. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. If any such
notice is given, the amount specified in such notice shall be due and payable on the date specified therein, together with (except in the case of Revolving Loans that are ABR Loans and Swingline Loans) accrued interest to such date on the amount
prepaid. Partial prepayments of Term Loans and Revolving Loans shall be in an aggregate principal amount of $1,000,000 or a whole multiple thereof. Partial prepayments of Swingline Loans shall be in an aggregate principal amount of $100,000 or a
whole multiple thereof. Each payment pursuant to this Section on account of principal of and interest on the Term Loans shall be applied as provided in Section 2.17(b). Each payment pursuant to this Section on account of principal of and
interest on the Revolving Loans shall be applied as provided in Section 2.17(c). 
 2.11. Mandatory Prepayments. (a) If any
Indebtedness shall be issued or incurred by any Group Member (excluding any Indebtedness incurred in accordance with Section 7.2, other than paragraph (l) thereof), an amount equal to 100% of the Net Cash Proceeds thereof shall be applied
on the date of such issuance or incurrence toward the prepayment of the Term Loans as set forth in Section 2.11(d). 

  
 40 

 (b) If on any date any Group Member shall receive Net Cash Proceeds from any Asset Sale or
Recovery Event then, unless a Reinvestment Notice shall be delivered in respect thereof, such Net Cash Proceeds shall be applied on such date toward the prepayment of the Term Loans as set forth in Section 2.11(d); provided, that,
notwithstanding the foregoing, (i) the aggregate Net Cash Proceeds of Asset Sales that may be excluded from the foregoing requirement pursuant to a Reinvestment Notice shall not exceed $2,500,000 in any fiscal year of the Borrower and
(ii) on each Reinvestment Prepayment Date, an amount equal to the Reinvestment Prepayment Amount with respect to the relevant Reinvestment Event shall be applied toward the prepayment of the Term Loans and the reduction of the Revolving
Commitments as set forth in Section 2.11(d). 
 (c) If, for any fiscal year of the Borrower commencing with the fiscal year ending
December 31, 2015, there shall be Excess Cash Flow, the Borrower shall, on the relevant Excess Cash Flow Application Date, prepay an aggregate amount of Term Loans in an amount equal to (A) the ECF Percentage of Excess Cash Flow for the
fiscal year covered by the financial statements for such fiscal year (such prepayment to be applied as set forth in Section 2.11(d) below), minus (B) solely to the extent not funded with the proceeds of Indebtedness, the aggregate amount
of all optional prepayments of the Term Loans pursuant to Section 2.10 made during such fiscal year. Each such prepayment and commitment reduction shall be made on a date (an “Excess Cash Flow Application Date”) no later than
five days after the earlier of (i) the date on which the financial statements of the Borrower referred to in Section 6.1(a), for the fiscal year with respect to which such prepayment is made, are required to be delivered to the Lenders and
(ii) the date such financial statements are actually delivered. 
 (d) Amounts to be applied pursuant to Section 2.11 shall be
applied to the prepayment of the Term Loans in accordance with Section 2.17(b). The application of any prepayment pursuant to Section 2.11 shall be made, first, to ABR Loans and, second, to Eurodollar Loans. Each prepayment
of the Loans under Section 2.11 shall be accompanied by accrued interest to the date of such prepayment on the amount prepaid. 
 (e)
Notwithstanding any other provisions of Section 2.11, to the extent any or all of the Net Cash Proceeds of any Asset Sale by a Foreign Subsidiary, the Net Cash Proceeds of any Recovery Event received by a Foreign Subsidiary or Excess Cash Flow
attributable to Foreign Subsidiaries, are prohibited or delayed by any applicable local law (including, without limitation, financial assistance, corporate benefit restrictions on upstreaming of cash intra group and the fiduciary and statutory
duties of the directors of such Foreign Subsidiary) from being repatriated or passed on to or used for the benefit of the Borrower or any applicable Domestic Subsidiary or if the Borrower has determined in good faith that repatriation of any such
amount to the Borrower or any applicable Domestic Subsidiary would have material adverse tax consequences (including a material acceleration of the point in time when such earnings would otherwise be taxed) with respect to such amount, the portion
of such Net Cash Proceeds or Excess Cash Flow so affected will not be required to be applied to prepay the Term Loans at the times provided in this Section 2.11 but may be retained by the applicable Foreign Subsidiary so long, but only so long,
as the applicable local law will not permit repatriation or the passing on to or otherwise using for the benefit of the Borrower or the applicable Domestic Subsidiary, or the Borrower believes in good faith that such material adverse tax consequence
would result, and once such repatriation of any of such affected Net Cash Proceeds or Excess Cash Flow is permitted under the applicable local law or the Borrower determines in good faith such repatriation would no longer have such material adverse
tax consequences, such repatriation will be promptly effected and such repatriated Net Cash Proceeds or Excess Cash Flow will be promptly (and in any event not later than five Business Days after such repatriation) applied (net of additional taxes
payable or reasonably estimated to be payable as a result thereof) to the prepayment of the Term Loans pursuant to Section 2.11; provided, that no such prepayment of the Term Loans pursuant to Section 2.11 shall be required in the
case of any such Net Cash Proceeds or Excess Cash Flow the repatriation of which the Borrower believes in good faith would result in material adverse tax consequences, if on or before the date on which such Net Cash Proceeds so retained would
otherwise have been required to be applied to reinvestments or prepayments pursuant to a 

  
 41 

 
Reinvestment Notice (or such Excess Cash Flow would have been so required if it were Net Cash Proceeds), the Borrower applies an amount equal to the amount of such Net Cash Proceeds or Excess
Cash Flow to such reinvestments or prepayments as if such Net Cash Proceeds or Excess Cash Flow had been received by the Borrower rather than such Foreign Subsidiary, less the amount of additional taxes that would have been payable or reserved
against if such Net Cash Proceeds or Excess Cash Flow had been repatriated (or, if less, the Net Cash Proceeds or Excess Cash Flow that would be calculated if received by such Foreign Subsidiary). For the purposes of this Section 2.11(e) only,
the term Domestic Subsidiary shall include a Foreign Subsidiary Holdco. 
 (f) Notwithstanding anything to the contrary contained in this
Section 2.11, if any Term Lender shall notify the Administrative Agent (i) on the date of such prepayment, with respect to any prepayment under Section 2.11(a) or (b) or (ii) at least one Business Day prior to the date of a
prepayment under Section 2.11(c) that it wishes to decline its share of such prepayment, such share (the “Declined Prepayment Amount”) shall be offered in accordance with the mandatory prepayment provisions of the Second Lien
Credit Agreement (or the applicable corresponding provisions of any document governing any Permitted Refinancing Indebtedness with respect thereto) and, if declined by the lenders thereunder, may be retained by the Borrower. 

2.12. Conversion and Continuation Options. (a) The Borrower may elect from time to time to convert Eurodollar Loans to ABR Loans by
giving the Administrative Agent prior irrevocable notice in the form of Exhibit J of such election no later than 11:00 A.M., New York City time, on the Business Day preceding the proposed conversion date, provided, that any such
conversion of Eurodollar Loans may only be made on the last day of an Interest Period with respect thereto. The Borrower may elect from time to time to convert ABR Loans to Eurodollar Loans by giving the Administrative Agent prior irrevocable notice
in the form of Exhibit J of such election no later than 11:00 A.M., New York City time, on the third Business Day preceding the proposed conversion date (which notice shall specify the length of the initial Interest Period therefor),
provided, that no ABR Loan under a particular Facility may be converted into a Eurodollar Loan when any Event of Default has occurred and is continuing and the Administrative Agent or the Majority Facility Lenders in respect of such Facility
have determined in its or their sole discretion not to permit such conversions. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. 

(b) Any Eurodollar Loan may be continued as such upon the expiration of the then current Interest Period with respect thereto by the Borrower
giving irrevocable notice in the form of Exhibit J to the Administrative Agent, in accordance with the applicable provisions of the term “Interest Period” set forth in Section 1.1, of the length of the next Interest Period to
be applicable to such Loans, provided, that no Eurodollar Loan under a particular Facility may be continued as such (i) when any Event of Default has occurred and is continuing and the Administrative Agent has or the Majority Facility
Lenders in respect of such Facility have determined in its or their sole discretion not to permit such continuations or (ii) if an Event of Default specified in clause (i) or (ii) of Section 8.1(f) with respect to the Borrower is
in existence, and provided, further, that if the Borrower shall fail to give any required notice as described above in this paragraph or if such continuation is not permitted pursuant to the preceding proviso such Loans shall be
automatically converted to ABR Loans on the last day of such then expiring Interest Period. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. 

2.13. Limitations on Eurodollar Tranches. Notwithstanding anything to the contrary in this Agreement, all borrowings, conversions and
continuations of Eurodollar Loans and all selections of Interest Periods shall be in such amounts and be made pursuant to such elections so that, (a) after giving effect thereto, the aggregate principal amount of the Eurodollar Loans comprising
each Eurodollar Tranche shall be equal to $5,000,000 or a whole multiple of $1,000,000 in excess thereof and (b) no more than 10 Eurodollar Tranches shall be outstanding at any one time. 

  
 42 

 2.14. Interest Rates and Payment Dates. (a) Each Eurodollar Loan shall bear interest
for each day during each Interest Period with respect thereto at a rate per annum equal to the Eurodollar Rate determined for such day plus the Applicable Margin. 

(b) Each ABR Loan shall bear interest at a rate per annum equal to the ABR plus the Applicable Margin. 

(c) (i) If all or a portion of the principal amount of any Loan or Reimbursement Obligation shall not be paid when due (whether at the stated
maturity, by acceleration or otherwise) and any grace period applicable thereto shall have expired, all outstanding Loans and Reimbursement Obligations (whether or not overdue) shall bear interest at a rate per annum equal to (x) in the case of
the Loans, the rate that would otherwise be applicable thereto pursuant to the foregoing provisions of this Section plus 2% or (y) in the case of Reimbursement Obligations, the rate applicable to ABR Loans under the Revolving Facility
plus 2%, and (ii) if all or a portion of any interest payable on any Loan or Reimbursement Obligation or any commitment fee or other amount payable hereunder shall not be paid when due (whether at the stated maturity, by acceleration or
otherwise), such overdue amount shall bear interest at a rate per annum equal to the rate then applicable to ABR Loans under the relevant Facility plus 2% (or, in the case of any such other amounts that do not relate to a particular Facility,
the rate then applicable to ABR Loans under the Revolving Facility plus 2%), in each case, with respect to clauses (i) and (ii) above, from the date of such non-payment until such amount is paid in full (as well after as before
judgment). 
 (d) Interest shall be payable in arrears on each Interest Payment Date, provided, that interest accruing pursuant to paragraph
(c) of this Section shall be payable from time to time on demand. 
 2.15. Computation of Interest and Fees. (a) Interest
and fees payable pursuant hereto shall be calculated on the basis of a 360-day year for the actual days elapsed, except that, with respect to ABR Loans the rate of interest on which is calculated on the basis of the Prime Rate, the interest thereon
shall be calculated on the basis of a 365- (or 366-, as the case may be) day year for the actual days elapsed. The Administrative Agent shall as soon as practicable notify the Borrower and the relevant Lenders of each determination of a Eurodollar
Rate. Any change in the interest rate on a Loan resulting from a change in the ABR or the Eurocurrency Reserve Requirements shall become effective as of the opening of business on the day on which such change becomes effective. The Administrative
Agent shall as soon as practicable notify the Borrower and the relevant Lenders of the effective date and the amount of each such change in interest rate. 

(b) Each determination of an interest rate by the Administrative Agent pursuant to any provision of this Agreement shall be conclusive and
binding on the Borrower and the Lenders in the absence of manifest error. The Administrative Agent shall, at the request of the Borrower, deliver to the Borrower a statement showing the quotations used by the Administrative Agent in determining any
interest rate pursuant to Section 2.14(a). 
 2.16. Inability to Determine Interest Rate. If prior to the first day of any
Interest Period: 
 (a) the Administrative Agent shall have determined (which determination shall be conclusive and binding
absent manifest error) that adequate and reasonable means (including, without limitation, by means of an Interpolated Rate) do not exist for ascertaining the Eurodollar Base Rate or the Eurodollar Rate, as applicable, for such Interest Period, or

  
 43 

 (b) the Administrative Agent shall have received notice from the Majority
Facility Lenders in respect of the relevant Facility that the Eurodollar Base Rate or the Eurodollar Rate, as applicable, determined or to be determined for such Interest Period will not adequately and fairly reflect the cost to such Lenders (as
conclusively certified by such Lenders) of making or maintaining their affected Loans during such Interest Period, then 
 the Administrative Agent shall
give telecopy or telephonic notice thereof to the Borrower and the relevant Lenders as soon as practicable thereafter. If such notice is given (x) any Eurodollar Loans under the relevant Facility requested to be made on the first day of such
Interest Period shall be made as ABR Loans, (y) any Loans under the relevant Facility that were to have been converted on the first day of such Interest Period to Eurodollar Loans shall be continued as ABR Loans and (z) any outstanding
Eurodollar Loans under the relevant Facility shall be converted, on the last day of the then-current Interest Period, to ABR Loans. Until such notice has been withdrawn by the Administrative Agent, no further Eurodollar Loans under the relevant
Facility shall be made or continued as such, nor shall the Borrower have the right to convert Loans under the relevant Facility to Eurodollar Loans. 

2.17. Pro Rata Treatment and Payments. (a) Each borrowing by the Borrower from the Lenders hereunder, each payment by the Borrower
on account of any commitment fee and any reduction of the Commitments of the Lenders shall be made pro rata according to the respective Term Percentages or Revolving Percentages, as the case may be, of the relevant Lenders. 

(b) Each payment (including each prepayment) by the Borrower on account of principal of and interest on the Term Loans shall be made pro rata
according to the respective outstanding principal amounts of the Term Loans then held by the Term Lenders. The amount of each mandatory principal prepayment of the Term Loans pursuant to Section 2.11 shall be applied to reduce the then
remaining installments of the Term Loans and Incremental Term Loans, as the case may be, pro rata based upon the respective then remaining principal amounts thereof. The amount of each optional prepayment of the Term Loans pursuant to
Section 2.10 shall be applied to reduce the then remaining installments of the Term Loans and Incremental Term Loans, as the case may be, in such order as the Borrower may direct. Amounts prepaid on account of the Term Loans may not be
reborrowed. 
 (c) Each payment (including each prepayment) by the Borrower on account of principal of and interest on the Revolving Loans
shall be made pro rata according to the respective outstanding principal amounts of the Revolving Loans then held by the Revolving Lenders. 

(d) All payments (including prepayments) to be made by the Borrower hereunder, whether on account of principal, interest, fees or otherwise,
shall be made without setoff or counterclaim and shall be made prior to 2:00 P.M., New York City time, on the due date thereof to the Administrative Agent, for the account of the Lenders, at the Funding Office, in Dollars and in immediately
available funds. The Administrative Agent shall distribute such payments to each relevant Lender promptly upon receipt in like funds as received, net of any amounts owing by such Lender pursuant to Section 9.7. If any payment hereunder (other
than payments on the Eurodollar Loans) becomes due and payable on a day other than a Business Day, such payment shall be extended to the next succeeding Business Day. If any payment on a Eurodollar Loan becomes due and payable on a day other than a
Business Day, the maturity thereof shall be extended to the next succeeding Business Day unless the result of such extension would be to extend such payment into another calendar month, in which event such payment shall be made on the immediately
preceding Business Day. In the case of any extension of any payment of principal pursuant to the preceding two sentences, interest thereon shall be payable at the then applicable rate during such extension. 

  
 44 

 (e) Unless the Administrative Agent shall have been notified in writing by any Lender prior to a
borrowing that such Lender will not make the amount that would constitute its share of such borrowing available to the Administrative Agent, the Administrative Agent may assume that such Lender is making such amount available to the Administrative
Agent, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrower a corresponding amount. If such amount is not made available to the Administrative Agent by the required time on the Borrowing Date therefor,
such Lender shall pay to the Administrative Agent, on demand, such amount with interest thereon, at a rate equal to the greater of (i) the NYFRB Rate and (ii) a rate determined by the Administrative Agent in accordance with banking
industry rules on interbank compensation, for the period until such Lender makes such amount immediately available to the Administrative Agent. A certificate of the Administrative Agent submitted to any Lender with respect to any amounts owing under
this paragraph shall be conclusive in the absence of manifest error. If such Lender’s share of such borrowing is not made available to the Administrative Agent by such Lender within three Business Days after such Borrowing Date, the
Administrative Agent shall also be entitled to recover such amount with interest thereon at the rate per annum applicable to ABR Loans under the relevant Facility, on demand, from the Borrower. 

(f) Unless the Administrative Agent shall have been notified in writing by the Borrower prior to the date of any payment due to be made by the
Borrower hereunder that the Borrower will not make such payment to the Administrative Agent, the Administrative Agent may assume that the Borrower is making such payment, and the Administrative Agent may, but shall not be required to, in reliance
upon such assumption, make available to the Lenders their respective pro rata shares of a corresponding amount. If such payment is not made to the Administrative Agent by the Borrower within three Business Days after such due date, the
Administrative Agent shall be entitled to recover, on demand, from each Lender to which any amount which was made available pursuant to the preceding sentence, such amount with interest thereon at the rate per annum equal to the daily average NYFRB
Rate. Nothing herein shall be deemed to limit the rights of the Administrative Agent or any Lender against the Borrower. 
 (g) If any Lender
shall fail to make any payment required to be made by it pursuant to Section 2.7(c), 2.7(d), 2.17(e), 2.17(f), 2.19(e), 3.4(a) or 9.7, then the Administrative Agent may, in its discretion and notwithstanding any contrary provision hereof,
(i) apply any amounts thereafter received by the Administrative Agent for the account of such Lender for the benefit of the Administrative Agent, the Swingline Lenders or the Issuing Lender to satisfy such Lender’s obligations to it under
such Sections until all such unsatisfied obligations are fully paid, and/or (ii) hold any such amounts in a segregated account as cash collateral for, and application to, any future funding obligations of such Lender under any such Section, in
the case of each of clauses (i) and (ii) above, in any order as determined by the Administrative Agent in its discretion. 
 2.18.
Requirements of Law. (a) If the adoption of or any change in any Requirement of Law or in the interpretation or application thereof or compliance by any Lender or other Credit Party with any request or directive (whether or not having
the force of law) from any central bank or other Governmental Authority made subsequent to the date hereof: 
 (i) shall
subject any Credit Party to any Taxes (other than (A) Indemnified Taxes, (B) Taxes described in clauses (b) through (d) of the definition of Excluded Taxes and (C) Connection Income Taxes) on its loans, loan principal,
letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto; 

  
 45 

 (ii) shall impose, modify or hold applicable any reserve, special deposit,
compulsory loan, insurance charge or similar requirement against assets held by, deposits or other liabilities in or for the account of, advances, loans or other extensions of credit (or participations therein) by, or any other acquisition of funds
by, any office of such Lender that is not otherwise included in the determination of the Eurodollar Rate; or 
 (iii) shall
impose on such Lender any other condition (other than Taxes); 
 and the result of any of the foregoing is to increase the cost to such Lender or such other
Credit Party, by an amount that such Lender or other Credit Party deems to be material, of making, converting into, continuing or maintaining Loans or issuing or participating in Letters of Credit, or to reduce any amount receivable hereunder in
respect thereof, then, in any such case, the Borrower shall promptly pay such Lender or such other Credit Party, upon its demand, any additional amounts necessary to compensate such Lender or such other Credit Party for such increased cost or
reduced amount receivable. If any Lender or such other Credit Party becomes entitled to claim any additional amounts pursuant to this paragraph, it shall promptly notify the Borrower (with a copy to the Administrative Agent) of the event by reason
of which it has become so entitled. 
 (b) If any Lender shall have determined that the adoption of or any change in any Requirement of Law
regarding capital adequacy or liquidity requirements or in the interpretation or application thereof or compliance by such Lender or any corporation controlling such Lender with any request or directive regarding capital adequacy or liquidity
requirements (whether or not having the force of law) from any Governmental Authority made subsequent to the date hereof shall have the effect of reducing the rate of return on such Lender’s or such corporation’s capital as a consequence
of its obligations hereunder or under or in respect of any Letter of Credit to a level below that which such Lender or such corporation could have achieved but for such adoption, change or compliance (taking into consideration such Lender’s or
such corporation’s policies with respect to capital adequacy or liquidity) by an amount deemed by such Lender to be material, then from time to time, after submission by such Lender to the Borrower (with a copy to the Administrative Agent) of a
written request therefor, the Borrower shall pay to such Lender such additional amount or amounts as will compensate such Lender or such corporation for such reduction. 

(c) Notwithstanding anything herein to the contrary, (i) all requests, rules, guidelines, requirements and directives promulgated by the
Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or by United States or foreign regulatory authorities, in each case pursuant to Basel III, and (ii) the Dodd-Frank Wall
Street Reform and Consumer Protection Act and all requests, rules, guidelines, requirements and directives thereunder or issued in connection therewith or in implementation thereof, shall in each case be deemed to be a change in any Requirement of
Law, regardless of the date enacted, adopted, issued or implemented. 
 (d) A certificate as to any additional amounts payable pursuant to
this Section submitted by any Lender to the Borrower (with a copy to the Administrative Agent) shall be conclusive in the absence of manifest error. Notwithstanding anything to the contrary in this Section, the Borrower shall not be required to
compensate a Lender pursuant to this Section for any amounts incurred more than nine months prior to the date that such Lender notifies the Borrower of such Lender’s intention to claim compensation therefor; provided, that, if the
circumstances giving rise to such claim have a retroactive effect, then such nine-month period shall be extended to include the period of such retroactive effect. The obligations of the Borrower pursuant to this Section shall survive the termination
of this Agreement and the payment of the Loans and all other amounts payable hereunder. 

  
 46 

 2.19. Taxes. (a) Any and all payments by or on account of any obligation of any Loan
Party under any Loan Document shall be made without deduction or withholding for any Taxes, except as required by applicable law. If any applicable law (as determined in the good faith discretion of an applicable withholding agent) requires the
deduction or withholding of any Tax from any such payment by a withholding agent, then the applicable withholding agent shall be entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant
Governmental Authority in accordance with applicable law and, if such Tax is an Indemnified Tax, then the sum payable by the applicable Loan Party shall be increased as necessary so that, after such deduction or withholding has been made (including
such deductions and withholdings applicable to additional sums payable under this Section 2.19), the applicable Credit Party receives an amount equal to the sum which it would have received had no such deduction or withholding been made. 

(b) The Loan Parties shall timely pay to the relevant Governmental Authority in accordance with applicable law, or at the option of the
Administrative Agent timely reimburse it for, Other Taxes. 
 (c) As soon as practicable after any payment of Taxes by any Loan Party to a
Governmental Authority pursuant to this Section 2.19, such Loan Party shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return
reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent. 
 (d) The Loan Parties shall
jointly and severally indemnify each Credit Party, within 10 days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section) payable
or paid by such Credit Party or required to be withheld or deducted from a payment to such Credit Party and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or
asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on
behalf of a Lender, shall be conclusive absent manifest error. 
 (e) Each Lender shall severally indemnify the Administrative Agent, within
10 days after demand therefor, for (i) any Taxes attributable to such Lender (but only to the extent that any Loan Party has not already indemnified the Administrative Agent for such Taxes and without limiting the obligation of the Loan Parties
to do so) and (ii) any Taxes attributable to such Lender’s failure to comply with the provisions of Section 10.6(c) relating to the maintenance of a Participant Register, in either case, that are payable or paid by the Administrative
Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to
the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing
to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this paragraph (e). 

  
 47 

 (f) (i) Any Lender that is entitled to an exemption from or reduction of withholding Tax with
respect to payments made under any Loan Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation
reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Lender, if reasonably requested by the Borrower or the Administrative
Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject
to backup withholding or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in
Section 2.19(f)(ii)(A), (ii)(B) and (ii)(D) below) shall not be required if in the Lender’s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would
materially prejudice the legal or commercial position of such Lender. 
 (ii) Without limiting the generality of the
foregoing, in the event that the Borrower is a U.S. Person, 
  

	 	(A)	any Lender that is a U.S. Person shall deliver to the Borrower and the Administrative Agent on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the
reasonable request of the Borrower or the Administrative Agent), executed originals of IRS Form W-9 certifying that such Lender is exempt from U.S. Federal backup withholding tax; 

 

	 	(B)	any Non-U.S. Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on
which such Non-U.S. Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), whichever of the following is applicable: 

 

	 	(1)	in the case of a Non-U.S. Lender claiming the benefits of an income tax treaty to which the United States is a party (x) with respect to payments of interest under any Loan Document, executed originals of IRS Form
W-8BEN or W-8BEN-E establishing an exemption from, or reduction of, U.S. Federal withholding Tax pursuant to the “interest” article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, IRS
Form W-8BEN or W-8BEN-E establishing an exemption from, or reduction of, U.S. Federal withholding Tax pursuant to the “business profits” or “other income” article of such tax treaty; 

 

	 	(2)	executed originals of IRS Form W-8ECI; 

  

	 	(3)	 in the case of a Non-U.S. Lender claiming the benefits of the exemption for portfolio interest under
Section 881(c) of the Code, (x) a certificate substantially in the form of Exhibit G-1 to the effect that such Non-U.S. Lender is 

  
 48 

	 	
not a “bank” within the meaning of Section 881(c)(3)(A) of the Code, a “10 percent shareholder” of the Borrower within the meaning of Section 881(c)(3)(B) of the
Code, or a “controlled foreign corporation” described in Section 881(c)(3)(C) of the Code (a “U.S. Tax Compliance Certificate”) and (y) executed originals of IRS Form W-8BEN or W-8BEN-E; or 

 

	 	(4)	to the extent a Non-U.S. Lender is not the beneficial owner, executed originals of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN or W-8BEN-E, a U.S. Tax Compliance Certificate substantially in the
form of Exhibit G-2 or Exhibit G-3, IRS Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided, that if the Non-U.S. Lender is a partnership and one or more direct or indirect partners
of such Non-U.S. Lender are claiming the portfolio interest exemption, such Non-U.S. Lender may provide a U.S. Tax Compliance Certificate substantially in the form of Exhibit G-4 on behalf of each such direct and indirect partner;

  

	 	(C)	any Non-U.S. Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on
which such Non-U.S. Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed originals of any other form prescribed by applicable law as a basis
for claiming exemption from or a reduction in U.S. Federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower or the Administrative Agent to determine the
withholding or deduction required to be made; and 

  

	 	(D)	if a payment made to a Lender under any Loan Document would be subject to U.S. Federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA
(including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested
by the Borrower or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the
Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the
amount to deduct and withhold from such payment. Solely for purposes of this clause (D), “FATCA” shall include any amendments made to FATCA after the date of this Agreement. 

  
 49 

 Each Lender agrees that if any form or certification it previously delivered expires or becomes
obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so. 

(g) If any party determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been
indemnified pursuant to this Section 2.19 (including by the payment of additional amounts pursuant to this Section 2.19), it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments
made under this Section with respect to the Taxes giving rise to such refund), net of all reasonable out-of-pocket expenses (including Taxes) of such indemnified party and without interest (other than any interest paid by the relevant Governmental
Authority with respect to such refund). Such indemnifying party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to this paragraph (g) (plus any penalties, interest or other
charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (g), in no event will the
indemnified party be required to pay any amount to an indemnifying party pursuant to this paragraph (g) the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been
in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This paragraph shall
not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the indemnifying party or any other Person. 

(h) Each party’s obligations under this Section 2.19 shall survive the resignation or replacement of the Administrative Agent or any
assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under the Loan Documents. 

(i) For purposes of this Section 2.19, the term “Lender” includes the Issuing Lender and the Swingline Lenders and the term
“applicable law” includes FATCA. 
 2.20. Indemnity. The Borrower agrees to indemnify each Lender for, and to hold each
Lender harmless from, any loss or expense that such Lender may sustain or incur as a consequence of (a) default by the Borrower in making a borrowing of, conversion into or continuation of Eurodollar Loans after the Borrower has given a notice
requesting the same in accordance with the provisions of this Agreement, (b) default by the Borrower in making any prepayment of or conversion from Eurodollar Loans after the Borrower has given a notice thereof in accordance with the provisions
of this Agreement or (c) the making of a prepayment (including any payment made to a Lender in connection with a forced assignment by such Lender of Loans in accordance with Section 2.22 or Section 10.1) of Eurodollar Loans on a day
that is not the last day of an Interest Period with respect thereto. Such indemnification may include an amount equal to the excess, if any, of (i) the amount of interest that would have accrued on the amount so prepaid, or not so borrowed,
converted or continued, for the period from the date of such prepayment or of such failure to borrow, convert or continue to the last day of such Interest Period (or, in the case of a failure to borrow, convert or continue, the Interest Period that
would have commenced on the date of such failure) in each case at the applicable rate of interest for such Loans provided for herein (excluding, however, the Applicable Margin included therein, if any) over (ii) the amount of 

  
 50 

 
interest (as reasonably determined by such Lender) that would have accrued to such Lender on such amount by placing such amount on deposit for a comparable period with leading banks in the
interbank eurodollar market. A certificate as to any amounts payable pursuant to this Section submitted to the Borrower by any Lender shall be conclusive in the absence of manifest error. This covenant shall survive the termination of this Agreement
and the payment of the Loans and all other amounts payable hereunder. 
 2.21. Change of Lending Office. Each Lender agrees that, upon
the occurrence of any event giving rise to the operation of Section 2.18 or 2.19(a) with respect to such Lender, it will, if requested by the Borrower, use reasonable efforts (subject to overall policy considerations of such Lender) to
designate another lending office for any Loans affected by such event with the object of avoiding the consequences of such event; provided, that such designation is made on terms that, in the sole judgment of such Lender, cause such Lender
and its lending offices to suffer no economic, legal or regulatory disadvantage, and provided, further, that nothing in this Section shall affect or postpone any of the obligations of the Borrower or the rights of any Lender pursuant
to Section 2.18 or 2.19(a). 
 2.22. Replacement of Lenders. The Borrower shall be permitted to replace any Lender that
(a) requests reimbursement for amounts owing pursuant to Section 2.18 or 2.19(a), (b) becomes a Defaulting Lender, or (c) does not consent to any proposed amendment, supplement, modification, consent or waiver of any provision of
this Agreement or any other Loan Document that requires the consent of all Lenders, of each of the Lenders or of each of the Lenders affected thereby (so long as the consent of the Required Lenders has been obtained), with a replacement financial
institution; provided, that (i) such replacement does not conflict with any Requirement of Law, (ii) no Event of Default shall have occurred and be continuing at the time of such replacement, (iii) prior to any such replacement
pursuant to clause (a) above, such Lender shall have taken no action under Section 2.21 so as to eliminate the continued need for payment of amounts owing pursuant to Section 2.18 or 2.19(a), (iv) the replacement financial
institution shall purchase, at par, all Loans and other amounts owing to such replaced Lender (including principal, interest and fees) on or prior to the date of replacement, (v) the Borrower shall be liable to such replaced Lender under
Section 2.20 if any Eurodollar Loan owing to such replaced Lender shall be purchased other than on the last day of the Interest Period relating thereto, (vi) the replacement financial institution shall be a Lender or reasonably
satisfactory to the Administrative Agent, (vii) the replaced Lender shall be obligated to make such replacement in accordance with the provisions of Section 10.6 (provided, that the Borrower or replacement financial institution
shall be obligated to pay the registration and processing fee referred to therein), (viii) until such time as such replacement shall be consummated, the Borrower shall pay all additional amounts (if any) required pursuant to Section 2.18
or 2.19(a), as the case may be, and (ix) any such replacement shall not be deemed to be a waiver of any rights that the Borrower, the Administrative Agent or any other Lender shall have against the replaced Lender. Each party hereto agrees that
an assignment required pursuant to this paragraph may be effected pursuant to an Assignment and Assumption executed by the Borrower, the Administrative Agent and the assignee, and that the Lender required to make such assignment need not be a party
thereto in order for such assignment to be effective. 
 2.23. Defaulting Lenders. Notwithstanding any provision of this Agreement to
the contrary, but without prejudice to Section 2.22, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender: 

(a) fees shall cease to accrue on the unfunded portion of the Revolving Commitment of such Defaulting Lender pursuant to Section 2.8(a);

 (b) the Revolving Commitment and Revolving Extensions of Credit of such Defaulting Lender shall not be included in determining whether the
Required Lenders have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to Section 10.1); provided, that this clause (b) shall not apply to the vote of a Defaulting
Lender in the case of an amendment, waiver or other modification requiring the consent of such Lender or each Lender affected thereby; 

  
 51 

 (c) if any Swingline Exposure or L/C Exposure exists at the time such Lender becomes a Defaulting
Lender then: 
 (i) all or any part of the Swingline Exposure and L/C Exposure of such Defaulting Lender (other than the
portion of such Swingline Exposure referred to in clause (b) of the definition of such term) shall be reallocated among the non-Defaulting Lenders in accordance with their respective Revolving Percentages but only to the extent the sum of all
non-Defaulting Lenders’ Revolving Extensions of Credit plus such Defaulting Lender’s Swingline Exposure and L/C Exposure does not exceed the total of all non-Defaulting Lenders’ Revolving Commitments; 

(ii) if the reallocation described in clause (i) above cannot, or can only partially, be effected, the Borrower shall
within one Business Day following notice by the Administrative Agent (x) first, prepay such portion of the Swingline Exposure not reallocated and (y) second, cash collateralize for the benefit of the Issuing Lender only the
Borrower’s obligations corresponding to such Defaulting Lender’s L/C Exposure (after giving effect to any partial reallocation pursuant to clause (i) above) in accordance with the procedures set forth in Section 8 for so long as
such L/C Exposure is outstanding; 
 (iii) if the Borrower cash collateralizes any portion of such Defaulting Lender’s
L/C Exposure pursuant to clause (ii) above, the Borrower shall not be required to pay any fees to such Defaulting Lender pursuant to Section 3.3(a) with respect to such Defaulting Lender’s L/C Exposure during the period such
Defaulting Lender’s L/C Exposure is cash collateralized; 
 (iv) if the L/C Exposure of the non-Defaulting Lenders is
reallocated pursuant to clause (i) above, then the fees payable to the Lenders pursuant to Section 2.8(a) and Section 3.3(a) shall be adjusted in accordance with such non-Defaulting Lenders’ Revolving Percentages; and 

(v) if all or any portion of such Defaulting Lender’s L/C Exposure is neither reallocated nor cash collateralized pursuant
to clause (i) or (ii) above, then, without prejudice to any rights or remedies of the Issuing Lender or any other Lender hereunder, all fees payable under Section 3.3(a) with respect to such Defaulting Lender’s L/C Exposure shall
be payable to the Issuing Lender until and to the extent that such L/C Exposure is reallocated and/or cash collateralized; and 
 (d) so long
as such Lender is a Defaulting Lender, the Swingline Lenders shall not be required to fund any Swingline Loan and the Issuing Lender shall not be required to issue, amend or increase any Letter of Credit, unless it is satisfied that the related
exposure and the Defaulting Lender’s then outstanding L/C Exposure will be 100% covered by the Revolving Commitments of the non-Defaulting Lenders and/or cash collateral will be provided by the Borrower in accordance with Section 2.23(c),
and participating interests in any newly made Swingline Loan or any newly issued or increased Letter of Credit shall be allocated among non-Defaulting Lenders in a manner consistent with Section 2.23(c)(i) (and such Defaulting Lender shall not
participate therein). 

  
 52 

 If (i) a Bankruptcy Event with respect to a Lender Parent of any Lender shall occur
following the date hereof and for so long as such event shall continue or (ii) the Swingline Lenders or the Issuing Lender have a good faith belief that any Lender has defaulted in fulfilling its obligations under one or more other agreements
in which such Lender commits to extend credit, the Swingline Lenders shall not be required to fund any Swingline Loan and the Issuing Lender shall not be required to issue, amend or increase any Letter of Credit, unless a Swingline Lender or an
Issuing Lender, as the case may be, shall have entered into arrangements with the Borrower or such Lender, satisfactory to such Swingline Lender or such Issuing Lender, as the case may be, to defease any risk to it in respect of such Lender
hereunder. 
 In the event that the Administrative Agent, the Borrower, each of the Swingline Lenders and each of the Issuing Lender agrees
that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then the Swingline Exposure and L/C Exposure of the Lenders shall be readjusted to reflect the inclusion of such Lender’s Revolving
Commitment and on such date such Lender shall purchase at par such of the Loans of the other Lenders (other than Swingline Loans) as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance
with its Revolving Percentage. 
 2.24. Incremental Facilities. (a) The Borrower and any one or more Lenders (including New
Lenders) may from time to time agree that such Lenders shall make, obtain or increase the amount of their Incremental Term Loans (an “Incremental Term Facility”) or Revolving Commitments (“Increased Revolving
Commitments”; together with any Incremental Term Facility, the “Incremental Facilities”), as applicable, by executing and delivering to the Administrative Agent an Increased Facility Activation Notice specifying
(i) the amount of such increase, (ii) the applicable Increased Facility Closing Date, (iii) in the case of Incremental Term Loans, (x) the applicable Incremental Term Maturity Date, (y) the amortization schedule for such
Incremental Term Loans, and (z) the Applicable Margin for such Incremental Term Loans; provided, that (i) no Event of Default exists or would exist after giving effect to such Incremental Facility, (ii) on a pro forma basis
after giving effect to the incurrence of any such Incremental Facility (assuming, if such Incremental Facility consists of Increased Revolving Commitments, such Increased Revolving Commitments are fully drawn as of such date) and after giving effect
to other permitted pro forma adjustment events and any repayments of Indebtedness after the beginning of the relevant period but prior to or simultaneous with the incurrence of such Incremental Facility, (x) the Borrower shall be in compliance
with the financial covenants set forth in Section 7.1 recomputed as of the last day of the fiscal quarter of the Borrower then most recently ended for which financial statements described in Section 6.1(a) or (b) have been delivered,
and (y) the Consolidated Leverage Ratio of the Borrower and its Restricted Subsidiaries as of the end of such fiscal quarter shall be no greater than 4.00:1.00, (iii) the representations and warranties set forth in Article IV shall be true
and correct in all material respects (except that such materiality qualifier shall not be applicable to the extent any such representations and warranties are already qualified or modified by materiality, it being understood and agreed that any
representation or warranty which by its terms is made as of a specified date shall be required to be true and correct in all material respects only as of such specified date) immediately prior to, and after giving effect to, the incurrence of such
Incremental Facility, (iv) the maturity date and Weighted Average Life to Maturity of any such Incremental Term Facility shall be no earlier than (or the same as) the maturity date and Weighted Average Life to Maturity, respectively, of the
Term Loans, (v) the interest rates and amortization schedule applicable to any Incremental Term Facility shall be determined by the Borrower and the lenders thereunder and (vi) any Increased Revolving Commitments shall be on terms and
pursuant to documentation applicable to the Revolving Facility (including the maturity date in respect thereof) and any Incremental Term Loan Facility shall be on terms and pursuant to documentation, to the extent such terms and documentation are
not consistent with, in the case of an Incremental Term Facility, the Term Facility (except to the extent permitted by clause (iv) and (v) above), reasonably satisfactory to the Administrative Agent (including as 

  
 53 

 
to the identity of the New Lenders); provided, that if the total yield (calculated for both the Incremental Term Loans and the Term Loans, including the upfront fees, any interest rate
floors and any OID (as defined below)) shared with all providers of such Incremental Term Loans, but excluding the effect of any arrangement, structuring, syndication or other fees payable in connection therewith that are not shared with all
providers of such financing, and without taking into account any fluctuations in the Eurodollar Rate or ABR in respect of any Incremental Term Loans exceeds the total yield for the existing Loans (it being understood that any such increase may take
the form of original issue discount (“OID”), with OID being equated to the interest rates in a manner determined by the Administrative Agent based on an assumed four-year life to maturity), the Applicable Margin for the Loans shall
be increased so that the total yield in respect of such Incremental Term Loans is no higher 0.50% greater than the total yield for the existing Term Loans. Notwithstanding the foregoing, (i) without the consent of the Required Lenders, the
aggregate amount of Increased Revolving Commitments obtained after the Restatement Effective Date pursuant to this paragraph, together with the aggregate amount of Incremental Term Loans obtained after the Restatement Effective Date pursuant to this
paragraph, shall not exceed $40,000,000 and (ii) without the consent of the Administrative Agent, each increase effected pursuant to this paragraph shall be in a minimum amount of at least $5,000,000. No Lender shall have any obligation to
participate in any increase described in this paragraph unless it agrees to do so in its sole discretion. 
 (b) Any additional bank,
financial institution or other entity which, with the consent of the Borrower and the Administrative Agent (which consent shall not be unreasonably withheld), elects to become a “Lender” under this Agreement in connection with any
transaction described in Section 2.24(a) shall execute a New Lender Supplement (each, a “New Lender Supplement”), substantially in the form of Exhibit H-3, whereupon such bank, financial institution or other entity (a
“New Lender”) shall become a Lender for all purposes and to the same extent as if originally a party hereto and shall be bound by and entitled to the benefits of this Agreement. 

(c) Unless otherwise agreed by the Administrative Agent, on each Increased Facility Closing Date with respect to the Revolving Facility, the
Borrower shall borrow Revolving Loans under the relevant increased Revolving Commitments from each Lender participating in the relevant increase in an amount determined by reference to the amount of each Type of Loan (and, in the case of Eurodollar
Loans, of each Eurodollar Tranche) which would then have been outstanding from such Lender if (i) each such Type or Eurodollar Tranche had been borrowed or effected on such Increased Facility Closing Date and (ii) the aggregate amount of
each such Type or Eurodollar Tranche requested to be so borrowed or effected had been proportionately increased. The Eurodollar Base Rate applicable to any Eurodollar Loan borrowed pursuant to the preceding sentence shall equal the Eurodollar Base
Rate then applicable to the Eurodollar Loans of the other Lenders in the same Eurodollar Tranche (or, until the expiration of the then-current Interest Period, such other rate as shall be agreed upon between the Borrower and the relevant Lender.

 (d) Notwithstanding anything to the contrary in this Agreement, each of the parties hereto hereby agrees that, on each Increased Facility
Activation Date, this Agreement shall be amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Incremental Term Loans evidenced thereby. Any such deemed amendment may be effected in writing by the
Administrative Agent with the Borrower’s consent (not to be unreasonably withheld) and furnished to the other parties hereto. 
 2.25.
Extensions of Term Loans and Revolving Commitments. (a) Notwithstanding anything to the contrary in this Agreement, pursuant to one or more offers (each, an “Extension Offer”) made from time to time by the Borrower to all
Lenders of Term Loans with a like maturity date or Revolving Commitments with a like maturity date, in each case on a pro rata basis (based on the aggregate outstanding principal amount of the respective Term Loans or Revolving Commitments with a

  
 54 

 
like maturity date, as the case may be) and on the same terms to each such Lender, the Borrower is hereby permitted to consummate from time to time transactions with individual Lenders that
accept the terms contained in such Extension Offers to extend the maturity date of each such Lender’s Term Loans and/or Revolving Commitments and otherwise modify the terms of such Term Loans and/or Revolving Commitments pursuant to the terms
of the relevant Extension Offer (including by increasing the interest rate or fees payable in respect of such Term Loans and/or Revolving Commitments (and related outstandings) and/or modifying the amortization schedule in respect of such
Lender’s Term Loans) (each, an “Extension”, and each group of Term Loans or Revolving Commitments, as applicable, in each case as so extended, as well as the original Term Loans and the original Revolving Commitments (in each
case not so extended), being a “tranche”; any Extended Term Loans shall constitute a separate tranche of Term Loans from the tranche of Term Loans from which they were converted, and any Extended Revolving Commitments shall constitute a
separate tranche of Revolving Commitments from the tranche of Revolving Commitments from which they were converted), so long as the following terms are satisfied: (i) each of the conditions set forth in Section 5.2 shall be satisfied at
the time the offering document in respect of an Extension Offer is delivered to the Lenders, (ii) except as to interest rates, fees and final maturity (which shall be determined by the Borrower and set forth in the relevant Extension Offer),
the Revolving Commitment of any Revolving Lender that agrees to an Extension (an “Extended Revolving Commitment”; and the Loans thereunder, “Extended Revolving Loans”), and the related outstandings, shall be a
Revolving Commitment (or related outstandings, as the case may be) with the same terms as the original Revolving Commitments (and related outstandings); provided, that (x) subject to the provisions of Sections 2.6(c) and 3.1(c) to the
extent dealing with Swingline Loans and Letters of Credit which mature or expire after a maturity date when there exist Extended Revolving Commitments with a longer maturity date, all Swingline Loans and Letters of Credit shall be participated in on
a pro rata basis by all Lenders with Revolving Commitments in accordance with their Revolving Percentages (and except as provided in Sections 2.6(c) and 3.1(c), without giving effect to changes thereto on an earlier maturity date with respect to
Swingline Loans and Letters of Credit theretofore incurred or issued) and all borrowings under Revolving Commitments and repayments thereunder shall be made on a pro rata basis (except for (A) payments of interest and fees at different rates on
Extended Revolving Commitments (and related outstandings) and (B) repayments required upon the maturity date of the non-extending Revolving Commitments) and (y) at no time shall there be Revolving Commitments hereunder (including Extended
Revolving Commitments) that have more than four different maturity dates, (iii) except as to interest rates, fees, amortization, final maturity date, premium, required prepayment dates and participation in prepayments (which shall, subject to
immediately succeeding clauses (iv), (v) and (vi), be determined between the Borrower and set forth in the relevant Extension Offer), the Term Loans of any Term Lender that agrees to an extension with respect to such Term Loans extended
pursuant to any Extension (“Extended Term Loans”) shall have the same terms as the tranche of Term Loans subject to such Extension Offer until the maturity of such Term Loans, (iv) the final maturity date of any Extended Term
Loans shall be no earlier than the then latest maturity date hereunder and the amortization schedule applicable to Term Loans pursuant to Section 2.3 for periods prior to the Term Loan Maturity Date, as applicable, may not be increased,
(v) the weighted average life of any Extended Term Loans shall be no shorter than the remaining weighted average life of the Term Loans extended thereby, (vi) any Extended Term Loans may participate on a pro rata basis or a less than pro
rata basis (but not greater than a pro rata basis) in any voluntary or mandatory repayments or prepayments hereunder, in each case as specified in the respective Extension Offer, (vii) if the aggregate principal amount of Term Loans (calculated
on the face amount thereof) or Revolving Commitments, as the case may be, in respect of which Term Lenders or Revolving Lenders, as the case may be, shall have accepted the relevant Extension Offer shall exceed the maximum aggregate principal amount
of Term Loans or Revolving Commitments, as the case may be, offered to be extended by the Borrower pursuant to such Extension Offer, then the Term Loans or Revolving Loans, as the case may be, of such Term Lenders or Revolving Lenders, as the case
may be, shall be extended ratably up to such maximum amount based on the respective principal amounts (but not to exceed actual holdings of record) with respect to which such Term Lenders or Revolving Lenders, as 

  
 55 

 
the case may be, have accepted such Extension Offer, (viii) all documentation in respect of such Extension shall be consistent with the foregoing, (ix) any applicable Minimum Extension
Condition shall be satisfied unless waived by the Borrower and (x) the Minimum Tranche Amount shall be satisfied unless waived by the Administrative Agent. 

(b) With respect to all Extensions consummated by the Borrower pursuant to this Section, (i) such Extensions shall not constitute
voluntary or mandatory payments or prepayments for purposes of Sections 2.9, 2.10, 2.11 or 2.17 and (ii) no Extension Offer is required to be in any minimum amount or any minimum increment; provided, that (x) the Borrower may at its
election specify as a condition (a “Minimum Extension Condition”) to consummating any such Extension that a minimum amount (to be determined and specified in the relevant Extension Offer in the Borrower’s sole discretion and
may be waived by the Borrower) of Term Loans or Revolving Commitments (as applicable) of any or all applicable tranches be tendered and (y) no tranche of Extended Term Loans shall be in an amount of less than $15,000,000 (or, if less, the then
aggregate outstanding amount of the Term Loans) (the “Minimum Tranche Amount”), unless such Minimum Tranche Amount is waived by the Administrative Agent. The Administrative Agent and the Lenders hereby consent to the transactions
contemplated by this Section (including, for the avoidance of doubt, payment of any interest, fees or premium in respect of any Extended Term Loans and/or Extended Revolving Commitments on such terms as may be set forth in the relevant Extension
Offer) and hereby waive the requirements of any provision of this Agreement (including Sections 2.9, 2.10, 2.11 or 2.17 or any other Loan Document that may otherwise prohibit any such Extension or any other transaction contemplated by this Section).

 (c) No consent of any Lender or the Administrative Agent shall be required to effectuate any Extension, other than (A) the consent of
each Lender agreeing to such Extension with respect to one or more of its Term Loans and/or Revolving Commitments (or a portion thereof) and (B) with respect to any Extension of the Revolving Commitments, the consent of the Issuing Lender and
the Swingline Lenders, which consent shall not be unreasonably withheld or delayed. All Extended Term Loans, Extended Revolving Loans and all obligations of any Loan Party in respect thereof shall be Obligations under this Agreement and the other
Loan Documents that are secured by the Collateral and guaranteed on a pari passu basis with all other applicable Obligations under this Agreement and the other Loan Documents. The Lenders hereby irrevocably authorize the Administrative Agent to
enter into amendments to this Agreement and the other Loan Documents with the Borrower as may be necessary in order to establish new tranches or sub-tranches in respect of Revolving Commitments or Term Loans so extended and such technical amendments
as may be necessary or appropriate in the reasonable opinion of the Administrative Agent and the Borrower in connection with the establishment of such new tranches or sub-tranches, in each case on terms consistent with this Section. Without limiting
the foregoing, in connection with any Extensions the respective Loan Parties shall (at their expense) amend (and the Administrative Agent is hereby directed to amend) any Mortgage (i) that states a maturity date prior to the then latest
maturity date so that such maturity date is extended to the then latest maturity date (or such later date as may be advised by local counsel to the Administrative Agent), (ii) in connection with such amendments the Loan Parties shall (at their
expense) deliver to the Administrative Agent a date-down endorsement or equivalent document to the title insurance policy covering the Mortgages that are being amended and (iii) if requested by the Administrative Agent, an opinion of local
counsel in each jurisdiction in which a Mortgage is being amended. 
 (d) In connection with any Extension, the Borrower shall provide the
Administrative Agent at least 10 Business Days’ (or such shorter period as may be agreed by the Administrative Agent) prior written notice thereof, and shall agree to such procedures (including regarding timing, rounding and other adjustments
and to ensure reasonable administrative management of the credit facilities hereunder after such Extension), if any, as may be established by, or acceptable to, the Administrative Agent, in each case acting reasonably to accomplish the purposes of
this Section. 

  
 56 

 SECTION 3. LETTERS OF CREDIT 

3.1. L/C Commitment. (a) Subject to the terms and conditions hereof, the Issuing Lender, in reliance on the agreements of the
other Revolving Lenders set forth in Section 3.4(a), agrees to issue letters of credit (“Letters of Credit”) for the account of the Borrower on any Business Day during the Revolving Commitment Period in such form as may be
approved from time to time by the Issuing Lender; provided, that the Issuing Lender shall have no obligation to issue any Letter of Credit if, after giving effect to such issuance, (i) the L/C Obligations would exceed the L/C Commitment
or (ii) the aggregate amount of the Available Revolving Commitments would be less than zero. Each Letter of Credit shall (i) be denominated in Agreed Currencies and (ii) expire no later than the first anniversary of its date of
issuance, unless consented to by the Issuing Lender; provided, that any Letter of Credit with a one-year term may provide for the renewal thereof for additional one-year periods; provided further, that in the event any such
Letter of Credit expires after or is renewed beyond the date that is five Business Days prior to the Revolving Termination Date, such Letter of Credit shall be cash collateralized or otherwise credit supported to the reasonable satisfaction of the
Administrative Agent and the Issuing Lender on or prior to the date that is five Business Days prior to the Revolving Termination Date. 

(b) The Issuing Lender shall not at any time be obligated to issue any Letter of Credit if such issuance would conflict with, or cause the
Issuing Lender or any L/C Participant to exceed any limits imposed by, any applicable Requirement of Law 
 (c) If the maturity date in
respect of any tranche of Revolving Commitments occurs prior to the expiration of any Letter of Credit, then (i) if one or more other tranches of Revolving Commitments in respect of which the maturity date shall not have occurred are then in
effect, (x) the outstanding Revolving Loans shall be repaid pursuant to Section 2.10 on such maturity date in an amount sufficient to permit the reallocation of the L/C Obligations relating to the outstanding Letters of Credit contemplated
by clause (y) below and (y) such Letters of Credit shall automatically be deemed to have been issued (including for purposes of the obligations of the Revolving Lenders to purchase participations therein and to make payments in respect
thereof pursuant to Section 3.4) under (and ratably participated in by Lenders pursuant to) the Revolving Commitments in respect of such non-terminating tranches up to an aggregate amount not to exceed the Revolving Commitments in respect of
such non-terminating tranches at such time (it being understood that (A) the participations therein of Revolving Lenders under the maturing tranche shall be correspondingly released and (B) no partial face amount of any Letter of Credit
may be so reallocated) and (ii) to the extent not reallocated pursuant to immediately preceding clause (i), but without limiting the obligations with respect thereto, the Borrower shall cash collateralize any such Letter of Credit in a manner
reasonably satisfactory to the Administrative Agent and the Issuing Lender. If, for any reason, such cash collateral is not provided or the reallocation does not occur, the Revolving Lenders under the maturing tranche shall continue to be
responsible for their participating interests in the Letters of Credit; provided that, notwithstanding anything to the contrary contained herein, upon any subsequent repayment of the Revolving Loans, the reallocation set forth in clause
(i) shall automatically and concurrently occur to the extent of such repayment (it being understood that no partial face amount of any Letter of Credit may be so reallocated). Except to the extent of reallocations of participations pursuant to
clause (i) of the second preceding sentence, the occurrence of a maturity date with respect to a given tranche of Revolving Commitments shall have no effect upon (and shall not diminish) the percentage participations of the Revolving Lenders in
any Letter of Credit issued before such maturity date. Commencing with the maturity date of any tranche of Revolving Commitments, the sublimit for Letters of Credit under any tranche of Revolving Commitments that has not so then matured shall be as
agreed with such Revolving Lenders; provided that in no event shall such sublimit be less than the sum of (x) the L/C Obligations of the Revolving Lenders under such extended tranche immediately prior to such maturity date and
(y) the face amount of the Letters of Credit reallocated to such tranche of Revolving Commitments pursuant to clause (i) above (assuming Revolving Loans are repaid in accordance with clause (i)(x)). 

  
 57 

 3.2. Procedure for Issuance of Letter of Credit. The Borrower may from time to time
request that the Issuing Lender issue a Letter of Credit by delivering to the Issuing Lender at its address for notices specified herein an Application therefor (which, for the avoidance of doubt, shall include the currency of the requested Letter
of Credit), completed to the satisfaction of the Issuing Lender, and such other certificates, documents and other papers and information as the Issuing Lender may request. Upon receipt of any Application, the Issuing Lender will process such
Application and the certificates, documents and other papers and information delivered to it in connection therewith in accordance with its customary procedures (including receiving information from the Administrative Agent that there is sufficient
availability under the L/C Commitment and the Revolving Commitment) and shall promptly issue the Letter of Credit requested thereby (but in no event shall the Issuing Lender be required to issue any Letter of Credit earlier than three Business Days
after its receipt of the Application therefor and all such other certificates, documents and other papers and information relating thereto) by issuing the original of such Letter of Credit to the beneficiary thereof or as otherwise may be agreed to
by the Issuing Lender and the Borrower. The Issuing Lender shall furnish a copy of such Letter of Credit to the Borrower promptly following the issuance thereof. The Issuing Lender shall promptly furnish to the Administrative Agent, which shall in
turn promptly furnish to the Lenders, notice of the issuance of each Letter of Credit (including the amount thereof). 
 3.3. Fees and
Other Charges. (a) The Borrower will pay a fee on all outstanding Letters of Credit at a per annum rate equal to the Applicable Margin then in effect with respect to Eurodollar Loans under the Revolving Facility, shared ratably among the
Revolving Lenders and payable quarterly in arrears in Dollars on each Fee Payment Date after the issuance date (and based on the Dollar Equivalent thereof, in the case of Foreign Currency Letters of Credit). In addition, the Borrower shall pay to
the Issuing Lender for its own account a fronting fee of 0.125% per annum on the undrawn and unexpired amount of each Letter of Credit, payable quarterly in arrears in Dollars on each Fee Payment Date after the issuance date (and based on the
Dollar Equivalent thereof, in the case of Foreign Currency Letters of Credit). 
 (b) In addition to the foregoing fees, the Borrower shall
pay or reimburse the Issuing Lender for such normal and customary costs and expenses as are incurred or charged by the Issuing Lender in issuing, negotiating, effecting payment under, amending or otherwise administering any Letter of Credit. 

3.4. L/C Participations. (a) The Issuing Lender irrevocably agrees to grant and hereby grants to each L/C Participant, and, to
induce the Issuing Lender to issue Letters of Credit, each L/C Participant irrevocably agrees to accept and purchase and hereby accepts and purchases from the Issuing Lender, on the terms and conditions set forth below, for such L/C
Participant’s own account and risk an undivided interest equal to such L/C Participant’s Revolving Percentage in the Issuing Lender’s obligations and rights under and in respect of each Letter of Credit and the amount of each draft
paid by the Issuing Lender thereunder. Each L/C Participant agrees with the Issuing Lender that, if a draft is paid under any Letter of Credit for which the Issuing Lender is not reimbursed in full by the Borrower in accordance with the terms of
this Agreement (or in the event that any reimbursement received by the Issuing Lender shall be required to be returned by it at any time), such L/C Participant shall pay to the Issuing Lender upon demand at the Issuing Lender’s address for
notices specified herein an amount equal to such L/C Participant’s Revolving Percentage of the amount that is not so reimbursed (or is so returned). Each L/C Participant’s obligation to pay such amount shall be absolute and unconditional
and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such L/C Participant may have against the Issuing Lender, the Borrower or any other 

  
 58 

 
Person for any reason whatsoever, (ii) the occurrence or continuance of a Default or an Event of Default or the failure to satisfy any of the other conditions specified in Section 5,
(iii) any adverse change in the condition (financial or otherwise) of the Borrower, (iv) any breach of this Agreement or any other Loan Document by the Borrower, any other Loan Party or any other L/C Participant or (v) any other
circumstance, happening or event whatsoever, whether or not similar to any of the foregoing. 
 (b) If any amount required to be paid by any
L/C Participant to the Issuing Lender pursuant to Section 3.4(a) in respect of any unreimbursed portion of any payment made by the Issuing Lender under any Letter of Credit is paid to the Issuing Lender within three Business Days after the date
such payment is due, such L/C Participant shall pay to the Issuing Lender on demand an amount equal to the product of (i) such amount, times (ii) the daily average NYFRB Rate during the period from and including the date such payment is
required to the date on which such payment is immediately available to the Issuing Lender, times (iii) a fraction the numerator of which is the number of days that elapse during such period and the denominator of which is 360. If any such
amount required to be paid by any L/C Participant pursuant to Section 3.4(a) is not made available to the Issuing Lender by such L/C Participant within three Business Days after the date such payment is due, the Issuing Lender shall be entitled
to recover from such L/C Participant, on demand, such amount with interest thereon calculated from such due date at the rate per annum applicable to ABR Loans under the Revolving Facility. A certificate of the Issuing Lender submitted to any L/C
Participant with respect to any amounts owing under this Section shall be conclusive in the absence of manifest error. 
 (c) Whenever, at
any time after the Issuing Lender has made payment under any Letter of Credit and has received from any L/C Participant its pro rata share of such payment in accordance with Section 3.4(a), the Issuing Lender receives any payment
related to such Letter of Credit (whether directly from the Borrower or otherwise, including proceeds of collateral applied thereto by the Issuing Lender), or any payment of interest on account thereof, the Issuing Lender will distribute to such L/C
Participant its pro rata share thereof; provided, however, that in the event that any such payment received by the Issuing Lender shall be required to be returned by the Issuing Lender, such L/C Participant shall return
to the Issuing Lender the portion thereof previously distributed by the Issuing Lender to it. 
 3.5. Reimbursement Obligation of the
Borrower. If any draft is paid under any Letter of Credit, the Borrower shall reimburse the Issuing Lender for the amount of (a) the draft so paid (and in the applicable currency) and (b) any taxes, fees, charges or other costs or
expenses incurred by the Issuing Lender in connection with such payment, not later than 5:00 P.M., New York City time, on (i) the Business Day that the Borrower receives notice of such draft, if such notice is received on such day prior to
10:00 A.M., New York City time, or (ii) if clause (i) above does not apply, the Business Day immediately following the day that the Borrower receives such notice; provided that, in the case of amounts denominated in Available
Foreign Currencies, in the event any such amount is not paid when due, such amount shall, for all purposes of this Agreement, be converted to an amount in Dollars based on the Dollar Equivalent thereof. Each such payment shall be made to the Issuing
Lender at its address for notices referred to herein in Dollars and in immediately available funds. Interest shall be payable on any such amounts from the date on which the relevant draft is paid until payment in full (x) in the case of amounts
denominated in Dollars at the rate set forth in (A) until the Business Day next succeeding the date of the relevant notice (or, if later, the Borrower’s receipt of the notice of drawing described in Section 3.7), Section 2.14(b)
and (B) thereafter, Section 2.14(c) and (y) in the case of amounts denominated in Available Foreign Currencies, the rate determined by the Issuing Lender as its cost of funding such amounts. 

  
 59 

 3.6. Obligations Absolute. The Borrower’s obligations under this Section 3 shall
be absolute and unconditional under any and all circumstances and irrespective of any setoff, counterclaim or defense to payment that the Borrower may have or have had against the Issuing Lender, any beneficiary of a Letter of Credit or any other
Person. The Borrower also agrees with the Issuing Lender that the Issuing Lender shall not be responsible for, and the Borrower’s Reimbursement Obligations under Section 3.5 shall not be affected by, among other things, the validity or
genuineness of documents or of any endorsements thereon, even though such documents shall in fact prove to be invalid, fraudulent or forged, or any dispute between or among the Borrower and any beneficiary of any Letter of Credit or any other party
to which such Letter of Credit may be transferred or any claims whatsoever of the Borrower against any beneficiary of such Letter of Credit or any such transferee. The Issuing Lender shall not be liable for any error, omission, interruption or delay
in transmission, dispatch or delivery of any message or advice, however transmitted, in connection with any Letter of Credit, except for errors or omissions found by a final and nonappealable decision of a court of competent jurisdiction to have
resulted from the gross negligence or willful misconduct of the Issuing Lender. The Borrower agrees that any action taken or omitted by the Issuing Lender under or in connection with any Letter of Credit or the related drafts or documents, if done
in the absence of gross negligence or willful misconduct, shall be binding on the Borrower and shall not result in any liability of the Issuing Lender to the Borrower. 

3.7. Letter of Credit Payments. If any draft shall be presented for payment under any Letter of Credit, the Issuing Lender shall
promptly notify the Borrower of the date and amount thereof. The responsibility of the Issuing Lender to the Borrower in connection with any draft presented for payment under any Letter of Credit shall, in addition to any payment obligation
expressly provided for in such Letter of Credit, be limited to determining that the documents (including each draft) delivered under such Letter of Credit in connection with such presentment are substantially in conformity with such Letter of
Credit. 
 3.8. Applications. To the extent that any provision of any Application related to any Letter of Credit is inconsistent with
the provisions of this Section 3, the provisions of this Section 3 shall apply. 
 SECTION 4. REPRESENTATIONS AND WARRANTIES 

To induce the Administrative Agent and the Lenders to enter into this Agreement and to make the Loans and issue or participate in the Letters
of Credit, the Borrower hereby represents and warrants to the Administrative Agent and each Lender that: 
 4.1. Financial Condition.
(a) The projected pro forma balance sheets of Bioventus Inc. and its consolidated subsidiaries as at June 30, 2016 and December 31, 2016 (including the notes thereto) (collectively, the “2016 Pro Forma Balance
Sheet”), copies of which have heretofore been furnished to each Lender, have been prepared after giving effect (as if such events had occurred on such date (in the case of the 2016 Pro Forma Balance Sheet)) to the Bioventus IPO
Transactions. The 2016 Pro Forma Balance Sheet has been prepared in good faith based on the best information available to the Borrower as of the date of delivery thereof, and presents a good faith estimate of the financial position of the Borrower
and its consolidated subsidiaries as at June 30, 2016 and December 31, 2016, as applicable, assuming that the events specified in the preceding sentence had actually occurred at such dates and based on the assumed amount of proceeds from
the Bioventus IPO stated therein. 
 (b) The audited consolidated balance sheet of the Borrower and its consolidated subsidiaries as at the
full year ended December 31, 2015, and the related consolidated statements of income and of cash flows for the fiscal year ended on such date, reported on by and accompanied by an unqualified report from PricewaterhouseCoopers LLP, present
fairly the consolidated financial condition of the Borrower and its consolidated subsidiaries as at such date, and the consolidated results of its operations and its consolidated cash flows for the respective fiscal years then ended. The unaudited

  
 60 

 
consolidated balance sheet of the Borrower and its consolidated subsidiaries as at April 2, 2016, and the related unaudited consolidated statements of income and cash flows for the
three-month period ended on such date, present fairly the consolidated financial condition of the Borrower and its consolidated subsidiaries as at such date, and the consolidated results of its operations and its consolidated cash flows for the
three-month period then ended (subject to normal year-end audit adjustments and the absence of footnotes). All such financial statements, including the related schedules and notes thereto, have been prepared in accordance with GAAP applied
consistently throughout the periods involved (except as approved by the aforementioned firm of accountants and disclosed therein). Immediately prior to the Restatement Effective Date, no Group Member has any material Guarantee Obligations,
contingent liabilities and liabilities for taxes, or any long-term leases or unusual forward or long-term commitments, including any interest rate or foreign currency swap or exchange transaction or other obligation in respect of derivatives, that
are not reflected in the most recent financial statements referred to in this paragraph and are required to be set forth in such financial statements in accordance with GAAP. During the period from December 31, 2015 to and including the date
hereof there has been no Disposition by any Group Member of any material part of its business or property. 
 4.2. No Change. Since
December 31, 2015, there has been no development or event that has had or could reasonably be expected to have a Material Adverse Effect. 

4.3. Existence; Compliance with Law. Each Group Member (a) is duly organized, validly existing and in good standing under the laws
of the jurisdiction of its organization, (b) has the power and authority, and the legal right, to own and operate its property, to lease the property it operates as lessee and to conduct the business in which it is currently engaged,
(c) is duly qualified as a foreign corporation or other organization and in good standing under the laws of each jurisdiction where its ownership, lease or operation of property or the conduct of its business requires such qualification and
(d) is in compliance with all Requirements of Law, except in the case referred to in clause (b) (other than with respect to the Borrower), (c) or (d), to the extent that the failure to comply therewith or to have such power would not,
in the aggregate, reasonably be expected to have a Material Adverse Effect. 
 4.4. Power; Authorization; Enforceable Obligations.
Each Loan Party has the power and authority, and the legal right, to make, deliver and perform the Loan Documents to which it is a party and, in the case of the Borrower, to obtain extensions of credit hereunder. Each Loan Party has taken all
necessary organizational action to authorize the execution, delivery and performance of the Loan Documents to which it is a party and, in the case of the Borrower, to authorize the extensions of credit on the terms and conditions of this Agreement.
No consent or authorization of, filing with, notice to or other act by or in respect of, any Governmental Authority or any other Person is required in connection with the execution, delivery, performance, validity or enforceability of this Agreement
or any of the Loan Documents, except (i) consents, authorizations, filings and notices described in Schedule 4.4, which consents, authorizations, filings and notices have been obtained or made and are in full force and effect and
(ii) the filings referred to in Section 4.19. Each Loan Document has been duly executed and delivered on behalf of each Loan Party party thereto. This Agreement constitutes, and each other Loan Document upon execution will constitute, a
legal, valid and binding obligation of each Loan Party party thereto, enforceable against each such Loan Party in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting the enforcement of creditors’ rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law). 

4.5. No Legal Bar. The execution, delivery and performance of this Agreement and the other Loan Documents, the issuance of Letters of
Credit, the borrowings hereunder and the use of the proceeds thereof will not violate any Requirement of Law applicable to any Group Member or any Contractual Obligation of any Group Member and will not result in, or require, the creation or
imposition 

  
 61 

 
of any Lien on any of their respective properties or revenues pursuant to any such Requirement of Law or any such Contractual Obligation (other than the Liens created by the Security Documents).
No Requirement of Law or Contractual Obligation applicable to the Borrower or any of its Subsidiaries would reasonably be expected to have a Material Adverse Effect. 

4.6. Litigation. No litigation, investigation or proceeding of or before any arbitrator or Governmental Authority is pending or, to the
knowledge of the Borrower, threatened by or against any Group Member or against any of their respective properties or revenues (a) with respect to any of the Loan Documents or any of the transactions contemplated hereby or thereby, or
(b) that would reasonably be expected to have a Material Adverse Effect. 
 4.7. No Default. No Group Member is in default under
or with respect to any of its Contractual Obligations in any respect that would reasonably be expected to have a Material Adverse Effect. No Default or Event of Default has occurred and is continuing. 

4.8. Ownership of Property; Liens. Each Group Member has title in fee simple to, or a valid leasehold interest in, all its real
property, and good title to, or a valid leasehold interest in, all its other property, except where the failure to have such title or valid leasehold interest would not, in the aggregate, reasonably be expected to have a Material Adverse Effect, and
none of such property is subject to any Lien except as permitted by Section 7.3. 
 4.9. Intellectual Property. Each Group Member
owns, or is licensed to use, all Intellectual Property necessary for the conduct of its business as currently conducted, except to the extent that the failure to own or have a license to use any such Intellectual Property would not, in the
aggregate, reasonably be expected to have a Material Adverse Effect. No material claim has been asserted and is pending by any Person challenging or questioning the use of any Intellectual Property or the validity or effectiveness of any
Intellectual Property, nor does the Borrower know of any valid basis for any such claim, in each case, except to the extent that any such claims would not, in the aggregate, reasonably be expected to have a Material Adverse Effect. To the knowledge
of the Group Members, the conduct of the business of each Group Member does not infringe the Intellectual Property rights of any Person in any material respect. 

4.10. Taxes. Except as would not, in the aggregate, reasonably be expected to have a Material Adverse Effect, (i) each Group Member
has filed or caused to be filed all Federal, state and other Tax returns that are required to be filed and has paid all Taxes shown to be due and payable on said returns or on any assessments made against it or any of its property and all other
Taxes, fees or other charges imposed on it or any of its property by any Governmental Authority (other than any the amount or validity of which are currently being contested in good faith by appropriate proceedings and with respect to which reserves
in conformity with GAAP have been provided on the books of the relevant Group Member) and (ii) no Tax Lien has been filed, and, to the knowledge of the Borrower, no claim is being asserted, with respect to any such Tax, fee or other charge.

 4.11. Federal Regulations. No part of the proceeds of any Loans, and no other extensions of credit hereunder, will be used
(a) for “buying” or “carrying” any “margin stock” within the respective meanings of each of the quoted terms under Regulation U as now and from time to time hereafter in effect for any purpose that violates the
provisions of the Regulations of the Board or (b) for any purpose that violates the provisions of the Regulations of the Board. No more than 25% of the assets of the Group Members consist of “margin stock” as so defined. If requested
by any Lender or the Administrative Agent, the Borrower will furnish to the Administrative Agent and each Lender a statement to the foregoing effect in conformity with the requirements of FR Form G-3 or FR Form U-1, as applicable, referred to in
Regulation U. 

  
 62 

 4.12. Labor Matters. Except as, in the aggregate, would not reasonably be expected to have
a Material Adverse Effect: (a) there are no strikes or other labor disputes against any Group Member pending or, to the knowledge of the Borrower, threatened; (b) hours worked by and payment made to employees of each Group Member have not
been in violation of the Fair Labor Standards Act or any other applicable Requirement of Law dealing with such matters; and (c) all payments due from any Group Member on account of employee health and welfare insurance have been paid or accrued
as a liability on the books of the relevant Group Member. 
 4.13. ERISA. (a) Each Group Member and each of their respective
ERISA Affiliates is in compliance with the applicable provisions of ERISA and the provisions of the Code relating to Plans and the regulations and published interpretations thereunder; (b) no ERISA Event or Foreign Plan Event has occurred or is
reasonably expected to occur; and (c) all amounts required by applicable law with respect to, or by the terms of, any retiree welfare benefit arrangement maintained by any Group Member or any ERISA Affiliate or to which any Group Member or any
ERISA Affiliate has an obligation to contribute have been accrued in accordance with Statement of Financial Accounting Standards No. 106. Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect, the present value of all accumulated benefit obligations under each Pension Plan (based on the assumptions used for purposes of Accounting Standards Codification No. 715: Compensation-Retirement Benefits) did not, as of the date of the
most recent financial statements reflecting such amounts, exceed the fair market value of the assets of such Pension Plan allocable to such accrued benefits, and the present value of all accumulated benefit obligations of all underfunded Pension
Plans (based on the assumptions used for purposes of Accounting Standards Codification No. 715: Compensation-Retirement Benefits) did not, as of the date of the most recent financial statements reflecting such amounts, exceed the fair market
value of the assets of all such underfunded Pension Plans. No Loan Party is an entity deemed to hold “plan assets” within the meaning of 29 C.F.R. § 2510.3-101 of an employee benefit plan (as defined in Section 3(3) of ERISA)
which is subject to Title I of ERISA or any plan (within the meaning of Section 4975 of the Code), and neither the execution of this Agreement nor the making of Loans hereunder gives rise to a Prohibited Transaction. 

4.14. Investment Company Act; Other Regulations. No Loan Party is an “investment company” within the meaning of the Investment
Company Act of 1940, as amended. No Loan Party is subject to regulation under any Requirement of Law (other than Regulation X of the Board) that limits its ability to incur Indebtedness, or which otherwise may render all or any portion of its
obligations under this Agreement and the other Loan Documents unenforceable. 
 4.15. Subsidiaries. Except as disclosed to the
Administrative Agent by the Borrower in writing from time to time after the Restatement Effective Date, (a) Schedule 4.15 sets forth the name and jurisdiction of incorporation of each Subsidiary and, as to each such Subsidiary, the percentage
of each class of Capital Stock owned by any Loan Party, and whether such Subsidiary is a Guarantor or an Unrestricted Subsidiary and (b) there are no outstanding subscriptions, options, warrants, calls, rights or other agreements or commitments
(other than stock options granted to employees or directors and directors’ qualifying shares) of any nature relating to any Capital Stock of any Subsidiary, except as set forth on Schedule 4.15 or as created by the Loan Documents. 

4.16. Use of Proceeds. The proceeds of the Term Loans shall be used to finance a portion of the Bioventus IPO Transactions, to pay
related fees and expenses and for general corporate purposes (including, without limitation, acquisitions permitted under this Agreement). The proceeds of the Revolving Loans, the Swingline Loans and any Incremental Facilities, and the Letters of
Credit, shall be used for working capital needs and general corporate purposes of Group Members (including, without limitation, acquisitions permitted under this Agreement). 

  
 63 

 4.17. Environmental Matters. Except as, in the aggregate, would not reasonably be expected
to have a Material Adverse Effect: 
 (a) the facilities and properties owned, leased or operated by any Group Member (the
“Properties”) do not contain, and to the Borrower’s knowledge have not previously contained, any Materials of Environmental Concern in amounts or concentrations or under circumstances that constitute or constituted a violation
of, or could give rise to liability under, any Environmental Law; 
 (b) no Group Member has received or is aware of any notice of violation,
alleged violation, non-compliance, liability or potential liability regarding environmental matters or compliance with Environmental Laws with regard to any of the Properties or the business operated by any Group Member (the
“Business”), nor does the Borrower have knowledge or reason to believe that any such notice will be received or is being threatened; 

(c) Materials of Environmental Concern have not been transported or disposed of from the Properties in violation of, or in a manner or to a
location that could give rise to liability under, any Environmental Law, nor have any Materials of Environmental Concern been generated, treated, stored or disposed of at, on or under any of the Properties in violation of, or in a manner that could
give rise to liability under, any applicable Environmental Law; 
 (d) no judicial proceeding or governmental or administrative action is
pending or, to the knowledge the Borrower, threatened, under any Environmental Law to which any Group Member is or will be named as a party with respect to the Properties or the Business, nor are there any consent decrees or other decrees, consent
orders, administrative orders or other orders, or other administrative or judicial requirements outstanding under any Environmental Law with respect to the Properties or the Business; 

(e) there has been no release or threat of release of Materials of Environmental Concern at or from the Properties, or arising from or related
to the operations of any Group Member in connection with the Properties or otherwise in connection with the Business, in violation of or in amounts or in a manner that could give rise to liability under Environmental Laws; 

(f) the Properties and all operations at the Properties are in compliance, and have in the last two years been in compliance, with all
applicable Environmental Laws, and there is no contamination at, under or about the Properties or violation of any Environmental Law with respect to the Properties or the Business; and 

(g) no Group Member has assumed any liability of any other Person under Environmental Laws. 

4.18. Accuracy of Information, etc. No statement or information contained in this Agreement, any other Loan Document, the Confidential
Information Memorandum or any other document, certificate or written (or unwritten if provided as part of a formal presentation) statement furnished by or on behalf of any Loan Party to the Administrative Agent or the Lenders, or any of them, for
use in connection with the transactions contemplated by this Agreement or the other Loan Documents, contained as of the date such statement, information, document or certificate was so furnished (or, in the case of the Confidential Information
Memorandum, as of the date of this Agreement), any untrue statement of a material fact or omitted to state a material fact necessary to make the statements contained herein or therein not misleading. The projections and pro forma
financial information contained in the materials referenced above are based upon good faith estimates and assumptions believed by management of the Borrower to be reasonable at the time made, it being recognized by the Lenders that such financial
information as it relates to future events is not to be viewed as fact and that actual results during the period or periods covered by such financial information may differ from the projected results set forth therein by a material amount. 

  
 64 

 4.19. Security Documents. (a) The Guarantee and Collateral Agreement is effective to
create in favor of the Administrative Agent, for the benefit of the Lenders, a legal, valid and enforceable security interest in the Collateral described therein and proceeds thereof. In the case of the Pledged Stock described in the Guarantee and
Collateral Agreement, when stock certificates representing such Pledged Stock are delivered to the Administrative Agent (together with a properly completed and signed stock power or endorsement), and in the case of the other Collateral described in
the Guarantee and Collateral Agreement, when financing statements and other filings specified on Schedule 4.19(a) in appropriate form are filed in the offices specified on Schedule 4.19(a), the Guarantee and Collateral Agreement shall
constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Loan Parties in such Collateral and the proceeds thereof, as security for the Obligations (as defined in the Guarantee and Collateral Agreement), in
each case to the extent that a security interest therein may be perfected by the filing of financing statements under Article 9 of the Uniform Commercial Code, possession or control of such Pledged Stock or by filings with the U.S. Copyright Office
and the U.S. Patent and Trademark Office and in each case prior and superior in right to any other Person (except, in the case of Collateral other than Pledged Stock, Liens permitted by Section 7.3). 

(b) Each of the Mortgages is effective to create in favor of the Administrative Agent, for the benefit of the Lenders, a legal, valid and
enforceable Lien on the Mortgaged Properties described therein and proceeds thereof, and when the Mortgages are filed in the offices specified on Schedule 4.19(b), each such Mortgage shall constitute a fully perfected Lien on, and
security interest in, all right, title and interest of the Loan Parties in the Mortgaged Properties and the proceeds thereof, as security for the Obligations (as defined in the relevant Mortgage), in each case prior and superior in right to any
other Person (except that the security interest created in such property may be subject to the Liens permitted by Section 7.3). Schedule 1.1B lists, as of the Restatement Effective Date, each parcel of owned real property and each
leasehold interest in real property located in the United States and held by the Borrower or any of its Subsidiaries that has a value, in the reasonable opinion of the Borrower, in excess of $1,000,000. 

4.20. Solvency. On a consolidated basis, the Borrower and its Subsidiaries are, and after giving effect to the Transaction will be,
Solvent. 
 4.21. Anti-Corruption Laws and Sanctions. The Borrower has implemented and maintains in effect policies and procedures
designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Borrower, its Subsidiaries and their respective officers and
employees, and to the knowledge of the Borrower its directors and agents, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. None of (a) the Borrower, any Subsidiary or any of their respective
directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned
Person. No Loan or Letter of Credit, use of proceeds or other transaction contemplated by this Agreement will violate Anti-Corruption Laws or applicable Sanctions. 

4.22. EEA Financial Institutions. No Loan Party is an EEA Financial Institution. 

  
 65 

 SECTION 5. CONDITIONS PRECEDENT 

5.1. Conditions to Initial Extension of Credit. The agreement of each Lender to make the initial extension of credit requested to be
made by it is subject to the satisfaction, prior to or concurrently with the making of such extension of credit on the Closing Date, of the following conditions precedent (it being acknowledged that such conditions were initially satisfied on
October 10, 2014): 
 (a) Credit Agreement; Guarantee and Collateral Agreement. The Administrative Agent shall
have received (i) this Agreement, executed and delivered by the Administrative Agent, the Borrower and each Person listed on Schedule 1.1A, (ii) the Guarantee and Collateral Agreement, executed and delivered by the Borrower and each
Subsidiary Guarantor and (iii) the Intercreditor Agreement, executed and delivered by each Loan Party, the Administrative Agent and the Second Lien Administrative Agent. 

(b) Refinancing. (i) The Administrative Agent shall have received evidence reasonably satisfactory to it that the
Existing Debt shall have been repaid (or shall be repaid substantially contemporaneously) and all commitments, security interests and guarantees in connection therewith shall have been terminated. After giving effect to the Closing Date, none of the
Borrower nor any of its Subsidiaries shall have any material third-party Indebtedness for borrowed money other than the Indebtedness incurred hereunder and Indebtedness incurred under the Second Lien Credit Agreement. 

(c) Financial Statements; Pro Formas. (i) The Lenders shall have received (y) audited consolidated financial
statements of the Borrower and its consolidated Subsidiaries for the partial fiscal year ended December 31, 2012, and the fiscal year ended December 31, 2013, and the related consolidated statements of income and stockholders’ equity
and cash flows for the fiscal years ended on such dates and (z) balance sheets and related statements of income, stockholders’ equity and cash flows of the Borrower and its consolidated Subsidiaries for each subsequent fiscal quarter ended
at least 45 days before the Closing Date. 
 (ii) The Administrative Agent shall have received the Pro Forma Balance Sheet
and the Pro Forma Statement of Operations. 
 (d) Projections. The Lenders shall have received satisfactory
projections through 2019. 
 (e) Approvals. All material governmental and third party approvals necessary in
connection with the continuing operations of the Group Members and the transactions contemplated hereby shall have been obtained and be in full force and effect, and all applicable waiting periods shall have expired without any action being taken or
threatened by any competent authority that would restrain, prevent or otherwise impose adverse conditions on the financing contemplated hereby. 

(f) Lien Searches. The Administrative Agent shall have received the results of a recent Lien search with respect to each
Loan Party, and such search shall reveal no Liens on any of the assets of the Loan Parties except for Liens permitted by Section 7.3 or discharged on or prior to the Closing Date pursuant to documentation satisfactory to the Administrative
Agent. 
 (g) Fees. The Lenders and the Administrative Agent shall have received all fees required to be paid, and all
expenses for which invoices have been presented (including the reasonable fees and expenses of legal counsel), on or before the Closing Date. All such amounts will be paid with proceeds of Loans made on the Closing Date and will be reflected in the
funding instructions given by the Borrower to the Administrative Agent on or before the Closing Date. 

  
 66 

 (h) Closing Certificate; Certified Certificate of Incorporation; Good Standing
Certificates. The Administrative Agent shall have received (i) a certificate of each Loan Party, dated the Closing Date, substantially in the form of Exhibit C, with appropriate insertions and attachments, including the certificate
of incorporation of each Loan Party that is a corporation certified by the relevant authority of the jurisdiction of organization of such Loan Party, and (ii) a good standing certificate for each Loan Party from its jurisdiction of
organization. 
 (i) Legal Opinions. The Administrative Agent shall have received (i) the legal opinion of Smith,
Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P., counsel to the Borrower and its Subsidiaries, substantially in the form of Exhibit F-1 and (ii) the legal opinion of Wollmuth Maher & Deutsch LLP, special New York
counsel to the Borrower and its Subsidiaries, substantially in the form of Exhibit F-2. Such legal opinions shall cover such customary matters incident to the transactions contemplated by this Agreement as the Administrative Agent may
reasonably require. 
 (j) Pledged Stock; Stock Powers; Pledged Notes. The Administrative Agent shall have received
(i) the certificates representing the shares of Capital Stock pledged pursuant to the Guarantee and Collateral Agreement, together with an undated stock power for each such certificate executed in blank by a duly authorized officer of the
pledgor thereof and (ii) each promissory note (if any) pledged to the Administrative Agent pursuant to the Guarantee and Collateral Agreement endorsed (without recourse) in blank (or accompanied by an executed transfer form in blank) by the
pledgor thereof. 
 (k) Filings, Registrations and Recordings. Each document (including any Uniform Commercial Code
financing statement and any short form Intellectual Property security agreement to be filed with the United States Patent and Trademark Office and United States Copyright Office) required by the Security Documents or under law or reasonably
requested by the Administrative Agent to be filed, registered or recorded in order to create in favor of the Administrative Agent, for the benefit of the Lenders, a perfected Lien on the Collateral described therein, prior and superior in right to
any other Person (other than with respect to Liens expressly permitted by Section 7.3), shall be in proper form for filing, registration or recordation. 

(l) Flood Hazards. The applicable Loan Party shall have delivered to the Administrative Agent (i) a
“Life-of-Loan” Federal Emergency Management Agency Standard Flood Hazard Determination with respect to any Mortgaged Property listed on Schedule 1.1B that is improved with one or more buildings and (ii) in the event any of the
improvements situated on such Mortgaged Property is located in an area identified by the Federal Emergency Management Agency (or any successor agency) as a special flood hazard area, (A) a notice about special flood hazard area status and flood
disaster assistance, duly executed by the applicable Loan Party and (B) evidence of flood insurance, with a financially sound and reputable insurer, naming the Administrative Agent, as mortgagee and loss payee, in an amount and otherwise in
form and substance reasonably satisfactory to the Administrative Agent and evidence of the payment of premiums in respect thereof in form and substance reasonably satisfactory to the Administrative Agent. 

(m) Solvency Certificate. The Administrative Agent shall have received a solvency certificate from the chief financial
officer or treasurer of the Borrower. 

  
 67 

 (n) Insurance. The Administrative Agent shall have received insurance
certificates satisfying the requirements of Section 5.2 of the Guarantee and Collateral Agreement. 
 (o) Patriot
Act. Before the end of the fifth day prior to the Closing Date, the Administrative Agent shall have received all documentation and other information, which has been requested at least 10 days prior to the Closing Date, required by regulatory
authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the Patriot Act. 

(p) Confidential Information Memorandum. The Administrative Agent shall have received the Confidential Information
Memorandum. 
 For the purpose of determining compliance with the conditions specified in this Section 5.1, each Lender that has signed
this Agreement shall be deemed to have accepted, and to be satisfied with, each document or other matter required under this Section 5.1 unless the Administrative Agent shall have received written notice from such Lender prior to the proposed
Closing Date specifying its objection thereto. 
 5.2. Conditions to Each Extension of Credit. The agreement of each Lender to make
any extension of credit requested to be made by it on any date (including its initial extension of credit) is subject to the satisfaction of the following conditions precedent: 

(a) Representations and Warranties. Each of the representations and warranties made by any Loan Party in or pursuant to the Loan
Documents shall be true and correct in all material respects (and in all respects if qualified by materiality) on and as of such date as if made on and as of such date, except that any representation or warranty which by its terms is made as of a
specified date shall be true and correct to such extent on and as of such date. 
 (b) No Default. No Default or Event of Default
shall have occurred and be continuing on such date or after giving effect to the extensions of credit requested to be made on such date. 

Each borrowing by and issuance of a Letter of Credit on behalf of the Borrower hereunder shall constitute a representation and warranty by the
Borrower as of the date of such extension of credit that the conditions contained in this Section 5.2 have been satisfied. 
 SECTION 6.
AFFIRMATIVE COVENANTS 
 The Borrower agrees that, from and after the Restatement Effective Date and so long as the Commitments remain in
effect, any Letter of Credit remains outstanding (unless cash collateralized or otherwise credit supported to the reasonable satisfaction of the Administrative Agent and the Issuing Lender) or any Loan or other amount is owing to any Lender or the
Administrative Agent hereunder (other than contingent indemnification obligations to the extent that no claim giving rise thereto has been asserted), the Borrower shall and shall cause each of its Restricted Subsidiaries to: 

6.1. Financial Statements. Furnish to the Administrative Agent: 

(a) as soon as available, but in any event within 120 days after the end of each fiscal year of the Borrower, a copy of the
audited consolidated balance sheet of the Borrower and its consolidated Subsidiaries as at the end of such year and the related audited consolidated statements of income and of cash flows for such year, setting forth in each case in comparative

  
 68 

 
form the figures for the previous year, reported on without a “going concern” or like qualification or exception, or qualification arising out of the scope of the audit, by
PricewaterhouseCoopers LLP or other independent certified public accountants of nationally recognized standing; and 
 (b) as
soon as available, but in any event not later than 45 days after the end of each of the first three quarterly periods of each fiscal year of the Borrower, the unaudited consolidated balance sheet of the Borrower and its consolidated Subsidiaries as
at the end of such quarter and the related unaudited consolidated statements of income and of cash flows for such quarter and the portion of the fiscal year through the end of such quarter, setting forth in each case in comparative form the figures
for the previous year, certified by a Responsible Officer as being fairly stated in all material respects (subject to normal year-end audit adjustments and the absence of footnotes). 

All such financial statements shall be complete and correct in all material respects and shall be prepared in reasonable detail and in accordance with GAAP
applied (except as approved by such accountants or officer, as the case may be, and disclosed in reasonable detail therein) consistently throughout the periods reflected therein and with prior periods. 

Notwithstanding anything to the contrary set forth in this Section 6.1 or in any other provision of this Agreement that refers to this
Section 6.1 or any clause hereof, the obligations of the Borrower set forth in clauses (a) and (b) of this Section 6.1 and clauses (d), (e) and (g) of Section 6.2 may be satisfied by furnishing the applicable
financial information required by such clause with respect to any Parent and its Subsidiaries on a consolidated basis in lieu of furnishing the applicable financial information required by such clause with respect to the Borrower and its
Subsidiaries on a consolidated basis; provided, that to the extent such financial information relates to any Parent and its Subsidiaries, such information is accompanied by consolidating information that explains in reasonable detail the
differences between the information relating to such Parent and its Subsidiaries (other than the Borrower and its Subsidiaries), on the one hand, and the information relating to the Borrower and its Subsidiaries on a consolidated basis, on the other
hand. 
 6.2. Certificates; Other Information. Furnish to the Administrative Agent (or, in the case of clause (h), to the
relevant Lender): 
 (a) concurrently with the delivery of the financial statements referred to in Section 6.1(a), a
certificate of the independent certified public accountants reporting on such financial statements stating that in making the examination necessary therefor no knowledge was obtained of any Default or Event of Default, except as specified in such
certificate; 
 (b) concurrently with the delivery of any financial statements pursuant to Section 6.1, (i) a
certificate of a Responsible Officer stating that such Responsible Officer has obtained no knowledge of any Default or Event of Default except as specified in such certificate and (ii) in the case of quarterly or annual financial statements,
(x) a Compliance Certificate containing all information and calculations necessary for determining compliance by each Group Member with the provisions of this Agreement referred to therein as of the last day of the fiscal quarter or fiscal year
of the Borrower, as the case may be; provided, that the Compliance Certificate delivered in connection with the financial statements for the fiscal year ended December 31, 2014 shall include pro forma adjustments for the Project Sandal
Acquisition, and (y) to the extent not previously disclosed to the Administrative Agent, (1) a description of any change in the jurisdiction of organization of any Loan Party, (2) a list of any Intellectual Property registered or
applied for in the United States Patent and Trademark Office and/or United States Copyright Office by any Loan Party and (3) a description of any Person that has become a Group Member, in each case since the date of the most recent report
delivered pursuant to this clause (y) (or, in the case of the first such report so delivered, since the Closing Date); 

  
 69 

 (c) as soon as available, and in any event no later than 90 days after the end of
each fiscal year of the Borrower, a detailed consolidated budget for the following fiscal year (including a projected consolidated balance sheet of the Borrower and its Subsidiaries as of the end of the following fiscal year, the related
consolidated statements of projected cash flow and projected income and a description of the underlying assumptions applicable thereto), and, as soon as available, significant revisions, if any, of such budget and projections with respect to such
fiscal year (collectively, the “Projections”), which Projections shall in each case be accompanied by a certificate of a Responsible Officer stating that such Projections are based on estimates, information and assumptions believed
to be reasonable at the time such Projections were prepared, and that such Responsible Officer has no reason to believe that such Projections are incorrect or misleading in any material respect; 

(d) within 45 days after the end of each fiscal quarter of the Borrower (or 120 days, in the case of the fourth fiscal quarter
of each fiscal year), a narrative discussion and analysis of the financial condition and results of operations of the Borrower and its Subsidiaries for such fiscal quarter and for the period from the beginning of the then current fiscal year to the
end of such fiscal quarter, as compared to the portion of the Projections covering such periods and to the comparable periods of the previous year; 

(e) within five days after the same are sent, copies of all financial statements and reports that the Borrower sends to the
holders of any class of its debt securities or public equity securities and, within five days after the same are filed, copies of all financial statements and reports that the Borrower may make to, or file with, the SEC; 

(f) promptly following receipt thereof, copies of any documents described in (i) Sections 101(f) or 101(j) of ERISA that
any Group Member or any ERISA Affiliate may receive with respect to a Pension Plan and/or (ii) Sections 101(f), 101(k) or 101(l) of ERISA that any Group Member or any ERISA Affiliate may request with respect to any Multiemployer Plan; provided,
that if the relevant Group Members or ERISA Affiliates have not requested such documents or notices from the administrator or sponsor of the applicable Multiemployer Plans, then, upon reasonable request of the Administrative Agent, such Group Member
or the ERISA Affiliate shall promptly make a request for such documents or notices from such administrator or sponsor and the Borrower shall provide copies of such documents and notices to the Administrative Agent promptly after receipt thereof;

 (g) simultaneously with the delivery of each set of consolidated financial statements referred to in Sections 6.1(a) and
6.1(b) above, the related consolidating financial statements reflecting the adjustments necessary to eliminate the accounts of Unrestricted Subsidiaries (if any) from such consolidated financial statements; and 

(h) promptly, such additional financial and other information as any Lender may from time to time reasonably request. 

Documents required to be delivered pursuant to Section 6.1(a) or (b) or Section 6.2(d), (e) or (g) shall be deemed to have been
delivered on the date (i) on which the Borrower or applicable Parent files such documents with the SEC and such documents are publicly available on the SEC’s EDGAR filing system or any successor thereto, (ii) on which the Borrower or
applicable Parent posts such documents, or provides a link thereto on the Borrower’s or such Parent’s website or (iii) on which such documents are 

  
 70 

 
posted on behalf of the Borrower or such Parent on an Internet or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a commercial, third-party
website or whether sponsored by the Administrative Agent); provided that (A) the Borrower shall deliver paper copies of such documents to the Administrative Agent for further distribution to any Lender that requests that the Borrower
deliver such paper copies and (B) in the case of clauses (i) and (ii) above, the Borrower shall (x) notify the Administrative Agent of the filing or posting of any such documents and (y) provide copies of all such documents
to the Administrative Agent for posting on an Internet or intranet website to which the Lenders have access. 
 6.3. Payment of
Obligations. Pay, discharge or otherwise satisfy at or before maturity or before they become delinquent, as the case may be, all its obligations of whatever nature, except (i) to the extent that the failure to pay, discharge or otherwise
satisfy any such obligations would, in the aggregate, reasonably be expected to have a Material Adverse Effect or (ii) where the amount or validity thereof is currently being contested in good faith by appropriate proceedings and reserves in
conformity with GAAP with respect thereto have been provided on the books of the relevant Group Member. 
 6.4. Maintenance of Existence;
Compliance. (a) (i) Preserve, renew and keep in full force and effect its organizational existence and (ii) take all reasonable action to maintain all rights, privileges and franchises necessary or desirable in the normal conduct
of its business, except, in each case, as otherwise permitted by Section 7.4 or Section 7.5 and except, in the case of clause (i) (other than with respect to the Borrower) or (ii) above, to the extent that failure to do so would
not, in the aggregate, reasonably be expected to have a Material Adverse Effect; (b) comply with all Contractual Obligations and Requirements of Law except to the extent that failure to comply therewith would not, in the aggregate, reasonably
be expected to have a Material Adverse Effect; and (c) maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with
Anti-Corruption Laws and applicable Sanctions. 
 6.5. Maintenance of Property; Insurance. Except if the failure to do so would not,
in the aggregate, reasonably be expected to have a Material Adverse Effect, (a) keep all property useful and necessary in its business in good working order and condition, ordinary wear and tear and casualty excepted and (b) maintain with
financially sound and reputable insurance companies insurance on all its property in at least such amounts and against at least such risks (but including in any event public liability, product liability and business interruption) as are usually
insured against in the same general area by companies engaged in the same or a similar business. 
 6.6. Inspection of Property; Books and
Records; Discussions. (a) Maintain proper books of record and account (in which full, true and correct entries shall be made of all material financial transactions and matters involving the assets and business of the Borrower and its
Subsidiaries) in a manner that permits the preparation of financial statements in accordance with GAAP and (b) permit representatives of the Administrative Agent or any Lender to visit and inspect any of its properties and examine and make
abstracts from any of its books and records at any reasonable time during normal business hours and upon reasonable advance notice, as often as may reasonably be desired, and to discuss the business, operations, properties and financial and other
condition of the Group Members with officers and employees of the Group Members and with their independent certified public accountants; provided that, unless an Event of Default has occurred and is continuing, only one (1) of such visits,
inspections and making of abstracts shall be at the expense of the Borrower during any calendar year for the Administrative Agent and all of the Lenders taken together. 

6.7. Notices. Promptly give notice to the Administrative Agent and each Lender of: 

(a) the occurrence of any Default or Event of Default; 

  
 71 

 (b) any (i) default or event of default under any Contractual Obligation of
any Group Member or (ii) litigation, investigation or proceeding that may exist at any time between any Group Member and any Governmental Authority, that in either case, if not cured or if adversely determined, as the case may be, would
reasonably be expected to have a Material Adverse Effect; 
 (c) any litigation or proceeding affecting any Group Member
(i) in which the amount involved is $5,000,000 or more and not covered by insurance, (ii) in which material injunctive or similar relief is sought or (iii) which relates to any Loan Document; 

(d) the occurrence of any ERISA Event or Foreign Plan Event that, alone or together with any other ERISA Events and/or Foreign
Plan Events that have occurred, could reasonably be expected to result in liability of any Group Member or any ERISA Affiliate in an aggregate amount exceeding $5,000,000, as soon as possible and in any event within 10 days after the Borrower knows
or has reason to know thereof; and 
 (e) any development or event that has had or could reasonably be expected to have a
Material Adverse Effect. 
 Each notice pursuant to this Section 6.7 shall be accompanied by a statement of a Responsible Officer setting forth details
of the occurrence referred to therein and stating what action the relevant Group Member proposes to take with respect thereto. 
 6.8.
Environmental Laws. Except to the extent that would not, in the aggregate, reasonably be expected to have a Material Adverse Effect, (i) comply with, and ensure compliance by all tenants and subtenants, if any, with, all applicable
Environmental Laws, and (ii) obtain and comply with and maintain, and ensure that all tenants and subtenants obtain and comply with and maintain, any and all licenses, approvals, notifications, registrations or permits required by applicable
Environmental Laws. 
 6.9. Interest Rate Protection. In the case of the Borrower, within 90 days after the Restatement Effective
Date, enter into, and thereafter maintain, Swap Agreements to the extent necessary to provide that at least 25% of the aggregate principal amount of the Term Loans is subject to either a fixed interest rate or interest rate protection for a period
of not less than three years, which Swap Agreements shall have terms and conditions reasonably satisfactory to the Administrative Agent. 

6.10. Additional Collateral, etc. (a) With respect to any property that is of a type described as Collateral in the Guarantee and
Collateral Agreement and that is acquired after the Closing Date by any Group Member (other than (x) any property described in paragraph (b), (c) or (d) below, (y) any property subject to a Lien expressly permitted by
Section 7.3(g) and (z) property acquired by any Foreign Subsidiary) as to which the Administrative Agent, for the benefit of the Lenders, does not have a perfected Lien, promptly (i) execute and deliver to the Administrative Agent
such amendments to the Guarantee and Collateral Agreement or such other documents as the Administrative Agent deems necessary or advisable to grant to the Administrative Agent, for the benefit of the Lenders, a security interest in such property and
(ii) take all actions reasonably necessary or advisable to grant to the Administrative Agent, for the benefit of the Lenders, a perfected first priority security interest in such property (to the extent required under the Guarantee and
Collateral Agreement with respect to property of that type, and subject only to Permitted Liens), including the filing of Uniform Commercial Code financing statements in such jurisdictions as may be required by the Guarantee and Collateral Agreement
or by law or as may be requested by the Administrative Agent and the filing of documents with the United States Patent and Trademark Office and the United States Copyright Office as may be required by the Security Documents or by law or as may be
requested by the Administrative Agent. 

  
 72 

 (b) With respect to any fee interest in any real property having a value (together with
improvements thereof) of at least $1,000,000 acquired after the Closing Date by any Group Member (other than (x) any such real property subject to a Lien expressly permitted by Section 7.3(g) and (y) real property acquired by any
Foreign Subsidiary), promptly deliver (i) the determinations and other materials required by Section 5.1(l) and (ii) the documents, certificates, opinions and other materials required by Section 6.12. 

(c) With respect to any Domestic Subsidiary (other than a Domestic Subsidiary designated as an Unrestricted Subsidiary as permitted by this
Agreement and any Domestic Subsidiary owned directly or indirectly by a Foreign Subsidiary) created or acquired after the Closing Date by any Group Member (which, for the purposes of this paragraph (c), shall include any existing Domestic Subsidiary
that ceases to be an Unrestricted Subsidiary), promptly (i) execute and deliver to the Administrative Agent such amendments to the Guarantee and Collateral Agreement as the Administrative Agent deems necessary or advisable to grant to the
Administrative Agent, for the benefit of the Lenders, a perfected first priority security interest in the Capital Stock of such Domestic Subsidiary that is owned by any Group Member, (ii) deliver to the Administrative Agent the certificates
representing such Capital Stock, together with undated stock powers, in blank, executed and delivered by a duly authorized officer of the relevant Group Member, (iii) cause such Domestic Subsidiary (A) to become a party to the Guarantee
and Collateral Agreement, (B) to take such actions as are reasonably necessary or advisable to grant to the Administrative Agent for the benefit of the Lenders a perfected first priority security interest in the Collateral described in the
Guarantee and Collateral Agreement with respect to such Domestic Subsidiary (to the extent required under the Guarantee and Collateral Agreement with respect to property of that type, and subject only to Permitted Liens), including the filing of
Uniform Commercial Code financing statements in such jurisdictions as may be required by the Guarantee and Collateral Agreement or by law or as may be requested by the Administrative Agent and (C) to deliver to the Administrative Agent a
certificate of such Domestic Subsidiary, substantially in the form of Exhibit C, with appropriate insertions and attachments, and (iv) if requested by the Administrative Agent, deliver to the Administrative Agent legal opinions
relating to the matters described above, which opinions shall be in form and substance, and from counsel, reasonably satisfactory to the Administrative Agent; provided, that the scope of such opinions shall be consistent with the scope of the
legal opinions delivered in respect of other Domestic Subsidiaries on the Closing Date. 
 (d) With respect to any Foreign Subsidiary (other
than a Foreign Subsidiary designated as an Unrestricted Subsidiary as permitted by this Agreement) created or acquired after the Closing Date by any Group Member (other than by any Group Member that is a Foreign Subsidiary), promptly
(i) execute and deliver to the Administrative Agent such amendments to the Guarantee and Collateral Agreement as the Administrative Agent deems necessary or advisable to grant to the Administrative Agent, for the benefit of the Lenders, a
perfected first priority security interest in the Capital Stock of such Foreign Subsidiary that is owned by any such Group Member (provided that in no event shall more than 65% of the total outstanding voting Capital Stock of any such Foreign
Subsidiary be required to be so pledged) and (ii) deliver to the Administrative Agent the certificates representing such pledged Capital Stock, together with undated stock powers, in blank, executed and delivered by a duly authorized officer of
the relevant Group Member, and take such other action as may be reasonably necessary or, in the opinion of the Administrative Agent, desirable to perfect the Administrative Agent’s security interest therein; provided, that such Group
Member shall not be required to provide a local law pledge agreement with respect to such Capital Stock. 
 Notwithstanding anything to the contrary
contained herein, if any Subsidiary shall guarantee obligations in respect of the Second Lien Credit Agreement (or any Permitted Refinancing Indebtedness in respect thereof), such Subsidiary shall promptly become a party to the Guarantee and
Collateral Agreement. 

  
 73 

 6.11. Designation of Subsidiaries. By action of its Board of Directors, the Borrower may
at any time after the Closing Date designate any Restricted Subsidiary of the Borrower as an Unrestricted Subsidiary or any Unrestricted Subsidiary as a Restricted Subsidiary; provided that (i) immediately before and after such designation on a
pro forma basis, no Default or Event of Default shall have occurred and be continuing, (ii) immediately after giving effect to such designation, the Borrower shall be in compliance, on a pro forma basis, with the financial covenants set forth
in Section 7.1 (it being understood that as a condition precedent to the effectiveness of any such designation, the Borrower shall deliver to the Administrative Agent a certificate of a Responsible Officer setting forth in reasonable detail the
calculations demonstrating such compliance), (iii) no Subsidiary may be designated as an Unrestricted Subsidiary or continue as an Unrestricted Subsidiary if thereafter (x) it is a “Restricted Subsidiary” for the purpose of the
Second Lien Loan Documents or any other Indebtedness of the Borrower or (y) the Borrower or any Restricted Subsidiary provides any guarantee or credit support of any kind, including any undertaking, guarantee, indemnity, agreement or instrument
that would constitute Indebtedness (other than pursuant to Section 7.2(l) and other than the pledge of Capital Stock of Unrestricted Subsidiaries) of any Indebtedness of such Unrestricted Subsidiary or is directly or indirectly liable on such
Indebtedness, as a guarantor or otherwise or any Indebtedness of such Unrestricted Subsidiary contains a default that would permit, upon notice, lapse of time or both, any holder of any Indebtedness of Borrower or any Restricted Subsidiary to
declare a default under such other Indebtedness or cause the payment thereof to be accelerated or payable prior to its stated maturity, (iv) no Restricted Subsidiary may be designated an Unrestricted Subsidiary if it was previously designated
an Unrestricted Subsidiary, (v) no Subsidiary of an Unrestricted Subsidiary may be a Restricted Subsidiary and (vi) if a Restricted Subsidiary is being designated as an Unrestricted Subsidiary hereunder, the sum of (A) the value of
the assets of such Subsidiary as of such date of designation (the “Designation Date”), as set forth on such Subsidiary’s most recent balance sheet, plus (B) the aggregate value of assets of all Unrestricted
Subsidiaries designated as Unrestricted Subsidiaries pursuant to this Section 6.11 prior to the Designation Date (in each case measured as of the date of each such Unrestricted Subsidiary’s designation as an Unrestricted Subsidiary),
plus (C) the amount of all Investments outstanding pursuant to Section 7.8(o), as of the Designation Date shall not exceed 5% of the Consolidated Total Assets as of the Designation Date on a pro forma basis for such designation. The
designation of any Subsidiary as an Unrestricted Subsidiary after the Closing Date shall constitute an Investment by the Borrower therein at the date of designation in an amount equal to the net book value of the Borrower’s or its
Subsidiary’s (as applicable) investment therein. The designation of any Unrestricted Subsidiary as a Restricted Subsidiary shall constitute (i) the incurrence at the time of designation of any Investment, Indebtedness or Liens of such
Subsidiary existing at such time and (ii) a return on any Investment by the Borrower in Unrestricted Subsidiaries pursuant to the preceding sentence in an amount equal to the Fair Market Value at the date of such designation of the
Borrower’s or its Subsidiary’s (as applicable) Investment in such Subsidiary. 
 6.12. Post-Closing Obligations. 

(a) Within 90 days after the Closing Date (as such period may be extended from time to time by the Administrative Agent upon request of the
Borrower, such extension not to be unreasonably withheld or delayed), deliver to the Administrative Agent (and, in the case of clause (ii), the title insurance company referred to in clause (iii) below (the “Title Insurance
Company”)) with respect to each Mortgaged Property listed on Schedule 1.1B each of the following in form and substance reasonably satisfactory to the Administrative Agent: 

(i) a fully executed counterpart of a Mortgage, which Mortgage shall cover such Mortgaged Property, together with evidence that
counterparts of such Mortgage has been delivered to the title insurance company insuring the Lien of such Mortgage for recording in all places where such Mortgage is recorded, which Mortgage shall effectively create in favor of the Administrative
Agent for the benefit of the Secured 

  
 74 

 
Parties, a first-priority mortgage Lien on such Mortgaged Property, subject only to Liens that are permitted under Section 7.3 of this Agreement, and which Mortgage shall secure an amount
limited to the Fair Market Value of such Mortgaged Property, if the recordation of such Mortgage would otherwise require payment of a Mortgage Tax; 

(ii) (A) maps or plats of an as-built survey of the sites of the Mortgaged Properties certified to the Administrative Agent and
the Title Insurance Company in a manner satisfactory to them, dated a date satisfactory to the Administrative Agent and the Title Insurance Company by an independent professional licensed land surveyor satisfactory to the Administrative Agent and
the Title Insurance Company, or (B) such surveys as are in the possession of the Borrower or any Loan Party and such other documents as the Administrative Agent may reasonably request with respect to any such Mortgaged Property, as may be
reasonably necessary to cause the title insurance company to issue the title insurance required pursuant to clause (iii) below, but in any event including a survey endorsement, comprehensive endorsement, location endorsement, address
endorsement, contiguity endorsement and Easement – Damage from Forced Removal endorsement; 
 (iii) with respect to each
Mortgage intended to encumber such Mortgaged Property, a policy or policies of title insurance insuring the Lien of the Mortgage on such Mortgaged Property, in an amount equal to the aggregate of the Loan Party’s interest in the land value and
insurable building, improvements and site improvements value of such Mortgaged Property (or such other amount as may reasonably be requested by Administrative Agent) (the “Mortgage Policies”), issued by a nationally recognized title
insurance company insuring the Lien of such Mortgage as a valid Lien on the Mortgaged Property described therein, free of any other Liens that are permitted under Section 7.3 of this Agreement, containing no general survey exception and issued
together with such endorsements as the Administrative Agent may reasonably request; 
 (iv) opinions, addressed to the
Administrative Agent and the Lenders, of (1) outside counsel or in-house counsel, as to the due authorization, execution and delivery of the Mortgages by the applicable Loan Party, and (2) local counsel in each jurisdiction where such
Mortgaged Property is located as to enforceability of the Mortgages, each in form and substance reasonably satisfactory to the Administrative Agent; 

(v) if necessary or required, proper fixture filings under the Uniform Commercial Code on Form UCC-1 for filing under the
Uniform Commercial Code in the appropriate jurisdiction in which such Mortgaged Property is located, desirable to perfect the security interests in fixtures purported to be created by the Mortgages in favor of the Administrative Agent; 

(vi) such affidavits, certificates, instruments of indemnification and other items (including a so-called “gap”
indemnification) as shall be reasonably required to induce the title insurance company to issue the Mortgage Policies and endorsements contemplated above; 

(vii) evidence reasonably acceptable to the Administrative Agent of payment by the Borrower of all Mortgage Policy premiums,
search and examination charges, mortgage recording taxes, fees, charges, costs and expenses required for the recording of the Mortgages, fixture filings and issuance of the Mortgage Policies referred to above; and 

  
 75 

 (viii) all recorded documents referred to, or listed as exceptions to title in,
the title policy or policies referred to in clause (iv) above and a copy of all other material documents affecting the Mortgaged Properties. 

(b) Within 60 days after the Closing Date (as such period may be extended from time to time by the Administrative Agent upon request of the
Borrower, such extension not to be unreasonably withheld or delayed), the Administrative Agent shall have received, in form and substance reasonably satisfactory to the Administrative Agent, duly executed account control agreements in order to
perfect the Administrative Agent’s security interest under the UCC in Collateral for which a control agreement is required for perfection (excluding, for the avoidance of doubt, accounts that are not required to be pledged under the Loan
Documents). 
 SECTION 7. NEGATIVE COVENANTS 

The Borrower hereby agrees that, from and after the Restatement Effective Date and so long as the Commitments remain in effect, any Letter of
Credit remains outstanding (unless cash collateralized or otherwise credit supported to the reasonable satisfaction of the Administrative Agent and the Issuing Lender) or any Loan or other amount is owing to any Lender or the Administrative Agent
hereunder (other than contingent indemnification obligations to the extent that no claim giving rise thereto has been asserted), the Borrower shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly: 

7.1. Financial Condition Covenants. 

(a) Consolidated Leverage Ratio. Permit the Consolidated Leverage Ratio as at the last day of any period of four consecutive fiscal
quarters of the Borrower ending with any fiscal quarter set forth below to exceed 3.50 to 1.00; provided that once in any four fiscal quarter period (but in any event, no more than two times over the term of the Facilities), the
Borrower may request to increase the maximum Consolidated Leverage Ratio to 4.00:1.00 for a period of four consecutive fiscal quarters commencing with the fiscal quarter during which a Qualified Acquisition, financed in whole or in part with
Indebtedness, shall have occurred. 
 (b) Consolidated Fixed Charge Coverage Ratio. Permit the Consolidated Fixed Charge Coverage
Ratio for any period of four consecutive fiscal quarters of the Borrower ending on or after December 31, 2014, to be less than 1.25 to 1.00. 

7.2. Indebtedness. Create, issue, incur, assume, become liable in respect of or suffer to exist any Indebtedness, except: 

(a) Indebtedness of any Loan Party pursuant to any Loan Document; 

(b) [intentionally omitted]; 

(c) (i) Indebtedness of the Borrower to any Restricted Subsidiary and of any Subsidiary Guarantor to the Borrower or any other
Restricted Subsidiary, (ii) Indebtedness of any Restricted Subsidiary that is not a Subsidiary Guarantor to any other Restricted Subsidiary that is not a Subsidiary Guarantor and (iii) Indebtedness of any Restricted Subsidiary that is not
a Subsidiary Guarantor to the Borrower or any Subsidiary Guarantor; provided, that the aggregate principal amount of all Indebtedness incurred pursuant to this clause (iii) shall not exceed the Dollar equivalent of €11,000,000 when
incurred; 

  
 76 

 (d) Guarantee Obligations incurred in the ordinary course of business (i) by
the Borrower or any of its Restricted Subsidiaries of Indebtedness of any Subsidiary Guarantor and (ii) by any Restricted Subsidiary that is not a Subsidiary Guarantor of Indebtedness of another Restricted Subsidiary that is not a Subsidiary
Guarantor; 
 (e) Indebtedness outstanding on the date hereof and listed on Schedule 7.2(e) and any refinancings,
refundings, renewals or extensions thereof (without increasing, or shortening the maturity of, the principal amount thereof (determined as of the Restatement Effective Date)); 

(f) Indebtedness (including, without limitation, Capital Lease Obligations) (i) secured by Liens permitted by
Section 7.3(g) in an aggregate principal amount not to exceed $4,000,000 at any one time outstanding or (ii) secured by Liens permitted by Section 7.3(r) in an aggregate principal amount not to exceed $5,000,000 at any one time
outstanding; 
 (g) Indebtedness of the Borrower in respect of Specified Cash Management Agreements, netting services,
overdraft protections and other cash management, intercompany cash pooling and similar arrangements in connection with deposit accounts, in each case in the ordinary course of business; 

(h) Indebtedness arising under any Swap Agreement permitted by Section 7.12; 

(i) Indebtedness (other than for borrowed money) that may be deemed to exist pursuant to any guarantees, warranty or
contractual service obligations, performance, surety, statutory, appeal, bid, prepayment guarantee, payment (other than payment of Indebtedness) or completion of performance guarantees or similar obligations incurred in the ordinary course of
business; 
 (j) Indebtedness in respect of workers’ compensation claims, payment obligations in connection with health,
disability or other types of social security benefits, unemployment or other insurance obligations, reclamation and statutory obligations, in each case in the ordinary course of business; 

(k) Indebtedness arising from the honoring by a bank or other financial institution of a check, draft or similar instrument
drawn against insufficient funds, so long as such Indebtedness is covered or extinguished within five Business Days; 
 (l)
additional Indebtedness of the Borrower or any of its Restricted Subsidiaries in an aggregate principal amount (for the Borrower and all Restricted Subsidiaries) not to exceed $10,000,000 at any one time outstanding; and 

(m) Indebtedness associated with the Project Sandal Acquisition and the Biostructures Acquisition pursuant to the Biostructures
Purchase Agreement. 
 Notwithstanding the foregoing, any intercompany Indebtedness permitted pursuant to this Section 7.2 shall (A) if owing to
or owed by a Loan Party be evidenced by the Global Intercompany Note or other promissory note reasonably acceptable to the Administrative Agent, and if owing to a Loan Party, be subject to a Lien pursuant to the Guarantee and Collateral Agreement
and (B) if owed by a Loan Party, be subordinated in right of payment (pursuant to the terms of the Global Intercompany Note) to the payment in full of the Obligations. 

  
 77 

 7.3. Liens. Create, incur, assume or suffer to exist any Lien upon any of its property,
whether now owned or hereafter acquired, except: 
 (a) Liens for Taxes not yet due or that are being contested in good faith
by appropriate proceedings, provided that adequate reserves with respect thereto are maintained on the books of the Borrower or its Restricted Subsidiaries, as the case may be, in conformity with GAAP; 

(b) carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s or other like Liens arising in
the ordinary course of business that are not overdue for a period of more than 30 days or that are being contested in good faith by appropriate proceedings; 

(c) pledges or deposits in connection with workers’ compensation, unemployment insurance and other social security
legislation; 
 (d) deposits to secure the performance of bids, trade contracts (other than for borrowed money), leases,
statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business; 

(e) easements, rights-of-way, restrictions and other similar encumbrances incurred in the ordinary course of business (and,
with respect to any Mortgaged Property, such title exceptions reasonably acceptable to the Administrative Agent as may be set forth in the related title policy) that, in the aggregate, are not substantial in amount and that do not in any case
materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of the Borrower or any of its Restricted Subsidiaries; 

(f) Liens in existence on the date hereof listed on Schedule 7.3(f), securing Indebtedness permitted by
Section 7.2(e), provided that no such Lien is spread to cover any additional type of property after the Restatement Effective Date and that the amount of Indebtedness secured thereby is not increased; 

(g) Liens securing Indebtedness of the Borrower or any Restricted Subsidiary incurred pursuant to Section 7.2(f) to
finance the acquisition of fixed or capital assets, provided that (i) such Liens shall be created substantially simultaneously with the acquisition of such fixed or capital assets or within 90 days thereafter, (ii) such Liens do not
at any time encumber any property other than the property financed by such Indebtedness and reasonably related property, including accessions, attachments, warranty claims and proceeds, and (iii) the amount of Indebtedness secured thereby is
not increased; 
 (h) Liens created pursuant to the Security Documents; 

(i) (i) any interest or title of a lessor or licensor under any lease or license entered into by the Borrower or any Restricted
Subsidiary in the ordinary course of its business and covering only the assets so leased or licensed and (ii) statutory, common law and contractual landlords’ Liens (not securing Capital Lease Obligations) in respect of property leases to
which the Borrower or any of its Restricted Subsidiaries is a party; 

  
 78 

 (j) Liens arising from filing Uniform Commercial Code or personal property
security financing statements (or substantially equivalent filings outside of the United States) regarding leases; 
 (k)
Liens arising out of conditional sale, title retention, consignment or similar arrangements for sale of goods entered into by the Borrower or any other Restricted Subsidiary in the ordinary course of business and permitted by this Agreement; 

(l) non-exclusive licenses, sublicenses, leases and subleases of Intellectual Property of any Group Member in the ordinary
course of business; 
 (m) Liens encumbering reasonable and customary initial deposits and margin deposits and similar Liens
attaching to brokerage accounts incurred in the ordinary course of business and not for speculative purposes; 
 (n) Liens
that are contractual rights of set-off (i) relating to the establishment of depository relations with banks not given in connection with the issuance of Indebtedness, (ii) relating to pooled deposit or sweep accounts of the Borrower or any
Restricted Subsidiary to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business of the Borrower and its Restricted Subsidiaries and (iii) relating to purchase orders and other agreements entered into
with customers of the Borrower or any Restricted Subsidiary in the ordinary course of business; 
 (o) Liens in favor of
customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods in the ordinary course of business; 

(p) Liens securing judgments for the payment of money not constituting an Event of Default under Section 8.1(h); 

(q) (i) leases, licenses, subleases or sublicenses granted to other Persons in the ordinary course of business which do not
(A) interfere in any material respect with the business of the Borrower and the Restricted Subsidiaries, taken as a whole, or (B) secure any Indebtedness for borrowed money and (ii) the rights reserved or vested in any Person by the
terms of any lease, license, franchise, grant or permit held by the Borrower or any of its Restricted Subsidiaries or by a statutory provision, to terminate any such lease, license, franchise, grant or permit, or to require annual or periodic
payments as a condition to the continuance thereof; and 
 (r) Liens not otherwise permitted by this Section so long as
neither (i) the aggregate outstanding principal amount of the obligations secured thereby nor (ii) the aggregate fair market value (determined as of the date such Lien is incurred) of the assets subject thereto exceeds (as to the Borrower
and all Restricted Subsidiaries) $5,000,000 at any one time. 
 7.4. Fundamental Changes. Enter into any merger, consolidation or
amalgamation, or liquidate, wind up or dissolve itself (or suffer any liquidation or dissolution), or Dispose of all or substantially all of its property or business, except that: 

(a) (i) any Subsidiary of the Borrower may be merged or consolidated with or into the Borrower (provided that the
Borrower shall be the continuing or surviving corporation) or with or into any Subsidiary Guarantor (provided that the Subsidiary Guarantor shall be the continuing or surviving corporation) and (ii) any Subsidiary of the Borrower that is
not a Loan Party may be merged or consolidated with or into any other Subsidiary of the Borrower that is not a Loan Party; 

  
 79 

 (b) any Subsidiary of the Borrower may Dispose of any or all of its assets
(i) to the Borrower or any Subsidiary Guarantor (upon voluntary liquidation or otherwise) or (ii) pursuant to a Disposition permitted by Section 7.5 ; 

(c) any Subsidiary of the Borrower that is not a Loan Party may (i) Dispose of any or all of its assets to any other
Subsidiary of the Borrower that is not a Loan Party (upon voluntary liquidation or otherwise) or (ii) liquidate or dissolve if the Borrower determines in good faith that such liquidation or dissolution is in the best interest of the Borrower
and is not materially disadvantageous to the Administrative Agent or the Lenders; 
 (d) any Investment expressly permitted
by Section 7.8 may be structured as a merger, consolidation or amalgamation; and 
 (e) the Borrower and its Restricted
Subsidiaries may incur Liens permitted by Section 7.3 and may make Investments permitted by Section 7.8. 
 7.5. Disposition of
Property. Dispose of any of its property, whether now owned or hereafter acquired, or, in the case of any Restricted Subsidiary, issue or sell any shares of such Restricted Subsidiary’s Capital Stock to any Person, except: 

(a) (i) the Disposition of obsolete or worn out property (other than accounts receivable or inventory) in the ordinary course
of business and Dispositions of property (other than accounts receivable or inventory) no longer used or useful in the conduct of the business of Group Members and (ii) the abandonment of Intellectual Property that is in the reasonable good
faith judgment of the Borrower no longer economically practicable to maintain or useful in the conduct of business of the Group Members taken as a whole; 

(b) Dispositions of inventory and Cash Equivalents in the ordinary course of business; 

(c) (i) Dispositions permitted by Section 7.4(b)(i) or Section 7.4(c)(i) and (ii) Dispositions of the assets of
the Borrower to any Subsidiary Guarantor; 
 (d) the sale or issuance of any Restricted Subsidiary’s Capital Stock to
the Borrower or any Subsidiary Guarantor; 
 (e) Dispositions consisting of the sale, transfer, assignment or other
disposition of unpaid accounts receivable in connection with the collection, compromise or settlement thereof in the ordinary course of business and not as part of a financing transaction; 

(f) Dispositions of property to the extent that (i) such property is exchanged for credit against the purchase price of
similar replacement property or (ii) the proceeds of such Disposition are promptly applied to the purchase price of such replacement property; 

(g) Dispositions resulting from casualty events or condemnation proceedings; 

(h) non-exclusive licenses, sublicenses, leases and subleases of Intellectual Property of the Group Members in the ordinary
course of business; 

  
 80 

 (i) any surrender or waiver of contractual rights or the settlement, release or
surrender of contractual rights or other litigation claims in the ordinary course of business; 
 (j) Dispositions of the
Capital Stock of, or Indebtedness or other securities of, an Unrestricted Subsidiary; 
 (k) Dispositions consisting of Liens
permitted by Section 7.3, and Dispositions consisting of Investments permitted by Section 7.8; and 
 (l) the
Disposition of other property having a fair market value not to exceed $5,000,000 in the aggregate for any fiscal year of the Borrower. 

7.6. Restricted Payments. Declare or pay any dividend (other than dividends payable solely in common stock of the Person making such
dividend) on, or make any payment on account of, or set apart assets for a sinking or other analogous fund for, the purchase, redemption, defeasance, retirement or other acquisition of, any Capital Stock of any Group Member, whether now or hereafter
outstanding, or make any other distribution in respect thereof, either directly or indirectly, whether in cash or property or in obligations of any Group Member (collectively, “Restricted Payments”), except that: 

(a) any Subsidiary may make Restricted Payments ratably to its equity holders; 

(b) so long as no Default or Event of Default shall have occurred and be continuing, the Borrower may (or may make Restricted
Payments to allow any Parent to) purchase or redeem or otherwise acquire or retire for value any Capital Stock of the Borrower or any Parent held by any future, present or former director, officer, employee, consultant or other agent (or any
spouses, former spouses, successors, executors, administrators, heirs, legatees or distributees of any of the foregoing) of the Borrower, any Subsidiary or any Parent upon the death, disability, retirement, resignation or termination of employment
of any such Person or otherwise pursuant to any employee or director equity plan, employee or director stock option or profits interest plan or any other employee or director benefit plan or any agreement (including any separation, stock
subscription, shareholder or partnership agreement) with any director, officer, employee, consultant or other agent of the Borrower, any Subsidiary or any Parent in an aggregate amount after the Restatement Effective Date together with the aggregate
amount of loans and advances to any Parent made pursuant to Section 7.8(u) in lieu of Restricted Payments permitted by this clause (b), not to exceed $2,500,000 in any calendar year with unused amounts in any calendar year being carried over to
the next two succeeding calendar years; provided that such amount in any calendar year may be increased by (A) an amount not to exceed the cash proceeds of key man life insurance policies received by the Borrower or the Restricted Subsidiaries
after the Restatement Effective Date, (B) to the extent contributed in cash to the common equity of the Borrower and not theretofore utilized to make a Restricted Payment under this clause (b), the proceeds from the sale of Capital Stock of the
Borrower or any Parent, in each case to directors, officers, employees, consultants or other agents of the Borrower, any Subsidiary or any Parent that occurs after the Restatement Effective Date and (C) the amount of any cash bonuses or other
compensation otherwise payable to any future, present or former director, officer, employee, consultant or other agent of the Borrower, any Subsidiary or any Parent that are foregone in return for the receipt of Capital Stock of the Borrower or any
Parent; 
 (c) the Borrower may make Restricted Payments to any Parent in respect of taxes: 

  
 81 

 (i) with respect to any taxable period ending on or prior to the Bioventus IPO
Date, the Borrower may make distributions to the holders of its Capital Stock and their Affiliates, including Permitted Investors, to pay any income Taxes that are attributable to such Persons’ direct or indirect ownership of the Borrower and
its Subsidiaries with respect to such taxable period; provided, that for each such taxable period, the amount of such payments made in respect of such taxable period in the aggregate shall not exceed the amount of such Person’s actual or
estimated liability (as applicable) for income Taxes attributable to the direct or indirect ownership of the Borrower and its Subsidiaries by the holders of its Capital Stock and their Affiliates, including Permitted Investors, that such Persons are
actually required to pay to a Governmental Authority (with the amount of such Taxes to be calculated utilizing the highest marginal income tax rates in the applicable jurisdictions); and 

(ii) with respect to any taxable period ending after the Bioventus IPO Date, (1) for so long as for U.S. federal income
tax purposes the Borrower is taxed as a partnership or disregarded entity and is not wholly owned (directly or indirectly) by a corporate parent, an amount in cash sufficient to fund tax distributions required under Section 4.01(b) of the
Borrower LLC Agreement as in effect on the Bioventus IPO Date; and (2) for so long as Borrower or any of its Subsidiaries is a member of an affiliated, consolidated, combined, unitary or other group for U.S. federal, state and/or local income,
franchise and similar tax purposes of which Borrower or any Parent is the common parent (a “Tax Group”), or for which Borrower is a partnership or disregarded entity that is wholly-owned (directly or indirectly) by a corporate
Parent (a “Corporate Parent”), an amount in cash sufficient to pay the portion of the Tax Group’s or Corporate Parent’s actual cash income, franchise or other state and/or local tax liability attributable to Borrower
and/or its Subsidiaries, in an amount not to exceed the income, franchise or other similar U.S. federal, state and/or local tax liability that would have been payable by Borrower and/or its Subsidiaries if such entities had been taxable on a
stand-alone basis (reduced by any such income, franchise or other similar taxes paid or to be paid directly by Borrower or its Subsidiaries); 

(d) the Borrower may make Restricted Payments to any Parent: 

(i) the proceeds of which shall be used to pay operating costs and expenses (including, following the consummation of a
Qualified IPO, Public Company Costs) of any Parents, the Borrower and the Subsidiaries incurred in the ordinary course of business and other corporate overhead costs and expenses (including administrative, legal, accounting and similar expenses
provided by third parties, which are reasonable and customary and incurred in the ordinary course of business, attributable to the ownership or operations of the Borrower and its Subsidiaries; 

(ii) fees, franchise, excise and similar taxes and expenses required to maintain any Parents’ corporate or legal
existence; 
 (iii) in the minimum amount necessary to enable such Parents to make repurchases of Capital Stock deemed to
occur upon the exercise of stock options if such Capital Stock represents a portion of the exercise price thereof or the minimum amount of taxes due upon such exercises; 

(iv) to finance any acquisition by such Parent that would constitute an Investment permitted to be made pursuant to
Section 7.8 if made by the Borrower; provided that (A) such Restricted Payment shall be made substantially concurrently with the closing of such Investment and (B) the applicable Parent or Parents shall,

  
 82 

 
immediately following the closing thereof, cause (1) all property acquired (whether assets or Capital Stock) to be contributed to the Borrower or a Restricted Subsidiary (which shall be a
Subsidiary Guarantor to the extent required by Section 7.8) or (2) the merger (to the extent permitted in Section 7.4) of the Person formed or acquired with the Borrower or a Restricted Subsidiary, in each case, in accordance with the
requirements of Sections 6.10 and 7.8; 
 (v) the proceeds of which shall be used to pay costs, fees and expenses (other than
to Affiliates that are not a Parent) related to any unsuccessful equity or debt securities offering and/or any unsuccessful acquisition; and 

(vi) the proceeds of which (A) shall be used to pay customary salary, bonus and other benefits payable to directors,
officers and employees of any Parent to the extent such salaries, bonuses and other benefits are attributable to the ownership or operation of the Borrower and the Restricted Subsidiaries or (B) shall be used to make payments permitted under
clauses (iii) and (vii) in the proviso to Section 7.10 (but only to the extent such payments have not been and are not expected to be made by the Borrower or a Restricted Subsidiary); 

(e) from and after the Bioventus IPO, the Borrower may make restricted Payments to Bioventus Inc. to the extent the Borrower
LLC Agreement requires (i) to reimburse Bioventus Inc. for expenses incurred on behalf or directly for the benefit of the Borrower and its Subsidiaries, including without limitation expenses incurred in connection with the Bioventus IPO,
(ii) if any member of the Borrower exercises its right to have its units in the Borrower redeemed in accordance with the Borrower LLC Agreement, the Borrower may make Restricted Payments in connection with such redemption in the form of any
cash or Capital Stock contributed to the Borrower by Parent for such purpose (it being understood that Parent shall have contributed to the Borrower an amount equal to the amount of any such cash prior to the making of any such Restricted Payment),
and (iii) in accordance with the Borrower LLC Agreement, the Borrower shall be permitted to (A) undertake all actions, including, without limitation, a reclassification, distribution, division or recapitalization, with respect to its
common units, to maintain at all times a one-to-one ratio between the number of common units owned by Bioventus Inc. and the number of outstanding shares of Class A common stock of Bioventus Inc. (disregarding, for purposes of maintaining the
one-to-one ratio, such Capital Stock of Bioventus Inc. as provided in the Borrower LLC Agreement); provided that, in the case of any action pursuant to this clause (e)(iii)(A) involving a distribution or other transfer by the Borrower of cash
or assets (other than Capital Stock of the Borrower), such distribution or other transfer is then permitted pursuant one or more other clauses of this Section 7.6, and (B) issue, transfer or deliver from treasury stock any units of the
Borrower to Bioventus Inc.; 
 (f) from and after the Bioventus IPO, the Borrower may make Restricted Payments to Bioventus
Inc. to the extent (i) the Tax Receivable Agreement requires Bioventus Inc. to pay any Permitted Tax Receivable Payments and (ii) any Bioventus Incentive Plan requires Bioventus Inc. to pay any award granted thereunder in cash (as opposed
to Capital Stock) or any cash requirements in connection with the administration thereof; 
 (g) any Group Member may make
Restricted Payments with respect to earn-out payments or contingent obligations in connection with any Permitted Acquisition, any acquisition by a Parent described in clause (d)(iv) above, or the Biostructures Acquisition; provided, that the
Borrower shall first submit a pro forma Compliance Certificate to the Administrative Agent containing all information and calculations necessary for determining pro forma compliance by each Group Member with the financial covenants set forth in
Section 7.1; and 

  
 83 

 (h) the Borrower may make additional Restricted Payments to the holders of its
Capital Stock and their Affiliates, including Permitted Investors, in an aggregate amount (which shall not be less than zero) equal to the portion, if any, of the Cumulative Credit on the date of such election that the Borrower elects to apply to
this Section 7.6(h), such election to be specified in a written notice of a Responsible Officer of the Borrower calculating in reasonable detail the amount of Cumulative Credit immediately prior to such election and the amount thereof elected
to be so applied, so long as (A) the aggregate amount of any such Restricted Payments does not exceed $1,000,000 in any fiscal year, (B) immediately before and immediately after giving pro forma effect to any such Restricted Payment, no
Event of Default shall have occurred and be continuing and (C)(x) the Group Members shall be in pro forma compliance with the financial covenant set forth in Section 7.1(a) and (y) the Borrower shall be in pro forma compliance with a
minimum Fixed Charge Coverage Ratio for the previous four consecutive fiscal quarters of 1.50 to 1.00, such compliance for clauses (x) and (y) above to be determined on the basis of the financial information most recently delivered to the
Administrative Agent and the Lenders pursuant to Section 6.1(a) or 6.1(b) as though such Restricted Payment had been made as of the first day of the applicable four fiscal quarter period covered thereby; provided that for each fiscal
year, an aggregate amount equal to $1,000,000 minus the aggregate amount of all Restricted Payments made pursuant to this Section 7.6(h) during such fiscal year may be carried forward to succeeding fiscal years and utilized to make
Restricted Payments pursuant to this Section 7.6(h). 
 7.7. Capital Expenditures. Make or commit to make any Capital
Expenditure, except: 
 (a) Capital Expenditures of the Borrower and its Restricted Subsidiaries in the ordinary course of
business not exceeding (A) $12,000,000 for the fiscal year ended December 31, 2016 or (B) $6,000,000 in any other fiscal year; provided, that (i) up to $3,000,000 of any such amount referred to above, if not so expended in
the fiscal year for which it is permitted, may be carried over for expenditure in the next succeeding fiscal year and (ii) Capital Expenditures made pursuant to this Section during any fiscal year shall be deemed made, first, in respect
of amounts permitted for such fiscal year as provided above and, second, in respect of amounts carried over from the prior fiscal year pursuant to clause (i) above; 

(b) Capital Expenditures made with the portion, if any, of the Cumulative Credit on the date that the Borrower elects to apply
all or a portion thereof to this Section 7.7(b), such election to be specified in a written notice of a Responsible Officer of the Borrower calculating in reasonable detail the amount of Cumulative Credit immediately prior to such election and
the amount thereof elected to be so applied, so long as (A) immediately before and immediately after giving pro forma effect to any such Capital Expenditure, no Event of Default shall have occurred and be continuing and (B) the Group
Members shall be in pro forma compliance with the financial covenants set forth in Section 7.1, such compliance to be determined on the basis of the financial information most recently delivered to the Administrative Agent and the Lenders
pursuant to Section 6.1(a) or 6.1(b) as though such Capital Expenditure had been made as of the first day of the applicable four fiscal quarter period covered thereby; 

(c) Permitted Acquisitions, to the extent constituting Capital Expenditures; and 

(d) reinvestment of the proceeds of any Reinvestment Deferred Amount in accordance with Section 7.8(e). 

  
 84 

 7.8. Investments. Make any advance, loan, extension of credit (by way of guaranty or
otherwise) or capital contribution to, or purchase any Capital Stock, bonds, notes, debentures or other debt securities of, or any assets constituting a business unit of, or make any other investment in, any Person (all of the foregoing,
“Investments”), except: 
 (a) extensions of trade credit and prepayment of expenses to vendors and
suppliers, each in the ordinary course of business; 
 (b) investments in Cash Equivalents; 

(c) Guarantee Obligations permitted by Section 7.2; 

(d) (i) loans and advances to employees of any Group Member in the ordinary course of business (including for travel,
entertainment and relocation expenses) and (ii) the Borrower and its Restricted Subsidiaries may acquire and hold obligations of any officer or employee of any Subsidiary in connection with such officer’s or employee’s acquisition of
Capital Stock of the Borrower; provided, that no cash is actually advanced by the Borrower or any Restricted Subsidiary in connection therewith; provided, further, that the aggregate amount of Investments for all Group Members
pursuant to clauses (i) and (ii) combined may not exceed $2,000,000 at any one time outstanding; 
 (e) Investments
in assets useful in the business of the Borrower and its Restricted Subsidiaries made by the Borrower or any of its Restricted Subsidiaries with the proceeds of any Reinvestment Deferred Amount; 

(f) (i) intercompany Investments by any Group Member in the Borrower or any Person that, prior to such investment, is a
Subsidiary Guarantor, (ii) intercompany Investments by any Restricted Subsidiary that is not a Subsidiary Guarantor in any other Restricted Subsidiary that is not a Subsidiary Guarantor and (iii) intercompany Investments by the Borrower or
any Subsidiary Guarantor in a Restricted Subsidiary that is not a Subsidiary Guarantor as permitted under Section 7.2(c)(iii); 

(g) promissory notes and other non-cash consideration received in connection with Dispositions permitted by Section 7.4 or
Section 7.5 or received in connection with collections and compromises of accounts receivable in the ordinary course of business; 

(h) Investments received in connection with the bankruptcy or reorganization of, or settlement of delinquent accounts and
disputes with, customers and suppliers, in each case in the ordinary course of business; 
 (i) the Borrower and the other
Restricted Subsidiaries may enter into Swap Agreements permitted under Section 7.12; 
 (j) Investments made as a result
of the receipt of non-cash consideration from a sale, transfer or other disposition of any asset in compliance with Section 7.4 or Section 7.5; 

(k) advances of payroll payments to employees in the ordinary course of business and consistent with past practices; 

  
 85 

 (l) guarantees by the Borrower or any Restricted Subsidiary of leases (other than
Capital Lease Obligations) or of other obligations that do not constitute Indebtedness, in each case entered into in the ordinary course of business; 

(m) Investments made to effect the pledges and deposits described in, and permitted under, Sections 7.3(c) and 7.3(d); 

(n) Investments existing or contemplated on the Restatement Effective Date and listed on Schedule 4.15 or
Schedule 7.8(n); 
 (o) Investments made with the portion, if any, of the Cumulative Credit on the date that the
Borrower elects to apply all or a portion thereof to this Section 7.8(o), such election to be specified in a written notice of a Responsible Officer of the Borrower calculating in reasonable detail the amount of Cumulative Credit immediately
prior to such election and the amount thereof elected to be so applied, so long as (A) immediately before and immediately after giving pro forma effect to any such Investment, no Event of Default shall have occurred and be continuing and
(B) the Group Members shall be in pro forma compliance with the financial covenants set forth in Section 7.1, such compliance to be determined on the basis of the financial information most recently delivered to the Administrative Agent
and the Lenders pursuant to Section 6.1(a) or 6.1(b) as though such Investment had been made as of the first day of the applicable four fiscal quarter period covered thereby; 

(p) purchases of the Capital Stock, bonds, notes, debentures or other debt securities of, or of any assets constituting a
business unit of, any Person which, upon the consummation thereof, will be owned directly by the Borrower or one or more of its Restricted Subsidiaries; provided, that with respect to each such purchase made pursuant to this
Section 7.8(p) (each of the foregoing, a “Permitted Acquisition”): 
 (i) each applicable Loan Party
and any such newly created or acquired Subsidiary shall, or will within the times specified therein, have complied with the applicable requirements of Section 6.10; 

(ii) the lines of business of the Person to be (or the property of which is to be) so purchased shall be substantially the same
lines of business, or reasonably related, incidental or complimentary thereto, as one or more of the businesses in which the Group Members are engaged on the date of this Agreement; 

(iii) (1) immediately before and immediately after giving pro forma effect to such purchase, no Event of Default shall have
occurred and be continuing and (2) immediately after giving effect to such purchase, on a pro forma basis, the Consolidated Leverage Ratio would not exceed the maximum Consolidated Leverage Ratio then permitted pursuant to Section 7.1
minus 0.25 to 1.00, such compliance to be determined on the basis of the financial information most recently delivered to the Administrative Agent and the Lenders pursuant to Section 6.1(a) or Section 6.1(b) as though such purchase had
been consummated as of the first day of the applicable four fiscal quarter period covered thereby; 
 (iv) after giving
effect on a pro forma basis to any such purchase, the aggregate amount of (A) all unrestricted cash and Cash Equivalents of the Loan Parties and (B) the aggregate Available Revolving Commitments shall be at least $10,000,000; 

  
 86 

 (v) the aggregate purchase consideration (whether cash or equity, as valued in
good faith by the Board of Directors of the Borrower) for all purchases consummated in reliance on this Section 7.8(p) shall not exceed $50,000,000 in any fiscal year; and 

(vi) the Borrower shall have delivered to the Administrative Agent, no later than the date on which such purchase is
consummated, a certificate of a Responsible Officer certifying that all of the requirements set forth in this Section 7.8(p) have been satisfied or will be satisfied on or prior to the consummation of such purchase, and setting forth in
reasonable detail calculations demonstrating compliance with the requirement set forth in clauses (iii)(2) and (iv) above; 

(q) Investments made pursuant to the Project Sandal Acquisition; 

(r) Investments with respect to earn-out payments or contingent obligations in connection with any Permitted Acquisition;
provided, that the Borrower shall first submit a pro forma Compliance Certificate to the Administrative Agent containing all information and calculations necessary for determining pro forma compliance by each Group Member with the financial
covenants set forth in Section 7.1; 
 (s) in addition to Investments otherwise expressly permitted by this Section,
Investments by the Borrower or any of its Restricted Subsidiaries in an aggregate amount (valued at cost) not to exceed $5,000,000 during the term of this Agreement; 

(t) the Biostructures Acquisition; 

(u) loans and advances to any Parent in lieu of, and not in excess of the amount of (after giving effect to any other loans,
advances or Restricted Payments in respect thereof), Restricted Payments to the extent permitted to be made to any Parent in accordance with Sections 7.6(b) through (f); and 

(v) Investments received from Bioventus Inc. in accordance with the Borrower LLC Agreement. 

7.9. Optional Payments and Modifications of Certain Debt Instruments; Organizational Documents. (a) Make or offer to make any
optional or voluntary payment, prepayment, repurchase or redemption of or otherwise optionally or voluntarily defease or segregate funds with respect to any Indebtedness permitted pursuant to Section 7.2(m) or any Permitted Refinancing
Indebtedness with respect thereof other than (i) with the proceeds of any Permitted Refinancing Indebtedness in respect thereof, (ii) with any Declined Prepayment Amount or (iii) with the Net Cash Proceeds from a Qualified IPO (other
than that portion of the Net Cash Proceeds from the Bioventus IPO used to prepay the Second Lien Loans on the Restatement Effective Date), (b) amend, modify, waive or otherwise change, or consent or agree to any amendment, modification, waiver
or other change to, any of the terms of Indebtedness permitted pursuant to Section 7.2(m) (other than any such amendment, modification, waiver or other change that would not materially adversely affect the interests of the Lenders) or
(c) amend, modify or otherwise change any of its Organizational Documents, other than (i) the amendment and restatement of the Borrower LLC Agreement (in a manner consistent with the definition thereof) in connection with a Bioventus IPO
and (ii) any such amendments, modifications or changes which are not, and would not reasonably be expected to be, materially adverse to the interests of the Administrative Agent or any Lender. Notwithstanding the foregoing, the Borrower may
prepay the Second Lien Loans in full on the Restatement Effective Date with the proceeds from the Bioventus IPO. 

  
 87 

 7.10. Transactions with Affiliates. Enter into any transaction, including any purchase,
sale, lease or exchange of property, the rendering of any service or the payment of any management, advisory or similar fees, with any Affiliate (other than the Borrower or any Subsidiary Guarantor) unless such transaction is (a) otherwise
permitted under this Agreement, (b) in the ordinary course of business of the relevant Group Member, and (c) upon fair and reasonable terms no less favorable to the relevant Group Member than it would obtain in a comparable arm’s
length transaction with a Person that is not an Affiliate; provided, that the foregoing restriction in clause (b) shall not apply to: 

(i) transactions between or among the Loan Parties; 

(ii) transactions permitted under Section 7.6; 

(iii) the payment of customary directors’ or managers’ fees and indemnification and reimbursement of expenses to
directors, managers, officers or employees of Borrower, any Subsidiary or any Parent; 
 (iv) any issuance of securities or
other payments, awards or grants in cash, securities or otherwise pursuant to, or the funding of, employment agreements, stock options and stock ownership plans (including the Borrower’s Management Incentive Plan and Phantom Profits Interests
Plan) approved by the Borrower’s Board of Directors; 
 (v) employment and severance arrangements entered into in the
ordinary course of business between the Borrower or any Restricted Subsidiary and any employee thereof and, to the extent entered into after the Closing Date, approved by the Borrower’s Board of Directors; 

(vi) intercompany transactions undertaken in good faith (as certified by a Responsible Officer of the Borrower) for the purpose
of improving the consolidated tax efficiency of the Group Members; 
 (vii) the payment of management, advisory, structuring,
administrative and similar fees in the ordinary course of business and consistent with past practice; 
 (viii) reimbursement
of out-of-pocket expenses of the Permitted Investors’ tax manager pursuant to the Borrower’s Limited Liability Company Agreement not exceeding $350,000 in any fiscal year of the Borrower; 

(ix) issuances of Capital Stock and other equity interests of the Borrower not constituting a Change in Control; 

(x) Investments permitted under Section 7.8(d), Section 7.8(n) or Section 7.8(o); 

(xi) Tax distributions to be paid to Permitted Investors in connection with the 2012 transition and spin-off of the Borrower,
as in effect on the Closing Date; 
 (xii) prepayment of the Existing Debt on the Closing Date; 

(xiii) transactions in existence on the Closing Date and listed on Schedule 7.10; 

  
 88 

 (xiv) in connection with the Bioventus IPO, the entry into the Borrower LLC
Agreement, the Tax Receivable Agreement, the IPO Common Unit Purchase Agreement, the Bioventus Merger Agreement and the Bioventus Incentive Plans, and (B) transactions arising from the performance of such agreements (including pursuant to any
amendment to such Contractual Obligations or documentation replacing such Contractual Obligations to the extent that such amendment or agreement is permitted hereunder and is not more disadvantageous to the applicable Credit Party or the Lenders in
any material respect than the original Contractual Obligation). 
 7.11. Sales and Leasebacks. Enter into any arrangement with any
Person providing for the leasing by any Group Member of real or personal property that has been or is to be sold or transferred by such Group Member to such Person or to any other Person to whom funds have been or are to be advanced by such Person
on the security of such property or rental obligations of such Group Member. 
 7.12. Swap Agreements. Enter into any Swap Agreement,
except (a) Swap Agreements entered into to hedge or mitigate risks to which the Borrower or any Restricted Subsidiary has actual exposure (other than those in respect of Capital Stock) and (b) Swap Agreements entered into in order to
effectively cap, collar or exchange interest rates (from fixed to floating rates, from one floating rate to another floating rate or otherwise) with respect to any interest-bearing liability or investment of the Borrower or any Restricted
Subsidiary. 
 7.13. Changes in Fiscal Periods. Permit the fiscal year of the Borrower to end on a day other than December 31 or
change the Borrower’s method of determining fiscal quarters. 
 7.14. Negative Pledge Clauses. Enter into or suffer to exist or
become effective any agreement that prohibits or limits the ability of any Group Member to create, incur, assume or suffer to exist any Lien upon any of its property or revenues, whether now owned or hereafter acquired, to secure its obligations
under the Loan Documents to which it is a party other than (a)(i) this Agreement, the other Loan Documents and the Second Lien Loan Documents (or any documentation governing any Permitted Refinancing Indebtedness in respect of the Second Lien Loans,
so long as any such prohibition or limitation included in any such documentation governing any such Permitted Refinancing Indebtedness is no more restrictive than the applicable prohibition or limitation included in the Second Lien Loan Documents)
and (ii) any agreement governing any Indebtedness incurred pursuant to Section 7.2 to the extent such prohibition or limitation is customary in agreements governing Indebtedness of such type and in any event so long as any such agreement
is not more restrictive than the Loan Documents, (b) any agreements governing any purchase money Liens or Capital Lease Obligations otherwise permitted hereby (in which case, any prohibition or limitation shall only be effective against the
assets financed thereby), (c) any agreement in effect at the time any Restricted Subsidiary becomes a Restricted Subsidiary of the Borrower, so long as such agreement was not entered into in contemplation of such Person becoming a Restricted
Subsidiary of the Borrower, as such agreement may be amended, restated, supplemented, modified extended renewed or replaced, so long as such amendment, restatement, supplement, modification, extension, renewal or replacement does not expand in any
material respect the scope of any restriction contemplated by this Section 7.14 contained therein, (d) customary provisions restricting assignments, subletting, sublicensing, pledging or other transfers contained in leases, subleases,
licenses or sublicenses, so long as such restrictions are limited to the property or assets subject to such leases, subleases, licenses or sublicenses, as the case may be or (e) customary restrictions and conditions contained in agreements
relating to the sale of a Restricted Subsidiary or any assets pending such sale, provided that such restrictions or conditions apply only to the Restricted Subsidiary or assets that is to be sold and such sale is permitted hereunder. 

  
 89 

 7.15. Clauses Restricting Subsidiary Distributions. Enter into or suffer to exist or
become effective any consensual encumbrance or restriction on the ability of any Restricted Subsidiary of the Borrower to (a) make Restricted Payments in respect of any Capital Stock of such Restricted Subsidiary held by, or pay any
Indebtedness owed to, any Group Member, (b) make loans or advances to, or other Investments in, any Group Member or (c) transfer any of its assets to any Group Member, except for such encumbrances or restrictions existing under or by
reason of (i) any restrictions existing under (A) the Loan Documents or the Second Lien Loan Documents (or any documentation governing any Permitted Refinancing Indebtedness in respect of the Second Lien Loans, so long as any such
restriction included in any such documentation governing any such Permitted Refinancing Indebtedness is no more restrictive than the applicable restriction included in the Second Lien Loan Documents) or (B) any agreement governing Indebtedness
incurred pursuant to Section 7.2 so long as such encumbrance or restriction is customary in agreements governing Indebtedness of such type, (ii) any restrictions with respect to a Restricted Subsidiary imposed pursuant to an agreement that
has been entered into in connection with the Disposition of all or substantially all of the Capital Stock or assets of such Subsidiary, (iii) any restriction under any agreement in effect at the time any Restricted Subsidiary becomes a
Restricted Subsidiary of the Borrower, so long as such agreement was not entered into in contemplation of such Person becoming a Restricted Subsidiary of the Borrower, as such agreement may be amended, restated, supplemented, modified extended
renewed or replaced, so long as such amendment, restatement, supplement, modification, extension, renewal or replacement does not expand in any material respect the scope of any restriction contemplated by this Section 7.15 contained therein,
(iv) customary provisions restricting assignments, subletting, sublicensing, pledging or other transfers contained in leases, subleases, licenses or sublicenses, so long as such restrictions are limited to the property or assets subject to such
leases, subleases, licenses or sublicenses, as the case may be or (v) customary restrictions and conditions contained in agreements relating to the sale of a Restricted Subsidiary or any assets pending such sale, provided that such restrictions
or conditions apply only to the Restricted Subsidiary or assets that is to be sold and such sale is permitted hereunder. 
 7.16. Lines of
Business. Enter into any business, either directly or through any Restricted Subsidiary, except for those businesses in which the Borrower and its Restricted Subsidiaries are engaged on the date of this Agreement or that are reasonably related
thereto. 
 7.17. Use of Proceeds. Use, and the respective directors, officers, employees and agents of the Borrower and its
Subsidiaries shall not use, the proceeds of any Loan or Letter of Credit (A) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any
Anti-Corruption Laws, (B) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country or (C) in any manner that would result in the violation
of any Sanctions applicable to any party hereto. 
 SECTION 8. EVENTS OF DEFAULT 

8.1. Events of Default. If any of the following events shall occur and be continuing: 

(a) the Borrower shall fail to pay any principal of any Loan or Reimbursement Obligation when due in accordance with the terms
hereof; or the Borrower shall fail to pay any interest on any Loan or Reimbursement Obligation, or any other amount payable hereunder or under any other Loan Document, within five days after any such interest or other amount becomes due in
accordance with the terms hereof; or 

  
 90 

 (b) any representation or warranty made or deemed made by any Loan Party herein
or in any other Loan Document or that is contained in any certificate, document or financial or other statement furnished by it at any time under or in connection with this Agreement or any such other Loan Document shall prove to have been
inaccurate in any material respect on or as of the date made or deemed made; or 
 (c) any Loan Party shall default in the
observance or performance of any agreement contained in Section 3.1(c), clause (i) or (ii) of Section 6.4(a) (with respect to the Borrower only), Section 6.7(a) or Section 7 of this Agreement or Sections 5.5 and 5.7(b)
of the Guarantee and Collateral Agreement; or 
 (d) any Loan Party shall default in the observance or performance of any
other agreement contained in this Agreement or any other Loan Document (other than as provided in paragraphs (a) through (c) of this Section), and such default shall continue unremedied for a period of 30 days after notice to the Borrower
from the Administrative Agent or the Required Lenders; or 
 (e) any Group Member shall (i) default in making any
payment of any principal of any Indebtedness (including any Guarantee Obligation constituting Indebtedness, and including, for purposes of this Section 8.1(e), obligations in respect of Swap Agreements, but excluding the Loans) on the scheduled
or original due date with respect thereto; or (ii) default in making any payment of any interest on any such Indebtedness beyond the period of grace, if any, provided in the instrument or agreement under which such Indebtedness was created; or
(iii) default in the observance or performance of any other agreement or condition relating to any such Indebtedness or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or
condition exist, the effect of which default or other event or condition is to cause, or to permit the holder or beneficiary of such Indebtedness (or a trustee or agent on behalf of such holder or beneficiary) to cause, with the giving of notice if
required, such Indebtedness to become due prior to its stated maturity or (in the case of any such Indebtedness constituting a Guarantee Obligation) to become payable but excluding with respect to Swap Agreements, termination events or equivalent
events (in respect of which no Loan Party is an “Affected Party,” as such term is defined in the 1992 or 2002 Master Agreement, as published by the International Swaps and Derivatives Association, as applicable) pursuant to the terms of
such Swap Agreements and not as a result of any default thereunder by the Borrower or any Restricted Subsidiary; provided, that a default, event or condition described in clause (i), (ii) or (iii) of this paragraph (e) shall
not at any time constitute an Event of Default unless, at such time, one or more defaults, events or conditions of the type described in clauses (i), (ii) and (iii) of this paragraph (e) shall have occurred and be continuing with
respect to Indebtedness the aggregate outstanding principal amount (valued, in the case of a Swap Agreement, as the maximum aggregate amount (giving effect to any netting arrangements permitted under such Swap Agreement) that the Borrower or any
Restricted Subsidiary would be required to pay if such Swap Agreement were terminated at such time) of which is $5,000,000 or more; provided that this paragraph (e) shall not apply to that secured Indebtedness that becomes due solely as
a result of the voluntary sale or transfer of the property or assets (to the extent not prohibited by this Agreement) securing such Indebtedness; or 

(f) (i) any Group Member shall commence any case, proceeding or other action (A) under any existing or future law of any
jurisdiction, domestic or foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it a bankrupt or insolvent, or seeking
reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition or other relief with 

  
 91 

 
respect to it or its debts, or (B) seeking appointment of a receiver, trustee, custodian, conservator or other similar official for it or for all or any substantial part of its assets; or
(ii) there shall be commenced against any Group Member any case, proceeding or other action of a nature referred to in clause (i) above that (A) results in the entry of an order for relief or any such adjudication or appointment or
(B) remains undismissed or undischarged for a period of 60 days; or (iii) there shall be commenced against any Group Member any case, proceeding or other action seeking issuance of a warrant of attachment, execution, distraint or similar
process against all or any substantial part of its assets that results in the entry of an order for any such relief that shall not have been vacated, discharged, or stayed or bonded pending appeal within 60 days from the entry thereof; or
(iv) any Group Member shall take any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in clause (i), (ii), or (iii) above; or (v) any Group Member shall generally not,
or shall be unable to, or shall admit in writing its inability to, pay its debts as they become due; or (vi) or any Group Member shall make a general assignment for the benefit of its creditors; or 

(g) (i) an ERISA Event and or a Foreign Plan Event shall have occurred; (ii) a trustee shall be appointed by a United
States district court to administer any Pension Plan; (iii) the PBGC shall institute proceedings to terminate any Pension Plan; (iv) any Group Member or any of their respective ERISA Affiliates shall have been notified by the sponsor of a
Multiemployer Plan that it has incurred or will be assessed Withdrawal Liability to such Multiemployer Plan and such entity does not have reasonable grounds for contesting such Withdrawal Liability or is not contesting such Withdrawal Liability in a
timely and appropriate manner; or (v) any other event or condition shall occur or exist with respect to a Plan, a Foreign Benefit Arrangement, or a Foreign Plan; and in each case in clauses (i) through (v) above, such event or
condition, together with all other such events or conditions, if any, could, in the sole judgment of the Required Lenders, reasonably be expected to result in a Material Adverse Effect; or 

(h) one or more judgments or decrees shall be entered against any Group Member involving in the aggregate a liability (not paid
or fully covered by insurance as to which the relevant insurance company has acknowledged coverage) of $5,000,000 or more, and all such judgments or decrees shall not have been vacated, discharged, stayed or bonded pending appeal within 30 days from
the entry thereof; or 
 (i) any of the Security Documents shall cease, for any reason, to be in full force and effect, or
any Loan Party or any Affiliate of any Loan Party shall so assert, or any Lien created by any of the Security Documents shall cease to be enforceable and of the same effect and priority purported to be created thereby; or 

(j) the guarantee contained in Section 2 of the Guarantee and Collateral Agreement shall cease, for any reason, to be in
full force and effect or any Loan Party or any Affiliate of any Loan Party shall so assert; or 
 (k) a Change in Control
shall occur; 
 then, and in any such event, (A) if such event is an Event of Default specified in clause (i) or (ii) of paragraph
(f) above with respect to the Borrower, automatically the Commitments shall immediately terminate and the Loans (with accrued interest thereon) and all other amounts owing under this Agreement and the other Loan Documents (including all amounts
of L/C Obligations, whether or not the beneficiaries of the then outstanding Letters of Credit shall have presented the documents required thereunder) shall immediately become due and payable, and (B) if such event is any other Event of
Default, either or both of the following actions may be taken: (i) with the consent of the Required 

  
 92 

 
Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall, by notice to the Borrower declare the Revolving Commitments to be terminated
forthwith, whereupon the Revolving Commitments shall immediately terminate; and (ii) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall, by notice
to the Borrower, declare the Loans (with accrued interest thereon) and all other amounts owing under this Agreement and the other Loan Documents (including all amounts of L/C Obligations, whether or not the beneficiaries of the then outstanding
Letters of Credit shall have presented the documents required thereunder) to be due and payable forthwith, whereupon the same shall immediately become due and payable. With respect to all Letters of Credit with respect to which presentment for honor
shall not have occurred at the time of an acceleration pursuant to this paragraph, the Borrower shall at such time deposit in a cash collateral account opened by the Administrative Agent an amount equal to 103% of the aggregate then undrawn and
unexpired amount of such Letters of Credit. Amounts held in such cash collateral account shall be applied by the Administrative Agent to the payment of drafts drawn under such Letters of Credit, and the unused portion thereof after all such Letters
of Credit shall have expired without any pending drawing or been fully drawn upon, if any, shall be applied to repay other obligations of the Borrower hereunder and under the other Loan Documents. After all such Letters of Credit shall have expired
without any pending drawing or been fully drawn upon, all Reimbursement Obligations shall have been satisfied and all other obligations of the Borrower hereunder and under the other Loan Documents shall have been paid in full, the balance, if any,
in such cash collateral account shall be returned to the Borrower (or such other Person as may be lawfully entitled thereto). Except as expressly provided above in this Section, presentment, demand, protest and all other notices of any kind are
hereby expressly waived by the Borrower. 
 8.2. Application of Proceeds. The proceeds received by the Administrative Agent in respect
of any sale of, collection from or other realization upon all or any part of the Collateral pursuant to the exercise by the Administrative Agent of its remedies shall be applied, in full or in part, together with any other sums then held by the
Administrative Agent pursuant to this Agreement, promptly by the Administrative Agent as follows: 
 (a) First, to the
payment of all reasonable costs and expenses, fees, commissions and taxes of such sale, collection or other realization including compensation to the Administrative Agent and its agents and counsel, and all expenses, liabilities and advances made or
incurred by the Administrative Agent in connection therewith and all amounts for which the Administrative Agent is entitled to indemnification pursuant to the provisions of any Loan Document, together with interest on each such amount pursuant to
Section 2.14 from and after the date such amount is due, owing or unpaid until paid in full; 
 (b) Second, to
the payment of all other reasonable out-of-pocket costs and expenses of such sale, collection or other realization including compensation to the other Secured Parties and their agents and counsel and all costs, liabilities and advances made or
incurred by the other Secured Parties in connection therewith, together with interest on each such amount at the highest rate then in effect under this Agreement from and after the date such amount is due, owing or unpaid until paid in full; 

(c) Third, to the payment in full in cash of the principal amount of the Obligations, any interest and premium thereon
and any breakage, termination or other payments under agreements giving rise to Obligations and any interest accrued thereon and to provide cash collateral for all Letters of Credit with respect to which presentment for honor shall not have occurred
at such time in an amount equal to 103% of the aggregate then undrawn and unexpired amount of such Letters of Credit; and 

  
 93 

 (d) Fourth, the balance remaining after the Obligations shall have been
paid in full, no Letters of Credit shall be outstanding and the Commitments shall have terminated, if any, to the person lawfully entitled thereto (including the applicable Loan Party or its successors or assigns) or as a court of competent
jurisdiction may direct. 
 Notwithstanding the foregoing, no amount received from any Guarantor shall be applied to any Excluded Swap
Obligation of such Guarantor. 
 In the event that any such proceeds are insufficient to pay in full the items described in clauses
(a) through (d) of this Section 8.2, the Loan Parties shall remain liable, jointly and severally, for any deficiency. 

SECTION 9. THE AGENTS 
 9.1.
Appointment. Each Lender hereby irrevocably designates and appoints the Administrative Agent as the agent of such Lender under this Agreement and the other Loan Documents, and each such Lender irrevocably authorizes the Administrative Agent,
in such capacity, to take such action on its behalf under the provisions of this Agreement and the other Loan Documents and to exercise such powers and perform such duties as are expressly delegated to the Administrative Agent by the terms of this
Agreement and the other Loan Documents, together with such other powers as are reasonably incidental thereto. Notwithstanding any provision to the contrary elsewhere in this Agreement, the Administrative Agent shall not have any duties or
responsibilities, except those expressly set forth herein, or any fiduciary relationship with any Lender, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or any other Loan
Document or otherwise exist against the Administrative Agent. 
 9.2. Delegation of Duties. The Administrative Agent may execute any
of its duties under this Agreement and the other Loan Documents by or through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties. The Administrative Agent shall not be responsible
for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care. 
 9.3. Exculpatory
Provisions. Neither any Agent nor any of their respective officers, directors, employees, agents, advisors, attorneys-in-fact or affiliates shall be (i) liable for any action lawfully taken or omitted to be taken by it or such Person under
or in connection with this Agreement or any other Loan Document (except to the extent that any of the foregoing are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from its or such Person’s own
gross negligence or willful misconduct) or (ii) responsible in any manner to any of the Lenders for any recitals, statements, representations or warranties made by any Loan Party or any officer thereof contained in this Agreement or any other
Loan Document or in any certificate, report, statement or other document referred to or provided for in, or received by the Agents under or in connection with, this Agreement or any other Loan Document or for the value, validity, effectiveness,
genuineness, enforceability or sufficiency of this Agreement or any other Loan Document or for any failure of any Loan Party a party thereto to perform its obligations hereunder or thereunder. The Agents shall not be under any obligation to any
Lender to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this Agreement or any other Loan Document, or to inspect the properties, books or records of any Loan Party. 

  
 94 

 9.4. Reliance by Administrative Agent. The Administrative Agent shall be entitled to rely,
and shall be fully protected in relying, upon any instrument, writing, resolution, notice, consent, certificate, affidavit, letter, telecopy or email message, statement, order or other document or conversation believed by it to be genuine and
correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including counsel to the Borrower), independent accountants and other experts selected by the Administrative Agent. The
Administrative Agent may deem and treat the payee of any Note as the owner thereof for all purposes unless a written notice of assignment, negotiation or transfer thereof shall have been filed with the Administrative Agent. The Administrative Agent
shall be fully justified in failing or refusing to take any action under this Agreement or any other Loan Document unless it shall first receive such advice or concurrence of the Required Lenders (or, if so specified by this Agreement, all Lenders)
as it deems appropriate or it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense that may be incurred by it by reason of taking or continuing to take any such action. The Administrative Agent
shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement and the other Loan Documents in accordance with a request of the Required Lenders (or, if so specified by this Agreement, all Lenders), and such
request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and all future holders of the Loans. 

9.5. Notice of Default. The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or
Event of Default unless the Administrative Agent has received notice from a Lender or the Borrower referring to this Agreement, describing such Default or Event of Default and stating that such notice is a “notice of default”. In the event
that the Administrative Agent receives such a notice, the Administrative Agent shall give notice thereof to the Lenders. The Administrative Agent shall take such action with respect to such Default or Event of Default as shall be reasonably directed
by the Required Lenders (or, if so specified by this Agreement, all Lenders); provided, that unless and until the Administrative Agent shall have received such directions, the Administrative Agent may (but shall not be obligated to) take such
action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable in the best interests of the Lenders. 

9.6. Non-Reliance on Agents and Other Lenders. Each Lender expressly acknowledges that neither the Agents nor any of their respective
officers, directors, employees, agents, advisors, attorneys-in-fact or affiliates have made any representations or warranties to it and that no act by any Agent hereafter taken, including any review of the affairs of a Loan Party or any affiliate of
a Loan Party, shall be deemed to constitute any representation or warranty by any Agent to any Lender. Each Lender represents to the Agents that it has, independently and without reliance upon any Agent or any other Lender, and based on such
documents and information as it has deemed appropriate, made its own appraisal of and investigation into the business, operations, property, financial and other condition and creditworthiness of the Loan Parties and their affiliates and made its own
decision to make its Loans hereunder and enter into this Agreement. Each Lender also represents that it will, independently and without reliance upon any Agent or any other Lender, and based on such documents and information as it shall deem
appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Loan Documents, and to make such investigation as it deems necessary to inform itself as to
the business, operations, property, financial and other condition and creditworthiness of the Loan Parties and their affiliates. Except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative
Agent hereunder, the Administrative Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the business, operations, property, condition (financial or otherwise), prospects or
creditworthiness of any Loan Party or any affiliate of a Loan Party that may come into the possession of the Administrative Agent or any of its officers, directors, employees, agents, advisors, attorneys-in-fact or affiliates. 

  
 95 

 9.7. Indemnification. The Lenders severally agree to indemnify each Agent and its
officers, directors, employees, affiliates, agents, advisors and controlling persons (each, an “Agent Indemnitee”) (to the extent not reimbursed by the Borrower and without limiting the obligation of the Borrower to do so), ratably
according to their respective Aggregate Exposure Percentages in effect on the date on which indemnification is sought under this Section (or, if indemnification is sought after the date upon which the Commitments shall have terminated and the Loans
shall have been paid in full, ratably in accordance with such Aggregate Exposure Percentages immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs,
expenses or disbursements of any kind whatsoever that may at any time (whether before or after the payment of the Loans) be imposed on, incurred by or asserted against such Agent Indemnitee in any way relating to or arising out of, the Commitments,
this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by such Agent Indemnitee under or in connection with
any of the foregoing; provided that no Lender shall be liable for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements that are found by a final
and nonappealable decision of a court of competent jurisdiction to have resulted from such Agent Indemnitee’s gross negligence or willful misconduct. The agreements in this Section shall survive the termination of this Agreement and the payment
of the Loans and all other amounts payable hereunder. 
 9.8. Agent in Its Individual Capacity. Each Agent and its affiliates may make
loans to, accept deposits from and generally engage in any kind of business with any Loan Party as though such Agent were not an Agent. With respect to its Loans made or renewed by it and with respect to any Letter of Credit issued or participated
in by it, each Agent shall have the same rights and powers under this Agreement and the other Loan Documents as any Lender and may exercise the same as though it were not an Agent, and the terms “Lender” and “Lenders” shall
include each Agent in its individual capacity. 
 9.9. Successor Administrative Agent. The Administrative Agent may resign as
Administrative Agent upon 30 days’ notice to the Lenders and the Borrower. If the Administrative Agent shall resign as Administrative Agent under this Agreement and the other Loan Documents, then the Required Lenders shall appoint from among
the Lenders a successor agent for the Lenders, which successor agent shall (unless an Event of Default under Section 8.1(a) or Section 8.1(f) with respect to the Borrower shall have occurred and be continuing) be subject to approval by the
Borrower (which approval shall not be unreasonably withheld or delayed), whereupon such successor agent shall succeed to the rights, powers and duties of the Administrative Agent, and the term “Administrative Agent” shall mean such
successor agent effective upon such appointment and approval, and the former Administrative Agent’s rights, powers and duties as Administrative Agent shall be terminated, without any other or further act or deed on the part of such former
Administrative Agent or any of the parties to this Agreement or any holders of the Loans. If no successor agent has accepted appointment as Administrative Agent by the date that is 30 days following a retiring Administrative Agent’s notice of
resignation, the retiring Administrative Agent’s resignation shall nevertheless thereupon become effective, and the Lenders shall assume and perform all of the duties of the Administrative Agent hereunder until such time, if any, as the
Required Lenders appoint a successor agent as provided for above. After any retiring Administrative Agent’s resignation as Administrative Agent, the provisions of this Section 9 and of Section 10.5 shall continue to inure to its
benefit. 
 9.10. Arrangers and Syndication Agent. Neither the Arrangers nor the Syndication Agent shall have any duties or
responsibilities hereunder in their respective capacities as such. 

  
 96 

 SECTION 10. MISCELLANEOUS 

10.1. Amendments and Waivers. Neither this Agreement, any other Loan Document, nor any terms hereof or thereof may be amended,
supplemented or modified except in accordance with the provisions of this Section 10.1. The Required Lenders and each Loan Party party to the relevant Loan Document may, or, with the written consent of the Required Lenders, the Administrative
Agent and each Loan Party party to the relevant Loan Document may, from time to time, (a) enter into written amendments, supplements or modifications hereto and to the other Loan Documents for the purpose of adding any provisions to this
Agreement or the other Loan Documents or changing in any manner the rights of the Lenders or of the Loan Parties hereunder or thereunder or (b) waive, on such terms and conditions as the Required Lenders or the Administrative Agent, as the case
may be, may specify in such instrument, any of the requirements of this Agreement or the other Loan Documents or any Default or Event of Default and its consequences; provided, however, that no such waiver and no such amendment, supplement or
modification shall (i) forgive the principal amount or extend the final scheduled date of maturity of any Loan, extend the scheduled date of any amortization payment in respect of any Term Loan, reduce the stated rate of any interest or fee
payable hereunder (except (x) in connection with the waiver of applicability of any post-default increase in interest rates (which waiver shall be effective with the consent of the Majority Facility Lenders of each adversely affected Facility)
and (y) that any amendment or modification of defined terms used in the financial covenants in this Agreement shall not constitute a reduction in the rate of interest or fees for purposes of this clause (i)) or extend the scheduled date of any
payment thereof, or increase the amount or extend the expiration date of any Lender’s Revolving Commitment, in each case without the written consent of each Lender directly affected thereby; (ii) eliminate or reduce the voting rights of
any Lender under this Section 10.1 without the written consent of such Lender; (iii) reduce any percentage specified in the definition of Required Lenders, consent to the assignment or transfer by the Borrower of any of its rights and
obligations under this Agreement and the other Loan Documents, release all or substantially all of the Collateral or release all or substantially all of the Subsidiary Guarantors from their obligations under the Guarantee and Collateral Agreement,
in each case without the written consent of all Lenders; (iv) amend, modify or waive any provision of Section 2.17 without the written consent of all Lenders in respect of each Facility adversely affected thereby; (v) reduce the
amount of Net Cash Proceeds or Excess Cash Flow required to be applied to prepay Loans under this Agreement without the written consent of the Majority Facility Lenders with respect to each Facility adversely affected thereby; (vi) reduce the
percentage specified in the definition of Majority Facility Lenders with respect to any Facility without the written consent of all Lenders under such Facility; (vii) amend, modify or waive any provision of Section 9 or any other provision
of any Loan Document that affects the Administrative Agent without the written consent of the Administrative Agent; (viii) amend, modify or waive any provision of Section 2.6 or 2.7 without the written consent of the Swingline Lenders;
(ix) amend, modify or waive any provision of Section 3 without the written consent of the Issuing Lender; (x) amend Section 2.23 without the written consent of the Required Lenders, the Administrative Agent, the Swingline Lenders
and the Issuing Lender; (xi) amend, modify or waive any provision of Section 8.2 without the written consent of each Lender directly and adversely affected thereby; or (xii) amend Section 3.1(c) without the consent of Lenders
holding more than 50% of the Revolving Commitments in respect of the applicable maturing Revolving Commitments (or, if the Revolving Commitments in respect of such tranche have been terminated, the Total Revolving Extensions of Credit then
outstanding in respect of such maturing tranche); provided further that (A) this Agreement and the other Loan Documents may be amended solely with the consent of the Administrative Agent to incorporate the terms of any Extension or any
Incremental Facility, (B) after the Restatement Effective Date, the conditions set forth in Section 5.2 may be waived solely with the consent of the Majority Facility Lenders in respect of the Revolving Facility and (C) this Agreement
may be amended solely with the consent of the Borrower and the Majority Facility Lenders with respect to the applicable Facility with respect to any amendments or modifications that affect only such Facility (it being understood that increases in
the Applicable Margin, amendments or modifications to the amortization of the Term Loans as in effect on the Restatement Effective Date, any amendment to the Maturity Date such that the Term Loans mature prior to the Maturity Date as in effect on
the Restatement Effective Date and any waiver of conditions to the provision of any Incremental Facility shall be deemed to affect each Facility). Any such waiver and any such amendment, supplement or modification shall apply equally to each of the
Lenders and shall be binding upon the Loan Parties, the 

  
 97 

 
Lenders, the Administrative Agent and all future holders of the Loans. In the case of any waiver, the Loan Parties, the Lenders and the Administrative Agent shall be restored to their former
position and rights hereunder and under the other Loan Documents, and any Default or Event of Default waived shall be deemed to be cured and not continuing; but no such waiver shall extend to any subsequent or other Default or Event of Default, or
impair any right consequent thereon. To the extent that this Section 10.1 requires the consent of all Lenders to any amendment, waiver or modification, a Defaulting Lender’s vote shall not be included; provided, that (i) such
Defaulting Lender’s Commitment may not be increased or extended without its consent and (ii) the principal amount of, or interest or fees payable on, Loans or L/C Disbursements may not be reduced or excused or the scheduled date of payment
may not be postponed as to such Defaulting Lender without such Defaulting Lender’s consent. Furthermore, notwithstanding the foregoing, the Administrative Agent, with the consent of the Borrower, may amend, modify or supplement any Loan
Document without the consent of any Lender or the Required Lenders in order to correct, amend or cure any ambiguity, inconsistency or defect or correct any typographical error or other manifest error in any Loan Document; provided, that such
amendment, modification or supplement to correct, amend or cure an ambiguity, inconsistency or defect may not be materially adverse to the Lenders. 

Notwithstanding the foregoing, this Agreement may be amended (or amended and restated) with the written consent of the Required Lenders, the
Administrative Agent and the Borrower (a) to add one or more additional credit facilities to this Agreement and to permit the extensions of credit from time to time outstanding thereunder and the accrued interest and fees in respect thereof to
share in the benefits of this Agreement and the other Loan Documents with the Term Loans and Revolving Extensions of Credit and the accrued interest and fees in respect thereof and (b) to include appropriately the Lenders holding such credit
facilities in any determination of the Required Lenders and Majority Facility Lenders. 
 In addition, notwithstanding the foregoing, this
Agreement may be amended with the written consent of the Administrative Agent, the Borrower and the Lenders providing the relevant Replacement Term Loans (as defined below) to permit the refinancing, replacement or modification of all outstanding
Term Loans (“Replaced Term Loans”) with a replacement term loan tranche hereunder (“Replacement Term Loans”), provided that (a) the aggregate principal amount of such Replacement Term Loans shall not
exceed the aggregate principal amount of such Replaced Term Loans, (b) the applicable margin for such Replacement Term Loans shall not be higher than the Applicable Margin for such Replaced Term Loans and (c) the Weighted Average Life to
Maturity of such Replacement Term Loans shall not be shorter than the Weighted Average Life to Maturity of such Replaced Term Loans at the time of such refinancing. 

10.2. Notices. All notices, requests and demands to or upon the respective parties hereto to be effective shall be in writing (including
by telecopy), and, unless otherwise expressly provided herein, shall be deemed to have been duly given or made when delivered, or three Business Days after being deposited in the mail, postage prepaid, or, in the case of telecopy notice, when
received, addressed as follows in the case of the Borrower and the Administrative Agent, and as set forth in an administrative questionnaire delivered to the Administrative Agent in the case of the Lenders, or to such other address as may be
hereafter notified by the respective parties hereto: 
  

					
		 	Borrower:	  	 Bioventus LLC
 4721 Emperor Boulevard, Suite
100
 Durham, NC 27703

		 		  	Attention: Chief Financial Officer
		 		  	Telecopy: (919) 474-6802
		 		  	Telephone: (919) 474-6771
			
		 	Administrative Agent:	  	 JPMorgan Chase Bank, N.A.
 10 South Dearborn,
Floor 07
 Chicago, IL 60603-2300

		 		  	Attention: Darren Cunningham
		 		  	Telecopy: (888) 303-9732
		 		  	 Telephone: (312) 385-7080
 Email:
jpm.agency.servicing.1@jpmchase.com

  
 98 

 provided that any notice, request or demand to or upon the Administrative Agent or the Lenders shall not
be effective until received. 
 Notices and other communications to the Lenders hereunder may be delivered or furnished by electronic
communications pursuant to procedures approved by the Administrative Agent; provided that the foregoing shall not apply to notices pursuant to Section 2 unless otherwise agreed by the Administrative Agent and the applicable Lender. The
Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it; provided that approval of such procedures may be
limited to particular notices or communications. 
 10.3. No Waiver; Cumulative Remedies. No failure to exercise and no delay in
exercising, on the part of the Administrative Agent or any Lender, any right, remedy, power or privilege hereunder or under the other Loan Documents shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy,
power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights,
remedies, powers and privileges provided by law. 
 10.4. Survival of Representations and Warranties. All representations and
warranties made hereunder, in the other Loan Documents and in any document, certificate or statement delivered pursuant hereto or in connection herewith shall survive the execution and delivery of this Agreement and the making of the Loans and other
extensions of credit hereunder. 
 10.5. Payment of Expenses and Taxes. The Borrower agrees (a) to pay or reimburse the
Administrative Agent and the Arrangers for all of their respective reasonable out-of-pocket costs and expenses incurred in connection with the syndication of the Facilities and development, preparation and execution of, and any amendment, supplement
or modification to, this Agreement and the other Loan Documents and any other documents prepared in connection herewith or therewith, and the consummation and administration of the transactions contemplated hereby and thereby, including the
reasonable fees and disbursements of counsel to the Administrative Agent and the Arrangers and filing and recording fees and expenses, with statements with respect to the foregoing to be submitted to the Borrower (i) prior to the Closing Date
(in the case of amounts to be paid on the Closing Date), prior to the Restatement Effective Date (in the case of amounts to be paid on the Restatement Effective Date) and (iii) from time to time thereafter on a quarterly basis or such other
periodic basis as the Administrative Agent shall deem appropriate, (b) to pay or reimburse each Lender, the Issuing Lender, the Swingline Lenders and the Administrative Agent for all its costs and expenses incurred in connection with the
enforcement or preservation of any rights under this Agreement, the other Loan Documents and any such other documents, including the fees and disbursements of counsel (including the allocated fees and expenses of in-house counsel), (c) without
duplication of Section 2.19(b), to pay, indemnify, and hold each Lender, the Issuing Lender, the Swingline Lenders and the Administrative Agent harmless from, any and all recording and filing fees and any and all liabilities with respect to, or
resulting from any delay in 

  
 99 

 
paying, stamp, excise and other similar Taxes, if any, that may be payable or determined to be payable in connection with the execution and delivery of, or consummation or administration of any
of the transactions contemplated by, or any amendment, supplement or modification of, or any waiver or consent under or in respect of, this Agreement, the other Loan Documents and any such other documents, and (d) to pay, indemnify, and hold
each Lender, the Issuing Lender, the Swingline Lenders and the Administrative Agent, their respective affiliates, and their respective officers, directors, employees, agents, advisors, representatives and controlling persons (each, an
“Indemnitee”) harmless from and against any and all other liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever with respect to the
execution, delivery, enforcement, performance and administration of this Agreement, the other Loan Documents and any such other documents, including any claim, litigation, investigation or proceeding regardless of whether any Indemnitee is a party
thereto and whether or not the same are brought by the Borrower, its equity holders, affiliates or creditors or any other Person, including any of the foregoing relating to the use of proceeds of the Loans or the violation of, noncompliance with or
liability under, any Environmental Law applicable to the operations of any Group Member or any of the Properties and the reasonable fees and expenses of legal counsel in connection with claims, actions or proceedings by any Indemnitee against any
Loan Party under any Loan Document and any losses, costs and expenses relating to the conversion of any amount due hereunder in an Available Foreign Currency into Dollars (all the foregoing, collectively, the “Indemnified
Liabilities”); provided, that the Borrower shall have no obligation hereunder to any Indemnitee with respect to Indemnified Liabilities to the extent such Indemnified Liabilities (x) are found by a final and nonappealable
decision of a court of competent jurisdiction to have resulted from the gross negligence or willful misconduct of such Indemnitee or its Affiliates or (y) arise from claims of any Indemnitee solely against one or more Indemnitees that have not
resulted from the action, inaction, participation or contribution of the Borrower or any of its Affiliates, representatives or advisors, and provided, further, that this Section 10.5(d) shall not apply with respect to Taxes other
than any Taxes that represent losses or damages arising from any non-Tax claim; and provided, further, that the Borrower shall not be required to pay or reimburse the fees or disbursements of more than one counsel to the Indemnitees taken as
a whole (and in the case of a conflict of interests among or between Indemnitees, one additional counsel to each affected Indemnitee and, if necessary, one local counsel to the Indemnitees taken as a whole in each appropriate jurisdiction). Without
limiting the foregoing, and to the extent permitted by applicable law, the Borrower agrees not to assert and to cause its Subsidiaries not to assert, and hereby waives and agrees to cause its Subsidiaries to waive, all rights for contribution or any
other rights of recovery with respect to all claims, demands, penalties, fines, liabilities, settlements, damages, costs and expenses of whatever kind or nature, under or related to Environmental Laws, that any of them might have by statute or
otherwise against any Indemnitee. No Group Member or Indemnitee shall be liable for any damages arising from the use by others of information or other materials obtained through electronic, telecommunications or other information transmission
systems, except to the extent any such damages are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from the gross negligence or willful misconduct of such Indemnitee or its Affiliates. No Group
Member or Indemnitee shall be liable for any indirect, special, exemplary, punitive or consequential damages in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby. All amounts due under this
Section 10.5 shall be payable not later than 10 days after written demand therefor. Statements payable by the Borrower pursuant to this Section 10.5 shall be submitted to Jeanne Forneris (Telephone No. (919) 474-6756) (Telecopy No.
(919) 474-6802) (Email: jeanne.forneris@bioventusglobal.com), at the address of the Borrower set forth in Section 10.2, or to such other Person or address as may be hereafter designated by the Borrower in a written notice to the
Administrative Agent. The agreements in this Section 10.5 shall survive the termination of this Agreement and the repayment of the Loans and all other amounts payable hereunder. 

  
 100 

 10.6. Successors and Assigns; Participations and Assignments. (a) The provisions of
this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby (including any affiliate of the Issuing Lender that issues any Letter of Credit), except that
(i) the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender (and any attempted assignment or transfer by the Borrower without such consent shall be null and
void) and (ii) no Lender may assign or otherwise transfer its rights or obligations hereunder except in accordance with this Section. 

(b) (i) Subject to the conditions set forth in paragraph (b)(ii) below, any Lender may assign to one or more assignees (other than the Borrower
or any of its Affiliates) (each, an “Assignee”), other than a natural person, all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans at the time owing to it)
with the prior written consent of: 
  

	 	(A)	the Borrower (such consent not to be unreasonably withheld), provided that no consent of the Borrower shall be required for an assignment to a Lender, an affiliate of a Lender, an Approved Fund (as defined below)
or, if an Event of Default under Section 8.1(a) or (f) has occurred and is continuing, any other Person; and provided, further, that the Borrower shall be deemed to have consented to any such assignment unless the Borrower
shall object thereto by written notice to the Administrative Agent within 10 Business Days after having received notice thereof by overnight courier, facsimile or email; 

 

	 	(B)	the Administrative Agent, provided that no consent of the Administrative Agent shall be required for an assignment of all or any portion of a Term Loan to a Lender, an affiliate of a Lender or an Approved Fund;
and 

  

	 	(C)	the Issuing Lender and the Swingline Lenders, only if such assignment is of Revolving Commitment or Revolving Loan. 

  

	 	(ii)	Assignments shall be subject to the following additional conditions: 

  

	 	(A)	except in the case of an assignment to a Lender, an affiliate of a Lender or an Approved Fund or an assignment of the entire remaining amount of the assigning Lender’s Commitments or Loans under any Facility, the
amount of the Commitments or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than
$1,000,000 (in the case of Term Loans) and $5,000,000 (in the case of the Revolving Facility) unless each of the Borrower and the Administrative Agent otherwise consent, provided that (1) no such consent of the Borrower shall be required if an
Event of Default has occurred and is continuing and (2) such amounts shall be aggregated in respect of each Lender and its affiliates or Approved Funds, if any; 

  
 101 

	 	(B)	(1) the parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $3,500 and (2) the assigning Lender shall
have paid in full any amounts owing by it to the Administrative Agent; and 

  

	 	(C)	the Assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an administrative questionnaire in which the Assignee designates one or more credit contacts to whom all syndicate-level information
(which may contain material non-public information about the Borrower and its Affiliates and their related parties or their respective securities) will be made available and who may receive such information in accordance with the assignee’s
compliance procedures and applicable laws, including Federal and state securities laws. 

 For the purposes of this
Section 10.6, “Approved Fund” means any Person (other than a natural person) that is engaged in making, purchasing, holding or investing in bank loans and similar extensions of credit in the ordinary course of its business and
that is administered or managed by (a) a Lender, (b) an affiliate of a Lender or (c) an entity or an affiliate of an entity that administers or manages a Lender. 

(iii) Subject to acceptance and recording thereof pursuant to paragraph (b)(iv) below, from and after the effective date
specified in each Assignment and Assumption the Assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the
assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning
Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.18, 2.19, 2.20 and 10.5). Any assignment or transfer by a Lender of rights or
obligations under this Agreement that does not comply with this Section 10.6 shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (c) of
this Section. 
 (iv) The Administrative Agent, acting for this purpose as an agent of the Borrower, shall maintain at one of
its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amount (and stated interest) of the Loans and L/C Obligations
owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive (absent manifest error), and the Borrower, the Administrative Agent, the Issuing Lender and the
Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. 

(v) Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an Assignee, the
Assignee’s completed administrative questionnaire (unless the Assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b) of this Section and any written consent to such assignment
required by paragraph (b) of this Section, the Administrative Agent shall accept such Assignment and Assumption and record the information contained therein in the Register. No assignment shall be effective for purposes of this Agreement unless
it has been recorded in the Register as provided in this paragraph. 

  
 102 

 (c) Any Lender may, without the consent of the Borrower or the Administrative Agent, sell
participations to one or more banks or other entities (a “Participant”) in all or a portion of such Lender’s rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans owing to it);
provided that (i) such Lender’s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, and (iii) the
Borrower, the Administrative Agent, the Issuing Lender and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement. Any agreement pursuant to
which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; provided that such
agreement may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver that (i) requires the consent of each Lender directly affected thereby pursuant to the proviso to the second
sentence of Section 10.1 and (ii) directly affects such Participant. Each Lender that sells a participation agrees, at the Borrower’s request and expense, to use reasonable efforts to cooperate with the Borrower to effectuate the
provisions of Section 2.22 with respect to any Participant. The Borrower agrees that each Participant shall be entitled to the benefits of Sections 2.18, 2.19 and 2.20 (subject to the requirements and limitations therein, including the
requirements under Section 2.19(f) (it being understood that the documentation required under Section 2.19(f) shall be delivered to the participating Lender)) to the same extent as if it were a Lender and had acquired its interest by
assignment pursuant to paragraph (b) of this Section; provided that such Participant (i) agrees to be subject to the provisions of Sections 2.18, 2.19, 2.21 and 2.22 as if it were an assignee under paragraph (b) of this Section
and (ii) shall not be entitled to receive any greater payment under Sections 2.18 or 2.19, with respect to any participation, than its participating Lender would have been entitled to receive, except to the extent such entitlement to receive a
greater payment results from an adoption of or any change in any Requirement of Law described in clause (ii) of the definition thereof or in the interpretation or application thereof or compliance by any Lender with any request or directive
(whether or not having the force of law) from any central bank or other Governmental Authority made subsequent to the date hereof that occurs after the Participant acquired the applicable participation. To the extent permitted by law, each
Participant also shall be entitled to the benefits of Section 10.7(b) as though it were a Lender, provided such Participant shall be subject to Section 10.7(a) as though it were a Lender. Each Lender that sells a participation
shall, acting solely for this purpose as an agent of the Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or
other obligations under the Loan Documents (the “Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register to any Person (including the identity of
any Participant or any information relating to a Participant’s interest in any Commitments, Loans, Letters of Credit or its other obligations under any Loan Document) except to the extent that such disclosure is necessary to establish that such
Commitment, Loan, Letter of Credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender
shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its
capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register. 

  
 103 

 (d) Any Lender may at any time pledge or assign a security interest in all or any portion of its
rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank, and this Section shall not apply to any such pledge or assignment of a security interest;
provided that no such pledge or assignment of a security interest, or any enforcement or foreclosure thereof, shall release a Lender from any of its obligations hereunder or substitute any such pledgee or Assignee for such Lender as a party
hereto. The Borrower, upon receipt of written notice from the relevant Lender, agrees to issue Notes to any Lender requiring Notes to facilitate transactions of the type described in this paragraph (d); provided, that a transfer of any Note
may be effected only by the surrender of the original Note and either re-issuance by the Borrower of the original Note to a new holder or the issuance by the Borrower of a new Note to a new holder. 

10.7. Adjustments; Set-off. (a) Except to the extent that this Agreement or a court order expressly provides for payments to be
allocated to a particular Lender or to the Lenders under a particular Facility, if any Lender (a “Benefitted Lender”) shall receive any payment of all or part of the Obligations owing to it (other than in connection with an
assignment made pursuant to Section 10.6), or receive any Collateral in respect thereof (whether voluntarily or involuntarily, by set-off, pursuant to events or proceedings of the nature referred to in Section 8.1(f), or otherwise), in a
greater proportion than any such payment to or Collateral received by any other Lender, if any, in respect of the Obligations owing to such other Lender, such Benefitted Lender shall purchase for cash from the other Lenders a participating interest
in such portion of the Obligations owing to each such other Lender, or shall provide such other Lenders with the benefits of any such Collateral, as shall be necessary to cause such Benefitted Lender to share the excess payment or benefits of such
Collateral ratably with each of the Lenders; provided, however, that if all or any portion of such excess payment or benefits is thereafter recovered from such Benefitted Lender, such purchase shall be rescinded, and the purchase price
and benefits returned, to the extent of such recovery, but without interest; provided, further, that to the extent prohibited by applicable law as described in the definition of “Excluded Swap Obligation,” no amounts received
from, or set off with respect to, any Guarantor shall be applied to any Excluded Swap Obligations of such Guarantor. 
 (b) In addition to
any rights and remedies of the Lenders provided by law, each Lender shall have the right, without notice to the Borrower, any such notice being expressly waived by the Borrower to the extent permitted by applicable law, upon any Obligations becoming
due and payable by the Borrower (whether at the stated maturity, by acceleration or otherwise), to apply to the payment of such Obligations, by setoff or otherwise, any and all deposits (general or special, time or demand, provisional or final), in
any currency, and any other credits, indebtedness or claims, in any currency, in each case whether direct or indirect, absolute or contingent, matured or unmatured, at any time held or owing by such Lender, any affiliate thereof or any of their
respective branches or agencies to or for the credit or the account of the Borrower; provided that if any Defaulting Lender shall exercise any such right of setoff, (i) all amounts so set-off shall be paid over immediately to the
Administrative Agent for further application in accordance with the provisions of this Agreement and, pending such payment, shall be segregated by such Defaulting Lender from its other funds and deemed held in trust for the benefit of the
Administrative Agent, the Issuing Lender, the Swingline Lenders and the Lenders and (ii) the Defaulting Lender shall provide promptly to the Administrative Agent a statement describing in reasonable detail the obligations owing to such
Defaulting Lender as to which it exercised such right of set-off. Each Lender agrees promptly to notify the Borrower and the Administrative Agent after any such application made by such Lender; provided, that the failure to give such notice
shall not affect the validity of such application. 
 10.8. Counterparts. This Agreement may be executed by one or more of the parties
to this Agreement on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Agreement by email or facsimile
transmission shall be effective as delivery of a manually executed counterpart hereof. A set of the copies of this Agreement signed by all the parties shall be lodged with the Borrower and the Administrative Agent. 

  
 104 

 10.9. Severability. Any provision of this Agreement that is prohibited or unenforceable in
any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not
invalidate or render unenforceable such provision in any other jurisdiction. 
 10.10. Integration. This Agreement, the other Loan
Documents and the Fee Letter represent the entire agreement of the Borrower, the Administrative Agent and the Lenders with respect to the subject matter hereof and thereof, and there are no promises, undertakings, representations or warranties by
the Administrative Agent or any Lender relative to the subject matter hereof not expressly set forth or referred to herein or in the other Loan Documents. 

10.11. GOVERNING LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND
CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 
 10.12. Submission To Jurisdiction; Waivers. Each
party hereto hereby irrevocably and unconditionally: 
 (a) submits for itself and its property in any legal action or
proceeding relating to this Agreement and the other Loan Documents to which it is a party, or for recognition and enforcement of any judgment in respect thereof, to the exclusive jurisdiction of the courts of the County of New York, State of New
York, the courts of the United States for the Southern District of New York, and appellate courts from any thereof; provided, that nothing contained herein or in any other Loan Document will prevent any Lender or the Administrative Agent from
bringing any action to enforce any award or judgment or exercise any right under the Security Documents or against any Collateral or any other property of any Loan Party in any other forum in which jurisdiction can be established; 

(b) consents that any such action or proceeding may be brought in such courts and waives any objection that it may now or
hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same; 

(c) agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or
certified mail (or any substantially similar form of mail), postage prepaid, to such party at its address set forth in Section 10.2 or at such other address of which the Administrative Agent shall have been notified pursuant thereto; 

(d) agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law; and

 (e) waives, to the maximum extent not prohibited by law, any right it may have to claim or recover in any legal action or
proceeding referred to in this Section any indirect, special, exemplary, punitive or consequential damages. 
 10.13.
Acknowledgements. The Borrower hereby acknowledges and agrees that (a) no fiduciary, advisory or agency relationship between the Loan Parties and the Credit Parties is intended to be or has been created in respect of any of the
transactions contemplated by this Agreement or the other Loan Documents, irrespective of whether the Credit Parties have advised or are advising the Loan Parties 

  
 105 

 
on other matters, and the relationship between the Credit Parties, on the one hand, and the Loan Parties, on the other hand, in connection herewith and therewith is solely that of creditor and
debtor, (b) the Credit Parties, on the one hand, and the Loan Parties, on the other hand, have an arm’s length business relationship that does not directly or indirectly give rise to, nor do the Loan Parties rely on, any fiduciary duty to
the Loan Parties or their affiliates on the part of the Credit Parties, (c) the Loan Parties are capable of evaluating and understanding, and the Loan Parties understand and accept, the terms, risks and conditions of the transactions
contemplated by this Agreement and the other Loan Documents, (d) the Loan Parties have been advised that the Credit Parties are engaged in a broad range of transactions that may involve interests that differ from the Loan Parties’
interests and that the Credit Parties have no obligation to disclose such interests and transactions to the Loan Parties, (e) the Loan Parties have consulted their own legal, accounting, regulatory and tax advisors to the extent the Loan
Parties have deemed appropriate in the negotiation, execution and delivery of this Agreement and the other Loan Documents, (f) each Credit Party has been, is, and will be acting solely as a principal and, except as otherwise expressly agreed in
writing by it and the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for the Loan Parties, any of their affiliates or any other Person, (g) none of the Credit Parties has any obligation to the
Loan Parties or their affiliates with respect to the transactions contemplated by this Agreement or the other Loan Documents except those obligations expressly set forth herein or therein or in any other express writing executed and delivered by
such Credit Party and the Loan Parties or any such affiliate and (h) no joint venture is created hereby or by the other Loan Documents or otherwise exists by virtue of the transactions contemplated hereby among the Credit Parties or among the
Loan Parties and the Credit Parties. 
 10.14. Releases of Guarantees and Liens. (a) Notwithstanding anything to the contrary
contained herein or in any other Loan Document, the Administrative Agent is hereby irrevocably authorized by each Lender (without requirement of notice to or consent of any Lender except as expressly required by Section 10.1) and hereby agrees
to take any action requested by the Borrower having the effect of releasing any Collateral or Guarantee Obligations or subordinating any Lien securing the same (i) to the extent necessary or reasonably requested to permit consummation of any
transaction not prohibited by any Loan Document or that has been consented to in accordance with Section 10.1 or (ii) under the circumstances described in paragraph (b) below. 

(b) At such time as the Loans, the Reimbursement Obligations and the other obligations under the Loan Documents (other than obligations under
or in respect of Specified Swap Agreements or Specified Cash Management Agreements and contingent indemnification obligations to the extent no claim giving rise thereto has been asserted) shall have been paid in full, the Commitments have been
terminated and no Letters of Credit shall be outstanding (unless cash collateralized or otherwise credit supported to the reasonable satisfaction of the Administrative Agent and the Issuing Lender), the Collateral shall be released from the Liens
created by the Security Documents, and the Security Documents and all obligations (other than those expressly stated to survive such termination) of the Administrative Agent and each Loan Party under the Security Documents shall terminate, all
without delivery of any instrument or performance of any act by any Person. 
 10.15. Confidentiality. Each of the Administrative
Agent and each Lender agrees to keep confidential all non-public information provided to it by any Loan Party, the Administrative Agent or any Lender pursuant to or in connection with this Agreement and the other Loan Documents; provided that
nothing herein shall prevent the Administrative Agent or any Lender from disclosing any such information (a) to the Administrative Agent, any other Lender or any affiliate thereof, (b) subject to an agreement to comply with the provisions
of this Section, to any actual or prospective Transferee or any direct or indirect counterparty to any Swap Agreement (or any professional advisor to such counterparty), (c) to its employees, directors, agents, attorneys, accountants and other
professional advisors or those of any of its affiliates; provided, that such Persons have been advised of the confidentiality provisions hereof 

  
 106 

 
and are subject thereto, (d) upon the request or demand of any Governmental Authority, (e) in response to any order of any court or other Governmental Authority or as may otherwise be
required pursuant to any Requirement of Law described in clause (ii) of the definition thereof, (f) if advised or required to do so in connection with any litigation or similar proceeding, (g) that has been publicly disclosed,
(h) to the National Association of Insurance Commissioners or any similar organization or any nationally recognized rating agency that requires access to information about a Lender’s investment portfolio in connection with ratings issued
with respect to such Lender, (i) in connection with the exercise of any remedy hereunder or under any other Loan Document, (j) if agreed by the Borrower in its sole discretion, to any other Person, (k) to any regulatory or
self-regulatory agency having supervisory authority over any Lender in connection with an examination of such Lender by such agency, (l) in connection with any public filings; provided such information is limited to the Borrower’s
name and address and information related to the Loans or (m) to any lender of a Lender; provided such lender is subject to commercially reasonable confidentiality provisions. 

Each Lender acknowledges that information furnished to it pursuant to this Agreement or the other Loan Documents may include material
non-public information concerning the Borrower and its Affiliates and their related parties or their respective securities, and confirms that it has developed compliance procedures regarding the use of material non-public information and that it
will handle such material non-public information in accordance with those procedures and applicable law, including Federal and state securities laws. 

All information, including requests for waivers and amendments, furnished by the Borrower or the Administrative Agent pursuant to, or in the
course of administering, this Agreement or the other Loan Documents will be syndicate-level information, which may contain material non-public information about the Borrower and its Affiliates and their related parties or their respective
securities. Accordingly, each Lender represents to the Borrower and the Administrative Agent that it has identified in its administrative questionnaire a credit contact who may receive information that may contain material non-public information in
accordance with its compliance procedures and applicable law, including Federal and state securities laws. 
 10.16. WAIVERS OF JURY
TRIAL. THE BORROWER, THE ADMINISTRATIVE AGENT AND THE LENDERS HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVE TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN.

 10.17. USA Patriot Act. Each Lender hereby notifies the Borrower that pursuant to the requirements of the USA Patriot Act
(Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “Patriot Act”), it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the
Borrower and other information that will allow such Lender to identify the Borrower in accordance with the Patriot Act. 
 10.18.
Intercreditor Agreement. Each Lender hereby authorizes and directs the Administrative Agent to enter into any intercreditor agreement reasonably satisfactory to the Administrative Agent on its behalf and substantially similar in scope and
effect to the Intercreditor Agreement, perform such intercreditor agreement on its behalf and take any actions thereunder as determined by the Administrative Agent to be necessary or advisable to protect the interests of the Lenders and the Issuing
Lender, and each Lender agrees to be bound by the terms of such intercreditor agreement. 

  
 107 

 10.19. Judgment Currency. 

(a) The Loan Parties’ obligations hereunder and under the other Loan Documents to make payments in Dollars shall not be discharged or
satisfied by any tender or recovery pursuant to any judgment expressed in or converted into any currency other than Dollars, except to the extent that such tender or recovery results in the effective receipt by the Administrative Agent, the
respective Lender or the Issuing Lender of the full amount of Dollars expressed to be payable to the Administrative Agent or such Lender or the Issuing Lender under this Agreement or the other Loan Documents. If, for the purpose of obtaining or
enforcing judgment against any Loan Party in any court or in any jurisdiction, it becomes necessary to convert into or from any currency other than Dollars (such other currency being hereinafter referred to as the “Judgment
Currency”) an amount due in Dollars, the conversion shall be made at the Dollar Equivalent determined as of the Calculation Date immediately preceding the day on which the judgment is given. 

(b) If there is a change in the rate of exchange prevailing between the Calculation Date described in clause (a) above and the date of
actual payment of the amount due, the Loan Parties shall pay, or cause to be paid, such additional amounts, if any (but in any event not a lesser amount) as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at
the rate of exchange prevailing on the date of payment, will produce the amount of Dollars which could have been purchased with the amount of Judgment Currency stipulated in the judgment or judicial award at the rate of exchange prevailing on the
Calculation Date. 
 (c) For purposes of determining the Dollar Equivalent or any other rate of exchange for this Section 10.19, such
amounts shall include any premium and costs payable in connection with the purchase of Dollars. 
 10.20. Acknowledgement and Consent to
Bail-In of EEA Financial Institutions. Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA
Financial Institution arising under any Loan Document may be subject to the write-down and conversion powers of an EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by: 

(a) the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may
be payable to it by any party hereto that is an EEA Financial Institution; and 
 (b) the effects of any Bail-In Action on any such
liability, including, if applicable: 
 (i) a reduction in full or in part or cancellation of any such liability; 

(ii) a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial
Institution, its parent entity, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability
under this Agreement or any other Loan Document; or 
 (iii) the variation of the terms of such liability in connection with
the exercise of the write-down and conversion powers of any EEA Resolution Authority. 
 [Signatures Pages Intentionally
Omitted] 

  
 108

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}]]